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Abstract  
Factor H (FH) is a plasma glycoprotein that plays a central role in regulating 
the alternative pathway of complement. It is composed of 20 short complement 
regulator (SCR) domains. The SCR-1/5 fragment is required for decay acceleration 
and cofactor activity, while the SCR-16/20 fragment possesses binding sites for 
complement C3d and host cell-surface polyanionic ligands. C3d is a 35-kDa 
fragment of C3b, the activated form of the central complement protein C3. C-
reactive protein (CRP) is an acute-phase reactant that activates complement through 
the classical pathway but inhibits the alternative pathway. In this thesis, X-ray 
scattering, analytical ultracentrifugation (AUC) and constrained modelling were used 
to determine solution structures for the SCR-1/5 and SCR-16/20 fragments, as well 
as for intact FH.  Surface plasmon resonance (SPR) was used in conjunction with 
these methods to investigate the interactions of FH with C3d and CRP in the fluid 
and solid phases. Structural studies revealed that at physiological concentrations, 
SCR-1/5 is monomeric and SCR-16/20 exists in a weak monomer-dimer equilibrium. 
In the best-fit models, both FH fragments adopt a partially folded-back orientation in 
solution, and the SCR-16/20 dimer is formed by association of two SCR-20 domains. 
FH exists in a partially folded-back orientation in solution and forms oligomers. 
Here, these FH oligomers were shown to exist under different buffer conditions of 
NaCl concentration and pH, and these two factors also influence the conformation of 
FH. New, significantly improved molecular structures showed that FH orientation is 
maintained by short-to-middle distance interdomain interactions. There was no 
evidence of long distance interactions between the N- and C-terminals of FH. Studies 
on the interaction of FH with C3d identified a number of multimeric complexes 
formed between C3d and both SCR-16/20 and native FH. Binding to C3d did not 
significantly increase the overall length of FH, and this interaction is NaCl 
concentration-dependent. CRP, another ligand of FH, is known to exist 
physiologically as a pentamer. Here, CRP is shown to exist in a pentamer-decamer 
equilibrium under physiological buffer conditions. This equilibrium is NaCl 
concentration dependent and occurs in both fluid and solid phases. SPR binding 
studies showed that interaction with CRP inhibits FH oligomerisation, and further 
identified a novel CRP-binding site within SCR-16/20 of FH. Thus ionic strength-
dependence may be a general feature of FH interaction with its ligands. These results 
provide insight into the complement regulatory activity of FH.   ii
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Chapter One 
 
The Complement cascade   2
(1.1)  Introduction to complement 
The term “complement” refers to a group of proteins that react with each other 
in a cascade and work with antibody to eliminate infectious agents from the host. The 
complement system is not antigen-specific, although some complement proteins are 
activated by interaction with antibodies. Complement can thus be said to be both a 
part of the innate and adaptive immune systems (Janeway et al., 2005).  
 “Complement” as a nomenclature was first used by Erhlich and Morgenroth 
to describe a heat-labile component of the immune system that was thought to 
complement the action of the cells of the immune system. However, the earliest 
record of complement activity was in the late nineteenth century when fresh, cell-free 
blood serum was found to lyse bacteria (Nuttal, 1888; Buchner, 1889). Buchner 
named the observed bactericide activity “alexin”. In an attempt to explain this 
observation, Jules Bordet demonstrated that this property of serum could be classified 
into heat-stable and heat-labile components. He showed that red blood cell lysis was 
dependent on the action of the heat-labile component, and that the heat-stable 
component was ineffective on its own. The heat-stable component was found to 
confer immunity against specific microbes (this component corresponds to 
antibodies), while the heat-labile component was responsible for non-specific 
antimicrobial activity (this component is now known as complement). Bordet 
proposed that Buchner’s bactericidal component of normal serum, alexin, was 
identical to complement as described by Erhlich and Morgenroth (Bordet, 1909). 
Bordet is therefore recognised as having discovered the complement system as his 
complement fixation test not only clearly differentiated between complement and 
antibodies, but also showed that complement was not merely an auxiliary factor of 
host immunity. 
The resolution of the components of complement began in the late nineteenth 
century with the observation of particulate “globulin” and soluble “albumin” fractions 
of serum, and that neither of these alone could destroy bacteria (Buchner, 1889). 
Ferrata (Ferrata, 1907) later reproduced these results with his immune haemolysis 
experiment, and further showed that the recombined fractions regained lytic activity, 
and that the “globulin” fraction reacted first with antibody, then the “albumin” 
fraction reacted second to cause cell lysis. In the early twentieth century, a third 
component of complement was discovered in two separate studies with cobra venom 
(Flexner & Noguchi, 1903) and yeast (Coca, 1914), both of which showed the   3
inactivation of complement by removal of an activity factor. This activity factor was 
later named the third component (Whitehead et al., 1925), and a fourth component 
was discovered during the same period (Gordon et al., 1914). Thus within the first 
half of the twentieth century, it was known that complement consisted of at least four 
components which were all required to lyse erythrocytes coated with antibody or kill 
bacteria sensitised with antibody (Pillemer  et al., 1941). Through the use of “R” 
reagents developed during this period for measurement of complement components, it 
was shown that the order of reactivity of the four components was C1, C4, C2 and C3 
(Bier et al., 1945). The development of a large number of new and powerful protein 
separation techniques during the late-1950s and early-1960s made it possible to 
purify and characterise most of the complement proteins. At this time Nelson (Nelson 
et al., 1966) and Müller-Eberhard (Müller-Eberhard, 1968) characterized the 
immunologically-activated pathway called the classical pathway. By the late-1960s 
therefore, complement was known to comprise 11 proteins which reacted in the order 
of: C1q, C1r, C1s, C4, C2, C3, C5, C6, C7, C8 and C9. 
Earlier, in 1954, Pillemer (Pillemer et al., 1954) had described a previously 
unidentified serum protein named “properdin” which bound to bacteria and yeast, and 
activated only the latter complement components without appearing to utilize the 
earlier components. This finding was not generally accepted until the late-1960s and 
early-1970s, at which time this hypothesis was confirmed by several other 
independent experiments, (Ellman et al., 1970; Sandberg & Osler, 1971; Götze & 
Müller-Eberhard, 1971) and the pathway was finally recognised as an “alternative” 
pathway of complement activation. More recently, the lectin pathway was discovered 
with the purification of mannan-binding lectin (MBL) from rabbit liver in the late-70s 
(Kawasaki et al., 1978). Its human homologue was later discovered (Kawasaki et al., 
1983), and the lectin pathway is now established as a third pathway of complement 
activation (Ikeda et al., 1987; Ji et al., 1988). 
 
(1.2) Complement activation 
Complement activation can take place at the occurrence of any of the following 
events: (a) Interaction of C1 complement protein with immune complex, aggregated 
monomeric antibody IgG or pentameric IgM, or C-reactive protein (CRP), (b) 
spontaneous hydrolysis or molecular perturbation of the C3 complement protein, or 
(c) Interaction of C4 and C2 with mannan-binding lectin (MBL), a specialised protein    4
 
 
Figure 1.1  
The central role of C3 in complement activation. The α and β chains of C3 are 
shown in different colours. Activation of C3 may take place through three pathways 
leading to the generation of C3b. The endpoint of C3b deposition on the pathogen cell 
is the formation of the cytolytic membrane attack complex (MAC).   5
that binds the microbial polysaccharide mannose. These three events represent the 
classical, alternative and lectin activation pathways of complement respectively 
(Morley & Walport, 2000). When complement is activated, a cascade of reactions 
involving other complement proteins, proteases, regulatory proteins and membrane-
bound control proteins and receptors takes place, the goal of which is to eliminate 
foreign particles from the host. Several complement proteins are zymogens. When 
activated, they become proteases which, in turn, activate other proteins in the 
complement system by cleaving them to expose reactive groups or active sites. The 
endpoint of complement activation is the formation of the membrane attack complex 
(MAC). The complement component C3 is the convergence point for all three 
pathways of complement activation (Figure 1.1)  
 
(1.2.1) C3 in complement activation 
  C3 is a 187-kDa protein that belongs to the α2-macroglobulin (α2M) family. 
The large proteins (with approximately 1400-1800 amino acid residues) belonging to 
this family are characterised by homologous sequence features, including a unique 
thioester site and a central highly variable part (Janssen et al., 2005). Other members 
of the α2M family include the complement components C4 and C5, the proteinase 
inhibitor α2M and the insect and nematode thioester-containing proteins (TEPs). C3 
has at least 10 distinct binding sites with which it interacts separately with other 
complement proteins, receptors and regulators, as well as with non-complement 
foreign particles such as viral and bacterial proteins (Müller-Eberhard, 1988). C3 is 
the precursor of a number of biologically active fragments that are released by 
sequential proteolytic cleavage. Initial proteolytic activation of C3 yields C3a, a small 
anaphylatoxic fragment, and C3b, a 177-kDa protein and the major active fragment of 
C3 (Figure 1.1). Deposition of C3b on a target triggers the amplification step of the 
complement cascade (Section 1.2.3). To prevent complement activation at host 
surfaces, C3b is degraded by sequential cleavage to iC3b (with the release of C3f), 
C3c, C3dg and C3d. 
  C3 consists of two chains β (residues 1-645) and α (residues 650-1641), which 
together form a total of 13 domains (Figure 1.2). In the crystal structure of C3 
(Janssen et al., 2005), each of the two chains forms six domains, while they are 
intertwined to form the 13th domain (MG6). Of these 13 domains, there are eight MG   6
 
Figure 1.2  
The crystal structure of C3 showing the 13 domains in different colours. 
INSIGHT II 98.0 molecular graphics software (Accelrys, San Diego, CA, USA) was 
used to generate a ribbon diagram from PDB entry 2A73 (Janssen et al., 2005).    7
(macroglobulin) domains and one each of LNK (linker), ANA (anaphylatoxin), CUB, 
TED (thioester-containing domain) and C345C domains. Domains MG1 - MG5 span 
residues 1-534, while MG6 spans residues 535-577 (β chain) and 746-806 (α chain). 
The two chains within MG6 are interrupted by the LNK (residues 578-645) and ANA 
(residues 650-726) domains. Two other domains, CUB (residues 912-962; 1269-
1330) and TED (residues 963-1268), separate MG7 and MG8 from MG6. MG7 and 
MG8 occupy residues 807-911 and 1331-1474 respectively. Within the CUB domain 
is the polypeptide chain that is cleaved by factor I, first at the sites Arg1281-Ser1282 
and Arg1298-Ser1299 to release the C3f fragment, then at or around the site Arg932-
Glu933 to yield the fragments C3dg and C3c (Rother et al., 1998). The last domain, 
C345C, is located between residues 1496-1641. The cleavage site (Arg726-Ser727) 
for C3 convertases is located in a disordered surface loop (residues 720-729), part of 
which comprises the N-terminal region of C3b after cleavage. The ANA domain 
forms the small C3a fragment of C3 when excised, and the TED domain corresponds 
to the C3d fragment of C3. During C3 activation, cleavage of the ANA domain (C3a) 
triggers a large conformational change involving the TED domain, which reveals the 
previously hidden reactive thioester group (Figure 1.3).   
 
(1.2.2) The classical pathway 
In the classical pathway, the multiple-subunit protein C1 has long been 
recognised for its ability to bind pathogens either directly or after their recognition by 
antibodies or C-reactive protein (CRP) (Jiang et al., 1991; Gaboriaud et al., 2004). C1 
has three subunits q, r and s which are products of different genes. Within the C1 
complex, the active sites of these subunits are positioned in close proximity, and 
activation of one of the subunits leads to activation of the others in turn. The C1q 
subunit is the recognition subunit and makes the first contact with the primary 
activating body, thus recognising abnormal structures from self.  
C1q normally circulates in blood as a Ca
2+-dependent complex with two 
molecules each of the serine protease zymogens C1r and C1s. It is composed of three 
subunits arranged in a collagen-like triple helix with an N-terminal “stalk” and six 
globular “flower heads”. An activator-binding site is located in each of the six heads. 
A change in its conformation is stimulated when more than one of these six “flower 
heads” interacts with an activated surface. C1q interacts readily with antibodies of the 
   8
 
 
 
 
Figure 1.3  
C3 cleavage and activation. The colour scheme follows that of Figure 1.2. The 
reactive thioester group is located in the TED domain and hidden in inactive C3. 
Upon cleavage, conformational changes and domain rearrangement occur within C3 
to expose the reactive thioester group, thus forming C3b. Nascent C3b can either be 
stabilised by reacting with active groups on the target surface or inactivated by 
reacting with water molecules in the fluid phase. 
   9
 IgG or IgM class (though relatively weakly with single monomeric units of IgG) and 
CRP. It has also been reported to bind to apoptotic cells (Navratil et al., 2001; Botto 
& Walport, 2002), with growing evidence of interaction with β-amyloid fibrils 
(Rogers et al., 1992; Tacnet-Delorme et al., 2001)  and the pathological form of the 
prion protein (Mabbott  et al., 2001; Klein et al., 2001). In the case of immune 
complexes, its “flower heads” readily interact with the Cγ2 domains of adjacent IgG 
molecules or with the Cµ3 domain of pentameric IgM. Occupation of two or more of 
its activator sites induces a conformational change in C1q, which causes 
autoactivation of C1r from a single-chain zymogen to a two-chain, disulphide-linked 
active protease. C1r then cleaves a single peptide bond in the C1s zymogen to form 
the two-chain active protease C1s (Volanakis & Frank, 1998). The C1 activation 
scheme is summarized in Figure 1.4. 
On activation, C1s cleaves C4 to yield a small C4a and a larger C4b particle. 
The C4a particle is slightly inflammatory and chemoattractant, and is released into 
plasma. C4b has an exposed metastable thioester bond with which it binds to 
hydroxyl and amino groups on the activating surface. Following the deposition of 
C4b on the activating surface, C2 is covalently attached to it in the presence of 
magnesium ions. C2 is then cleaved by C1s to yield C2b and C2a. C4b and C2a 
combine to form C4b2a, which is the C3 convertase of the classical pathway. This 
convertase cleaves C3 to C3a and C3b. C3b, like C4b, possesses a metastable 
thioester which enables its deposition on the activating cell surface. Further binding 
of C3b by C4b2a forms the C5 convertase of the classical pathway, C4b2a3b, which 
cleaves C5 into C5a and C5b. C3a and C5a are released into plasma to perform 
inflammatory, anaphylactic and chemoattractive functions.  
C1q interacts with CRP within the collagenous region just below its globular 
heads (Jiang et al., 1991). In a proposed interaction model, electrostatic interactions 
allow the positively-charged C1q head to fit into the central negatively-charged 
central pore of pentameric CRP. This interaction involves all three subunits of C1q, in 
contrast to the model for C1q-IgG interaction, which involves only a single C1q 
subunit (Gaboriaud et al., 2004).  
 
(1.2.3) The alternative pathway 
Activation of complement by the alternative pathway is initiated by a variety 
of cellular surfaces, including those of various pathogenic bacteria, parasites, viruses,   10
 
Figure 1.4  
A tentative scheme for C1 activation as seen from the bottom view of the 
complex. In the inactive complex, the zymogen C1r2-C1s2 is in an 8-shaped, closed 
conformation. Conformational change of C1q triggers autoactivation of C1r, leading 
to an S-shaped open conformation and subsequent activation of C1s (Gaboriaud et al., 
2004).   11
virally-infected cells and fungi (Pangburn & Müller-Eberhard, 1984) without 
antibody involvement. C3 is directly activated by either spontaneous hydrolysis, 
which constantly takes place in plasma at very low levels (C3 tick-over), or so-called 
non-specific molecular perturbations. These perturbations either allow water into the 
globular C3 molecule to hydrolyse the otherwise hidden thioester bond between the 
amino acid residues Cys-1010 and Gln-1013 of the sequence Cys-Gly-Glu-Gln 
located in the α-chain, or cause this bond to be exposed to water in plasma (Rother et 
al., 1998). The contribution of this process to complement activation is minimal 
unless the activated product (C3*) is stabilized by proteins such as plasmin and other 
inflammation products.  This is because C3* is unstable and readily reacts with water 
molecules to inactivate the reactive thioester group (Law & Reid, 1995). 
Hydrolysis of C3 yields active C3.H2O (C3*), whose exposed reactive 
thioester group readily binds to foreign targets. C3* binds the serum protein factor B. 
Following this, C3*-bound factor B is cleaved by the protease factor D to yield a 
small Bb fragment. The resulting enzyme complex, C3*Bb, is the second C3 
convertase. C3*Bb cleaves the α-chain of inactive C3 between Arg-726 and Ser-727 
to yield C3a and C3b. This cleavage induces a conformational change that makes the 
thioester bond briefly accessible for nucleophilic attack, either by water molecules or 
hydroxyl and amino groups on the target surface. If the thioester bond is attacked by 
water, Gln-1013 is converted to Glu-1013 and C3b remains unbound and rapidly 
becomes inactive. If the thioester bond reacts with an active hydroxyl or amino group 
on a target surface, C3b is deposited on that surface and retains its active 
conformation (Figure 1.3).  It then combines with factor B, which is cleaved by factor 
D, to produce more molecules of C3bBb. Whereas initial spontaneous hydrolysis of 
C3 takes place only very slowly, activation of subsequent C3 molecules by C3bBb 
takes place very fast and at exponential rates. This is the amplification step of 
complement activation (Figure 1.5), and it can theoretically proceed indefinitely until 
one or more of the reactants are exhausted. 
 
(1.2.4) The Lectin pathway 
In this pathway, complement is activated independent of antibody by 
interaction of C4 and C2 with specialised proteins that bind to mannose, a sugar 
found in microbial surface polysaccharides. MBL (Mannose-Binding Lectin) is 
produced by the liver in response to microbial infection. Structural similarities of   12
MBL, MASP-1 (MBL-associated serine protease 1) and MASP-2 with C1q, C1r and 
C1s respectively provide some explanation as to how this occurs. MBL is known to 
have two to six “heads” in the same way as C1q and is associated with MASP-1 and 
MASP-2 in the same way as C1q with C1r and C1s. 
MBL binds specifically to mannose and certain other sugars such as fucose 
with a spacing pattern that permits its attachment on the surface of microbial cells. 
These resides are usually shielded by other sugar groups such as sialic acid in 
vertebrate cells, and this provides an important way of differentiating between self 
and non-self. Interaction with these sugar residues triggers a conformational change 
in MBL, which stimulates a conversion of the zymogen MASP-2 into a protease. 
MASP-2 cleaves C4 and C2 in turn to produce the C3 convertase. Cells bound by 
MBL are hence more susceptible to phagocytosis (Reid, 1998). 
 
(1.2.5) The Membrane Attack Complex (MAC) 
The membrane attack complex is a group of soluble hydrophilic proteins C5b, 
C6, C7, C8 and C9. Through a non-enzymatic process of self assembly, they form a 
protein complex containing up to 18 molecules of C9 which behaves as an integral 
membrane protein complex or transmembrane channel. 
Binding of the first C9 molecule to the MAC appears to stimulate 
conformational changes that enhance the binding of subsequent C9 molecules to the 
complex. The initial C5b6789 complex acts as a core for the formation of a C9 barrel-
like polymer that bores through the cell membrane of the target cell. In general, about 
ten to eighteen C9 molecules are thought to be involved, and it is believed that 
involvement of greater numbers of C9 molecules in MAC formation improves the 
lytic reactivity of the complex.  The channel thus created allows the transmembrane 
equilibration of cellular solutes, efflux of cell contents and osmotic lysis by the 
explosive influx of water. This is referred to as reactive lysis (Rother et al., 1998). 
The most important function of complement is to facilitate and enhance the uptake 
and destruction of pathogens by phagocytes. In addition to this, complement can also 
directly lyse cells and play a role in the clearance of immune complexes and 
inflammation. The pathways of complement activation are summarized in Figure 1.5. 
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Figure 1.5 
Schematic diagram summarizing the three activation pathways of the 
complement cascade.    14
(1.3) Regulation of Complement Activation 
Complement activation is largely localised and confined to the surface on 
which it commences. Regulation ensures that complement activation is initiated only  
on non-self surfaces, otherwise its hugely destructive capability would be turned on 
host cells and the complement proteins in circulation would be quickly depleted. This 
scenario is exemplified by deficiencies of complement regulatory proteins, which 
lead to excessive complement activation and pathologic states. One means of 
regulating complement activation by the host is selective binding of complement 
proteins to non-host cell surfaces. Hence surface markers to which complement 
proteins bind, when also present on host cells, are protected by other groups that 
prevent their interaction with complement proteins. For example, mannose residues 
with which MBL interacts are shielded by other sugars on host cell surfaces.  In 
addition, several of the activated components are either unstable and decay easily, or 
have labile binding sites that display only transient ability to bind to target surfaces. 
Stabilising proteins are present on target surfaces to perpetuate the effect of such 
components. For example, the C3 convertase C3bBb decays rapidly and is stabilised 
on target surfaces by properdin, also known as factor P. Properdin binds to many 
microbial surfaces and thus may be regarded as a positive regulatory factor of 
complement. 
On the surface of host cells, certain surface-expressed regulatory proteins 
ensure that complement activation is rapidly brought under control. Complement 
receptor 1 (CR1), decay activating factor (DAF) and membrane cofactor protein 
(MCP) are examples of such proteins. CR1 is a receptor for C3b and C4b and 
competes with factor B in binding to the reactive sites of these complement proteins. 
On binding C3b and C4b, it serves as a cofactor for their factor I-mediated cleavage 
and consequent inactivation. Furthermore, CR1 also accelerates the decay of C3 and 
C5 convertases, effectively ensuring that their activity is inhibited on the host cell 
surfaces. A degree of redundancy is observed in the action of most complement 
regulatory proteins, thus DAF also accelerates the decay of C3 and C5 convertases on 
host cell surfaces and MCP acts as cofactor for the cleavage of C3b and C4b by factor 
I. 
Regulation is not restricted to the activity of proteins expressed at host cell 
surfaces. A number of soluble plasma proteins also play a role in regulating 
complement activation. C1 is inhibited by C1 inhibitor (C1INH), a serine protease   15
inhibitor (serpin) that binds to sites on activated C1r and C1s, inactivating them and 
causing their dissociation from C1q (Law & Reid, 1995). C1INH limits the length of 
time C1 stays activated and able to cleave C4 and C2,  preventing over-activation of 
complement through the classical pathway. High plasma levels of cleaved fragments 
of C4 and C2 have been used in the past as pointers to functional deficiency of 
C1INH. 
The activity of the anaphylatoxins C5a, C3a and C4a is regulated in plasma by 
the anaphylatoxin inactivator serum carboxypeptidase N. This enzyme inactivates the 
proteins by cleaving them at the C-terminal arginine residue. C4b-binding protein 
(C4BP) and Factor H (FH) are plasma proteins that regulate the activity of C4b and 
C3b respectively. C4BP binds C4b and acts as a cofactor for its cleavage by the serine 
protease factor I. It also accelerates decay of the C3 convertase C4b2a and the C5 
convertase C4b3b2a. FH performs the same functions in the alternative pathway; as a 
cofactor for the factor I-mediated cleavage of C3b and decay-acceleration of the C3 
convertase C3bBb. 
Factor I is a plasma serine protease that cleaves and inactivates C4b and C3b. 
It circulates in plasma in active form but can only cleave C3b and C4b when they are 
bound by cell receptors or their regulators FH and C4BP. It cleaves C3b to yield iC3b 
(inactive C3b) with the release of C3f, and then further to yield C3c, C3dg and C3d. 
These products of C3b breakdown also play a role in opsonisation and clearance of 
immune complexes when bound to appropriate receptors. C3d remains bound to the 
pathogen surface and is bound by complement receptor type 2 (CR2) which, when 
cross-linked to a B cell receptor through a C3d-antigen complex, amplifies a signal 
transduction cascade. Thus CR2 provides an important link between the innate and 
adaptive immune systems. Factor I also cleaves C4b to yield C4c and C4d. 
The membrane attack complex is regulated by a number of proteins, both 
membrane-bound and soluble. CD59, also known as homologous restriction factor 
(HRF20), MAC inhibiting factor (MACIF) or membrane inhibitor of reactive lysis 
(MIRL), is a protein expressed on the surface of host cells that inhibits the assembly 
of C9 polymer in the C5b-8 complex and hence protects host cells from reactive lysis 
(Zalman  et al., 1986). The activity of CD59 is thought to be responsible for the 
significantly reduced lytic activity of MAC on homologous cells. In fluid phase, S-
protein (site-specific protein), a serum protein synonymous with vitronectin (serum 
spreading factor), has been found to bind to a metastable binding site on C5b-7,   16
preventing its insertion into cell membranes. Clusterin (also known as apolipoprotein 
SP40, 40) performs a similar function. In both cases, C8 and C9 binding and 
subsequent assembly of the MAC may still occur, but the assembled complex is 
lytically inactive (Liszewski & Atkinson, 1998). Regulation of the complement 
pathway is summarised in Figure 1.6. 
 
(1.4) Biosynthesis of complement proteins 
  Most soluble complement proteins are primarily synthesized in the liver, with 
varying degrees of extrahepatic biosynthesis. Important exceptions are C1q, factor D, 
properdin and C7. Extrahepatic synthesis may provide important sources of localised 
immune response to invasion. The primary sites of C1q synthesis are macrophages 
(Schwaeble et al., 1995). In addition to secreting C1q, macrophages are thought to 
also display the molecule on their surfaces where it binds to a variety of molecules to 
activate complement (Law & Reid, 1995). The major site of synthesis of factor D is 
adipose tissue (White et al., 1992), and it is thought to probably play a role in fat 
metabolism distinct from its complement function. Properdin is synthesised in 
monocytes, T-cells and granulocytes (Wirthmueller et al., 1997) while C7 is mainly 
synthesised in granulocytes (Hogasen et al., 1995).  
 
(1.5) Complement in disease 
Deficiencies in classical pathway activation components (C1 complex, C4 and C2) 
are generally associated with immune complex disorders and systemic lupus 
erythematosus (SLE)-like symptoms. In the case of C4, immune complex disorder is 
correlated with deficiency of its C4A isotype only (Law & Reid, 1995). C3 deficiency 
leads to increased susceptibility to pyogenic infections, membranoproliferative 
glomerulonephritis and SLE-like illness (Morley & Walport, 1999), however 
deficiencies in the alternative pathway are of relatively low frequency. MBL 
deficiency is one of the most commonly found in humans and leads to increased risk 
of suffering from recurrent infections and opsonin deficiency in both children (Super 
et al., 1989) and adults (Summerfield et al., 1995). MBL mutations and deficiency 
have been shown to have an increased frequency in cases of SLE (Davies et al., 1995; 
1997). Deficiencies in the terminal complex (MAC) components are associated with 
recurrent  Neisserial infections, possibly because of the ability of these 
microorganisms to survive intracellularly in phagocytes. However, individuals    17
 
 
Figure 1.6 
Schematic diagram summarizing the regulation of the complement system. 
Positive regulators are shown in blue while negative regulators are shown in red.    18
deficient in C9 are mostly healthy. MAC activation also plays an important role in 
ischaemia-reperfusion (I/R) tissue injury (Reidemann & Ward, 2003). Deficiencies in 
complement regulatory proteins lead to uncontrolled complement activation and 
disturbed homeostasis. Deficiency in the C1-inhibitor C1INH causes depleted levels 
of C4 and C2 in serum, often with recurrent localised oedema on the skin, 
gastrointestinal tract or larynx. Individuals with this deficiency may also develop 
SLE-like symptoms (Davis, 1998). Factor I deficiency leads to increased C3 
activation, increased incidence of recurrent pyogenic infection and SLE-like illness 
(Vyse et al., 1996). Low levels of FH in plasma are associated with uncontrolled C3 
activation leading to membranoproliferative glomerulonephritis (MPGN) and renal 
failure (Ault  et al., 1997), as well as increased susceptibility to meningococcal 
infections (Nielsen et al., 1989). Deficiencies in FH function due to mutations and 
polymorphisms are implicated in atypical haemolytic uraemic syndrome (aHUS) 
(Zipfel et al, 2006), and age-related macular degeneration (AMD) (Klein et al., 2005; 
Haines et al., 3005; Edwards et al., 2005). Deficiencies in DAF, CD59 and other GPI-
anchored proteins result in an inability of the proteins to insert into the cell 
membrane, and lead to paroxysmal nocturnal haemoglobinuria (Nicholson-Weller et 
al., 1983; Pangburn et al., 1983).   19
Chapter Two 
 
Factor H of complement   20
(2.1) Factor H expression and biosynthesis 
(2.1.1) The Factor H gene family 
  FH is the best-characterised protein of the FH gene family, members of which 
belong to the regulators of complement activation (RCA) family of proteins. First 
identified in 1965 as β1H globulin (Nilsson & Müller-Eberhard, 1965), it is a 154-
kDa (Fenaille et al., 2007), soluble glycoprotein that circulates in human plasma at a 
concentration of 235-810 µg/ml (Saunders  et al., 2006). The FH gene family 
provides a prime example of a multidomain multifunctional protein family whose 
individual members are defined by conserved common structural elements and 
display diverse but often overlapping functions. There are six identified members of 
this protein family of secreted plasma proteins that are primarily synthesized in the 
liver, and they are all thought to have similar roles in complement control (Zipfel et 
al., 1999). FH-like protein 1 (FHL-1 or reconectin) shares complement regulatory 
functions with FH and interacts with heparin. It displays cell spreading activity and 
binds to the N-terminus of the streptococcal M protein (Zipfel & Skerka, 1999). The 
functions of the FH-related proteins (FHR-1 to FHR-4) are not well defined. FHR-1, 
FHR-2 (Zipfel et al., 2002) and FHR-4 (Skerka et al., 1997) are constituents of 
lipoproteins, while FHR-3 is known to interact with heparin (Hellwage et al., 1999). 
Binding to C3b and C3d has been demonstrated for FHR-3 and FHR-4 and the two 
proteins display cofactor-related activity (Hellwage et al., 1999). FHR-4 has recently 
been shown to bind C-reactive protein and may have a role in the opsonisation of 
necrotic cells (Mihlan et al., 2009). 
 
(2.1.2) Factor H expression and sequence 
FH is found at the RCA gene cluster and is encoded by a single gene (HF1) 
located on human chromosome 1q32 (Rodriguez de Córdoba et al., 1999). HF1 is 
closely linked to the FHR1, FHR2, FHR3, FHR4 and FHR5 genes encoding five FH-
related human plasma proteins (Zipfel et al., 1999) (Fig. 2.1). Sequence analyses of 
the HF1/FHR1–5 gene region shows the existence of a number of large genomic 
duplications within this region, including different exons of the HF1/FHR1–5 genes 
(Rodriguez de Córdoba et al., 2004). HF1 comprises 23 exons distributed over 94 kb 
of genomic DNA (Male  et al., 2000) (Fig. 2.1). Each SCR (short complement 
regulator) domain in FH is encoded by a single exon, except for SCR-2 that is   21
encoded by exons 3 and 4. Exons 8–9 and 21–23 of HFI are duplicated in FHR3 and 
FHR1 (Rodriguez de Córdoba et al., 2004).  
 
(2.1.3) Biosynthesis of Factor H  
FH is synthesized as a single-chain molecule of 1231 amino acid residues, 
including an 18-residue leader sequence (Ripoche et al., 1988). It is constitutively 
produced by the liver (Schwaeble et al., 1987), although extrahepatic synthesis also 
occurs in a wide variety of cell types, such as peripheral blood lymphocytes, 
myoblasts, rhabdomyosarcoma cells, fibroblasts, umbilical vein endothelial cells, 
glomerular mesangial cells, neurons, and glia cells (Friese et al., 1999). FH synthesis 
has also been reported to occur in the human retinal pigment epithelium (RPE) and 
choroid (Wistow et al., 2002; Klein et al., 2005). The proinflammatory cytokine 
IFNγ and T cell growth factor (Brooimans  et al., 1989), as well as the anti-
inflammatory glucocorticoid dexamethasone (Friese et al., 2000), have been reported 
to induce and regulate FH biosynthesis. Particularly strong inductive effects have 
been reported with IFNγ and dexamethasone, both of which may lead to increased 
local FH biosynthesis in response to inflammation. The inductive effect of 
dexamethasone is consistent with the presence of a glucocorticoid responsive 
element in the TATA-less human HF1 promoter (Ward et al., 1997).   
 
(2.2) Structure of Factor H 
(2.2.1) The SCR domain structure  
SCR (short complement regulator/ short consensus repeat) domains are the 
most abundant domain type in the complement system and are connected by inter-
SCR linkers, the length of which generally determines the degree of flexibility 
between two adjacent SCR domains within the molecule. FH is composed entirely of 
20 SCR domains in linear arrangement, each about 61 residues in length. SCR 
domains exist in other non-RCA family complement proteins, including C2, C6, C7, 
C1r and C1s, as well the complement receptor proteins CR1 and CR2. SCR domains 
are also found outside the complement system in proteins such as the β-subunit of 
factor XIII (Ichinose  et al., 1986), haptoglobin (Kurosky  et al., 1980) and β2 
glycoprotein I (β2 GP-I) (Lozier et al., 1984). Within each domain there are four 
invariant Cys residues that form disulphide bridges in a 1-3, 2-4 pattern, and one 
conserved Trp residue, in addition to several other conserved hydrophobic residues    22
 
 
 
 
 
Figure 2.1  
A schematic representation of the HF1 gene showing its position within the 
RCA gene cluster. The top part of the figure shows the short and long arms (1p and 
1q respectively) of human chromosome 1, with the band 1q32 highlighted. Within 
this band (middle part of the figure) are found all the RCA genes, as well as the gene 
encoding the B subunit of the coagulation Factor XIII, F13B. The bottom part of the 
figure illustrates the encoding of both FH and FHL-1 by exons 1-9 (black-and-white), 
whereas exon 10 (black) encodes only FHL-1, and exons 11-23 (white) encode only 
FH (adapted from Rodriguez de Córdoba et al., 2004). 
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Figure 2.2 Sequence alignment of the 20 SCR domains of human complement FH (PDB accession number P08603).  Conserved cysteine and 
tryptophan residues are highlighted in light brown. Other conserved residues are in yellow, the putative carbohydrate sites are underlined, and the 
linker residues are boxed. The Define Secondary Structure Prediction (DSSP)-assigned β-strand secondary structure regions are highlighted in 
grey, and the position and labelling of the eight consensus β-strands b1 to b8 are shown below the alignment.    24
(Figure 2.2). Each SCR domain is surrounded by two antiparallel β strands that run 
approximately along its long axis. These β strands are in turn joined by loops and 
turns, including the poorly conserved hypervariable loop found between the β-strand 
secondary structure regions b2 and b3 (Figure 2.2). There are nine potential N-
glycosylation sites on FH, one of which is known to be unoccupied in SCR-4 (Morley 
& Walport, 2000; Aslam & Perkins, 2001; Fenaille et al., 2007).  
 
(2.2.2) Structures of Factor H SCR domains 
The domains of proteins containing several SCR domains are usually arranged 
contiguously, like beads on a string. The average length of inter-SCR linkers is four 
amino acid residues, with the shortest being three and the longest eight residues. 
Inherent flexibility thus presents potential problems in structure determination for 
multi-SCR proteins such as FH (20 SCRs) and complement receptor 1 protein CR1 
(30 SCRs). The structures of several SCR domains have been investigated by X-ray 
crystallography, nuclear magnetic resonance (NMR), electron microscopy (EM) and 
small angle scattering (SAS). These studies show that, in general, the orientation 
between two adjacent SCR domains is not easily predicted (Perkins  et al., 2002; 
Lehtinen et al., 2004). Atomic level structures are often constrained to one or two 
domains, and the sensitivity of NMR and X-ray crystallography techniques to linker 
flexibility limits their usefulness in studying molecules such as FH in their native 
form. EM techniques, while able to directly observe the intact molecule, give only a 
static picture, and the conditions of study are generally harsh and non-physiological.  
Thus, to date, intact FH has not been crystallised for reason of its size, 
glycosylation and inter-SCR flexibility. However, other methods such as solution 
scattering, analytical ultracentrifugation and electron microscopy have been applied 
to demonstrate that FH does not possess a fully-extended SCR structure in solution 
but is partially folded back (Perkins, 1991; Discipio, 1992; Aslam & Perkins, 2001; 
Chapter 5). To date therefore, the only molecular structures for intact FH are 
medium-resolution constrained X-ray scattering models (Aslam & Perkins, 2001; 
Chapter 5) based on medium-to-high-resolution structures for individual (or groups 
of) SCR domains. NMR structures have been determined for SCR-5 (Barlow et al., 
1992), SCR-15/16 (Barlow et al., 1993) and more recently SCR-1/3 (Hocking et al., 
2008), while crystal structures have been determined for SCR-19/20 (Jokiranta et al., 
2006) and SCR-6/8 (Prosser et al., 2007) (Table 2.1). Homology models for the    25
 
 
 
 
Figure 2.3 
FH domain structure (modified from Aslam & Perkins, 2001). (a)  Schematic 
view of the 20 SCR domains of FH. The positions of three C3b binding sites, with 
the first region also having decay acceleration and cofactor activity (grey-coloured 
domains) are shown. Also shown are two heparin-binding sites on SCR-7 and SCR-
20 (black), and nine putative N-linked glycosylation sites (Y). (b) 3-D model of FH 
showing its flexible ball-on-string domain arrangement (PDB code 1 HAQ, Aslam & 
Perkins, 2001).    26
 
FH domains  PDB entry code Method of 
determination 
a 
Comments/ Reference 
SCR-1/2 
SCR-2/3 
2RLP 
2RLQ 
NMR  Hocking et al., 2008 
SCR-1/5 2QFG  SAXS    Chapter 4 
SCR-6/8 2IC4  SAXS  Fernando et al., 2007 
SCR-6/8 2UWN 
2V8E 
X-ray 
crystallography 
402H variant; resolutions 
2.35 Å (UWN) and 2.50 Å 
(2V8E). Prosser et al., 2007 
SCR-7 2JGW 
2JGX 
NMR  402H variant (2JGW); 402Y 
variant (2JGX). Herbert et 
al., 2007 
SCR-15 1HFI  NMR  Barlow et al., 1993 
SCR-15/16 1HFH  NMR  Barlow et al., 1993 
SCR-16 1HCC  NMR  Barlow et al., 1993 
SCR-16/20 2QFH  SAXS    Chapter 4 
SCR-19/20 2BZM  NMR  Herbert et al., 2006 
SCR-19/20 2G7I  X-ray 
crystallography 
Resolution 1.75 Å. 
Jokiranta et al., 2006 
SCR-1/20 1HAQ  SAXS  Aslam & Perkins, 2001 
SCR-1/20 3GAU 
3GAV 
3GAW 
SAXS  In 50 mM NaCl (3GAU); 
in 137 mM NaCl (3GAV); 
in 250 mM NaCl (3GAW)
Chapter 5 
 
aAbbreviations: NMR, nuclear magnetic resonance; SAXS, small angle X-ray 
scattering. 
 
Table 2.1  
Experimentally-determined FH domain structures available in the protein data 
bank (March 2009).   27
remaining SCR domains have been described (Aslam & Perkins, 2001; Saunders et 
al., 2006).  
 
(2.2.3) Factor H inter-domain arrangements  
Since the orientation between two adjacent SCR domains is variable and not 
easily predicted (Perkins et al., 2002; Lehtinen et al., 2004), methods that study the 
molecule in solution and under near-physiological conditions may yield structural 
information not readily available otherwise. X-ray scattering and analytical 
ultracentrifugation in combination with constrained scattering modelling leads to 
medium resolution molecular structures (Perkins et al., 1998; 2005; 2008). Using 
these techniques, solution structures for full-length FH (Aslam & Perkins, 2001; 
Chapter 5), SCR-6/8 (Fernando et al., 2007) and SCRs 1/5 and 16/20 (Chapter 4) 
have been described, revealing that FH is bent and has a tendency to dimerise at 
SCRs 6/8 and 16/20 (Fernando et al., 2007; Chapter 4). This is consistent with early 
electron micrographs showing its flexibility (Discipio, 1992) and other studies 
showing the tendency of FH fragments to self-associate (Perkins  et al., 1991; 
Jokiranta et al., 2000; 2006; Opermann et al., 2006).  
The folded-back structure of FH may be important for its regulatory function 
(Chapter 4). However, the molecular basis of this inter-domain arrangement remains 
unknown. For example, intramolecular interactions between the N- and C- regions to 
stabilise an omega-shaped structure for FH have been proposed as a possible 
mechanism (Oppermann  et al., 2006). This proposed mechanism, based on the 
interaction between SCR-1/7 and SCR-1/20 as observed by surface plasmon 
resonance, may however be alternatively explained by the tendency of SCR-6/8 to 
dimerise (Fernando  et al., 2007). Shorter-distance intra-molecular interactions 
between SCR domains in close proximity, stabilised by electrostatic forces, are 
another possible basis for maintaining a folded-back structure in solution. If such 
electrostatic interactions contribute towards maintaining a stable folded back FH 
structure under physiological conditions, then FH conformation will be affected by 
ionic strength and pH. This would suggest that effect of electrostatics in FH 
interaction with its ligands is not limited to the residues near the binding surface, but 
extends to other residues important for stabilising an optimal structure for these 
interactions. This may also provide a partial explanation for the importance of 
mutations located outside the known functional regions of FH. For example, a small   28
but significant number of aHUS mutations occur outside SCR-19 and SCR-20, and 
the reason for this is not known (Section 2.4; Saunders et al., 2007).  
In this thesis, the interdomain arrangements within the functionally-relevant 
SCR-1/5 and SCR-16/20 fragments of FH have been studied with a view to 
explaining the overall structure of FH (Chapter 4). Also, electrostatic interactions 
have been hypothesized to contribute towards maintaining a stable folded back FH 
structure under physiological conditions. Accordingly, the effects of ionic strength 
and pH on the conformational properties of native FH have been investigated by 
analytical ultracentrifugation. Through the use of improved X-ray scattering 
instrumentation and aggregate-free FH purifications, new molecular models for FH 
have been derived for deposition in the Protein Data Bank (Chapter 5). These new 
models give much improved scattering curve fits compared to the previous (Aslam & 
Perkins, 2001). 
 
(2.3) Function of Factor H in complement 
(2.3.1) Regulation of complement activation 
The primary role of FH in complement is the regulation of the alternative 
pathway C3 convertase C3bBb and its C3b component, both in plasma and on host 
cell surfaces. FH binds to C3b and acts as a cofactor for the factor I-mediated 
proteolytic inactivation of C3b (Figure 2.4; Pangburn et al., 1977), while competing 
with Factor B in binding to C3b to form the alternative pathway C3-convertase 
C3bBb (Whaley and Ruddy, 1976). It also accelerates the decay of C3bBb (Weiler et 
al., 1976). However, while FH readily binds and inactivates C3b in the fluid-phase, 
the inactivation of surface-bound C3b by FH is significantly affected by the nature of 
the surface to which C3b is bound. On host cell surfaces, sialic acids, 
glycosaminoglycans or sulphated polysaccharides such as heparin are known to 
increase the affinity of FH for C3b (Fearon, 1978). The ability of some 
microorganisms to recruit FH to their surface by mimicking these surface 
polysaccharides is an important factor in their pathogenicity. For example, FH binds 
to surface sialylated lipopolysaccharides of Neisseria gonorrhoeae ( Ram  et al., 
1999), a membrane lipoprotein of Borrelia burdorferi (Helwage et al., 2001; Brooks 
et al., 2005) and the M protein of Group A Streptococci (Jarva et al., 2003). Other 
microbes that recruit FH to their surface include Echinococcus granulosus, 
Onchocerca volvulus, N. meningitidis and HIV (Schneider et al., 2006).    29
 
Figure 2.4 
Inactivation of C3b by FH.  Sites of cleavage by the C3-converstase and 
factor I in the α-chain are indicated by arrows. Inactivation of C3b, first to iC3b 
(with the release of C3f), then C3c and C3dg by factor I requires the cofactor 
function of FH. The positions of the C3 internal thioester (*), glycosylation sites (**) 
and interchain disulphide bonds (S S) are shown (modified from Rother et al., 1998). 
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(2.3.2) Factor H binding to C3b 
FH regulates surface-bound C3b activity by recognising charge (anionic) 
clusters on host cell surfaces that are mimicked by heparin. FH makes the initial 
contact with host cells through the C-terminal SCR-20, and this is followed by N-
terminal regulatory activity (Oppermann et al., 2006; Ferreira et al., 2006). FH has 
three C3b-binding sites (Figure 2.3(a)). The four N-terminal domains SCR-1/4 bind 
to intact C3b, a second site in SCR-6/10 binds to the C3c region of C3b, and a third 
site within SCR-16/20 binds to the C3d region of C3b (Lambris et al., 1988; Sharma 
& Pangburn, 1996; Jokiranta et al., 2000; 2001).  
A molecular understanding of the FH-C3b complex requires the dissection of 
the role of each of these C3b sites on FH. In terms of the C3d fragment, ligand-
binding assays in 137 mM NaCl buffer first revealed that a peptide derived from C3d 
inhibited FH binding to C3b (Lambris  et al., 1988). Surface plasmon resonance 
analysis in 50 mM and 75 mM NaCl indicated that C3d binds weakly to FH and the 
FH-related proteins FHR-3 and FH-4 with dissociation constants KD of 0.09-0.36 µM 
(Hellwage et al., 2002). The interaction of FH with C3d in 50 mM and 75 mM NaCl 
was further confirmed, and the binding site was localised to SCR-19/20 and 
subsequently to SCR-20 (Jokiranta et al., 2000; Hellwage et al., 1999). Mutations in 
SCR-20 lead to reduced binding of C3d and heparin (Manuelian  et al., 2003; 
Jokiranta et al., 2005). The binding sites for C3d and heparin partially overlap and 
lead to a ternary complex of FH-C3d-heparin in 70 mM NaCl (Hellwage et al., 2002; 
Jokiranta et al., 2005). Other related studies showed that dimeric C3dg remains bound 
to IgG after C3b inactivation, suggesting that dimeric C3d is required for efficient 
binding to CR2 and that C3d oligomers may be physiologically important (Arnaout et 
al 1983; Dempsey et al., 1996; Jelezarova et al., 2003). 
In this thesis, insight into FH interaction with C3b has been obtained by 
studying its complex with C3d (Chapter 6). The effect of ionic strength on these 
interactions has been investigated in an effort to obtain new insight into complement 
regulation and host protection, as well as a clearer understanding of the molecular 
mechanism involved in some of the disease conditions in which FH mutations are 
implicated. 
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(2.3.3) Factor H binding to CRP  
(2.3.3.1) Introduction to human CRP 
  C-reactive protein (CRP) is an acute-phase protein of the pentraxin family of 
Ca
2+-dependent ligand-binding proteins found in serum. The other member of this 
family in humans is serum amyloid P component (SAP). CRP was originally 
discovered in 1930 during studies of patients with Streptococcus pneumoniae 
infection as a substance in serum that reacted with the C-polysaccharide of 
Pneumococcus  (Tillett & Francis, 1930), hence its nomenclature. CRP occurs in 
serum at a median concentration of 0.8 mg/L, up to a maximum of around 10 mg/L 
(Pepys & Hirschfield, 2003). This concentration may rise up to 10,000 times within 
six hours of acute inflammation events such as infection, peaking after 48 hours. With 
a constant half-life of 19 hours, its serum level is mainly determined by the rate of 
production which is in turn influenced by the severity of infection. This feature of 
CRP is exploited diagnostically in its use as a marker of inflammation. The gene 
encoding human CRP is on chromosome 1 (1q21-1q23).  
CRP transcription occurs only in hepatocytes and is regulated predominantly 
by the cytokine interleukine-6. On translation, CRP comprises 224 amino acids, of 
which residues 1-18 are the signal peptide with 19-224 making up the mature protein. 
Native CRP is unglycosylated and consists of 5 identical subunits arranged non-
covalently as a cyclic pentameter (Figure 2.5), with an overall molecular weight of 
115 kDa. Each subunit or protomer has 206 amino acids and a molecular weight of 23 
kDa. CRP protomers possesses a characteristic “lectin fold” composed of a two-
layered β-sheet with flattened jellyroll topology and one concave side (Shrive et al., 
1996; Thompson et al., 1999). The β-sheets are linked by loops on the periphery 
(Figure 2.5). A single α-helix in the CRP protomer is located on the “A” face 
opposite the Ca
2+-binding site and spans amino acid residues 168-176 (Shrive et al., 
1996). The concave side, or “B” face, contains the phosphocholine-binding site, with 
two Ca
2+ bound 4 Å apart by protein side chains (Figure 2.5; Pepys & Hirschfield, 
2003).  
CRP binds phosphocholine (Volanakis & Kaplan, 1971) ,  a s  w e l l  a s  
phosphoethanolamine, microbial surface proteins, chromatin, histones, fibronectin, 
small nuclear ribonucleoproteins, laminin and polycations (Black  et al., 2004). 
Ligand-bound or aggregated CRP activates the classical pathway of complement by   32
 
 
 
Figure 2.5 
Crystal structure of native CRP pentamer complexed with phosphocholine 
(Thompson et al., 1999). INSIGHT II 98.0 molecular graphics software (Accelrys, 
San Diego, CA, USA) was used to generate a ribbon diagram from PDB entry 1B09. 
The Ca
2+ are yellow and phosphocholine is red. The cyclic pentameric arrangement 
of its protomers is shown. This structure is viewed with the B face uppermost.   33
interacting with C1q.  Also, CRP interacts with immunoglobulin receptors FcγRI and 
FcγRII to stimulate phagocytic cells. CRP has been described as producing both pro- 
and anti-inflammatory effects (Black et al., 2004). Some of its pro-inflammatory 
effects include up-regulation of adhesion molecule expression in endothelial cells, 
inhibition of endothelial nitric oxide synthase expression in aortic endothelial cells, 
stimulation of interleukin-8 release from several cell types and increase of tumour 
necrosis factor-α release. Examples of its anti-inflammatory effects include the 
induction of interleukin-1 receptor antagonist expression, increase of the release of 
the anti-inflammatory interleukin-10 and the repression of interferon-γ synthesis. 
This apparent contradiction in CRP activity results from the study  of CRP in either 
its native form or as abnormally modified forms (mCRP), with different biological 
and antigenic properties (Potempa et al., 1983a; 1983b; 1987; Khreiss et al., 2002). 
mCRP consists of dissociated CRP protomers which are produced in vitro under 
harsh conditions of high acidic pH (2.0), temperature (above 60°C) or 8 M urea. It 
has been suggested that mCRP may occur naturally in normal or inflamed human and 
animal tissues (Samols et al., 1985; Rees et al., 1988; Egenhofer et al., 1993; Diehl 
et al., 2000), and that Ca
2+ depletion of native CRP may lead to spontaneous 
formation of mCRP (Motie et al., 1996; Wu et al., 2002). mCRP or CRP aggregation 
or multimerisation is suggested to be important for CRP function at cell surfaces 
(Jiang et al., 1991; Taylor & van den Berg, 2006). However, once CRP is denatured, 
it is rapidly catabolised, and there is no firm evidence for the persistence of 
monomeric, denatured or aggregated CRP in vivo (Pepys & Hirschfield, 2003). 
In this thesis, a multidisciplinary strategy using analytical ultracentrifugation, 
X-ray scattering, constrained molecular modelling and surface plasmon resonance 
was applied to resolve the solution properties of CRP (Chapter 7) to provide insights 
into the multivalent interaction of CRP with a range of macromolecular ligands. 
 
(2.3.3.2) Factor H interaction with CRP as a means of complement regulation 
  CRP activates complement via the classical pathway (Kaplan and Volanakis, 
1974), but inhibits activation by the alternative pathway. Evidence of this was found 
on examining the presence of individual components when complement was 
activated by CRP. Activation was found to be efficient only at the initial stages 
involving C1-C4, with little activation of the late proteins C5-C9 (Mold et al., 1999). 
The net effect of this is the ability of CRP to participate in host defence systems   34
while limiting the potentially damaging effects of the late stage complement 
components by acting as a regulator of complement activation. CRP up-regulation of 
the expression of the complement inhibitory factors decay-accelerating factor (DAF), 
membrane co-factor protein (MCP) and CD59 has been suggested as one mechanism 
for this effect (Li et al., 2004). However, evidence for the recruitment of FH by CRP 
suggests that the inhibitory effect of CRP on alternative pathway activation may be 
mediated mainly by its interaction with FH. Direct evidence for this was first 
provided by an ELISA assay of plastic-immobilised CRP binding of FH (Mold et al., 
1999). However, in the same study, fluid-phase CRP only bound to immobilised FH 
with less than 1% efficiency. 
 
(2.3.3.3) The role of the interaction between Factor H and CRP in the molecular 
mechanism of age-related macular degeneration 
  In an early surface plasmon resonance study, CRP was immobilised on the 
sensor chip surface by amine coupling in the absence of Ca
2+. SCR-7 and SCR-8/11 
of FH were found to bind to CRP in a Ca
2+-dependent manner (Jarva et al., 1999). 
Reverse binding of CRP to immobilised FH in the presence of Ca
2+ was also reported 
in the same study. Binding of FH to immobilised CRP has since then been 
demonstrated repeatedly, with differences in binding affinity between the H402 and 
Y402 variants of FH (Laine et al. 2007; Sjoberg et al., 2007; Skerka et al., 2007; Yu 
et al., 2007; Herbert et al., 2007). Because the Y402H polymorphism within SCR-7 
of FH has been implicated as a risk factor in age-related macular degeneration, AMD 
(Section 2.4), this interaction has been suggested to be important in the molecular 
mechanism of AMD. However, a recent study using size exclusion chromatography 
and analytical ultracentrifugation (sedimentation equilibrium) has suggested that the 
observed interactions are a result of CRP denaturation resulting from its 
immobilisation in the absence of Ca
2+, and that FH does not interact with native 
pentameric CRP (Hakobyan et al., 2008). 
  In this thesis, the interaction of FH with CRP was investigated in detail by 
analytical ultracentrifugation, surface plasmon resonance and X-ray scattering 
(Chapter 8). The discrepancy between these studies was re-examined in 
physiological buffer conditions and protein concentrations, being careful to work in 
conditions when CRP retains its native pentameric arrangement. To ensure that CRP 
remained in native undenatured form during surface plasmon resonance studies, CRP   35
immobilisation was carried out in the presence of Ca
2+, and reverse binding 
experiments were used to verify the results. Together with improved knowledge of 
the solution properties of native CRP (Chapter 7), this study will help clarify the role 
of FH in the molecular mechanism of AMD and aHUS diseases.  
 
(2.3.4) Factor H binding to other ligands 
Two separate binding sites for heparin and cell surface polyanions (Figure 
2(a)) have been identified in SCR-7 (Blackmore et al., 1996; Schmidt et al., 2008) 
and SCR-20 (Blackmore et al., 1998; Schmidt et al., 2008) of FH, with the possibility 
of a third site in SCR-9 (Ormsby  et al., 2006) or SCR-13 (Sharma & Pangburn, 
1996). FH can also function as an adhesion ligand enhancing the activation response 
of neutrophils. The receptor mediating this interaction has been identified as the 
integrin MAC-1 (CD11b/CD18), which is also a receptor for iC3b (CR3) and ICAM-
1 (DiScipio et al., 1998).  
 
(2.4) Factor H mutations and disease 
Over 130 known mutations in FH are associated with disease (Saunders et al., 
2007; www.fh-hus.org). The majority of these mutations (85 of 134, more than 60%) 
occur at the C-terminus within SCR-16/20, 25 occur within SCR-11/15 and 24 in the 
region between SCR-1/10 (www.fh-hus.org). The N-terminal SCR-1/4 region of FH 
is essential for the cofactor activity of FH (Gordon et al., 1995; Sharma & Pangburn, 
1996). SCR-7 and SCR-8/11 are important for binding of heparin and CRP, while the 
C3b/polyanion-binding site located within SCR-16/20 is critical for cell binding and 
recognition (Ferreira et al., 2006, Opermann et al., 2006). These functional regions 
participate in the complement-regulatory activity of FH at host cell surfaces. FH 
ligand-binding sites may possess specificity for multiple ligands. For example, SCR-
7 binds to both heparin and CRP (Blackmore  et al., 1996; Jarva et al., 1999; 
Giannakis  et al., 2003; Schmidt et al., 2008), the C3b-binding site in SCR-6/10 
(Lambris  et al., 1988; Sharma & Pangburn, 1996; Jokiranta et al., 2000; 2001) 
overlaps with this and another CRP-binding site in SCR-8/11 (Jarva et al., 1999), 
while SCR-20 binds both C3d and heparin (Hellwage et al., 2002).  
Defects in plasma proteins are generally classified as Type I or Type II. Type 
I is defined as when the protein plasma concentration is reduced and indicates a 
secretory defect or rapid degradation. Type II defects show normal plasma   36
concentrations but reduced protein function. Mutations within FH can be classified 
as Type I or Type II according to the same definitions (Perkins & Goodship, 2002). 
Of the 134 currently known mutations in FH, 27 are classified as Type I and 52 as 
Type II, while the rest have an undescribed phenotype (www.fh-hus.org). Type I 
mutations in FH are associated mainly with membranoproliferative 
glomerulonephritis (MPGN), while Type II mutations are principally associated with 
haemolytic uraemic syndrome (HUS). A single Tyr402His polymorphism within FH 
has been strongly linked to the development of age-related macular degeneration 
(AMD) (Klein et al., 2005; Haines et al., 2005; Edwards et al., 2005; Hageman et al., 
2005; Saunders et al., 2007).  
Type I FH mutations have been shown to strongly correlate with development 
of MPGN. MPGN is a rare kidney disease characterized by complement deposition 
within the basement membrane of the glomerular capillary wall. Associated 
phenotypes of this condition include progressive glomerulonephritis, mesangial cell 
proliferation and an increase in mesangial matrix size (Saunders et al., 2006). Type II 
mutations at the C-terminus of FH are mainly associated with atypical HUS (aHUS). 
HUS is a clinical syndrome that manifests with thrombocytopaenia, microangiopathic 
haemolytic anaemia and progressive renal failure. HUS may be classified as 
diarrhoeal (D+ or typical HUS) which occurs in association with enterohaemorrhagic 
Escherichia coli, or non-diarrhoeal (D- or atypical HUS). aHUS is a disease of 
complement dysregulation caused by genetically determined deficiencies in the 
activity of FH and other complement regulatory proteins including MCP and factor I 
(Section 1.3; Amirlak & Amirlak, 2006; Kavanagh et al., 2006). Mutations in FH 
account for up to 30% of all reported cases of aHUS (Kavanagh et al., 2006). The 
primary event for aHUS is endothelial cell activation in which a procoagulant 
phenotype is maintained above a noncoagulant phenotype. Damage of the endothelial 
surface attracts platelets to the site of damage, and where this is enhanced by 
unregulated complement activation in small vessels, blockage of the small vessel 
occurs due to the presence of large numbers of platelets at the site (thrombotic 
microangiopathy). This disease has a poor prognosis and may lead to irreversible 
renal damage and lifetime dependence on kidney dialysis (Kavanagh et al, 2006).  
The Tyr402His polymorphism in FH is strongly associated with AMD, the 
most common cause of blindness in the Western world (Klein et al., 2005; Haines et 
al., 2005; Edwards et al., 2005; Hageman et al., 2005; Saunders et al., 2007). One of   37
the hallmarks of AMD is the appearance of drusen, an amyloid plaque-like deposition 
in the Bruch’s membrane. Drusen contains around 120 oxidised lipids and aggregated 
proteins, including FH. The Bruch’s membrane is a layer interposed between the 
retinal pigment epithelium and the choroidal vasculature (Bird, 1992; Bird et al., 
1995). Both unregulated complement activation at the retina and uncontrolled self-
association of FH are thought to be relevant to drusen formation (Nan et al., 2008a). 
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Chapter Three 
 
Protein structure and interaction measurement   39
(3.1) Introduction to protein structure determination  
Protein structure determination is often necessary to understand the 
molecular basis of protein function. Given an amino acid sequence, it is possible to 
predict the secondary structure of a protein. However, experimental determinations 
of three-dimensional tertiary structures provide more complete structural information 
on interactions between amino acid residues not close together in the primary or 
secondary structure. Protein amino acid sequences can be determined directly by 
mass spectrometry or using Edman degradation, Sanger’s reagent or Dansyl chloride 
methods. They can also be determined indirectly by sequencing the protein gene or 
cDNA. Protein secondary structure can be determined by low-resolution methods 
that analyse the characteristic β-sheet and α-helix contents of the protein, such as 
circular dichroism and Fourier transform infrared spectroscopy. Nuclear magnetic 
resonance (NMR) spectroscopy can also be used to determine protein secondary 
structure.  
For protein tertiary structure determination, there are a variety of low (~ 2-4 
nm) and high (atomic coordinate level) resolution techniques. Low resolution 
techniques include analytical ultracentrifugation (AUC) (Section 3.2), small angle X-
ray and neutron scattering (SAXS and SANS) (Section 3.3) and electron microscopy 
(EM), while high resolution techniques include NMR and X-ray crystallography. 
AUC extracts hydrodynamic and structural information from the sedimentation 
behaviour of macromolecules under high centrifugal forces. Small angle X-ray or 
neutron scattering  studies the diffraction of X-rays or neutrons by macromolecules 
in solution. The resolution of SAXS and SANS can be improved to medium levels 
(0.5-1.0 nm) if combined with biomolecular modelling (Section 3.4).  
EM is a low resolution method that has the same operating principle as light 
microscopy, except that it uses an electron beam and electrostatic and 
electromagnetic lenses to visualise protein molecular shapes. The greater resolution 
and magnification of an electron microscope compared to a light microscope is due 
to the wavelength of an electron being much smaller than that of light. However, not 
only can the high level of electron radiation potentially damage a protein sample, the 
relatively harsh conditions of sample preparation can damage or distort the protein 
structure. For example protein fixation and staining, as well as dehydration and in 
vacuo viewing, are some of the processes that may be involved in sample 
preparation and analysis. In a typical solution, protein molecules may exist in several   40
different conformations rather than a single, ordered orientation. Hence structural 
information obtained under such harsh conditions may not fully represent the 
protein’s native conformation. This is particularly true for flexible molecules with 
interdomain linkers such as FH. Furthermore, a low signal-to-noise ratio means that 
structural information from several macromolecules must be averaged, presenting 
difficulties in analysing highly flexible structures.  
High resolution protein structure determination by NMR utilises the magnetic 
properties of certain nuclei, most notably 
1H and 
13C. Magnetic nuclei within protein 
samples are aligned with a constant magnetic field at different frequencies and then 
exposed to another magnetic field in a perpendicular direction. The perturbation of 
this alignment results in a characteristic absorption energy which differs according to 
the chemical environment of different nuclei within the same molecule. This 
dependence of nuclear magnetic energy levels on the local electronic environment is 
known as chemical shift. The chemical shift is reported as a relative value measured 
against a standard reference signal. In two-dimensional NMR (2D-NMR) used for 
structure determinations, multinuclear NMR and different types of experiments 
allow chemical shifts to be assigned to specific nuclei. Nuclear Overhauser effects 
(Overhauser, 1953) permit the specification of spatial relationships between atoms, 
thus allowing three-dimensional models to be created for the protein structure 
(Wuthrich, 1986). NMR studies proteins in solution, but an upper molecular weight 
constraint of about 35 kDa for most traditional techniques, beyond which the signal 
resolution deteriorates rapidly, means that it is unsuitable for studying relatively 
large proteins in their intact forms. 
In X-ray crystallography, positions of individual atoms are determined by 
interpreting the diffraction of X-rays by protein crystals. The ease of obtaining these 
crystals is affected by the conformational properties of proteins as well as the 
presence of post-translational modifications such as glycosylation. It is difficult to 
grow FH crystals for both reasons. Provided the protein crystals can be grown, this 
method can yield high resolution structures (0.1-0.3 nm). When these crystals are 
exposed to a monochromatic, collimated X-ray beam, electrons within the protein 
scatter the beam, and the resulting diffraction pattern depends on the properties of 
the scattered waves. Thus only waves that are in phase and exhibit constructive 
interference will produce a diffraction spot (Rhodes, 2000). A fundamental 
limitation in interpreting the diffraction pattern is the loss of phase. This occurs   41
because the detector measures only the intensity of the diffracted beam, whereas 
both intensity (amplitude) and phase are needed to determine the electron density 
within the protein. Calculation of the phase of a diffracted beam can be done by 
several methods. Two examples of such methods are molecular replacement (if a 
homologous protein is known) and multiple isomorphous replacement (MIR) using 
heavy atoms (e.g. Selenomethionine) to replace a number of atoms in the protein, 
thereby altering the diffraction properties of the crystal. When molecular 
replacement is done, the resulting replacement molecular model can be fitted to the 
obtained electron density map. When MIR is done, the strong scattering of the 
replacement heavy atoms allows the determination of the phase. Electron density 
mapping of the protein atomic coordinates is done by trial-and-error, and further 
refinement of the structure is carried out using goodness-of-fit R factor and R free 
values.  
 
(3.2) Analytical ultracentrifugation  
(3.2.1) Introduction to the analytical ultracentrifuge 
The analytical ultracentrifuge (AUC)
† is different from preparative 
ultracentrifuges. It combines the features of a preparative ultracentrifuge with a 
sensitive optical detection system that allows the direct measurement of sample 
concentrations within the cells during sedimentation. This makes possible the 
monitoring of sedimentation events in real time, and a combination of these features 
enables the use of AUC to characterise core biophysical properties of molecules, 
rather than as a purification or preparative step for further analysis (Cole & Hansen, 
1999). The most popular analytical ultracentrifuges are the Optima™ or 
Proteomelab™ XL-A and XL-I systems, both made by Beckman Coulter Instruments. 
The XL-A uses UV and visible absorbance optics for absorbance measurements, 
while the XL-I uses integrated absorbance and interference optics for both absorbance 
and interference measurements (McRorie & Voekler, 1993). More recently, 
fluorescence optics have been developed for integration into the XL-I optical system 
(Coleman et al., 2008). 
 
                                                 
† The acronym AUC is generally used in reference to both ‘analytical ultracentrifuge’ and ‘analytical 
ultracentrifugation’.   42
(3.2.2) Uses of analytical ultracentrifugation 
  AUC can be used to assess sample purity, size and shape distributions, 
polydispersity and conformational changes. It can also be used to determine average 
sample molecular weights and kinetic constants for associating systems. 
Sedimentation velocity measurements can provide information on sample 
heterogeneity and polydispersity (Section 3.2.5.1). Sedimentation and diffusion 
coefficients obtained from these measurements can be used to analyse the size and 
shape of molecules and complexes. When this information is combined with average 
molecular weights, it is possible to detect the presence of relatively small quantities of 
contaminants. Sedimentation coefficients, in particular, can be used to track changes 
in the conformation of proteins.  
Molecular weights ranging from several hundreds (for example, sucrose) to 
several millions (for example, virus particles and organelles) can be measured by 
sedimentation equilibrium (Section 3.2.5.2). Equilibrium constants can be derived by 
studying the changes in molecular weight when molecules associate to form a more 
complex structure. Compared to electrophoresis techniques which can provide 
information on the components of a complex and measure their relative stoichiometry 
in the complex, sedimentation equilibrium measurements by AUC can also be used to 
measure the molecular weight of the complex as it exists in solution, independent of 
its shape.  
 
(3.2.3) Theory of sedimentation 
   A particle suspended in a solvent and subjected to a gravitational force is 
acted upon by three forces (Figure 3.1). The sedimenting force, Fs, acts in the 
direction of acceleration of the particle and is proportional to the velocity of angular 
rotation, ω, the radius of rotation, r, and the mass (in grams, g), m.  
 
(Eq. 3.1)   Fs = ω
2rm  
 
In general, the mass of a material can be determined from the equation: 
 
(Eq. 3.2)   m = M 
             n 
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 vρ 
where M is the molar concentration of the material in g/mol, and n is the number of 
moles of the material.  
The buoyant force, Fb, acts in an opposing direction to the sedimenting force. 
Derived from Archimedes’ principle, it is equivalent to the weight of fluid displaced 
by the particle in solution.  
 
(Eq. 3.3) Fb = -ω
2rmO 
 
The mass of fluid displaced by the particle is denoted by mO, and given by the 
equation: 
 
(Eq. 3.4)          mO =            = M     
                  N 
 
where ΰ is the partial specific volume of the particle, ρ is the density of the solvent 
and N is Avogadro’s constant (6.023 x 10
23). The partial specific volume is the 
volume in millilitres (ml) that each gram of the solute occupies in solution and is the 
inverse of its density. The density and viscosity of the solvent can be calculated from 
its composition using tabulated data, or measured directly using a density or viscosity 
meter.  
Provided that the density of the solute is greater than that of the solvent, the 
particle begins to move towards the bottom of the cell in a radial direction when 
gravitational force is applied. As it moves away from the meniscus, its velocity 
increases due to increasing acceleration (a =ω
2r; acceleration is proportional to radial 
distance). A particle moving through a fluid experiences a frictional force Ff 
proportional to its velocity, and acting in an opposite direction to the sedimentation 
force, Fs (Figure 3.1). As the particle moves further along the radius, Ff increases 
proportionally with its velocity.  
 
(Eq. 3.5) Ff  = -ƒu        
 
ƒ is the frictional coefficient and is dependent on the shape and size of the particle. 
Bulky, elongated or rough particles will experience a greater frictional force than 
small, compact or smooth ones. The three forces come into equilibrium within a very 
short time (usually less than 10
-6 seconds). From Figure 3.1, 
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 vρ 
 
(Eq. 3.6) Fs + Ff + Fb = 0 
Substituting values from Equations 3.1, 3.3 and 3.5,  
(Eq. 3.7)  ω
2rm – ƒu – ω
2r        = 0.      
 
Rearranging, 
(Eq. 3.8)   ω
2rm (1 -     ) = ƒu. 
 
Dividing both sides of Equation 3.8 by the common factor and substituting m,  
 
(Eq. 3.9)  M (1- ΰρ) = u ≡ s 
  Nf       ω
2r 
   
The quantity u/ω
2r is called the sedimentation coefficient (s) and is directly 
proportional to the buoyant weight of the particle M(1-  ΰρ), and inversely 
proportional to the frictional coefficient (ƒ). It has a unit of seconds (s), but is 
conventionally expressed in terms of Svedberg units (S) in honour of Thé Svedberg, 
the original inventor of the AUC. Most sedimentation coefficient values lie between 1 
x 10 
-13 s and 100 x 10 
-13 s, and one Svedberg unit is equivalent to 10 
-13 s. Therefore 
a value of 4.5 S would translate to 4.5 x10 
-13 s. Equation 3.9 can be alternatively 
expressed in standard form as the Svedberg equation: 
 
(Eq. 3.10)  M (1- ΰρ) = s 
    RT         D, 
 
where R is the gas constant and T is the absolute temperature in Kelvin. The 
sedimentation coefficient of a particle may therefore be defined as the velocity of the 
particle per unit gravitational acceleration. It is dependent on the following properties 
of the particle: molecular weight, frictional coefficient (a function of its shape and 
size), partial specific volume (volume per gram of particle) and density of the solvent. 
In practice, experimentally-observed s values are often converted to standard 
conditions (water at 20°C) by correcting for the buffer and temperature conditions 
(Balbo & Schuck, 2005). This standard s value is expressed as s
0
20,w.  
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Figure 3.1 
 The forces acting on a solute particle in a gravitational field. Ff and Fb act in 
an upward direction, while Fs and u act downwards (Ralston, 1993).   46
(3.2.4) Instrumentation 
In order to achieve rapid sedimentation and minimize diffusion, the AUC 
must spin samples at relatively high speeds up to 60,000 r.p.m. To minimize friction 
and eliminate aerodynamic turbulence, the rotors are spun in an evacuated chamber. It 
is also important to avoid wobbling or precession (change in direction of axis of 
rotation). This can lead to stirring of the cell contents and, particularly during studies 
with low solute concentration and concentration gradient, can lead to uncertainty in 
the concentration distribution. 
 
(3.2.4.1) The rotor 
At speeds of 60,000 r.p.m., a typical ultracentrifuge rotor generates a 
gravitational force of about 250,000 x g in the cell. Under these conditions of 
enormous gravitational force, a mass of 1g would weigh 250,000 times its weight, 
250 kg. It is therefore necessary that the rotor be capable of withstanding great 
gravitational stress. AUC rotors must also be able to allow the passage of light 
through the cells. These rotors contain either four or eight holes and are capable of 
holding three or seven sample cells respectively, together with a reference cell used 
for radial calibration. The multiple-cell system of operation makes possible the study 
of more than one sample in a single experiment.  
 
(3.2.4.2) The cells 
An AUC cell consists of sample cavities sealed off by two thick windows 
made of optical-grade sapphire or quartz (Figure 3.2) and assembled within a cell 
housing. The material containing the cavities (called sectors or channels) is known as 
a centrepiece. The centrepiece is usually made of aluminium-filled or charcoal-filled 
epon for experiments at speeds up to 42,000 r.p.m., or aluminium for higher speeds. 
The use of specialised materials ensures that the cell is able withstand high 
gravitational forces, does not leak or change shape, and allows the passage of light. 
AUC cells contain two sectors for sedimentation velocity experiments and two, six or 
eight channels for equilibrium experiments. For sedimentation velocity experiments 
using absorbance or interference optics, the column height is 12 mm and the cell is 
sector-shaped because of the radial direction of particle movement during 
sedimentation. If the cell walls are parallel, sedimenting particles will collide with the 
cell walls and cause convective disturbances in the solution. If the cell walls diverge    47
 
 
Figure 3.2 
Sedimentation velocity and equilibrium cell designs. The left panel shows a 
two-sector cell during a sedimentation velocity experiment. The sample is loaded into 
the upper sector, and the reference solution (buffer) is loaded into the bottom sector. 
The sample is centrifuged at high rotational velocity, generating a boundary that 
moves toward the bottom the cell. The right panel illustrates a six-channel 
sedimentation equilibrium cell. Three sample-reference pairs are loaded into the cell, 
which is centrifuged at moderate rotational velocity, resulting in equilibrium 
concentration gradients in each sample channel (Adapted from Cole & Hansen, 
1999).   48
more or less than the radius of sedimentation, disturbances will also occur. In 
contrast, the sedimentation equilibrium cell is shaped like a regular cuboid and is 
usually 3mm long with six channels. The use of shorter cells with eight channels 
enables the quicker attainment of equilibrium and requires less sample volume, but 
does not provide as much information per data set (Cole & Hansen, 1999).  
 
(3.2.4.3) Absorbance optics 
The absorbance optical system of the AUC makes use of a high intensity 
xenon flash lamp and a scanning monochromator that is sensitive enough for 
measurements at wavelengths ranging between 190 and 800 nm (Figure 3.3). The 
xenon lamp ‘flashes’ briefly as the selected sector passes the detector. Timing 
information is provided with the aid of a reference magnet located at the base of the 
rotor. The xenon flash lamp moves radially along the length of the sector, allowing 
different positions of the solute to be scanned. A slit below the sample moves to allow 
the light through to the cells. This way, the AUC can perform wavelength scans at a 
fixed position in the cell, as well as radial scans at a fixed wavelength. Absorbance 
measurements produce good results for molecular species containing strong 
chromophores (for example, proteins at 230 nm and nucleic acids at 260 nm), even at 
relatively low concentrations. In addition, data collection at multiple wavelengths can 
be carried out within the same experiment for species with different absorption 
properties. 
 
(3.2.4.4) Interference optics 
Interference optical measurements are based on the refraction of light as it 
moves from one medium to another. When two beams of light from the same source 
(and therefore of the same wavelength and phase) pass through different media, they 
are refracted to different extents. Superposition of the emergent beams of light from 
the two media will produce a pattern called an interference fringe. The AUC uses the 
Rayleigh interference optical system. In this system, two beams of light are passed 
through the sample and reference sectors. Differences in refractive index occur 
because of different solute concentrations in the two sectors, and an interference 
fringe is produced when the two emergent beams are superposed. During 
sedimentation experiments, a displacement of the interference fringe pattern occurs 
due to changes in solute concentration at the boundary region.    49
  
 
 
Figure 3.3 
Schematic diagram of the optical system of the Beckman Optima™ XL-A 
AUC (Taken from Ralston, 1993). 
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Because virtually all materials refract light, interference optics can be used to 
analyse samples that do not contain natural chromophores. Also, the high sensitivity 
of interference measurements means they can be used to study solutions which are 
too dilute for absorbance measurements. This method is useful for samples of high 
molecular weight or complex associating systems because scans can be collected 
more rapidly and frequently than for absorbance optics. It can also be used to analyse 
associating systems since fringe displacement is proportional to sample concentration 
over a wide range. It is particularly useful for measurements of samples containing 
strongly absorbing buffer components, as well as for measurements at high sample 
concentrations (at which the absorbance optics are saturated). 
 
(3.2.5) Applications of analytical ultracentrifugation 
The AUC can be used to perform two basic types of experiments: 
sedimentation velocity and sedimentation equilibrium.  
 
(3.2.5.1) Sedimentation velocity 
In a sedimentation velocity experiment, a sufficiently high angular velocity is 
applied to a solute suspended in solvent. Initially there is uniform concentration of 
solute throughout the solution. As the velocity increases, there is relatively rapid 
movement of solute away from the meniscus toward the bottom of the cell. The 
movement of solute particles causes a reduction in its concentration near the meniscus 
(Figure 3.4 (a)). With time, a sharp boundary is formed between the depleted region 
and the uniform concentration of sedimenting solute. Although movement of 
individual particles cannot be analysed, the change in concentration at the boundary 
region causes a gradual shift of the concentration boundary. Measurements of the rate 
of boundary movement and broadening are taken as a function of time, and this can 
be analysed to determine the sedimentation coefficient. As the boundary moves down 
the cell, boundary broadening from diffusion occurs and the concentration in the 
plateau region reduces due to radial dilution (Figure 3.4 (a)). Solute particles moving 
from the narrower end toward the bottom are dissolved in an increasingly larger 
volume of the solvent and a small drop in the solute concentration consequently 
occurs. Each species of solute in solution will produce a different concentration 
boundary in a sedimentation velocity experiment. Thus, single or multiple 
sedimenting boundaries can be taken as evidence of homogeneity or heterogeneity of   51
the sample. In some cases, two components of the system may have sedimentation 
coefficients so similar that they cannot be easily separated. Such components will not 
be well resolved by sedimentation velocity. 
  
(3.2.5.2) Sedimentation equilibrium 
In sedimentation equilibrium experiments, a small volume of an initially 
uniform solution is centrifuged at a lower angular velocity than required for a 
sedimentation velocity experiment. As the solute begins to sediment towards the 
bottom of the cell and the concentration at the bottom increases, the process of 
diffusion opposes the process of sedimentation. After an appropriate period of time, 
the two opposing forces reach equilibrium (Figure 3.4 (b)).  This technique is 
sensitive to the mass but not the shape of the molecules. When several species with 
different molecular weights are present, each of the species will be distributed over 
the sample cell until it reaches equilibrium. As a consequence, higher molecular 
weight species will be located towards the bottom of the cell, while the lower 
molecular weight species will dominate at the top. It provides complementary 
information to sedimentation velocity measurements and when both techniques are 
combined, the best results can be obtained. The molecular weight (MW) of the 
sample is determined according the equation: 
 
(Eq. 3.11) cr = cro exp [(ω
2/2RT) MW (1- v ρ) (r
2 - ro
2)], 
 
where cr is the concentration at radius r, cro is the concentration of the protein at the 
reference radius ro,  ω is the angular velocity, R is the gas constant, T is the 
temperature (Kelvin), and ρ is the density of the buffer. 
 
(3.2.5.3) Analytical ultracentrifugation data analyses 
  There are a number of methods for analysing AUC data, with many 
alternative approaches and software packages available. For sedimentation velocity 
experiments, examples of data analysis programmes include the time derivative dc/dt 
transformation DCDT+ (Stafford, 2000; Philo, 2006), the c(s) analysis (SEDFIT) and 
global analysis of interacting systems (SEDPHAT) software (Schuck, 1998; 2000;   52
 
 
Figure 3.4 
  Boundary movement in sedimentation velocity and equilibrium experiments. 
(a) Movement of the boundary in a sedimentation velocity experiment as the 
boundary progresses down the cell. (b) Schematic representation of sedimentation 
equilibrium. Sedimentation is balanced by diffusion, which increases with 
concentration gradient. The boundary is shaped like an exponential curve as a result 
of the balance between sedimentation and diffusional forces.   53
2003), the Van Holde-Wieschet method in ULTRASCAN (Van Holde & Wieschet, 
1978; Demeler & Van Holde, 2004; Demeler, 2005), and an alternative 
implementation of boundary modelling of reactive systems in time-difference mode, 
SEDANAL (Stafford & Sherwood, 2004). Other examples are the direct boundary 
modelling software LAMM (Behlke & Ristau, 1997) and SVEDBERG (Philo, 1997). 
For sedimentation equilibrium experiments, examples of analysis programmes 
include WINNONLIN (Johnson & Straume, 1994), HETEROANALYSIS (Cole, 
2004) and ULTRASPIN (Cole et al., 2008), all of which are specifically designed to 
implement a nonlinear least squares algorithm. Other programmes that can also be 
used for this include SEDPHAT, SEDANAL and ULTRASCAN. Software that 
implement the molecular weight moment determination method include SEDANAL, 
ULTRASPIN (Cole et al., 2008) and MSTAR (Harding et al., 1992).  
In this thesis, two approaches were used for analysing sedimentation velocity 
data, namely the dc/dt and c(s) methods. In the dc/dt method, a number of closely-
spaced scans are subtracted in pairs to approximate (∆c/∆t) the time derivative of the 
data and determine how much material is sedimenting at various rates (Philo, 2006; 
Cole et al., 2008). Subtraction removes systematic noise, following which the data is 
transformed to an apparent sedimentation coefficient distribution g(s*). Several pairs 
of scans are averaged to improve the signal-to-noise ratio. Individual peaks in the 
g(s*) distribution can be fitted to Gaussian functions to derive the concentration (from 
the peak area), the sedimentation coefficient (from the centre position) and the 
diffusion coefficient (from the width of the peak) for homogeneous species or non-
interacting mixtures (Philo, 2006). The dc/dt analysis can provide a simple means to 
assess homogeneity and stoichiometry (for interacting species). For example, a shift 
in peak position with increasing concentration is evidence for a mass-action 
equilibrium where the species interact on the timescale of sedimentation. It is 
important to restrict the number of scans analysed to values below the peak 
broadening limit calculated by the software (DCDT+ version 2.06). This is because as 
the time span increases, the ∆c/∆t curve calculated from each pair of scans deviates 
more from the true derivative, dc/dt. This deviation can lead to errors in diffusion 
coefficients.   
The second approach used in this thesis is the c(s) analysis implemented in 
SEDFIT (Schuck, 1998; 2000), which describes a superposition of sedimentation 
boundaries of many species with different sedimentation coefficient (s) values (Balbo   54
& Schuck, 2005). The sedimentation boundary for each species is fitted according the 
Lamm equation (Lamm, 1929), which is derived by combining the law of diffusion 
with centrifugal migration. Analysis using SEDFIT does not restrict the number of 
scans that can be loaded, and this is an important difference from the dc/dt method. In 
addition, diffusion broadening is deconvoluted from the distribution based on the 
scaling relationship between s and D (Equation 3.10). c(s) analyses take into account 
the diffusion of all species by assuming the same frictional ratio for all sedimenting 
species (Schuck, 2000). The frictional ratio f/fO is a measure of macromolecular 
elongation, where f is the observed frictional coefficient (Section 3.2.3), and fO is the 
frictional coefficient  of a sphere with the same volume as the hydrated 
macromolecule. The assumption of equivalent frictional ratio is based on the fact that 
f/fO is not very sensitive to shape changes, and hence will be similar for broadly 
analogous molecules. The c(s) analysis results in peaks that reflect the populations of 
different sedimenting species, along with residuals for assessing goodness-of-fit. 
Since the c(s) distribution is a calculated curve obtained from modelling the raw data, 
it is important that the goodness-of-fit parameters (boundary fits, r.m.s.d. values, and 
residuals bitmaps) are carefully inspected to determine if the model adequately 
describes the experimental data. In general, the c(s) analysis will be strictly accurate 
only for dilute monodisperse samples or non-interacting protein mixtures.  
For interacting mixtures, it is more difficult to assign peaks to discrete 
sedimenting species due to the presence of reaction boundaries (Dam & Schuck, 
2005; Brown & Schuck, 2006). Reaction boundaries are peaks that correspond to the 
co-sedimentation of both free and complexed species. They are distinct from 
undisturbed boundaries, which correspond to discrete (free, uncomplexed) 
sedimenting species. Reaction boundaries occur in distinct proportions and at well-
defined sedimentation coefficients in-between the s values of the free and complexed 
components (Scott & Schuck, 2005). However, if the peaks exhibit moderate or 
higher stability, the c(s) distribution and peak positions can give valuable insights into 
the reaction scheme and stoichiometry. Integration of the c(s) peaks gives the 
concentrations of the species. For a distribution containing a single major peak, the 
c(s) distribution can be transformed to a molar mass distribution c(M). A c(M) 
distribution may also be used for heterogeneous and interacting mixtures. In such 
cases the accuracy will depend on the degree of similarity of the f/fo values for the   55
different species, and the analysis will be valid only for peaks that correspond to 
sedimenting species and not reaction boundaries.  
  For sedimentation equilibrium experiments in this thesis, determination of 
molecular mass and equilibrium (association and dissociation) constants was done 
using the nonlinear least squares fitting method implemented in SEDPHAT (Schuck, 
2003). Generally, interactions in sedimentation equilibrium lead to an increased 
steepness of the sedimentation profile (Figure 3.4(b)) for reason of the species with 
higher molecular mass. A model-free analysis of sedimentation equilibrium data of 
interacting systems can be implemented in the form of weight-average molecular 
mass as a function of loading concentration (Equation 3.11; Balbo & Schuck, 2005). 
Interaction is revealed by an increase in average molecular mass with sample 
concentration. Where the reaction scheme is known, data can be fitted with specific 
models to determine equilibrium constants. In this thesis, prior knowledge on the 
reaction scheme was obtained by sedimentation velocity (Chapters 4; 6). Global 
analysis of several concentrations at different speeds can be used to improve the 
accuracy of the analysis. As for SEDFIT analysis, the goodness-of-fit parameters 
provide a good indication as to whether the chosen model adequately describes the 
experimental data. 
 
(3.3) Solution scattering 
(3.3.1) Introduction to solution scattering 
Solution scattering is a low resolution diffraction technique that is used to 
study the overall structure of biological macromolecules in random orientations 
(Perkins  et al., 2008). X-ray crystallography is the most powerful method of 
obtaining three-dimensional models of proteins at atomic resolutions of up to 0.1 nm, 
but only allows molecules to be viewed in a fixed orientation. In contrast, solution 
scattering allows structures to be viewed at resolutions of about 2-4 nm, but in 
various orientations. Not only does solution scattering complement crystallographic 
investigation, it can also provide the only means of analysing multidomain protein 
structures that are not crystallisable for various reasons, such as heavy glycosylation 
or the presence of flexible inter-domain linkers. The technique also minimizes the 
need for non-physiological high concentrations of sample, meaning that proteins can 
be studied at lower concentrations which often more closely resemble physiological 
conditions. Scattering experiments performed over time can be used to monitor   56
biological events such as conformational changes or oligomerisation processes. In 
comparison to other methods of biological structure determination such as 2D-NMR, 
EM and AUC, solution scattering provides a useful complementary approach to 
structural studies (Perkins et al., 2008).  
 
(3.3.2) Types of solution scattering 
Two common types of solution scattering experiments are X-ray and neutron 
scattering (static and dynamic light scattering experiments are a third type). X-rays 
are diffracted by electrons, and neutrons by nuclei, but all types of scattering 
experiments make use of the same physical principle. A sample solution is irradiated 
by a highly collimated (divergent or convergent rays converted into a bundle of 
parallel rays with minimum divergence or convergence) beam of X-rays or neutrons. 
The intensity of the scattering curve I(Q) is measured as a function of the scattering 
angle  2θ ( Figure 3.5), where the scattering vector Q = 4π sin θ/λ and λ is the 
wavelength.  
The overall radius of gyration (RG) and the forward scattering at zero angle 
I(0) can be obtained at small values of the scattering vector Q (Figure 3.6), while the 
cross-sectional radius of gyration (RXS)  can be determined at higher Q values. 
Solution scattering Q ranges are usually between 0.05-3 nm
-1, and analysis of the 
scattering curve by indirect Fourier transform gives the distance distribution function 
P(r), from which the maximum dimension of the molecule and its shape can be 
deduced. When used in conjunction with information from known protein sequences 
and crystal structures, the structural resolution of solution scattering is improved to a 
medium-resolution level of about 0.5-1.0 nm, which is the same resolution provided 
by homology modelling (where a known crystal structure is used to model another 
related protein). 
 
(3.3.3) Theory of Solution Scattering 
Diffraction is described by Bragg’s Law according to the equation 
 
(Eq. 3.12)   λ = 2d sin θ, 
 
where d is the diffraction spacing, and 2θ is the angle of diffraction (or scattering 
angle). In solution scattering, d corresponds to dimensions of 1-100 nm. Scattering   57
 
 
Figure 3.5 
A schematic diagram showing the scattering angle (2θ) from the main beam.   58
angles are given in terms of the scattering vector Q. The resolution of a scattering 
experiment is usually defined by 2π/Qmax (where Qmax is the largest Q value measured 
in the experiment). For any pair of scattering elements (electrons for x-rays, nuclei for 
neutrons), when 2θ is zero, the scattered waves are in phase and the intensity of 
scattering is at a maximum. Therefore, at 2θ = 0, the intensity of scattering, I(0), is a 
direct measure of molecular mass. 
When Q and 2θ are non-zero, the intensity of scattering I(Q) is given by the 
Debye equation:  
 
 (Eq. 3.13)  I(Q) = Σ Σ  fp fq   sin(rQ) 
                p q            rQ 
 
where the terms fp and fq (or bp and bq for neutrons) are the scattering lengths of the 
electrons (or nuclei) at points P and Q in the molecule, and r corresponds to the 
distance between P and Q. Whereas scattering length, f, is proportional to atomic 
number for X-rays, b for neutrons is roughly similar for different nuclei with the 
exception of 
1H (Table 3.1). The scattering density of a molecule is the total of all the 
scattering lengths within that molecule divided by its molecular volume.  
 
(3.3.4) Properties of X-ray scattering experiments 
 (1)  Most biological macromolecules are studied in high positive solute-solvent 
contrasts; only lipids have an electrical density less than that of water. Because 
positive contrast usually corresponds to the situation when the scattering density of 
the whole macromolecule is significantly higher than that of the solvent, the effect of 
this is to minimize systematic errors in the curve modelling of proteins and 
glycoproteins as internal density fluctuations can be neglected. 
(2)  Good counting statistics are obtained in this positive contrast, provided that 
high background levels from the instrument are minimized. This is not always 
possible at low Q values due to high instrumental background scattering levels. In 
distinction, the positive contrasts obtained using neutron data for samples in H2O 
buffers suffer from a high incoherent scattering background, as a result of which 
neutron signal-noise ratios can be poor for dilute samples.   59
 
 
 
Figure 3.6 
Definition of the scattering vector, Q. Q is usually measured in nm
-1, and ki 
and ks are the momentum of the incident and scattered rays, respectively.   60
 
Figure 3.7 
General features of a solution scattering curve showing the Guinier region at 
low and high Q values.    61
(3)  Instrumental errors caused by wavelength polychromicity and beam 
divergence are minimal for X-ray scattering experiments. Thus Guinier and wide-
angle analyses are not affected by systematic errors caused by the instrument 
geometry, and curve corrections do not have to be applied. 
(4)   X-ray scattering reveals the hydrated dimensions of the macromolecule. In 
solution, a monolayer of water molecules is hydrogen bonded to the protein surface, 
meaning that the electron density of bound water is increased compared to that of 
bulk water. The macromolecule is made to appear larger by the thickness of this 
water monolayer, which is readily detected by X-rays. 
 
(3.3.5) Instrumentation 
The probability of a diffraction event when an X-ray photon approaches an 
electron is very low at 10
-25. In distinction to the use of scattering in other disciplines 
such as chemistry or metallurgy, a drawback of biological experiments lies in low 
signal-to-noise ratios. This is because biological samples are typically dilute 
compared to other disciplines. The use of high flux sources overcomes this limitation. 
High flux X-ray sources characteristically comprise a synchrotron to 
accelerate an electron beam to high energies and a storage ring to maintain this beam 
for several hours. The electrons in the storage ring travel at very high speeds, and are 
constrained in a circular ring trajectory by electromagnets. This causes them to 
radiate energy, including X-rays. The lost energy is replenished by an oscillatory 
radiofrequency electric field. The use of magnetic devices such as undulators or 
wigglers improves the beam brightness. The brilliance of a synchrotron source (the 
flux divided by the angle through which the radiation is emitted and by the cross-
sectional area of the source) is the most important parameter for solution scattering. It 
is usually expressed in units of number of photons-s
-1.mrad
-2.mm
-2 per 0.1% relative 
bandwidth, and is often plotted as a function of photon energy or wavelength. Other 
important properties of synchrotron radiation for solution scattering are the very good 
intrinsic collimation of the beam and the range of wavelengths available (Perkins et 
al., 2008). 
 
(3.3.6) X-ray sources 
There are about 50 X-ray synchrotron sources in the world, of which the 
largest and most powerful ones are currently the 8 GeV (Giga electron Volt) super   62
  (a)  
   Atomic 
number 
f(2θ = 0º) 
(fm) 
B (fm) 
Hydrogen 
1H 
2H 
1 
1 
2.81 
2.81 
-3.742 
6.771 
Carbon 
12C 6  16.9  6.651 
Nitrogen 
14N 7  19.7  9.40 
Oxygen 
16O 8  22.5  5.804 
Phosphorus 
31P 15  42.3  5.1 
 
(b) 
Macromolecule X-rays   
(e
·nm
-3) 
Neutrons 
(% 
2H2O) 
H2O 
2H2O 
334 
334 
0 
100 
50 % (w/w) sucrose in H2O  402 13 
Lipids  310-340 10-14 
Detergents  300-430 6-23 
Proteins  410-450 40-45 
Carbohydrates  490 47 
DNA  590 65 
RNA  600 72 
 
 
 
Table 3.1  
Examples of scattering lengths and densities (Perkins, 1988a). 
(a) Scattering lengths of biologically important nuclei  
(b) Scattering densities of solvents and biological macromolecules.   63
 
 
Figure 3.8 
Linear relationship between the molecular weight and neutron I(0)/c values 
for glycoproteins in 100% 
2H2O buffer on the LOQ instrument (Perkins et al., 2008).  
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Figure 3.9 
            Schematic layout of the X-ray ID02 beamline at ESRF. The undulator provides a high photon flux with a low divergence. Only the central 
radiation cone of the undulator is used. The beamline optics consist of a cryogenic- (liquid nitrogen) cooled Si-111 channel-cut monochromator 
and a focusing torroidal mirror. There are two separate experimental stations, one for combined small/ wide angle scattering and the other for 
ultra-small angle scattering (not shown) (Perkins et al., 2008).   65
photon ring (Spring8) near Kyoto, Japan, the 6 GeV European synchrotron radiation 
facility (ESRF) in France, the 7 GeV advanced photon source (APS) in Chicago, 
Illinois, USA. Recently, a third-generation 3 GeV synchrotron (Diamond) has 
commenced full operation in the UK. The first accelerators (cyclotrons) were built by 
particle physicists in the 1930s, and atomic nuclei were split in these using the 
collision of high energy particles. Synchrotron radiation was seen for the first time at 
General Electric (USA) in 1947 in a different type of accelerator (synchrotron). It was 
first considered a nuisance because it caused the particles to lose energy, but it was 
then recognised in the 1960s as light with exceptional properties. A schematic 
diagram of the ID02 beamline at ESRF is shown in Figure 3.9. 
 
(3.3.7) Data Interpretation 
(3.3.7.1) Guinier Analyses 
At sufficiently low Q values, the Debye equation becomes the Guinier 
approximation (Perkins, 1988a; 1988b). The overall radius of gyration RG and the 
scattering intensity at zero scattering angle I(0) parameters are obtained from a plot of 
ln I(Q) against Q
2 (where Q is the scattering vector) (Figure 3.10):  
 
(Eq. 3.14)  ln I(Q) = ln I(0) – RG
2Q
2 
         3 
The RG parameter characterizes the degree of elongation of the structure. It is 
analogous to the sedimentation or diffusion coefficients of hydrodynamic 
experiments. I(0) is proportional to Mr
2 (Mr = relative molecular mass). Guinier plots 
are valid only at low Q, but the lowest Q values cannot be measured for reason of 
overlap with the main beam and beam stop. The smallest Q required to measure RG is 
given by Q.Dmax  ≤  π, where Dmax  is the maximum particle dimension (Glatter & 
Kratky, 1982). The largest Q permitted in Guinier plots depends on the particle shape, 
but the value of Q.RG is generally no larger than 1.5. The cross-sectional radius of 
gyration  RXS can be calculated for rod-like and ellipsoid shapes according to the 
general formula: 
 
(Eq. 3.15)  ln[I(Q).Q] = ln[I(Q)Q]Q→0 – RXS
2Q
2, 
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where [I(Q)Q]Q→0 is the cross-sectional intensity at zero angle and curve fit analyses 
are done in a different Q range that is larger than, and does not overlap with, the one 
used for the RG  determinations (Figure 3.10). The RG and RXS analyses lead to the 
triaxial dimensions of the macromolecule if the structure can be represented by an 
elliptical cylinder, where the maximum dimension, L, is given by the equation 
 
(Eq. 3.16)   L = √ 12(RG
2 - RXS
2) 
 
Concentration series for the samples should yield linear, reproducible Guinier 
plots. Molecular mass analyses are based on the I(0) parameter of Guinier plots. Thus 
after normalisation of the sample concentration, c, the I(0)/c values obtained in a 
given measurement will yield relative Mr data. It is important to note that absolute 
molecular mass values cannot be calculated from X-ray experiments, but can be 
obtained from neutron studies (Figure 3.8). Once validated using the I(0)/c values, the 
RG values can be analysed to obtain the mean and standard deviation. From the 
available data, the magnitude of any concentration dependence of the RG data can be 
determined. If the RG increases with dilution, interparticle effects may be important 
(when the protein molecules are too close together). If it decreases with dilution, 
dissociation may be occurring. In order to interpret the RG value properly, it must be 
compared with that calculated for a sphere of the same hydrated volume (RO). RG /RO, 
or the anisotropic ratio, will indicate the degree of macromolecular elongation when 
compared to a set of standard values for different shapes (Perkins, 1988b). 
 
(3.3.7.2) Distance distribution function analyses 
The distance distribution function P(r)  is measured in r units of nm and 
reveals the structure of the macromolecule in real space, in contrast to the scattering 
curve which is measured in reciprocal space with units of nm
-1. Indirect Fourier 
transformation of the scattering curve I(Q) yields the distance distribution function if 
a value for the maximum dimension L is assumed. Its main advantage is that L is 
readily obtained from the point where P(r) drops to zero (Figure 3.11). At this point r 
= L. This transformation requires the range 0 ≤ Q ≤ ∞, a range which introduces some 
difficulty, since data points will be missing at the lowest Q values due to the beam 
stop, and are truncated at the highest Q values at the limit of the active detector region 
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Figure 3.10 
Guinier RG and RXS analyses of SCR-1/5 and SCR-16/20 of FH. The I(Q) data 
in the Guinier regions used to obtain RG values are denoted by filled circles in the 
range enclosed by arrows. Plots are displaced arbitrarily on the intensity axis for 
reason of clarity (Chapter 4).  
   68
 
 
Figure 3.11 
Distance distribution functions P(r) for SCR-1/5 and SCR-16/20 of FH. The 
maximum of the P(r) curve is denoted by M, the most frequently occurring 
intramolecular distance. L denotes the maximum length, which is taken to be where 
the P(r) curve intersects P(r) = 0 (Chapter 4). 
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This problem is dealt with by the use of an automated procedure, the GNOM program 
of Svergun (Semenyuk & Svergun, 1991) which makes use of 10 to 20 B- spline 
mathematical functions optimally fitted to the scattering curve in order to represent 
the data as a continuous analytical function, after which the B-splines are transformed 
to give P(r).  
 
(3.4) Biomolecular modelling 
(3.4.1) Scattering curve modelling 
After data processing, molecular modelling of the X-ray and neutron 
scattering curves is performed to verify and extend data interpretation. The 
fundamental principle of scattering modelling is the generation of a three-dimensional 
model for a structure that will give rise to a calculated scattering curve corresponding 
to that observed experimentally. Scattering modelling improves the utility of solution 
scattering by providing a means of ruling out classes of structures that are 
incompatible with the experimental scattering curves. It is especially useful for 
multidomain proteins for which overall structures are unknown, yet molecular 
structures are available for all of the individual domains. Examples of such cases are 
large multidomain proteins that are not crystallisable (while intact) for reason of 
interdomain flexibility or heavy surface glycosylation. It should be noted that unique 
structures cannot be determined by this method. However it can be used to identify a 
group of best-fit conformers that meet well-defined selection criteria (Section 3.4.2). 
An outline of the modelling procedure is shown in Figure 3.12.  
 
(3.4.1.1) Analysis of protein composition 
  The first step towards solution scattering modelling is to determine essential 
protein parameters from the amino acid composition of the protein using the program 
SLUV (Perkins, 1986). SLUV also takes into account the actual or putative 
carbohydrate content of the protein. The most important parameters are the protein 
partial specific volume, estimated molecular mass and molecular volumes (hydrated 
and unhydrated). For concentration measurements, the absorption coefficient (at a 
wavelength of 280 nm) is calculated from the tryptophan, tyrosine and cysteine 
content of the protein (Perkins, 1986). 
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(3.4.1.2) Creating atomic models 
The use of known atomic structures to constrain the modelling of the 
scattering curve greatly improves the usefulness of the information provided by 
structural modelling. The first stage of this process is to identify the atomic structures 
that best represent the subunits of the full structure to be modelled, whether directly 
obtained from crystal or NMR structures, or indirectly by the application of 
homology or “comparative” modelling.  
 
(3.4.1.3) Molecular model searches 
After identifying the subunit structures, a set of molecular models, typically in 
the range of 2,000-10,000 is generated in random conformations. The details of the 
so-called “search” will depend on certain features such as the type of molecule that is 
being modelled, the quality of the atomic coordinates being used and hence the 
particular parameter that is being modelled, and its interaction with other molecules. 
Thus a search can be carried out in a variety of ways aimed at different permutations 
of the particular feature that is being randomly varied in the models. 
For a multidomain or multifragment protein, a translational search optimises 
the relative positions of the individual fragments within each molecule, while a 
rotational search is based on an automated set of systematic domain rotations with a 
fixed interdomain separation. A translational search therefore looks for the 
interdomain or inter-fragment distances without changing the domain rotational 
positions, while a rotational search looks for different possible rotations while 
keeping the interdomain distances fixed. This approach has been used to successfully 
model factor I of complement (Chamberlain et al, 1998). 
Symmetry often plays a role in the curve modelling of oligomeric proteins, 
and these considerations lead to the most precise scattering modelling fits. In this 
method, the symmetry of the oligomer (where known) is fixed while doing a 
translational search to optimise the positions of the monomers. One molecule can be 
held fixed while the other is translated along the symmetry axis in short steps of, say, 
0.1 nm. This method was successfully used in modelling AmiC, a two-domain 
periplasmic binding protein existing in a monomer-trimer equilibrium, and RuvA, a 
disc-shaped tetrameric molecule that forms face-to-face octamers and binds to a four-
stranded DNA helix structure called a Holliday junction (Chamberlain et al, 1998).   71
Additionally for multidomain proteins, it is sometimes better to replace the 
straightforward rotational and translational searches using a fragmented subunit 
structure with a full covalently-connected structure. This avoids the arbitrary nature 
of these searches, as each model is now stereochemically correct before it enters the 
curve fit process. If the conformationally variable inter-domain linker peptides are 
modelled using structural libraries calculated by molecular dynamics simulations, full 
models of the protein are generated by an automated process that assembles randomly 
selected linker peptides with the individual domains to create the full structure. Curve 
fits then become a trial-and-error procedure that is left to run until a sufficient number 
of good-fit solutions are obtained. This method has been used successfully with SCRs 
1/20, 1/5, 6/8 and 16/20 of FH (Aslam & Perkins, 2001; Fernando et al., 2007; 
Chapter 4). 
 
 (3.4.1.4) Sphere modelling 
The next stage is to convert the randomly generated three-dimensional protein 
molecular models into sphere models consisting of small non-overlapping spheres of 
uniform density and with the same total sphere volume as the dry protein. If a single 
subunit protein with a known rigid, well-defined and high-resolution structure is 
being studied, the coordinates of the atomic structure or model are converted directly 
to spheres by placing all the atoms within a three-dimensional grid of cubes of side 
about 0.6 nm. A cube is included as a sphere in the model if it contains sufficient 
atoms above a specified cut-off level such that the total volume of all the cubes that 
result from this cut-off equals that of the unhydrated protein calculated from the 
sequence. If residues are missing in the crystal structure or a homologous crystal 
structure is used, the ensuing volume discrepancy can be compensated by adjustment 
of the cut-off value for sphere generation in structures. The simplest way to hydrate 
the cube models is to increase the size of the cubes so that their total volume matches 
the hydrated volume. However, this can significantly distort the macromolecular 
structure if, for example, there is a void space at its centre. An improved approach is 
to add a layer of additional spheres evenly over the surface of the dry sphere model, 
where the total number of spheres gives the hydrated volume (Perkins, 1986; Ashton 
et al., 1997; Perkins et al., 2008).  
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 (3.4.1.5) Debye scattering curve calculation  
Curves are calculated from Debye’s law adapted to small spheres (Perkins et 
al, 1998): 
      m 
(Eq. 3.17)    I(Q) = g(Q) (n
-1 + 2n
-2 Σ Af sin Qrj 
          I(0)     
j=1      Qrj 
 
(Eq. 3.18)   g(Q) = (3(sin QR – QR cos QR))
2/Q
6R
6, 
 
where g(Q) is the squared form factor for the sphere of radius R, n is the number of 
spheres filling the body, Aj is the number of distances rj for that value of j, rj is the 
distance between the spheres, and m is the number of different distances rj. These 
spheres have to be sufficiently small (about 0.6 nm) so that their form factor in the 
Debye equation is almost invariant in the Q scattering range used. Interference 
between scattered waves gives rise to diffraction phenomena and consequently the 
spatial arrangement of electrons in the protein determine the scattering curve. The 
curves generated from this calculation can be compared directly with experimental 
curves to determine best-fit models. 
 
(3.4.2) Identification of best-fit models 
The identification of best-fit models and the removal of unsatisfactory models 
is achieved by the use of four filters: 
(1)  The systematic creation of models can result in physically unreasonable steric 
overlaps between domains or subunits. This is readily detected by the grid 
transformation which will give too few spheres if significant overlap occurs, and so a 
requirement of at least 95% of the expected total of spheres is necessary to ensure that 
only good models are selected. 
(2) The  RG and RXS values determined from the calculated curves in the same Q 
ranges used in the experimental Guinier fits of the experimental data are required to 
be within 5% of the experimental values in a good model. 
  (3)  The remaining good models are then assessed using a goodness-of-fit R-
factor, a rank ordering of all the good models to define the best-fit structures. An R 
factor is calculated for a quantitative comparison of each model scattering curve 
I(Q)cal against experimental scattering data I(0)exp over the whole Q range, where 
I(Q)cal is set as 1000. R factor is given by the equation:   73
 
(Eq. 3.19) R  =  Σ | I(Q) exp – I( Q) cal | x 100% 
            Σ | I(Q) exp | 
 
The R factor used here is analogous to that used for the refinement of crystallographic 
models. A good fit should therefore have an R factor less than 10%. A large 
spreadsheet is prepared with the geometrical steps used to define each model, the 
number of spheres in it, the RG and RXS values, and the R factor values. This is used to 
optimize the best cut-off filters, sort the models, and identify the best family of 
structures.  
(4) Sedimentation  coefficients of the best-fit models are calculated from the 
hydrated sphere models used for X-ray fits for comparison with the experimental 
values as an independent monitor. 
 
(3.4.3) Calculation of hydrodynamic properties 
Sedimentation coefficients are calculated directly from the hydrated scattering 
sphere models using the HYDRO program, (Garcia de la Torre et al., 1994) and also 
directly from the atomic coordinates in the HYDROPRO shell modelling program 
using the default value of 0.31 nm for the atomic element radius for all atoms to 
represent the hydration shell. (Garcia de la Torre et al., 2000). The sedimentation 
coefficient values are the final independent filter for the best-fit molecular models. 
 
(3.5) Introduction to protein interaction measurement 
Studying the interaction of a protein with ligand can often provide insight into 
its structure and help to clarify structure-function relationships. There are several 
methods used to detect these interactions, with varying degrees of specificity and 
sensitivity. In addition to AUC and solution scattering (Sections 3.2; 3.3), examples 
include co-immunoprecipitation, enzyme-linked immunosorbent assay (ELISA), label 
transfer, protein-protein docking, fluorescence resonance energy transfer (FRET) and 
surface plasmon resonance. Co-immunoprecipitation of endogenous proteins using 
antibodies is one of the most popular assays for verifying real interactions between 
suspected interaction partners. In this method, interacting proteins are identified by 
Western blotting, but since the technique involves specific interactions, it cannot be 
used for screening assays. In the ELISA technique, a protein is immobilised on a solid    74
 
 
Figure 3.12 
Flow chart of the automated modelling procedure (Taken from Perkins et al., 
2008).   75
support (usually plastic) either directly by adsorption or indirectly by high affinity 
molecular capture (for example, using an antibody). When the interaction partner is 
added, interaction is detected using an enzyme-linked antibody specific for the 
interaction partner. Substrates for the enzymatic detection are usually chromogenic 
or fluorogenic. The label transfer technique involves transferring a label between 
two interacting proteins, and this can provide information about reaction sites. It can 
be used for in-vitro screening of weak or transient reactions that are difficult to study 
using other methods. Protein-protein docking is a method involving computational 
modelling based on known structures for two potentially interacting molecules. 
Since this method is based on physical principles, it can be used to study relatively 
unknown interaction partners. However, it needs to be complemented and verified by 
experimental methods. FRET is a method based on the transfer of energy between 
two chromophores located within a certain distance (typically within 10 nm) of each 
other. Interactions can be studied if these chromophores are located on different 
potentially interacting molecules. 
 
(3.5.1) Surface plasmon resonance 
Surface plasmon resonance (SPR) is a phenomenon in which electron charge 
density waves (plasmons) are excited at the surface of a thin conducting film by 
incident light. It is the basis of measuring the interactions of molecules with material 
fixed on planar metal surfaces or metal nanoparticles. In its simplest form, SPR 
measurements can be used to detect changes in refractive index caused by binding of 
one molecule to another. The first biosensor based on SPR was developed in the early 
1990s (Jönsson et al., 1991; Jönsson & Malmqvist, 1992), and this technique is now 
very widely used for analysing macromolecular interactions. The Biacore™, 
manufactured by GE Healthcare, is the most widely-used SPR-based system and 
offers particular advantages for analysing weak macromolecular interactions (Van der 
Merwe, 2000).  
Light passing from a medium with higher refractive index to one with lower 
refractive index is partly reflected and partly refracted. Above a certain critical angle 
of incidence, no light is refracted across the refractive index interface, and total 
internal reflection is observed. Under conditions of total internal reflection, incident 
light generates an evanescent wave field that passes a short distance (tens to hundreds 
of nanometers) across the refractive index interface between different media. If this    76
 
 
 
 
Figure 3.13 
Diagram illustrating the SPR principle. (a) shows the Biacore™ detection 
setup, while (b) illustrates the reduction of reflected light intensity on binding of 
molecules to the sensor chip surface. (Adapted from the Biacore X100 handbook, 
2008)   77
interface is coated with a thin layer of metal, and the light is monochromatic and 
plane-polarised, the intensity of reflected light (reflectivity) of the incident light drops 
markedly at an angle called the SPR angle (Figure 3.13(a,b)). In the Biacore detection 
system, these media are the immobilising surface (sensor chip) and the sample or 
buffer solution within the flow cell (Figure 3.13(a)). The SPR angle is very sensitive 
to refractive index changes in the solution at the sensor chip surface. At a fixed 
wavelength and angle of incidence, these changes can be directly correlated to shifts 
in the SPR angle. This is the basis of measurement of molecular interactions in the 
Biacore detection system.  
  
(3.5.2) Experiments on the Biacore X100 
The Biacore X100 is an instrument controlled from a PC running Biacore 
X100 Control and Evaluation Software. It uses label-free detection for real-time 
monitoring of molecular interactions involving practically any biological molecule, 
including larger structures such as cells and viruses. 
The sensor chip in a Biacore system is a glass slide covered by a gold film and 
mounted on a supporting frame. There are several sensor chip types available for use 
on the Biacore (Table 3.2). Interaction between the molecules of interest occurs on 
the gold film surface which forms the lower wall of the flow cell (20-60 nanolitres in 
volume) when the sensor chip is docked (Figure 3.13(a)). Running buffer passes 
through the flow cell at a continuous flow rate of 1-100 µl/min. The SPR response is 
a measure of the refractive index of the solution within 300 nm from the surface of 
the sensor chip. Since this distance is small in relation to the sample volume, the SPR 
response effectively measures refractive index changes at the chip surface. This is 
related to the total mass of material bound to the chip surface, although a difference 
between the sample and running buffers will also generate a response. One response 
unit (RU) represents approximately 1 pg bound protein/mm
2 (Van der Merwe, 2000). 
The actual binding response for an experiment is obtained by subtracting the 
background response on a reference flow cell from that on the main flow cell. The 
real time graph of response units with time is called a sensorgram (Figure 3.14). 
When a molecule is fixed on the sensor chip surface, it is said to be 
immobilised. Immobilisation can be done either directly by covalent coupling, or 
indirectly via high-affinity capture (such as an antigen-antibody interaction). The 
ligand, defined in the context of a Biacore application, is the interaction partner    78
 
 
 
Figure 3.14 
A Biacore sensorgram of response units versus time. A report point is a 
specific point at which the response level is averaged over a short time window.  The 
response may be absolute (as determined by the detector) or relative (with respect to 
another specified report point). The bars below the curve indicate solutions that pass 
over the sensor surface. Equilibrium dissociation or association constants (KD or KA) 
can be calculated from the association (kon) and dissociation (koff) phases of the 
sensorgram (Adapted from the Biacore X100 handbook, 2008).    79
immobilised to the chip surface. The analyte is the interaction partner in solution, 
passed over the ligand. Regeneration is the process of removing bound analyte and/ or 
ligand without damaging the ligand or capturing molecule (Figure 3.15). A summary 
of the coupling chemistry and techniques for immobilisation used in Biacore chips is 
presented in Tables 3.3 and 3.4.  
To increase the amount of immobilisation possible, a 100-200 nm layer of 
carboxymethylated dextran matrix is attached to the general-purpose CM-family 
Biacore sensor chips (Table 3.2). This has two important drawbacks (Van der Merwe, 
2000). Firstly, the rate at which binding occurs at the chip surface may exceed the 
rate at which mass transport occurs (i.e., the rate at which the binding molecule is 
delivered to the surface).  A consequence of this is that the measured association rate 
constant (kon) is artificially slower that the true value. Secondly, following 
dissociation, binding can reoccur to unoccupied surface. This means that the 
measured dissociation rate constant (koff) may be artificially slower than its true value. 
Both problems are addressed by using high flow rates of at least 30 µl/min for 
equilibrium experiments and limiting the amount of immobilised ligand to quantities 
sufficient to reach a maximum response (Rmax) of 100-200 RU.  The required 
immobilisation level (RL) can be calculated from the equation: 
 
(Eq. 3.20) Rmax = Analyte MW x RL x Sm, 
                Ligand MW 
where Sm is the stoichiometric ratio of interaction.  
 
(3.5.3) Applications of Biacore systems 
  Biacore systems are generally unsuited to studying analytes that are very 
small (MW < 1 kDa) compared to ligand, as they give very small responses. Because 
high amounts of ligand need to be immobilised to achieve measurable responses, 
mass transport limitations and re-binding make it difficult to measure kinetic 
parameters for such interactions with confidence. Very large molecules such as 
viruses and cells should not be immobilised on the chip surface, but rather injected as 
sample. This is because detection decreases exponentially with distance away from 
the surface, therefore interactions at their distal ends may be outside the system’s 
detection limit. 
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(3.5. 3.1) Binding analysis 
Binding analysis on the Biacore can be used to assess the activity of native or 
recombinant proteins. Since interactions with ligands involve multiple residues and 
require correct folding to occur, a “yes or no” binding assay can determine the 
structural integrity of a recombinant protein. Binding specificity, formation of 
multimolecular complexes and the effects of different experimental conditions (e.g. 
pH, ionic strength and temperature) on binding can also be assessed by binding 
analysis. Typically, the results from such studies are based on report point values 
(Figure 3.14) and not complete association or dissociation phases, and are evaluated 
via plots and bar charts. 
 
(3.5. 3.2) Equilibrium analysis 
  Using multiple sequential injections of analyte at different concentrations, 
affinity (binding strength) and kinetic (association and dissociation rate-) constants of 
a ligand-analyte interaction can be determined. Low affinity interactions are easier to 
study as regeneration is more readily achieved. However, for high affinity 
interactions for which regeneration is very difficult, single-cycle assays may be used. 
In these assays, the analyte is injected at increasing concentrations without 
regenerating the chip surface in-between. Dissociation constants can be determined 
from equilibrium experiments in two ways, (i) by steady state affinity measurements 
and (ii) from kinetic rate constants. The steady state affinity model within the Biacore 
X100 evaluation software (version 1.1) is set to a default stoichiometry of 1:1, but 
other ratios can be included by the user where necessary. This model calculates the 
equilibrium dissociation constant KD from a plot of steady state binding levels (Req) 
against analyte concentration (C). The equation allows for the contribution of buffer 
to the signal, known as bulk refractive index (RI), to serve as a baseline offset to the 
Req axis. 
 
(Eq. 3.21) Req =   CRmax + RI 
   KD + C 
 
An alternative approach is to export the data to suitable analysis software such as 
Sigmaplot™ to calculate KD values, although this may not make sufficient allowance 
for the bulk refractive index. For KD values determined from affinity measurements to   81
be accurate, majority of the multiple sensorgrams within the experiment must attain 
steady-state binding levels. Steady-state is defined by the response level at which the 
net association and dissociation rates are zero, and appears as a sustained plateau on 
the sensorgram.  
  KD can also be determined from calculating the kinetic constants of the 
interaction (KD = koff/kon; Figure 3.14). The key utility of kinetic analysis lies in the 
fact that although two interactions may possess the same affinity, the kinetic rate 
constants (and hence the nature) of these interactions may be entirely different. Thus 
kinetic analyses provide insight into molecular interactions beyond simple affinity 
measurements. The Biacore X100 evaluation software implements a number of 
predefined mathematical models for data interpretation. All of these models extract 
kinetic parameters from experimental data using an iterative process that finds the 
best fit for a set of equations describing the interaction. The simplest model is the 1:1 
interaction, which fits for the parameters ka (or kon; association rate constant in M
-1s
-
1), kd (or koff; dissociation rate constant in s
-1), Rmax, tc (flow rate-independent aspect 
of the mass transfer constant) and RI (Biacore X100 handbook, 2008).  Kinetic 
analyses are possible where steady state binding levels are not attained, provided the 
sensorgrams have sufficient curvature. This is especially useful for interactions in 
which it is difficult to attain steady-state binding levels. However, for interactions 
with very fast association and dissociation phases, kinetic analyses may not be 
possible. The X100 evaluation software (version 1.1) can accurately determine kon 
values within the range of 3 x 10
2 M
-1s
-1 to 3 x 10
7 M
-1s
-1, and koff values between 10
-5 
s
-1  to 10
-1 s
-1. For interactions with kon and koff values outside these limits of 
quantitation, affinity measurements will provide more accurate values for KD.  
 
(3.5. 3.3) Concentration analysis 
This method establishes an unknown sample concentration by generating a 
calibration curve of known samples. This is especially useful for determining the 
concentration of a specific ingredient within a sample containing impurities, 
degradation products or matrix components. The principle of concentration 
measurement with Biacore is similar to that of established methods such as ELISA, 
with the following important differences: (i) there is no need to use labels for 
detection, (ii) the extent of interaction is measured directly, allowing the entire 
interaction process to be observed, and (iii) measurements can be done on a real-time   82
basis, as opposed to only end-point levels. Setting up a concentration assay involves 
five steps. These are: selecting an assay format (including choice of analyte, ligand 
and capture as applicable), preparing the sensor surface, establishing adequate 
regeneration conditions, determining a calibration curve using known analyte 
concentrations, and validating the assay by quantitating the relevant performance 
parameters. Performance parameters include specificity, selectivity and cross-
reactivity, accuracy, precision, limit of detection (LOD), limit of quantitation (LOQ), 
linearity, range, robustness and sensitivity (Biacore concentration analysis handbook, 
version AA, 2001).   83
 
 
 
 
Figure 3.15 
Illustration of direct and indirect immobilisation (capture) of ligand and the 
regeneration process in Biacore experiments (Adapted from the Biacore X100 
handbook, 2008).   84
 
Sensor chip 
type 
Surface chemistry  Free 
carboxymethyl 
groups 
Comments  
 CM5 
(research 
grade or 
certified) 
Carboxymethylated 
dextran (CMD) matrix 
Yes   Most widely used sensor chip, 
suitable for most applications.  
CM4  Lower degree of 
carboxymethylation 
than CM5 
Yes  Well suited for negatively 
charged molecules.  
CM3  CMD matrix with 
shorter dextran chains 
Yes  Useful for working with very 
large molecules. 
C1  No dextran matrix, but 
is carboxymethylated. 
Yes   Useful  for  multivalent 
interactions and large molecules. 
Also for interactions affected by 
the presence of dextran. 
L1  Lipophilic groups 
attached to a CMD 
matrix. 
No  Suitable for direct attachment of 
lipid vesicles to create a 
membrane-like environment. 
      
 SA  CMD matrix with 
streptavidin pre-coupled
No    Can be generated by coupling 
streptavidin to CM5 chip 
 NTA  CMD matrix with NTP 
pre-coupled 
No    For capturing proteins with 
Histidine tags 
HPA  Flat hydrophobic 
surface 
No  For immobilising lipid 
monolayers. 
 
 
Table 3.2.  
A summary of the Sensor chips available for Biacore systems.    85
 Surface  activation
a Group 
required on 
protein 
Protein preparation   Comments  
Amine  EDC/NHS
b Amine  groups 
(lysine and 
unblocked N-
termini) 
No preparation 
needed 
Can be used with 
most proteins. Risk 
of multiple coupling
Surface-thiol  EDC/NHS followed 
by cystamine/DTT 
to introduce a thiol 
group 
Amine or 
carboxyl groups 
Need to introduce 
reactive disulphide 
using 
heterobifuntional 
reagent such as 
PDEA (carboxyl) or 
SPDP (amine). 
Not widely used 
Ligand-thiol  EDC/NHS followed 
by PDEA to 
introduce a reactive 
disulphide group 
Surface-exposed 
free cysteine or 
disulphide. 
Reduce disulphides 
under non-
denaturing 
conditions to 
generate free 
cysteine. 
Useful for proteins 
with exposed 
disulphides or free 
cysteines.  
Aldehyde 
coupling 
EDC/NHS followed 
by hydrazine 
Aldehyde 
groups 
Create aldehydes by 
oxidising  cis-diols 
(in sugars) with 
periodate. Works 
especially well with 
sialic acid. 
Useful for 
polysaccharides and 
glycoproteins. 
 
a All coupling reactions utilise carboxymethyl groups on the sensor surface and can be used 
with any sensor chip which has free carboxymethyl groups.  The first step is to activate these 
groups with N-hydroxysuccinimide, thus creating a highly reactive succinimide ester which 
reacts with amine groups on protein, or can be further modified. 
b EDC, N-ethyl-N’-(dimethylaminopropyl) carbodiimide; NHS, N-hydroxysuccinimide; 
DTT, dithiothreitol; PDEA, 2-(2-pyridinyldithio) ethane-amine. 
 
Table 3.3.  
A summary of the covalent coupling chemistry for Biacore systems (Adapted 
from Van der Merwe, 2000).   86
 
 Covalently 
coupled molecule 
Captured ligand  Valency of ligand  Removal of tag 
Antibodies  Rabbit anti-mouse 
Fc polyclonal 
Any mouse IgG 
monoclonal 
Divalent No 
  Mouse anti-human 
Fc, monoclonal 
Any protein fused 
to the Fc portion of 
human IgG1. 
Divalent   Not routinely. 
  Mouse anti-rat 
CD4, monoclonal 
Any protein fused 
to rat CD4 domains 
3 and 4. 
Monovalent   No 
  Anti-GST
a Any  GST-fusion 
protein 
Divalent yes 
Other  Streptavidin Any  biotinylated 
molecule. 
Monovalent or 
tetravalent 
No 
  Ni-NTA  Any protein with 
oligohistidine tag 
Monovalent yes 
 
a GST, glutathione-S-transferase, Ni-NTA, nickel-nitriloacetic acid. 
 
Table 3.4.  
A summary of techniques for ligand capture in Biacore systems (Adapted 
from Van der Merwe, 2000).  87
Chapter Four 
 
The regulatory SCR-1/5 and cell-surface-binding SCR-16/20 fragments of 
Factor H reveal partially folded-back solution structures and different self-
associative properties  88
(4.1) Introduction 
The SCR-1/5 fragment of FH is important for cofactor, C3b-binding and 
decay-accelerating activity (Gordon et al., 1995; Sharma & Pangburn, 1996). The 
SCR-16/20 fragment comprises the major location for aHUS mutations that affect the 
ability of FH to regulate the C3 convertase, for which the distribution of over 100 
genetic alterations are summarised at http://www.fh-hus.org (Section 2.4; Saunders 
et al., 2007). The disease-related mutations in the N-terminal region appear to 
correspond to Type I quantitative reductions in plasma levels of FH, suggesting a 
distinct role for FH in this region (Saunders  et al., 2007). The aHUS related 
mutations cluster in SCR-20 and to a lesser degree in SCR-16 to SCR-19. As these 
mutations are generally located at surface-exposed positions and have normal FH 
plasma levels, they lead to Type II functional defects in FH (Saunders et al., 2007). 
An analysis of the first 12 C-terminal aHUS mutations to be identified suggested the 
location of a heparin-binding site in SCR-20, (Perkins & Goodship, 2002) and this 
prediction was supported by subsequent functional and NMR structural studies (Joszi 
et al., 2006; Herbert et al., 2006). Hence molecular structures for the SCR-1/5 and 
SCR-16/20 fragments of FH will reveal key insights into the role of these regions in 
the overall functional activity of FH.  
Methods such as solution scattering and electron microscopy have been 
applied to demonstrate that FH does not possess a fully-extended SCR structure in 
solution and may exist in monomeric and dimeric forms (Perkins  et al., 1991; 
DiScipio, 1992; Aslam & Perkins, 2001). NMR and crystal structures have been 
determined for SCR-1/3, SCR-5, SCR-6/8, SCR-15/16 and SCR-19/20, (Barlow et 
al., 1992, 1993; Soares & Barlow 2005; Herbert et al., 2006; Jokiranta et al., 2006; 
Prosser et al., 2007; Hocking et al., 2008) while homology models for the remaining 
SCR domains have been described (Aslam & Perkins, 2001; Saunders et al., 2006). 
However the orientation between two adjacent SCR domains is variable and not 
easily predicted (Perkins et al., 2002). X-ray scattering and AUC in combination 
with constrained scattering modelling leads to medium resolution molecular 
structures (Perkins et al., 1998; 2005; 2008). In this study, constrained scattering 
modelling is applied to the critical functional and recognition five SCR-domain 
fragments, SCR-1/5 and SCR-16/20. SCR-1/5 is shown to be a monomer in solution, 
unlike SCR-16/20 which exhibits a monomer-dimer equilibrium. The structural 
models are compared with the corresponding solution structures for rat Crry and β2- 89
glycoprotein I, each of which contains five SCR domains (Aslam  et al., 2003; 
Hammel  et al., 2002). Interestingly, both SCR-1/5 and SCR-16/20 show more 
folded-back bent SCR arrangements in line with that seen in the solution structure of 
intact FH. The relevance of these solution structures in clarifying several aspects of 
FH function and the FH-associated diseases aHUS and AMD are discussed.  
 
(4.2) Results and Discussion 
(4.2.1) X-ray scattering data for SCR-1/5 and SCR-16/20 
SCR-1/5 and SCR-16/20 were purified from yeast culture medium by virtue 
of their 6-His C-terminal peptides (Figure 4.1) using nickel affinity chromatography 
(Section 4.4). SCR-1/5 ran as a single homogeneous peak in size-exclusion gel 
filtration (Figure 4.2(a)) and as a single band on SDS-PAGE with an apparent 
molecular weight of 30 kDa under non-reducing conditions (Figure 4.2(c)). SCR-
16/20 reproducibly eluted as a broader peak which was occasionally partly-resolved 
into two components in size-exclusion gel filtration (Figure 4.2(b)). The molecular 
weight standards based on globular proteins resulted in estimated molecular weights 
that were larger than the expected values of 35.3 kDa and 39.7 kDa for SCR-1/5 and 
SCR-16/20 respectively. As the latter possess extended protein structures, a 
logarithmic plot of the elution volumes showed that the apparent molecular weights 
of the two peaks for SCR-16/20 were in the approximate ratio of 2:1, suggesting that 
this existed in an equilibrium between dimeric and monomeric forms. SCR-16/20 ran 
as a major band on non-reducing SDS-PAGE with an apparent molecular weight of 
37 kDa (Figure 4.2(c)). Both FH fragments are potentially glycosylated at one or two 
positions (Figure 4.1). Treatment with Endo H glycosidase showed no change for 
SCR-1/5 (Figure 4.2(c)), suggesting that, in agreement with previous work (Aslam & 
Perkins, 2001), the single site at SCR-4 is not occupied. Under these conditions, 
Endo H glycosidase resulted in a decrease of 2 kDa in the apparent molecular weight 
of SCR-16/20, suggesting that at least one of its two glycosylation sites is occupied 
(Figure 4.2(c)). Both purified proteins were stable upon storage at 4
oC.  
The domain arrangement and oligomerisation of SCR-1/5 was analysed by 
synchrotron X-ray scattering. In two distinct Q ranges (where Q = 4 π sin θ /λ; 2θ = 
scattering angle; λ = wavelength), Guinier analyses to measure the degree of 
elongation of SCR-1/5 resulted in two linear plots, from which the overall radius of   90
 
 
Figure 4.1 
(Figure legend overleaf)  91
(Figure 4.1 legend) 
  Schematic cartoon of the FH SCR-1/5 and SCR-16/20 fragments and their 
sequences  
(a) SCR-1/5 is shown together with the residue lengths of the four inter-SCR 
linkers and its overall length determined by X-ray scattering (below). A putative 
glycosylation site on SCR-4 is shown, but it is not occupied in the recombinant 
fragment  
(b) A possible SCR-16/20 dimer is shown if it is assumed that the SCR-20 
domains are in contact (see text). The putative positions of N-linked carbohydrates 
on SCR-17 and SCR-18 are highlighted, of which at least one is occupied  
(c) The sequences of the recombinant SCR-1/5 and SCR-16/20 proteins are 
shown, with the five conserved Trp and Cys residues highlighted in black and other 
conserved residues in yellow. The putative carbohydrate sites are underlined, and the 
linker residues are boxed. The Define Secondary Structure Prediction-assigned β-
strand secondary structure for the ten domains are highlighted in grey, and the 
position and labelling of the eight consensus β-strands b1 to b8 are shown below the 
alignment. In SCR-1/5, residues 17-EF-18 correspond to the EcoRI cloning site, and 
residues 323-HHHHHH-328 correspond to the 6-His tag used for purification. In 
SCR-16/20, residues 922-EAEAEF-927 correspond to the α-factor signal and EcoRI 
site, and residues 1232-PLEQKLISEEDLNSAVDHHHHHH-1254 correspond to the 
myc epitope and the 6-His tag. 
  92
 
Figure 4.2 
   Size-exclusion gel filtration and SDS-PAGE of SCR-1/5 and SCR-16/20. The 
eluate from the nickel affinity column was loaded onto a Superdex-200 prep grade 
XK 16/60 column  
(a) SCR-1/5 eluted as a monomeric peak M. The elution positions of three 
molecular mass standards are shown  
(b) SCR-16/20 eluted as a peak that was partly resolved into two components 
designated as monomer (M) and dimer (D). The recalibrated elution positions of 
three molecular mass standards are shown  
(c) Non-reducing SDS-PAGE analyses of SCR-1/5 and SCR-16/20 treated 
with Endo H (lanes 2 and 4; labelled with E) or not treated (lanes 1 and 3) are shown, 
as carried out by Dr. R. J. Ormsby (Australia).   93
gyration (RG) and the radius of gyration of the cross-section (RXS) values were 
obtained within satisfactory Q.RG and Q.RXS limits (Figures 4.3(a,b)). Time frame 
analyses during data acquisition showed that the RG values were affected by slight 
radiation damage only by the longest exposure times of 2 sec per frame in 4-bunch 
mode. To eliminate radiation damage effects, data were therefore collected at 
exposures of 1.0 sec, 0.5 sec and 0.2 sec in a flow cell for ten frames, of which only 
the first time frame was used for Guinier analyses. No concentration dependence of 
the Guinier parameters was seen between 0.21 mg/ml to 0.84 mg/ml. However at 
concentrations above 0.21 mg/ml, the Guinier RG fits showed that slight non-specific 
aggregates were present, and this was subsequently confirmed by molecular 
modelling (see below). Accordingly the final RG determination was performed at 
0.21 mg/ml. The mean X-ray RG and RXS values for SCR-1/5 were 4.26 (± 0.16) nm 
(3 values) and 1.46 (± 0.08) nm (10 values) respectively (Table 4.1).  
Compared to rat Crry, a five-SCR domain complement regulatory protein 
related to complement receptor type 1 with RG  and RXS value of 5.0 (± 0.4) nm and 
1.5 (± 0.1) nm respectively, (Aslam et al., 2003) these RG and RXS values indicated 
that SCR-1/5 showed a slightly less elongated structure than Crry. SCR-1/5 has a 
similar degree of domain bend or partial folding back when compared to human β2-
glycoprotein I with an RG value of 4.30 nm which has an S-shaped arrangement of 
five SCR domains in solution (Hammel et al., 2002). The anisotropy ratio RG/RO 
(where  RO is the RG value of the sphere with the same volume as the hydrated 
glycoprotein) was 2.32 and this is intermediate between that of 2.54 for rat Crry and 
that of 2.12 for human β2-glycoprotein I. Hence SCR-1/5 is more elongated than a 
globular protein, for which the typical RG/RO is 1.28 (Perkins, 1988b).
 Assuming that 
SCR-1/5 can be represented by an elliptical cylinder in shape, the combination of the 
RG and RXS values resulted in an overall length of 14.2 nm for SCR-1/5 (Section 4.4). 
The corresponding Guinier analyses for SCR-16/20 gave RG and RXS values within 
satisfactory Q.RG and Q.RXS limits (Figures 4.3(c,d); 4.4(c,d)). The individual time 
frames during data acquisition showed that the RG values were not affected by 
radiation damage, even with the longest exposure times of 2 sec per frame in 4-bunch 
mode, and 0.2 sec per frame in uniform bunch mode. Accordingly, data were 
collected at exposures of mostly 1.0, 0.5, 0.2 and 0.1 sec in 4-bunch mode and for 0.2 
and 0.1 sec in uniform bunch mode. Analyses were based on the average of all ten 94
 
Figure 4.3 
 Guinier  RG and RXS analyses for SCR-1/5 and SCR-16/20 monomers. The 
filled circles correspond to the I(Q) values used  to determine RG and RXS, while the 
straight lines correspond to the line of best fit through these points. The Q.RG  and 
Q.RXS values for the fitting ranges are arrowed  
(a) RG plot for SCR-1/5 at a concentration of 0.21 mg/ml using a Q range of 
0.16-0.29 nm
-1  
(b) RXS plot for SCR-1/5 at 0.21 mg/ml using a Q range of 0.30-0.60 nm
-1  
(c) RG plots for principally monomeric SCR-16/20 from 0.14 mg/ml to 0.62 
mg/ml using a Q range of 0.16-0.29 nm
-1  
(d) The corresponding RXS plots for SCR-16/20 in a Q range of 0.30-0.60 nm
-
1.   95
time frames. In distinction to SCR-1/5, SCR-16/20 exhibited a concentration 
dependence of both its RG and RXS values (Figure 4.4(a,b)). At the lowest 
concentrations, the Guinier fits showed slight non-specific aggregation. At the 
highest concentrations, the fits were consistent with weak dimer formation. 
Accordingly the Q ranges used to determine the RG and RXS values were set to 
exclude the lowest Q values at the lowest concentrations to avoid the slight 
aggregates (Figure 4.3(c)), and to exclude the larger Q values at the highest 
concentrations in order to accommodate the larger RG and RXS values (Figure 
4.4(c,d)). The Guinier I(0)/c values doubled from 0.0072 (± 0.0002) at low 
concentrations to 0.0147 (± 0.0005) at high concentrations, indicating that a 
monomer-dimer equilibrium has been observed.  
Over a concentration range of 0.05 mg/ml to 1.15 mg/ml, the RG values for 
SCR-16/20 ranged from 4.66 (± 0.13) nm to 8.46 (± 0.12) nm. A two-state regression 
fit gave a value of 4.95 (± 0.08) nm for the monomer and an estimate of 8.09 (± 0.21) 
nm for the dimer (20 values), noting that the dimer cannot be fully formed for reason 
of its weak KD value (Figure 4.4(a)). A two-state regression fit of the RXS values 
ranged from 1.74 (± 0.04) nm to 2.42 (± 0.14) nm (18 values) (Figure 4.4(b)). 
Assuming that SCR-16/20 can be represented by an elliptical cylinder in shape, the 
combination of the RG and RXS values resulted in overall lengths of 15 nm and 27 nm 
respectively for the monomer and dimer. On the basis of a monomer-dimer 
equilibrium, the regression analyses of the RG and RXS values resulted in estimated 
KD values of 16 (± 2) µM and 17 (± 4) µM respectively. The RG/RO ratio of 2.40 for 
monomeric SCR-16/20 is similar to that of 2.32 for SCR-1/5, suggesting that both 
FH fragments have similar extended structures, even though at least one 
oligosaccharide chain is present on SCR-16.20 (Figure 4.2(c)). However the 
estimated RG/RO ratio of 3.30 for the dimer shows this is significantly more elongated 
than the monomer. Interestingly the latter value is comparable to that for intact FH 
SCR-1/20 which is 3.65 (Aslam & Perkins, 2001). 
The distance distribution function curve P(r) provides structural information 
in real space (Figure 4.5). The maximum dimension L is determined from P(r) as the 
value of r when P(r) = 0 at large r and L is now independent of shape assumptions. 
The P(r) curves provide an alternative calculation of the mean RG value. For SCR-
1/5 this RG was similar at 4.42 (± 0.13) nm (3 values) to that from the Guinier 
analyses but is shorter than L of 18 nm for rat Crry (Aslam et al., 2003). The average  96
Figure 4.4 
Guinier RG and RXS analyses for SCR-16/20 dimer  
(a,b) Concentration dependence of the RG and RXS values of monomeric SCR-
16/20. The data were fitted to an arbitrary four-parameter logistic function of the 
form y = y0 + (a /(1 + (x/x0)
b )
-1 from which the monomer values are well determined 
but the dimer values are not well determined because of the weak association. 
Statistical error bars are shown where visible  
(c) RG plots for principally dimeric SCR-16/20 at 0.72 mg/ml, 0.86 mg/ml 
and 1.15 mg/ml, using a Q range of 0.05-0.12 nm
-1  
(d) The corresponding RXS plots for dimeric SCR-16/20 using a Q range of 
0.30-0.45 nm
-1.   97
length of a single SCR domain is 3.6 nm along its longest axis, (Aslam et al., 2003) 
thus a maximally-extended set of five SCR domains would be at least 18 nm in 
length. Hence the L value for SCR-1/5 corresponds well with a partly folded-back 
bent arrangement. The maximum in the P(r)  curve corresponds to the most 
frequently occurring interatomic distance within the structure. A single peak M was 
observed at an r value of 3.5 nm at 0.21 mg/ml (Figure 4.5(a)). In comparison, a 
single peak was observed at an r value of 2.7 nm for rat Crry, and this increase in r 
value for SCR-1/5 is in agreement with the greater degree of bend in its structure 
compared to that in Crry (Furtado et al., 2007). 
In contrast to SCR-1/5, the P(r) curve for SCR-16/20 showed a concentration 
dependence of L. The RG value was determined to be 4.81 (± 0.11) nm at the lowest 
concentrations (Figure 4.5(b)) and as 7.51 (± 0.24) nm at the highest concentrations 
(Figure 4.5(c)), both of which agree well with the corresponding Guinier values of 
4.66 (± 0.13) nm and 8.09 ± 0.21 nm respectively. At the lowest concentrations, L 
was 17 nm for the monomer (Figure 4.5(b)), and at the highest concentrations, L was 
27 nm when dimer was present (Figure 4.5(c)), both of which are comparable with 
the estimates of 15 nm and 27 nm from the Guinier analyses. The L value of 17 nm 
for the SCR-16/20 monomer shows that this is longer than SCR-1/5 (L value of 15 
nm), and this is most readily explained by the presence of a 26-residue C-terminal 
tail in SCR-16/20 in place of an eight-residue C-terminal tail in SCR-1/5. The 
increase in L with concentration reflects the formation of a more elongated structure, 
in agreement with the increase in the RG/RO value. A single peak maximum M was 
observed at all concentrations of SCR-16/20, and its r values increased from 4.1 nm 
to 5.8 nm as the concentration was increased. Together with the large increase in the 
RXS values with concentration, this shows that the SCR-16/20 dimer is formed by a 
partial side-by-side association of two monomers that increased the apparent folding 
back of the overall SCR domain arrangement.   
 
(4.2.2)  Analytical ultracentrifugation data for SCR-1/5 and SCR-16/20 
In sedimentation velocity experiments by AUC, the sedimentation coefficient 
s
0
20,w provides an independent measure of macromolecular elongation and 
oligomerisation. For SCR-1/5, sedimentation velocity experiments were performed at 
two rotor speeds at six concentrations between 0.04 mg/ml and 0.85 mg/ml. The 
analyses of 10 to 30 scans using DCDT+ time-derivative analyses  98
 
Figure 4.5 
Distance distribution function P(r) analyses for SCR-1/5 and SCR-16/20  
(a) For SCR-1/5, M represents the most frequent distance within the protein 
and is 3.5 nm at 0.21 mg/ml, and L represents its maximum dimension at 15 nm.  
(b) For SCR-16/20 at lower concentrations, M rises from 4.1 nm to 4.8 nm 
from 0.14 mg/ml to 0.55 mg/ml, and L increases from 17 nm to 19 nm  
(c) For primarily dimeric SCR-16/20 at 0.72 mg/ml, 0.86 mg/ml and 1.15 
mg/ml, M ranges from 5.1 nm to 5.8 nm and L ranges from 25 nm to 27 nm.   99
gave excellent fits with small residuals to Gaussian functions (Figure 4.6). The use of 
Lamm equation fits of up to 200 scans using SEDFIT with the same data sets was 
used to assess size distribution analyses c(s) of any species present in the samples. 
Both the interference and absorbance fits resulted in a single clean peak with an s20,w 
value of 2.4 S (Figure 4.7). The conversion of the c(s) plots to c(M) plots showed that 
this peak corresponded to a molecular weight of 38 (± 6) kDa, in good agreement 
with the sequence-derived value of 35.3 kDa. From the DCDT+ analyses, both the 
absorbance and interference fits showed no concentration dependence of the s20,w 
values, and this was determined to be 2.52 (± 0.02) S (Figure 4.8(a)). The SEDFIT 
analyses also showed no concentration dependence (Figure 4.8(b)). Thus the final 
s
0
20,w values extrapolated to zero concentration for DCDT+ and SEDFIT were in 
good agreement at 2.52 S and 2.37 S respectively. From these, the frictional 
coefficient ratio f/fo for SCR-1/5 is 1.45, which is larger than the value of 1.2 
typically seen for globular-shaped proteins.  
For SCR-16/20, the corresponding sedimentation velocity experiments 
confirmed the presence of a monomer-dimer equilibrium. Data were collected at five 
different rotor speeds at 20 concentrations between 0.01 mg/ml and 1.48 mg/ml 
(Materials & Methods). In the DCDT+ time-derivative analyses, the absorbance and 
interference fits for SCR-16/20 both showed a concentration dependence of the g(s*) 
curves (Figure 4.9(a,b)). This is consistent with a monomer-dimer equilibrium 
(Stafford, 2000).
 Extrapolation to zero concentration gave a DCDT+ sedimentation 
coefficient s
0
20,w value of 2.78 ± 0.30 S (Figure 4.8(a)). In the SEDFIT c(s) 
distribution analyses, both the absorbance and interference fits showed that two 
peaks could be resolved at all concentrations, more clearly so for the more detailed 
data sets from the interference optics and at the lowest concentrations (Figure 
4.10(a,b)). Even with the saturation of the absorbance optics in Figure 4.10(b), two 
peaks were seen. The conversion of the c(s) plots to c(M) plots showed that the two 
peaks correspond to molecular weights of 42 ± 7 kDa and (depending on the 
resolution) 60-80 kDa, showing that these peaks correspond respectively to the 
monomeric and dimeric forms of SCR-16/20. The mean values of these two peaks 
gave a sedimentation coefficient s
0
20,w value of 2.87 ± 0.20 S for the monomer and 
3.92 ± 0.23 S for the dimer (20 values) (Figure 4.8(b)). From these s
0
20,w values, the 
f/fo value is 1.35 for the monomer and 1.58 for the dimer. The first value of 1.35 is 
similar to that of 1.45 for SCR-1/5, suggesting that both monomeric SCR-16/20 and   100
 
Figure 4.6 
 Sedimentation  velocity  g(s*) analyses of SCR-1/5 using DCDT+.  
(a) Twenty absorbance scans for SCR-1/5 at 0.09 mg/ml and 0.85 mg/ml and 
a rotor speed of 35,000 r.p.m. gave s
o
20,w values of 2.50 S and 2.51 S respectively. 
The intensity of the g(s*) curve at 0.09 mg/ml was increased three-fold for reason of 
clarity.  
(b) The corresponding 14 and 22 interference scans from the same SCR-1/5 
experiment gave s
o
20,w values of 2.39 S and 2.49 S respectively.   101
 
Figure 4.7 
Sedimentation velocity c(s) distribution analyses of SCR-1/5 using SEDFIT. 
Every tenth scan in the total of 200 scans is shown in the boundary fits in the left 
panels, while the c(s) distributions are shown in the right panels. Fits at 0.85 mg/ml 
and 35,000 r.p.m. gave a s20,w value of 2.4 S for both the interference and absorbance 
data sets (upper and lower panels respectively).   102
 
Figure 4.8 
Concentration dependence of the observed s20,w values for SCR-1/5 and SCR-
16/20. Statistical error bars in these are shown where visible. 
(a) The DCDT+ analyses of 14-22 scans per experiment showed single peaks, 
where the s20,w values for SCR-1/5 are shown in red and those for part of the SCR-
16/20 data is shown in black  
(b) The SEDFIT analyses of 200 scans per experiment showed single peaks 
for SCR-1/5 and two peaks for SCR-16/20 (●, monomer; ○, dimer).   103
  
 
Figure 4.9 
Sedimentation velocity g(s*) analyses of SCR-16/20 using DCDT+.  
(a) Absorbance data for SCR-16/20 at 0.10 mg/ml (40,000 r.p.m.) and 0.62 
mg/ml, 1.33 mg/ml and 1.48 mg/ml (50,000 r.p.m.) showed that the s
o
20,w values 
increased from 2.8 S to 3.5 S as the concentration increased. The intensities of the 
g(s*) curves were equalised for reason of clarity  
(b) The corresponding interference data sets for SCR-16/20 showed that the 
s
o
20,w values likewise increased from 2.7 S to 3.5 S as the concentration increased.   104
 
Figure 4.10 
Sedimentation velocity c(s) distribution analyses of SCR-16/20 using 
SEDFIT.  
(a) The fits for monomeric SCR-16/20 at 0.22 mg/ml and 42,000 r.p.m. gave 
two peaks at s20,w values of 2.9 S and 3.9 S for the interference data and 2.9 S and 3.7 
S for the absorbance data (upper and lower panels respectively).  
 (b) The fits for dimeric SCR-16/20 at 1.48 mg/ml and 50,000 r.p.m. gave 
two peaks at s20,w values of 2.8 S and 3.6 S for the interference data and 2.9 S and 3.8 
S for the absorbance data (upper and lower panels respectively). Note that the 
absorbance optics are saturated as the absorbance is in excess of 2, nonetheless two 
peaks are observed.  105
SCR-1/5 have similar degrees of extended shapes. This outcome is consistent with 
the RG/RO ratios above.   
Sedimentation equilibrium experiments resulted in molecular weight (MW) 
determinations for SCR-1/5 and SCR-16/20. For reason of protein stability, the most 
successful data collection was performed at 4 
oC. For SCR-1/5, the MW was 
determined using a global fit of 15 curves in SEDPHAT at concentrations between 
0.06 mg/ml to 0.39 mg/ml on the assumption of a single species model with both 
absorbance and interference data. This gave MW values of 34.3 ± 0.4 kDa and 36.9 ± 
0.2 kDa respectively, in good agreement with the expected MW value of 35.3 kDa 
(Section 4.4). The analyses in Figure 4.11(a,b) show good visual fits with low 
random residuals. No concentration dependence was observed when data from each 
concentration was fitted globally at three speeds (not shown). Hence SCR-1/5 was 
concluded to be monomeric.  
For SCR-16/20, the equilibrium studies using six different rotor speeds with 
absorbance data also gave good individual fits with random residuals on the 
assumption of a monomer-dimer association model. A global fit of 18 data sets at 
eight different concentrations between 0.13 mg/ml to 0.43 mg/ml and five rotor 
speeds using SEDPHAT gave MW values of 40.8 ± 0.3 kDa and 42.0 ± 0.8 kDa for 
the absorbance and interference data respectively, in good agreement with the 
expected  MW of 39.7 kDa (Section 4.4). Even with the lower concentrations 
compared to Figure 4.4(a,b), the SEDPHAT analyses resulted in estimated similar 
weak KD values of 18 ± 2 µM and 13 ± 2 µM respectively from the absorbance and 
interference data for the monomer-dimer equilibrium at 4 
oC, in good agreement with 
the two Guinier-determined values of 16 ± 2 µM and 17 ± 4 µM at 22 
oC (Figure 
4.4(a,b)). The representative fits from the global analyses shown in Figure 4.12(a,b) 
show good visual agreements with low random residuals. The degree of curvature of 
the fits in Figure 4.12 at 20k r.p.m. is similar to that shown in Figure 4.11 at 25k 
r.p.m., indicating that the molecular weight of SCR-16/20 is larger than that of SCR-
1/5. Hence SCR-16/20 exists in both monomeric and dimeric forms. 
 
(4.2.3)  Constrained scattering modelling of SCR-1/5 and monomeric SCR-16/20 
  Solution structures for SCR-1/5 and SCR-16/20 were determined by 
constrained scattering modelling. The constraints are provided by the use of updated 
homology models and recent crystal and NMR structures for the ten SCR  106
 
Figure 4.11 
  Summary of the global sedimentation equilibrium fits for SCR-1/5 
absorbance data using SEDPHAT. The residuals of the fits are shown above each 
panell (a) The SCR-1/5 absorbance fit at the rotor speeds shown as insets and at 
concentrations of 0.30 mg/ml (first two upper left panels), 0.10 mg/ml (upper right 
panel) and 0.06 mg/ml (three lower panels).  (b) The SCR-1/5 interference fit at the 
same rotor speeds and at concentrations of 0.30 mg/ml (three upper panels), 0.06 
mg/ml (lower left two panels) and 0.10 mg/ml lower right panel).  107
 
Figure 4.12 
Summary of the global sedimentation equilibrium fits for SCR-16/20 using 
SEDPHAT. The residuals of the fits are shown above each panel (a) Absorbance fits 
at the rotor speeds shown as insets correspond to concentrations of 0.13 mg/ml, 0.22 
mg/ml, 0.13 mg/ml, 0.22 mg/ml, 0.39 mg/ml and 0.43 mg/ml (from upper left to 
lower right). (b) Interference fits at the rotor speeds shown as insets correspond to 
concentrations of 0.07 mg/ml, 0.14 mg/ml, 0.22 mg/ml, 0.07 mg/ml, 0.14 mg/ml and 
0.39 mg/ml (from upper left to lower right).   108
domains involved (Saunders  et al., 2006: Herbert et al., 2006; Jokiranta et al., 
2006).This method is identical to that used in the recent modelling of FH SCR-6/8, 
(Fernando et al., 2007) and utilises better SCR homology models than those used for 
the original modelling of intact FH (Aslam & Perkins, 2001). While several ab initio 
curve fit approaches based on shape envelopes, dummy atoms or permutations of 
spheres have been proposed, these do not utilise the structural constraints provided 
by the known SCR domain structures, so were not used here. Note that, for the SCR-
16/20 searches, the linker between SCR-19 and SCR-20 was held fixed in the 
slightly bent inter-SCR angle of 160
o observed in its crystal structure (Jokiranta et 
al., 2006). The experimental X-ray curves for the curve fitting utilised those used for 
the GNOM analyses in Figure 4.5(a,b) at 0.21 mg/ml and 0.84 mg/ml for SCR-1/5 to 
improve the available Q range, and at 0.05 mg/ml and 0.14 mg/ml for monomeric 
SCR-16/20 to minimise the contribution of dimer to about 5%.  
Models that fitted the X-ray data were identified from the trial-and-error 
searches. Molecular dynamics were used to produce libraries of 1000 randomised 
conformations for each of the four linker peptides and the N-terminal and C-teminal 
peptides (Figure 4.1(c)) by capturing these conformations at set intervals during the 
simulations (Methods). The lengths of the linkers were held fixed at their theoretical 
maximum lengths while they were allowed to reorientate, as this gives the best 
selection of trial models (Fernando  et al., 2007). The 6,000 linkers and terminal 
peptides were randomly selected in order to join up 2,000 trial full models for SCR-
1/5 or SCR-16/20 from the five SCR domains within each fragment, and these 
visibly displayed a full set of randomised conformations as required (Figure 
4.13(a,b)). The resulting coordinate models were converted to hydrated Debye sphere 
models with a sphere volume of 0.546
3 nm
3 (SCR-1/5) or 0.544
3 nm
3 (SCR-16/20) in 
order to calculate their scattering curves. A satisfactory sphere model needed a 
minimum total number N of 345 (SCR-1/5) or 391 (SCR-16/20) hydrated spheres in 
order to correspond to at least 95% of their composition-calculated volumes. Over 
99% of the 2,000 models met this “absence of steric overlap” criterion (Table 4.1), 
and those that did not were discarded. The comparisons of the RXS and R-factor 
(goodness of fit) values with the RG values from the two sets of models in Figures 
4.14(a,b) and 4.15(a-c) showed that the models encompassed the experimental RG 
and RXS values denoted by dashed lines. This confirmed that a sufficient number of 
randomised conformations had been generated. Of particular interest in Figures  109
Figure 4.13 
Structural analyses for 2000 trial models for SCR-1/5 and monomeric SCR-
16/20.  
(a,b) Every tenth model (totalling 200) of the 2000 models for each of SCR-
1/5 and SCR-16/20 are shown superimposed on SCR-3 and SCR-18 respectively 
(blue ribbon) in order to show the randomised SCR-1/5 and SCR-16/20 
conformations in use.   110
4.14(a) and 4.15(a) is the correlation between the RG and RXS values, in which an 
increase in the RG values above 4 nm correlates with a straightening of the structure 
and a reduction in the RXS values. The lowest R-factor values indicated the models 
showing the best agreement with the experimental X-ray curves from the 2,000 
models. For both SCR-1/5 and SCR-16/20, this minimum corresponded to an RG 
value that agreed well with the experimental value, provided that the trace aggregates 
detected in the Guinier plots had been allowed for (Figures 4.14(b); 4.15(b,c)).  
The identified best-fit models for both SCR-1/5 and SCR-16/20 were 
partially folded-back and bent in their appearance. All the models were assessed 
using the separation between the first and last Cys residues in the first and last SCR 
domains respectively in order to exclude the N-terminal and C-terminal peptides 
from this assessment. Thus the 12 best-fit SCR-1/5 models have N- and C-termini 
Cys separations of 10.6 nm to 12.4 nm (Table 4.1) in contrast to the maximum 
possible separation of 18 nm in a linear SCR arrangement and the full range of 1.2 
nm to 16.8 nm in all 2,000 models (Figure 4.14(d)). Likewise the ten best-fit SCR-
16/20 models have N- and C-termini Cys separations of 5.5 nm to 9.8 nm in contrast 
to the full range of 0.9 nm to 16.8 nm in all 2,000 models (Figure 4.15(e)).  These 
comparisons show that both sets of best-fit models have partially folded-back 
structures. The partially folded-back best fit structures in Figure 4.16(a) reproduced 
the experimental I(Q) curve between Q of 0.15 nm
-1 and 0.88 nm
-1 with an R factor 
of 3.6% for SCR-1/5 and in Figure 4.17(a) between Q of 0.30 nm
-1 and 0.88 nm
-1 
with an R factor of 2.3% for SCR-16/20. The same models fitted the experimental 
scattering data well at both 0.21 mg/ml and 0.84 mg/ml (SCR-1/5) and 0.05 mg/ml 
and 0.14 mg/ml (SCR-16/20). The best-fit P(r) curves (insets in Figures 4.16(a); 
4.17(a)) showed maxima M at r values close to those experimentally observed 
(Figure 4.5).  
Molecular graphics views showed that the maximum dimension of the best-fit 
unhydrated SCR-1/5 model is 14.2 nm, which is increased to 15 nm after addition of 
a hydration shell monolayer (Perkins, 2001). This agrees well with the L value of 15 
nm from the P(r) curve in Figure 4.5(a). Likewise the maximum dimension of the 
best-fit SCR-16/20 model is 18.0 nm, this being inclusive of the extended C-terminal 
26-residue polypeptide in SCR-16/20 of length 8 nm. This length is estimated to 
become 19.1 nm on addition of a hydration shell. This will be in good accord with 
the experimental L value of 17 nm from the P(r) analyses in Figure 4.5(b) if the C-  111
 
 
Figure 4.14 
Results of fitting 2,000 SCR-1/5 models (white circles) to the scattering data at 0.21 
mg/ml. Panel (a) compares the RXS values with the RG values. Panel (b) compares the R 
factors with the RG values. Panels (c,d) compare the α-carbon separation (N- to C- peptides) 
and (Cys-21 to Cys-320) with the RG values. The experimental RG and RXS values of 4.34 nm 
and 1.46 nm are shown as dashed lines (Table 4.1). The 12 best-fit models on the basis of the 
RG, RXS and R-factor filters are shown as yellow and green circles (Table 4.1). The best-fit 
model (green circle) and the most folded-back model as a representative poor fit (red circle) 
are also shown.   112
terminal tail is considered to be sufficiently flexible to adopt multiple conformations, 
some of which are reoriented towards the centre of the model to reduce its overall 
length.  
Three further sets of calculations clarified the outcome of the scattering 
modelling for SCR-1/5 and SCR-16/20. Firstly, the ten and 12 best-fit models for 
SCR-1/5 and SCR-16/20 (yellow and green circles in Figures 4.14 and 4.15) are 
found in similar locations in the distributions of Figures 4.14 and 4.15, suggesting 
that all the best-fit scattering models form one related family of structures. The 
superimposition of these best-fit structures upon the central SCR domain in Figure 
4.18 showed that all exhibited similar partially folded-back bent structures. Secondly, 
the scattering modelling is effective in rejecting poor-fit models. Two such examples 
are shown in Figures 4.14 and 4.15 (red circles) and the resulting poor fits in Figures 
4.16(b) and 4.17(b). One poor curve fit with an R factor of 20.5% is illustrated by a 
fully-folded-back SCR-1/5 model in which the five SCR domains form a U-shaped 
arrangement. This resulted in large deviations in both the I(Q) and P(r) curves from 
the experimental curves (Figure 4.16(b)), and gave an RG value of 2.49 nm and an 
RXS value of 0.97 nm in large deviation from the experimental values (Table 4.1). 
Furthermore steric clashes were observed between the SCR domains as the linker 
peptides are relatively short at four residues in each one. Another poor curve fit with 
an R factor of 15.9% is illustrated by an extended SCR-16/20 model (Figure 
4.17(b)). Again large deviations in both the I(Q) and P(r) curves from the experiment 
occurred (Figure 4.17(b)), and this gave an RG value of 6.72 nm and an RXS value of 
0.78 nm in large deviation from the experimental values. Thirdly, comparison with 
the four best-fit models A-D for intact FH (PDB code 1haq) showed that the SCR-
1/5 and SCR-16/20 fragments extracted from these mostly showed reasonable 
agreements with the scattering curves for SCR-1/5 and SCR-16/20. Model C had the 
closest resemblance to the presently-determined structure of SCR-1/5 with an R-
factor of 4.0% compared to that of 3.6% for the fit shown in Figure 4.16(a) and the 
12 best fit structures (Table 4.1). The other three models showed R factors of 5.4% to 
7.5%. Model D had the closest resemblance to the presently-determined structures of 
SCR-16/20 modelled here with an R-factor of 5.1% compared to that of 2.3% for the 
fit shown in Figure 4.17(a) (Aslam & Perkins, 2001). The other three models showed 
too high R factors of 8.7% to 15.1%; these deviated more because these structures 
were too extended. Hence the new partially bent back structures of SCR-1/5 and   113
 
Figure 4.15 
Summary of 2,000 fits to the monomeric SCR-16/20 scattering data at 0.14 mg/ml. 
Panel (a) compares the RXS values with the RG values. Panel (b) compares R factors with RG 
values for experimental scattering curves at 0.05 mg/ml and 0.27 mg/ml, while (c) compares 
R factors with RG values for the experimental scattering       
curve at 0.14 mg/ml. Panels (d,e) compare the α-carbon separation for SCR-16/20 (N- to C- 
peptides) and (Cys-922 to Cys-1228) with the RG values. The experimental RG and RXS 
values of 4.66 nm and 1.74 nm are shown as dashed lines (Table 4.1). The ten best-fit 
models are shown as yellow and green circles (Table 4.1). The best-fit model is shown in 
green, and the red circle denotes the most extended model as a representative poor fit.  114
SCR-16/20 determined in this study resemble those found within the previously 
determined intact FH solution structure.  
As an independent check of the scattering modelling, the s
0
20,w values of the 
12 best-fit SCR-1/5 models were calculated. These ranged from 2.28 S to 2.37 S 
(HYDRO) and 2.06 S to 2.27 S (HYDROPRO) (Table 4.1). The best-fit model gave 
calculated s
0
20,w values of 2.33 S and 2.22 S, which is in good agreement with the 
experimental values of 2.37 S to 2.52 S. The s
0
20,w values calculated for the ten best-
fit SCR-16/20 models ranged between 2.23 S to 2.30 S (HYDRO) and between 2.06 
S to 2.20 S (HYDROPRO) (Table 4.1). The best-fit scattering model gave calculated 
s
0
20,w values of 2.29 S and 2.17 S. These are about 0.6 S less than the experimental 
values of 2.78 S to 2.87 S. As the C-terminal tail is extended in all these models, this 
was reoriented back into the centre of the model. A model of overall length 12 nm in 
place of 17 nm gave calculated s
0
20,w values of 2.59 S and 2.35 S to show good 
agreement with experiment. Accordingly this discrepancy is likely to be due to the 
conformation of the disordered 26-residue C-terminal tail which is inferred to be 
flexible. In summary, these calculations support the outcome of the scattering 
modelling which is summarised in Figure 4.18. 
 
(4.2.4)  Trial models for dimeric SCR-16/20  
In order to account for the scattering curve and s
0
20,w value for the SCR-16/20 
dimer, molecular graphics was used with the best-fit partially folded-back model for 
SCR-16/20 to create manually trial conformations for two-fold symmetric SCR-
16/20 dimer models. These models assumed that no conformational change occurred 
in SCR-16/20 upon dimerisation. The weak association of SCR-16/20 meant that 
about 50% dimerisation had occurred at the 1.15 mg/ml concentration used for curve 
fits. Dimerisation had previously been observed for the SCR-15/18 and SCR-15/20 
fragments in non-reducing SDS PAGE, showing at least one dimerisation site is 
present in SCR-15/18 (Jokiranta et al., 1998). The earliest scattering modelling of the 
FH dimer suggested that the dimerisation site may occur at SCR-20, although there 
was no proof for this (Perkins et al., 1991). While no dimerisation in SCR-19/20 was 
observed by NMR, (Herbert et al., 2006) a Trp1183Leu mutant in SCR-20 showed 
enhanced oligomer formation (Jokiranta et al., 2006). Hence the weak association 
and the variables associated with dimer formation meant that it was not considered 
feasible to perform constrained modelling searches as above for the two monomers.  115
Table 4.1.  X-ray scattering and sedimentation coefficient fits for the solution structures of SCR-1/5 and SCR-16/20  
 
a Distance between the α-carbon atoms of the first and last residues in SCR-1/5 between Cys21 and Cys320, or that in SCR-16/20 
between Cys931 and Cys1228 (Figure 4.1).  
b The first value is from the Guinier RG analyses (Figures 4.3; 4.4); the second is from the GNOM P(r) analyses (Figure 4.5). The 
filtering of the 2,000 models and the RG/RO ratios used RG values of 4.34 nm (SCR-1/5) and 4.66 nm (SCR-16/20). 
 
c The first value is from the DCDT+ analyses (Figures 4.6; 4.9); the second is from the SEDFIT analyses (Figures 4.7; 4.10). 
 
d The first value is calculated from the model using HYDRO; the second is calculated using HYDROPRO
  Filter Models  Hydrated 
spheres 
RG (nm)  RXS (nm)  R factor (%)  N-C terminal 
separation (nm)
a 
s
0
20,w (S)  
Experimental (SCR-1/5)      363 
 
4.26 ± 0.16;  
4.42 ± 0.13
b  
1.46 ± 0.08      2.52 ± 0.02 
2.37 ± 0.03 
c 
Experimental (SCR-16/20 monomer)     412  4.66  ± 0.13;  
4.81 ± 0.11
b  
1.74 ± 0.04     2.78 ± 0.30 
2.87 ± 0.20
 c  
Experimental (SCR-16/20 dimer)     824  8.09 ± 0.21  
7.51 ± 0.24
 b   
2.42 ± 0.14     3.54 ± 0.14 
3.92 ± 0.23
 c  
Modelling (SCR-1/5)  None  2000  319 - 414  2.49 - 5.65  0.04 - 2.03  3.4 – 20.6  1.2 – 16.8  n.a. 
Modelling (SCR-1/5)  RG, RXS  and 
R factor 
12  365 – 392  4.31 - 4.45  1.46 - 1.54  3.6 – 4.5  10.6 – 12.4  2.28 – 2.37,  
2.06 – 2.27 
d 
Modelling (SCR-1/5)  Best fit   1  392  4.39  1.46  3.6   12.4   2.33, 2.22 
Modelling (SCR-16/20 monomer)  None  2000  393 – 487  3.34 – 6.72  0.04 - 2.32  2.2 – 21.5  0.9 - 16.8  n.a. 
Modelling (SCR-16/20 monomer)  RG, RXS  and 
R factor 
10  440 – 465  4.55 – 4.75  1.69 - 1.80  2.3 – 4.6  5.5 – 9.8  2.23 – 2.30,  
2.06 – 2.20 
d 
Modelling (SCR-16/20 monomer)  Best fit   1  446 4.69  1.70  2.3   6.91   2.29, 2.17 
Modelling (SCR-16/20 dimer)  R factor  8  855 – 892  5.57 – 9.10  1.61 - 2.62  5.9 – 13.7  n.a.  3.09 – 3.46,  
2.90 – 3.32 
d 
Modelling (SCR-16/20 dimer)  Best fit   1  857  7.11  1.78  5.9   n.a.  3.20, 3.06   116
 
Figure 4.16 
Best-fit and poor-fit X-ray scattering modelling for SCR-1/5. The fitted 
experimental scattering data in (a,b) at 0.21 mg/ml and 0.84 mg/ml are denoted by 
black points. The green and red lines correspond to the best-fit and poor-fit models 
respectively. The Q ranges employed in the experimental RG and RXS analyses are 
denoted by horizontal bars. The insets at the upper right show the modelled P(r) 
distance distribution functions in green and red for comparison with the experimental 
P(r) curve in black (Figure 4.5). The insets to the lower left show ribbon views of the 
models used to calculate the curves.  
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Accordingly a range of conformers involving the arbitrary choice of SCR-20 
or SCR-15 as the dimerisation contact point were assessed by using their s
0
20,w and 
RG values. For example, a best-fit dimer model involved anti-parallel side-by-side 
contacts between the SCR-20 domains (Figure 4.17(c)) and gave s
0
20,w values of 3.20 
S and 3.06 S (Table 4.1). These were in fair agreement with the observed 
experimental values of 3.54 S to 3.92 S. The calculated RG value of 7.11 nm was 
comparable with the experimental RG values of 7.51 nm to 8.09 nm. Scattering curve 
fitting gave a surprisingly reasonable R-factor of 5.9% and good visual agreement 
with the I(Q) and P(r) curves (Figure 4.17(c)). In contrast to this, a more compact 
inverted dimer model gave larger s
0
20,w values of 3.43 S and 3.25 S. While both 
values were in fair agreement with the observed experimental values of 3.54 S to 
3.92 S, the calculated RG value of 5.92 nm was much less than the experimental RG 
values of 7.51 nm to 8.09 nm. Larger deviations with the I(Q) and P(r) curves were 
seen (Figure 4.17(d)), and the R-factor was higher at 7.4%. No fits could be obtained 
on the basis of the overlapped domain arrangements seen in the crystal packing of 
SCR-19/20 tetramers, (Jokiranta  et al., 2006) as these would have significantly 
reduced the length of the dimer to below that observed in Figure 4.5(c) (see Figure 
4.1(b)). In conclusion, these calculations show that the dimer is formed as an 
extended arrangement of two SCR-16/20 monomers from contacts between two 
SCR-20 or SCR-15 domains or at a different pair of SCR domains.  
 
(4.3) Conclusions 
This study of the two most functionally-relevant fragments of FH has 
revealed new properties of this major complement regulator. Firstly, evidence from 
both X-ray scattering and AUC show that the SCR-16/20 fragment exists in a weak 
monomer-dimer equilibrium while this is not seen for the SCR-1/5 fragment. These 
results offer further insights into previous reports of the existence of monomeric or 
dimeric forms of FH (Perkins et al., 1991; Aslam & Perkins, 2001). Furthermore, 
conformational similarities in the partially folded-back and bent domain 
arrangements for both the SCR-1/5 and SCR-16/20 fragments of FH were identified. 
These are similar to the previously-deduced partially folded-back solution 
arrangement for the 20 SCR domains in intact FH (Aslam & Perkins, 2001).   118
 
Figure 4.17 
Best-fit and poor-fit X-ray scattering modelling for monomeric and dimeric SCR-
16/20.  The fitted experimental scattering data in (a,b) for monomeric SCR-16/20 at 0.05 
mg/ml and 0.14 mg/ml, and (c,d) for dimeric SCR-16/20 at 1.15 mg/ml are denoted by black 
points. The green and red lines correspond to the best-fit and poor-fit models respectively. 
The Q ranges employed in the experimental RG and RXS analyses are denoted by horizontal 
bars. The insets at the upper right show the modelled P(r) distance distribution functions in 
green and red for comparison with the experimental P(r) curve in black (Figure 4.5). The 
insets to the lower left show ribbon views of the models used to calculate the curves.   119
The Guinier and P(r) scattering data and the velocity and equilibrium AUC data 
show that SCR-1/5 does not exhibit self-associative properties, whereas SCR-16/20 
does. FH exists in plasma at concentrations of 0.235 mg/ml to 0.810 mg/ml (1.6 µM 
to 5.4 µM) (Saunders et al., 2006). The SCR-1/5 concentrations of 0.21-0.84 mg/ml 
(6.0 µM to 24.1 µM) and SCR-16/20 concentrations of 0.05-1.15 mg/ml (1.3 µM to 
29.0 µM) used in this study therefore includes and exceeds the physiological plasma 
concentration range of FH. Four determinations of the KD for the monomer-dimer 
equilibrium from the Guinier analyses and the sedimentation equilibrium fits give a 
mean KD of 16 ± 2 µM. If native FH behaves similarly to the SCR-16/20 fragment, 
then 7% to 21% of native FH in plasma will be dimeric by this mechanism. 
However, it should be noted that the observed self-association of SCR-16/20 may 
result from its recombinant nature or its 26-residue C-terminal peptide (Figure 
4.1(c)), and therefore it may not apply to native FH. Nonetheless the weak 
dimerisation of SCR-16/20 is consistent with previous demonstration of monomeric 
and dimeric forms of FH (Perkins et al., 1991; Aslam & Perkins, 2001). Previously a 
second weak dimerisation of the SCR-6/8 fragment in FH with a KD of 40 µM was 
identified, which corresponds to about 4% to 11% of dimeric FH in plasma 
(Fernando et al., 2007). FH is found in the drusen deposits of the eye retina that are a 
hallmark of age-related macular degeneration (Hageman et al., 2005). The potential 
dimerisation at separate pairs of SCR-6/8 and SCR-16/20 segments between different 
FH molecules may constitute a cross-linking mechanism by which FH could 
aggregate continuously to form larger assemblies. The dimerisation of FH may also 
increase its affinity for binding to heparin-like anionic ligands if the ligand and dimer 
sites are independent of each other, further promoting aggregation processes. This 
possibility is supported by the observation of oligomerisation in native FH from 
plasma (Nan et al., 2008a). 
The joint use of scattering and AUC experiments in conjunction with 
constrained modelling showed that both SCR-1/5 and SCR-16/20 are partially 
folded-back and bent in solution. The well-resolved peaks in the size distribution 
analyses of Figures 4.7 and 4.10 indicate no evidence of shape polydispersity. There 
are indications of disorder in the C-terminal tail of SCR-16/20 from the 
sedimentation coefficient modelling. The appearance of the model in Figure 4.18 
illustrates the degree of SCR arrangements that are possible. However it is stressed   120
that other partially folded-back structures that fit the scattering data are possible, and 
specific inter-SCR orientations cannot be identified by constrained modelling. Only 
the general degree to which this occurs can be elucidated. The coexistence of two 
conformations such as those shown in Figures 4.16(a,b) or 4.17(a,b) is ruled out by 
the good fits to the available Q ranges in Figures 4.16(a) and 4.17(a). The 
coexistence of multiple conformations had previously been reported for complement 
receptor type 2 with 15 SCR domains that gave Q-dependent curve fits, (Gilbert et 
al., 2006)
 however there were no indications of this in the present study. With two-
SCR or three-SCR fragments, it is possible to infer an averaged bend (Fernando et 
al., 2007; Gilbert et al., 2005). Here, with five-SCR fragments, both the SCR-1/5 and 
SCR-16/20 fragments exhibited an averaged inter-domain SCR angle of 127 ± 25
o 
and 125 ± 31
o respectively when averaged over the 12 and 10 best-fit models.  
These are significantly different from a linear SCR arrangement with an angle 
of 180
o. Comparison with an averaged inter-domain SCR angle of 85 ± 43
o for the 
SCR-1/5 and SCR-16/20 fragments extracted from the four best-fit models for intact 
FH shows that the partial folding back of the two fragments is similar to that found in 
the original constrained scattering modelling of FH (Aslam & Perkins, 2001). This is 
well illustrated by the comparative views in Figure 4.19. The advantage of modelling 
five-SCR fragments is that this reduces the uncertainty implicit in modelling the 
entire 20-SCR structure. If the central ten SCR domains in FH are arranged similarly 
to those in SCR-1/5 and SCR-16/20, this will provide an explanation of the shorter 
overall length of FH when this is compared to that expected from a maximally 
extended arrangement. This degree of partial folding-back in FH agrees with earlier 
electron micrographs of FH obtained in relatively harsh conditions (DiScipio, 1992). 
The main difference between this present study and the electron micrographs is to 
demonstrate that it is not necessary for two different SCR domains to interact with 
each other across the FH structure to form “alpha-shaped” arrangements in order to 
account for its reduced overall length. The proposed partial folding-back of the SCR 
domains is sufficient to achieve this with typical inter-SCR angles of about 85
o to 
127
o. In fact, if the alternative hypothesis of “alpha-shaped” arrangements of 
domains within FH is true, (Oppermann et al., 2006; DiScipio, 1992) the necessary 
contacts between different SCR domains within the same molecule would have to be 
sufficiently stable to favour their formation. This may offer the possibility for FH to  
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Figure 4.18 
Outcome of the constrained modelling fits for SCR-1/5 and SCR-16/20.  
The 12 best-fit models for SCR-1/5 and the ten best-fit models for monomeric SCR-
16/20 are shown superimposed on SCR-3 for SCR-1/5 and on SCR-18 for SCR-
16/20. SCR-3 and SCR-18 are shown as red ribbons. The overall best-fit models are 
shown in green, while the remainder is shown as blue ribbons.   122
self-aggregate continuously through interactions at non-identical SCR binding sites 
and cause it to precipitate from solution, which is unlikely.   
The functional significance of the SCR-1/5 and SCR-16/20 structures is best 
considered in the context of the macromolecular ligands to which they bind (Figure 
4.19). One question is the expected degree of inter-SCR flexibility within these two 
partially-folded back structures. The four linkers in SCR-1/5 are all four residues 
long (Figure 4.1(a)), while those in SCR-16/20 are three or four residues long with 
the interesting exception of the SCR-18/19 linker which is six residues long. It is 
possible that there may be specific hydrogen bonding networks at the linker regions 
to stabilise these structures, but a high resolution structure will be required to 
establish this. If it can be assumed that the partially folded-back structures persist, 
they appear to be ideal for protein-protein interactions with C3b as illustrated in 
Figure 4.19 at the three sites denoted H-1 to H-3 by being able to wrap themselves 
around a localised region of the C3b surface to prepare C3b for its cleavage by 
Factor I at the CUB domain to release C3d and C3c. However the six-residue SCR-
18/19 linker is longer and potentially more flexible. This may permit SCR-19/20 to 
bind to heparin-like oligosaccharides at host cell surfaces, whilst at the same time 
permitting the remaining SCR-1/18 segment of FH to orientate itself freely into the 
solution phase to facilitate contacts with C3b molecules. Poisson-Boltzmann 
electrostatic surface maps suggest that SCR-16/20 is predominantly basic in its 
surface regions while SCR-1/5 is predominantly acidic (Figure 4.20). Hence this 
suggests that SCR-16/20 is well adapted for binding to host cell surfaces as well as to 
C3d. A further indication of the nature of the interactions of SCR-16/20 with its 
ligands is the occurrence of Type II mutations within SCR-16/18 as well as in SCR-
19/20 that all lead to atypical haemolytic uraemic syndrome (Saunders et al., 2007). 
Type II mutations are associated with functional binding defects at the surface of the 
protein, in distinction to Type I mutations that cause protein misfolding to occur and 
lead to reduced quantities of FH in plasma. Up to now it has been difficult to account 
for these mutations in SCR-16/18 as well as in SCR-19/20. The comparison of the 
partially folded-back SCR-16/20 structure with the crystal structures of C3b (Janssen 
et al., 2006, Weisman et al., 2006; Abdul Ajees et al., 2006) with these mutations 
suggests that all five domains in SCR-16/20 may have a role to play in mediating 
functional interactions with C3d or with heparin-like ligands.  
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Figure 4.19 
The best-fit SCR-1/5 and SCR-16/20 models (green) are shown in 
comparison with the scattering models for SCR-6/8 (blue: PDB code 2ic4) and intact 
FH (red: PDB code 1haqA).  The comparison is shown to the same scale with the 
scattering model for Factor I (green SP domain; magenta: FIMAC, DC5 and LDLr 
domains). The C3b crystal structure (PDB code: 2i07) is shown in green (TED 
domain), cyan (CUB domain), orange (the MG1-MG8 domains) and purple (the 
C345C domain). The FH binding sites on C3b are shown in blue as H-1 to H-3.   124
 
Figure 4.20 
Electrostatic maps of the SCR-1/5 and SCR-16/20 best-fit models are shown 
in two 180
o front and back rotational views about their longest axes. Acidic surfaces 
are shown in red, while basic surfaces are shown in blue.  
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(4.4) Materials and Methods 
(4.4.1) Expression and preparation of SCR-1/5 and SCR-16/20  
The entire cloning and transformation aspects of protein preparation in this 
study were carried out by Ms. K. M. Griggs, Dr. R. J. Ormsby and Prof. D.L. Gordon 
at Flinders Medical Centre and Flinders University, Australia, (Okemefuna et al., 
2008) as well as some initial protein expression and affinity purification.  
The coding regions for recombinant SCR-1/5 and SCR-16/20 were 
constructed by PCR and cloned into the yeast expression vector pPICZαA 
(Invitrogen) downstream of the AOX1 methanol-inducible promoter (Figure 4.1). 
PCR reactions, cloning and transformation into E. coli were carried out according to 
standard protocols (Sambrook, Fritsch et al., 1989). SCR-1/5 was amplified using 
primers FH SCR 1 F (Eco RI) 5'-CGGAATTCGAAGATTGCAATGAACTTCC-3' 
and FH SCR 5 HIS R (Xba I) 5'-
GGTCTAGACTAGTGGTGGTGGTGGTGGTGCAAGGTACATCTCGGAGCAG-
3'. SCR-16/20 was amplified using primers FH SCR 16 F (Eco RI) 5'-
GGGAATTCGGCCTTCCTTGTAAATCTCC-3' and FH SCR 20 HIS R (Xba I) 5'-
GGTCTAGAGGTCTTTTTGCACAAGTTGG-3'. The FH SCR 20 HIS R (Xba I) 
reverse primer was designed so that the c-myc epitope, the polyhistidine tag and stop 
codon found in the pPICZαA vector were in frame and utilized (Figure 4.1). All 
PCR-amplified SCR constructs were digested with the appropriate restriction 
enzymes, cloned into the multiple cloning site of pPICZαA and transformed into E. 
coli DH5α.  Sequence analysis confirmed each construct had the correct sequence.  
Up to 10 µg of Sac I linearised pPICZαA DNA containing the two SCR 
constructs was electroporated into Pichia  pastoris strain X33, and transformants 
were selected on 100 µg/ml Zeocin (Invitrogen).  Expression of recombinant proteins 
was induced for 2-4 days in the presence of 2% methanol according to 
manufacturer’s instructions (Invitrogen). Recombinant proteins in yields of 1-2 mg 
per litre cell culture were purified by nickel affinity chromatography. Briefly, 200-
400 ml of P. pastoris supernatant was passed over 5 ml nickel affinity columns 
(Amersham Biosciences), washed extensively (0.02 M sodium phosphate, 0.5 M 
NaCl, pH 7.4) and eluted (0.02 M sodium phosphate, 0.5 M NaCl, 0.1 M imidazole, 
pH 7.4). Eluates were immediately dialyzed in PBS and the protein concentration 
was determined using a Micro BCA Protein Assay Reagent kit (Pierce). The SCR-
1/5 fragment retained functional activity as assessed by cofactor activity for factor I   126
mediated cleavage of C3b (data not shown) (Gordon et al., 1995). The SCR-16/20 
fragment likewise possesses activity by binding to heparin and also to 
glycosaminoglycans on human umbilical vein endothelial cells (Ormsby et al., 2006) 
The X-ray scattering and AUC experiments were performed separately or jointly on 
each sample preparation in phosphate buffered saline (PBS) after dialysis into this 
buffer (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.3). 
Compositional data for the data analyses are summarised. The SCR-1/5 and 
SCR-16/20 sequences were taken from SWISSPROT accession number P08603. 
SCR-1/5 was taken to be unglycosylated at its single putative N-linked site, while 
SCR-16/20 was taken to be glycosylated at one of its two putative sites in SCR-17 
and SCR-18 (Figure 4.1). SCR-1/5 has a calculated molecular weight of 35,300 Da, 
an unhydrated volume of 44.7 nm
3, a hydrated volume of 59.1 nm
3 (based on a 
hydration of 0.3g H2O/g of glycoprotein and an electrostricted volume of 0.0245 nm
3 
per bound water molecule), a partial specific volume v of 0.7202 ml/g, and an 
absorption coefficient at 280 nm (1%, 1 cm path length) of 17.2 (Perkins, 1986). 
SCR-16/20 has a calculated molecular weight of 39,700 Da, an unhydrated volume 
of 50.1 nm
3, a hydrated volume of 66.3 nm
3, a v of 0.7187 ml/g, and an absorption 
coefficient of 15.7 (Perkins, 1986). The buffer density was calculated as 1.00534 
g/ml from standard tabulations in the program SEDNTERP for use in data 
processing, (Laue  et al., 1992) and confirmed to be 1.00541 g/ml at 20
oC by 
measurement on an Anton-Paar DMA5000 density meter.  
 
(4.4.2) X-ray scattering data collection and analysis 
X-ray scattering data were obtained for SCR-1/5 and SCR-16/20 at the 
European Synchrotron Radiation Facility (ESRF), Grenoble, France operating with a 
ring energy of 6.0 GeV on the Beamline ID02 (Narayanan et al., 2001). Storage ring 
currents ranged from 22 mA to 42 mA for SCR-1/5 (one beam session in four bunch 
mode). For SCR-16/20, these currents ranged from 23 mA to 42 mA (three beam 
sessions in four bunch mode) and from 171 mA to 181 mA (one beam session in 
uniform bunch mode).  SCR-1/5 was studied at 0.21 mg/ml to 0.84 mg/ml, while 
SCR-16/20 was studied at 0.05 mg/ml to 1.15 mg/ml. After one initial session using 
a static sample holder, all the final samples were measured in flow cells to reduce 
radiation damage by moving the sample continuously during beam exposure in 10   127
time frames of duration 0.1 sec, 0.2 sec, 0.5 sec or 1.0 sec each, together with on-line 
checks for the absence of radiation damage, after which the frames were averaged. 
Other details including the data reduction procedure are described elsewhere (Gilbert 
et al., 2005). 
In a given solute-solvent contrast, the radius of gyration RG is a measure of 
structural elongation if the internal inhomogeneity of scattering densities within the 
protein has no effect. Guinier analyses at low Q gives the RG, and the forward 
scattering at zero angle I(0) (Glatter & Kratky, 1982):  
 
ln I(Q) = ln I(0) - RG
2 Q
2/3. 
 
This expression is valid in a Q.RG range up to 1.5. If the structure is elongated, the 
mean radius of gyration of cross-sectional structure RXS and the mean cross-sectional 
intensity at zero angle [I(Q)Q]Q→0 is obtained from: 
 
ln [I(Q)Q] = [I(Q)Q]Q→0 - RXS
2Q
2/2. 
 
The RG and RXS analyses lead to the triaxial dimensions of the macromolecule if the 
structure can be represented by an elliptical cylinder, where L = √ 12(RG
2 - RXS
2) and 
L is its length (Glatter & Kratky, 1982). The RG and RXS analyses were performed 
using an interactive PERL script program SCTPL7 (J. T. Eaton and S. J. Perkins, 
unpublished software) on Silicon Graphics O2 Workstations. Indirect transformation 
of the scattering data I(Q) in reciprocal space into real space to give the distance 
distribution function P(r) was carried out using the GNOM program (Semenyuk & 
Svergun, 1991): 
P(r) corresponds to the distribution of distances r between volume elements. The 
SCR-1/5 X-ray curve utilised up to 450 data points in the Q range between 0.15 nm
-1 
and 0.88 nm
-1 at 0.21 mg/ml (Figure 4.5(a)), supplemented by that between 0.16 nm
-1 
and 1.76 nm
-1 at 0.84 mg/ml for Figure 4.16. The SCR-16/20 monomer X-ray curves 
utilised up to 422 data points in the Q range between 0.16 nm
-1 and 0.96 nm
-1 at 0.14 
dQ   (Qr)   Qr   I(Q)    
2
1
  =   P(r)
o
2 sin ∫
∞
π
   128
mg/ml, and between 0.12 nm
-1 and 0.49 nm
-1 at 0.05 mg/ml (Figure 4.17(a,b)). The 
largest usable Q value increased with concentration. Thus the SCR-16/20 dimer X-
ray curve utilised 298 data points in the Q range between 0.06 nm
-1 and 2.01 nm
-1. 
Other details are as described previously (Gilbert et al., 2005). 
 
(4.4.3) Sedimentation velocity and equilibrium data for SCR-1/5 and SCR-16/20  
AUC data for SCR-1/5 and SCR-16/20 were obtained on a Beckman XL-I 
instrument using AnTi50 or AnTi60 rotors. Sedimentation velocity data was acquired 
at 20
oC at rotor speeds of 35,000 r.p.m and 42,000 r.p.m. for SCR-1/5 and 35,000 
r.p.m., 40,000 r.p.m., 42,000 r.p.m., 50,000 r.p.m. and 55,000 r.p.m. for SCR-16/20 
in two-sector cells with column heights of 12 mm. The different rotor speeds 
established the absence of diffusion effects on the sedimentation coefficient. The 
g(s*) time-derivative analyses of between 10 to 30 absorbance and interference scans 
were analysed using DCDT+ version 2.06, (Philo, 2006) from which the 
sedimentation and diffusion coefficients (and hence the molecular weight) were 
determined from the peak position and width. The number of scans selected for the 
DCDT+ analyses ensured that peak broadening effects were negligible (Philo, 2006). 
A second independent sedimentation analysis was performed using direct boundary 
Lamm fits of 200 scans using SEDFIT (version 9.4) (Schuck, 1998; 2000). SEDFIT 
resulted in size-distribution analyses c(s) that assumed that all species have the same 
frictional ratio f/fo, and this established the oligomeric species that were present. The 
final SEDFIT analyses optimised the c(s) model by floating the meniscus, frictional 
ratio, and baseline until the overall root mean square deviations and visual 
appearance of the fits were satisfactory (Figures 4.7; 4.10).  
Sedimentation equilibrium data were acquired during a run for 150 h using 
six-sector cells with solution column heights of 2 mm at rotor speeds of 11,000 
r.p.m., 14,000 r.p.m., 20,000 r.p.m., 25,000 r.p.m., 30,000 r.p.m., and 35,000 r.p.m. 
until equilibrium had been reached at each speed (confirmed by the perfect overlay 
of runs measured at 3 h intervals). For reason of protein stability, the most successful 
data collection was performed at 4
oC. The molecular weight MW for SCR-1/5 was 
initially determined on the assumption of a single species using SEDPHAT (version 
4.3; Schuck, 2003): 
   c r = cro exp [(ω
2/2RT) MW (1- v ρ) (r
2 - ro
2)] 
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where cr is the concentration at radius r, cro is the concentration of the protein at the 
reference radius ro,  ω is the angular velocity, R is the gas constant, T is the 
temperature (Kelvin), and ρ is the solvent density of the buffer. Final molecular 
weights were obtained using global fits of up to 15 curves in SEDPHAT in the 
“single species of interacting system” model with both the “M and s” and Marquardt-
Levenberg fitting routines, while floating the molar extinction coefficient, the 
baseline and the bottom of the cell.  The molecular weight MW for SCR-16/20 was 
initially determined using SEDPHAT on the assumption of a reversible monomer-
dimer self-association equilibrium, followed by global fits of up to 18 curves. For a 
protein in a reversible monomer-dimer self-association, the mass action law cr = 
cro
2K12 is fulfilled simultaneously in all positions within the solution column, leading 
to the distribution: (McRorie & Voelker, 1993)
  
 
   c r = cro exp [(ω
2/2RT) MW (1- v ρ) (r
2 - ro
2)]  
        + 2K12 cro
2 exp [(ω
2/2RT) 2MW (1- v ρ) (r
2 - ro
2)] 
 
where K12 is the association constant for dimer formation. Molecular weights were 
obtained by fitting on the basis of the “monomer-dimer self-association” model using 
the “M and s”, simplex and Marquardt-Levenberg fitting routines, while floating the 
baseline and the bottom of the cell. Statistical error analysis employed the Monte-
Carlo approach. 
 
(4.4.4) Modelling of the SCR-1/5 and SCR-16/20 solution structures  
The modelling of human SCR-1/5 and SCR-16/20 was based on the NMR 
structure for SCR-16 and the crystal structure for SCR-19/20 (Barlow et al., 1993, 
Jokiranta et al., 2006), and the updated homology models for the remaining seven 
SCR domains, which were prepared using MODELLER v7 (Saunders et al., 2006). 
The FH sequence numbering starts from the N-terminus of the 18-residue signal 
peptide and not that of the mature protein, to follow recent genetic publications 
(Klein et al., 2005; Haines et al., 2005; Edwards et al., 2005; Hageman et al., 2005). 
For SCR-1/5, N-terminal and C-terminal tail sequences 17-EFEDC-21 and 320-
CTLHHHHHH-328 and four linker sequences 80-CQKRPC-85, 141-CEVVKC-146, 
205-CVEISC-210 and 262-CEEKSC-267 (Figure 4.1) were created in extended β-  130
strand conformations using INSIGHT II 98.0 molecular graphics software (Accelrys, 
San Diego, CA, USA) on Silicon Graphics O2 and OCTANE Workstations. For 
SCR-16/20, N-terminal and C-terminal tail sequences 922-EAEAEFGLPC-931 and 
1228-CAKRPLEQKLISEEDLNSAVDHHHHHH-1254 and three linker sequences 
984-CIKTDC-989, 1043-CRDTSC-1048 and 1102-CKDSTGKC-1109 (i.e. 
excluding that between SCR-19 and SCR-20) (Figure 4.1) were created in the same 
manner. Libraries of 1,000 random linker and 1,000 random tail conformations were 
generated using molecular dynamics simulations. One structure from each library 
was randomly selected to assemble 2,000 full SCR-1/5 models and 2,000 full SCR-
16/20 monomer models. Further details are given elsewhere (Fernando et al., 2007). 
In these models, the inter-SCR domain angle is defined as the angle between the two 
longest axes of two adjacent SCR domains, where each axis is the line between the 
midpoint of the two αC atoms in the disulphide bridges at the two ends of the SCR 
domain (Gilbert et al., 2005). The N-C terminal distance is defined as the distance 
from Cys-21 to Cys-320 (SCR-1/5) and Cys-931 to Cys-1228 (SCR-16/20). 
 
(4.4.5) Debye scattering and sedimentation coefficient modelling  
Each SCR-1/5 or SCR-16/20 model was used to calculate X-ray scattering 
curves for comparison with the experimental curves using Debye sphere models 
(Gilbert et al., 2005). A cube side length of 0.546 nm (SCR-1/5) and 0.544 nm 
(SCR-16/20) in combination with a cutoff of 4 atoms for both models consistently 
produced 275- and 311-sphere unhydrated models respectively, each within 95% of 
the total volume calculated from its composition. The hydration shell was created 
using HYPRO, (Ashton et al., 1997) where the optimal total of hydrated spheres for 
SCR-1/5 is 363 and that for SCR-16/20 is 412. The X-ray scattering curve I(Q) was 
calculated using the Debye equation as adapted to spheres (Perkins & Weiss, 1983). 
Other details are given elsewhere (Perkins, 2001; Boehm et al., 1999). The number 
of spheres N in the dry and hydrated models after grid transformation was used to 
assess steric overlap between the SCR domains, where models showing less than 
95% of the optimal total were discarded. The models were assessed by calculation of 
the X-ray RG and RXS values from the modelled curves in the same Q ranges used for 
the experimental Guinier fits in order to allow for any approximations inherent in the 
use of the Q.RG range up to 1.5. Models that passed these three filters were then 
ranked using a goodness-of-fit R factor defined by analogy with protein   131
crystallography and based on the experimental curves, in the Q range extending to 
1.8 nm
-1. 
   Sedimentation  coefficients  s
0
20,w were calculated directly from the same 
hydrated SCR-1/5 and SCR-16/20 scattering sphere models using the HYDRO 
program, (Garcia de la Torre et al., 1994) and also directly from the atomic 
coordinates in the HYDROPRO shell modelling program using the default value of 
0.31 nm for the atomic element radius for all atoms to represent the hydration shell 
(Garcia de la Torre et al., 2000). 
 
(4.4.6) Protein Data Bank accession number 
  The best-fit SCR-1/5 and SCR-16/20 α-carbon co-ordinate models have been 
deposited in the Protein Data Bank with the accession codes 2qfg and 2qfh.    132
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Five 
 
Electrostatic interactions contribute to the folded-back conformation of wild-type 
human Factor H  133
(5.1) Introduction 
The FH SCR domain structure is not fully extended in solution but is partially 
folded back, as shown by solution scattering, AUC and electron microscopy (Perkins et 
al., 1991; Discipio, 1992; Aslam & Perkins, 2001). Constrained scattering modelling 
(Perkins et al., 2008) resulted in the first medium resolution molecular structures for FH 
and its SCR-6/8, SCR-1/5 and SCR-16/20 fragments to show that all four exhibited 
some degree of domain folding-back (Aslam & Perkins, 2001; Fernando et al., 2007; 
Chapter 4). This is distinct from the more extended solution structures found for the 30-
SCR and 15-SCR domains of complement receptor types 1 and 2 (CR1 and CR2) 
(Gilbert et al., 2006; Furtado et al., 2008). In addition, FH undergoes self-association 
and forms a significant percentage of oligomers at physiological concentrations (Perkins 
et al., 1991; Nan et al., 2008a). Other FH fragments, including SCR-6/8 and SCR-16/20, 
also self-associate to form dimers (Jokiranta et al., 2000; 2006; Oppermann et al., 2006; 
Fernando et al., 2007; Chapter 4). The presence of multiple self-dimerisation sites on FH 
suggested that FH might form indefinite oligomers. Significant amounts of these FH 
oligomers formed in the presence of at least 60 µM zinc or copper (Nan et al., 2008b). 
An understanding of FH regulation requires the elucidation of the conformation 
and self-association properties of FH in different solution conditions. Currently there are 
no explanations for its folded-back structure or self-association and its relevance to FH 
regulation. A significant proportion of aHUS mutations occur outside SCR-20, which 
contains the binding sites for C3d and heparin. Even though these aHUS mutations 
appear to affect the function of FH, the reason for their location outside SCR-20 is not 
yet known (Saunders et al., 2007). It is not clear if an omega-shaped structure for FH 
proposed from the interaction between SCR-1/7 and SCR-1/20 (Oppermann et al., 2006) 
may be alternatively explained by the dimerisation of SCR-6/8 (Fernando et al., 2007). 
The interactions between FH and C3b ligands have been studied by SPR and AUC to 
show that their affinities are weak with dissociation constants in the micromolar range 
and depend on salt concentration (Hellwage et al., 2002; Chapter 6; Hellwage et al., 
1999). In contrast, FH has a high affinity for heparin (Fernando et al., 2007). Thus it is 
possible that electrostatic interactions contribute towards the formation of a folded back 
FH structure. In this chapter, previous AUC data at pH 7.4 and 137 mM NaCl (Nan et   134
al., 2008a) are extended to other NaCl concentrations and pH values to show that the FH 
conformation depends on both these parameters. Histidine residues are shown to be 
involved in this. FH self-association also showed a dependence on the NaCl 
concentration. From new X-ray scattering data collection, improved molecular models 
for FH compared to those first determined (Aslam & Perkins, 2001) are derived, and 
these are similar in accuracy to those determined recently for CR1 and CR2 (Furtado et 
al., 2008; Gilbert et al., 2006).  
 
(5.2) Results and Discussion 
(5.2.1) Analytical ultracentrifugation of Factor H 
To assess if the folded-back domain structure of FH can result from inter-SCR 
charge attraction within FH, the charged groups in each SCR domain were summed up 
(Figure 5.1). There are 1213 residues between Glu19 and Arg1231 in mature FH. In 
addition, eight of the nine putative oligosaccharide sites are occupied by mostly 
biantennary sugars (Fenaille et al., 2007). Each oligosaccharide chain was assumed to 
possess two NeuNAc residues. This gave a total of 326 charged groups in FH with an 
overall net charge of -2, assuming that the His residues are protonated. The pI value of 
FH was predicted to be 6.34 using SEDNTERP software (Laue et al., 1993), and 6.12 
from the ProtParam tool on the EXPASY website 
(http://www.expasy.ch/tools/protparam.html), neither of which took glycosylation into 
account. Thus SCR-7, SCR-13 and SCR-20 showed positive net charges of +5 or 
greater, while SCR-9, SCR-12, SCR-14 and SCR-15 showed negative net charges of -4 
or greater (Figure 5.1). The large variations in net charge between individual FH SCR 
domains make it possible that relatively distant SCR domains might attract each other 
within FH and contribute to its folded back structure.  
For AUC, wild-type FH was freshly purified from a pool of just-outdated 
anonymised human plasma using an anti-FH monoclonal antibody MRC-OX23 column 
(Section 5.4.1). This plasma pool is identical to that used before (Nan et al., 2008a; 
2008b). Data for FH in 137 mM NaCl, pH 7.4 were collected by   135
 
Figure 5.1 
Charge summation in the 20 SCR domains of FH. The total charge at physiological pH 
is shown under each SCR. It is assumed that each His residue is protonated and there is one 
additional positive or negative charge at the N- or C-terminus respectively. The linker residues 
preceding each SCR domain are included within the summation for that domain. The summation 
for SCR-20 includes the 1229-AKR-1231 C-terminus. The seven glycosylated domains are 
shaded in grey. SCR-4 is not glycosylated despite the presence of a putative site for this (see 
text). Each oligosaccharide chain is assumed to contain two N-acetyl-neuraminic acid residues.  136
Miss Ruodan Nan (Nan et al., 2008a), and this is acknowledged accordingly in the 
relevant figure legends. 
FH showed similar elution profiles as a single peak (not shown) by gel filtration 
in buffers containing 50 mM or 137 mM NaCl. Sedimentation velocity runs using 
interference optics were performed in order to determine sedimentation coefficient s20,w 
and molecular weight data for FH. The s20,w  value monitors the degree of 
macromolecular elongation. Conformational changes in monomeric FH were revealed 
by performing these runs as a function of three NaCl concentrations between 50 mM and 
350 mM NaCl in phosphate-buffered saline (PBS), all at pH 7.4 (Section 5.4.1; Figure 
5.2(a)).  These were supplemented using a fourth data set previously collected in 137 
mM NaCl HEPES buffer (Nan et al., 2008a). The observed sedimentation boundaries 
were fitted to yield a sedimentation coefficient distribution, c(s) according to the Lamm 
equation using SEDFIT (Section 5.4.2). This takes into account all the species present in 
the sample, although the algorithm assumes that the same frictional ratio applies for all 
the sedimenting species.  
The SEDFIT analyses of up to 300 scans revealed excellent boundary fits (Figure 
5.2(c,d)). Concentration series were performed in order to investigate the 
oligomerisation of FH (Nan et al., 2008a). No concentration dependence in the s20,w 
value of FH was observed between 0.1 to 1.0 mg/ml FH in each salt concentration 
(Figure 5.3). However the s20,w value decreased significantly as the salt concentration 
increased with values of 50 mM NaCl, 137 mM, 250 mM and 350 mM NaCl. The s20,w 
values were 5.66 S, 5.56 S, 5.41 S and 5.31 S in that order (Table 5.1). Conformational 
reversibility was demonstrated by dialysis of FH from 350 mM NaCl buffer to 50 mM 
NaCl buffer, whereupon the s20,w  value reverted from 5.31 S to 5.66 S (Figure 5.2(e)). 
Additional velocity runs were performed at pH 5.4 and pH 9.4 in PBS with 137 mM 
NaCl in six concentrations starting from 0.8 mg/ml FH (Figure 5.4). For the FH 
monomer, the mean s20,w value of 5.54 ± 0.05 S at pH 5.4 was similar at all rotor speeds 
to that of 5.56 ± 0.08 S at pH 7.4 (Nan et al., 2008a). However, that at pH 9.4 was 
consistently lower at 5.40 ± 0.05 S (Figures 5.2(b); 5.4(b)). Conversion of the c(s) plots 
to molecular weight size distribution c(M) plots can provide useful insight on 
macromolecular sizes, provided that the peaks correspond to discrete sedimenting   137
species and the individual components have similar frictional ratios f/fo (where fO is the 
frictional coefficient of the sphere with the same volume as the hydrated glycoprotein) 
(Brown & Schuck, 2005; Dam & Schuck, 2005). The c(M)  plots yielded a mean 
molecular weight of 157 ± 9 kDa for the major peak (four NaCl concentrations and two 
additional pH values), in good agreement with the value of 154 kDa calculated from the 
composition of the FH monomer, hence corroborating the assignment of this peak. It is 
concluded that a NaCl concentration-dependent conformational change occurs in 
monomeric FH, in which FH becomes more extended in higher salt. Given that His 
residues deprotonate with a pK close to 7, the change seen at pH 9.4 indicates that the 
folded-back FH domain structure at low pH becomes more elongated at high pH and 
involves the release of a charged interaction involving histidine(s). 
FH forms dimers (Perkins et al., 1991; Nan et al., 2008a). At FH concentrations 
below 1 mg/ml, a dissociation constant KD of 28 µM between the monomer and dimer in 
137 mM NaCl (pH 7.4) has been reported (Nan et al., 2008a). The c(s) plots in Figure 
5.3 showed that the most prominent peak after that for the monomer is peak 2 in 
concentrations up to 1.0 mg/ml. This is assigned as dimeric FH for two reasons: (i) The 
relative intensity of peak 2 visibly increased with FH concentration in Figure 5.3, 
showing that peak 2 is in equilibrium with the FH monomer as expected. Integration of 
peak 2 confirmed this (Figure 5.6(a)). (ii) Assuming that the f/fo ratio is unaltered, the 
c(M) size distribution plots from the six experiments showed that peak 2 corresponded to 
a mean molecular weight of 234 ± 17 kDa, which is about one-and-half times that of the 
monomer at 157 ± 9 kDa. One explanation of the molecular weight difference from the 
expected value of 309 kDa is that a conformational change in the FH dimer results in a 
smaller frictional ratio of the FH dimer, and indicative modelling calculations supported 
this possibility (Nan et al., 2008a). In addition to this, further complexity is indicated by 
the rotor-speed dependence of the s20,w values for peak 2 in the c(s) plots. At 40k r.p.m., 
50k r.p.m. and 60k r.p.m., the data sets in 50 mM, 137 mM, 250 mM and 350 mM NaCl 
buffers showed that the four sets of s20,w values for peak 2 decreased with increase in  
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Figure 5.2 
Sedimentation velocity c(s) distribution analyses of FH. The curve for 137 mM NaCl, 
pH 7.4 is used with permission from Miss Ruodan Nan (Nan et al., 2008a). (a,b) The effect of 
NaCl concentration and pH on monomeric Factor H at 1.0 mg/ml. The horizontal arrows show 
the decrease of the sedimentation coefficient s20,w values with increase of the NaCl concentration 
and the pH. The three s20,w values at pH 5.4, pH 7.4 and pH 9.4 in 137 mM NaCl are arrowed. 
Here and below, 50 mM NaCl is denoted by red, 137 mM NaCl by black, 250 mM NaCl by 
green and 350 mM NaCl in blue.  (c,d) The boundary fits for the sedimentation of FH in 50 mM 
(red) and 350 mM (blue) NaCl at pH 7.4 are shown in intervals of 10 scans. (e,f) The dialysis of 
FH from 350 mM (blue line) into 50 mM NaCl buffer (dashed blue line) is compared with FH in 
50 mM NaCl buffer (red line). The peak for monomeric FH showed positional reversibility in 
(c), while the peak for dimeric FH shows incomplete positional reversibility in (d).    139
rotor speed.
I Similar decreases with increase in rotor speed were seen also at pH 5.4 and 
pH 9.4. Thus a second explanation of the molecular weight difference is the occurrence 
of rate exchange processes between the FH monomer and dimer that are comparable to 
the sedimentation rate, and that peak 2 may correspond to a reaction boundary and not to 
a dimer (Balbo & Schuck, 2005). Separately from this, an increase in NaCl 
concentration showed that the s20,w value for peak 2 in Figure 3 decreased with salt 
concentration.
II Interestingly, peak 2 for FH at the highest concentration of 1 mg/ml in 
350 mM NaCl did not revert to its original position at 50 mM NaCl after back-dialysis; 
this may indicate a lack of reversibility in conformation or rate exchange processes 
(Figure 5.2(d)). The pH dependence of peak 2 showed no clear variation, unlike peak 
1.
III It is concluded that a reversible equilibrium between monomer and dimer occurs 
over the range of NaCl concentrations that was studied. The FH dimer possesses a 
structure that becomes more elongated with increase in NaCl concentration like the FH 
monomer.  
FH also forms higher oligomers. This was indicated by the deviations from a 
uniform sedimentation profile in the uppermost region of the boundary fits, which were 
most marked in 50 mM NaCl (Figures 5.2(c,d) and 5.3). The corresponding c(s) plots 
showed a variable range of small peaks 3 to 8 in a range between 8 S and 20 S in all four 
NaCl concentrations (Figure 5.3). Similar peaks were seen at pH 7.4 and 137 mM NaCl 
irrespective of whether the data were acquired using interference or absorption optics, 
although the peak resolution was weaker with absorption optics (Figure 5.5). Their 
average  s20,w  values agreed with previously reported values, and were previously 
assigned to higher FH oligomers on the basis of indicative modelling calculations (Nan 
                                                 
I The s20,w value of peak 2 decreased from 7.66 ± 0.33 S to 6.88 ± 0.24 S (50 mM NaCl), 
7.88 ± 0.30 S to 7.13 ± 0.30 S (137 mM NaCl), 7.23 ± 0.37 S to 6.80 ± 0.32 S (250 mM 
NaCl) and 7.07 ± 0.14 S to 6.65 ± 0.28 S (350 mM NaCl) with increase in rotor speed.  
II The four mean s20,w values of peak 2 were 7.22 ± 0.33 S, 7.3 ± 0.2 S, 6.79 ± 0.28 S and 
6.71 ± 0.23 S in that order from 50 mM NaCl to 350 mM NaCl. 
III The mean s20,w values of peak 2 were 6.88 ± 0.38 S at pH 5.4, 7.43 ± 0.30 S at pH 7.4, 
and 6.80 ± 0.30 S at pH 9.4, all at 50,000 r.p.m..   140
 
Figure 5.3 (Figure legend overleaf)   141
(Figure 5.3 legend) 
NaCl concentration-dependence of the sedimentation of FH oligomers. Figure 
(b) is used with permission from Miss Ruodan Nan (Nan et al., 2008a).  
Experiments at a rotor speed of 50,000 r.p.m. correspond to buffers containing  
(a) 50 mM,  
(b) 137 mM,  
(c) 250 mM and,  
(d) 350 mM NaCl.  
The plots are displaced vertically on the c(s)-axis and the peak intensities are normalised 
for clarity. The boundary fits corresponding to 1.0 mg/ml are shown in the upper panels, 
where every tenth scan is shown. Peak 1 corresponds to monomeric FH, and the peaks 
attributable to other FH oligomers are labelled from 2 to 9 in order of increasing s20,w 
values. Protein concentrations range from 0.1 to 1.0 mg/ml, and are labelled at the right 
of each c(s) plot.  
In  (a), the dashed line at 1.0 mg/ml corresponds to a FH sample that was 
previously in 350 mM NaCl (Figure 5.2(e,f)). The colour code is given in Figure 5.2.   142
et al., 2008a). The concentration range at 0.1-1.0 mg/ml FH spanned the physiological 
FH serum concentration of 0.235-0.81 mg/ml (1.6–5.4 µM) observed in vivo. However 
the intensities and resolutions of peaks 3-8 were not consistent at different NaCl 
concentrations, although more peaks appeared at higher FH concentrations (Figure 5.3; 
5.4). This is attributed to the lack of reversibility of oligomer formation, especially at 
higher FH concentrations (Nan  et al., 2008a), and also to possible exchange rate 
processes involving these peaks. 
Integration of the c(s) plots provided the proportion of oligomers corresponding 
to peaks 2-8 (Figure 5.6). The greatest proportion of oligomer was observed in 50 mM 
NaCl, ranging from 19% to 34% of the total FH (Figure 5.6(a)). This decreased to a 
range of 8% to 23% in 137 mM, 250 mM and 350 mM NaCl. The proportion of 
oligomers increased slightly from 0.1 to 1.0 mg/ml in 50 mM NaCl. No pH dependence 
of FH oligomerisation was detected, with the proportion of oligomers remaining 
between 15-17% between pH 5.4 and pH 9.4 (Figure 5.6(b)). These results show that the 
proportion of FH oligomers is physiologically significant, and that electrostatic 
interactions promote FH oligomer formation in low salt conditions.  
To test whether oligosaccharides affect the FH conformation (Figure 5.1), FH 
was deglycosylated using PNGase F (Section 5.4.1). SDS-PAGE analysis showed a 
reduction of the apparent FH molecular weight from 116 kDa to 96 kDa, which is in 
good accord with the predicted reduction from 154 kDa to 137 kDa from the FH 
composition. At 0.05 mg/ml and 0.1 mg/ml, velocity runs showed a major FH monomer 
peak in the c(s) plot with a s20,w value of 5.34 ± 0.03 S and an estimated molecular 
weight of 128 ± 14 kDa. The fitted frictional ratio was determined to be 1.62, which was 
slightly less than that of 1.75 fitted for native FH. In the c(s)  plots, multiple peaks 
corresponding to oligomers were observed, although these were shifted to different 
values compared to those for native FH for reason of the change in mass. These data 
indicated that carbohydrate has little influence on the FH conformation or its 
oligomerisation.  
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Figure 5.4 
pH-dependence of the sedimentation of FH oligomers. Experiments are at a rotor 
speed of 50,000 r.p.m. and correspond to buffers containing 137 mM NaCl at (a) pH 5.4 
and (b) pH 9.4. Protein concentrations range from 0.1 to 0.8mg/ml. Other details follow 
Figure 5.3.    144
 
Figure 5.5  
Screen shots of SEDFIT sedimentation analyses of FH in 137 mM NaCl, pH 7.4 at a 
rotor speed of 40,000 r. p. m. for (a) absorbance optics and (b) interference optics. Boundary fits 
are shown in the top panel of each screen shot, while c(s) distributions are shown in the bottom 
panel. The fit residuals, along with the corresponding bitmap image (grey), are shown in the 
middle panel. Fit parameters of r.m.s.d. (goodness of fit), frictional ratio, meniscus and bottom, 
fitting range, baseline and partial specific volume (vbar) are shown in the text at the top left 
corner.   145
 
Figure 5.6  
NaCl concentration and pH dependence of the formation of FH dimer and 
oligomer. At each concentration, the percentage of dimer (dashed lines) and oligomer 
(solid lines) corresponds to the mean ± standard deviation of those obtained at 40,000, 
50,000 and 60,000 r.p.m. The dimer corresponds to peak 2 and the oligomer corresponds 
to peaks 2-8 in Figure 5.3. The colour code is given in Figure 5.2. (a) Dependence in 
four NaCl concentrations with 50 mM, 137 mM, 250 mM and 350 mM NaCl, all at pH 
7.4. (b) pH dependence in three pH values at pH 5.4 (♦) and 9.4 (◊).   146
(5.2.2) X-ray scattering data for Factor H 
X-ray scattering is a diffraction technique that studies the overall structure of 
biological macromolecules in random orientations in solution (Perkins et al., 2008). The 
domain arrangement of FH was assessed by Guinier analyses of the X-ray I(Q) data in 
three separate Q ranges (Q = 4 π sin θ /λ; 2θ = scattering angle; λ = wavelength) to give 
the  radius of gyration RG and two cross-sectional radii of gyration RXS  (Perkins et al., 
1991; Aslam & Perkins, 2001). The RG value monitors the degree of elongation of the 20 
SCR domains. The cross-sectional radius of gyration RXS-1 value monitors medium-range 
spatial relationships between non-neighbouring SCR domains, and this parameter is 
unique to FH and CR1 amongst the SCR proteins (Furtado et al., 2008). The cross-
sectional radius of gyration RXS-2 monitors the degree of bend between adjacent pairs of 
SCR domains (Fernando et al., 2007).  
NaCl concentration effects on FH were studied at 0.4 mg/ml to reduce the effect 
of reversible dimer formation while obtaining sufficient signal-to-noise ratios (Figure 
5.7). The buffers contained 50 mM (PBS), 137 mM (HEPES), 250 mM (PBS) and 350 
mM (PBS) NaCl, with the 137 mM data being previously collected by Miss Ruodan Nan 
(Nan  et al., 2008a). Despite the high background in the higher salt buffers, linear 
Guinier analyses were obtained within satisfactory Q.RG  and  Q.RXS  limits (Figures 
5.7(a,b)). Trace amounts of non-specific aggregation were visible in 50 mM and 350 
mM NaCl, accordingly a reduced Q range was used for these RG fits (Figure 5.7(a)). In 
50 mM, 137 mM, 250 mM and 350 mM NaCl, the mean X-ray RG values 8.57 nm, 8.90 
nm, 9.22 nm and 9.28 nm (three to six values each) increase in that order (Table 5.1; 
Figure 5.8(a)). The corresponding RXS-1 values were steadier at 2.54 nm, 2.51 nm, 2.31 
nm and 2.71 nm respectively (Table 5.1; Figure 5.8(b)). The RXS-2 values were almost 
unaffected in a range from 1.43 nm to 1.87 nm (Figure 5.8(c)). Even though the X-ray 
data correspond to an average of FH monomer, dimer and oligomer, and the RG values 
will be overestimated for that reason, a small increase in the RG values occurred with 
increase in [NaCl] that showed that the FH domain structure becomes more extended at 
high NaCl concentration. This conformational change agrees with the AUC data.  
The X-ray distance distribution function curve P(r)  provides both structural 
information in real space and an alternative calculation of the Guinier RG value following    147
 
Figure 5.7 
Determination of the Guinier parameters for FH. The left and right sides of each 
panel correspond to NaCl concentrations and pH conditions respectively. The curve for 
137 mM NaCl and pH 7.4 was used with permission from Miss Ruodan Nan (Nan et al., 
2008a). Filled circles correspond to the I(Q) values used to determine the best fit lines 
that give the RG and RXS-1 values at 0.4 mg/ml FH. The Q.RG and Q.RXS-1 values for the 
fit ranges are arrowed. The colour code is given in Figure 5.2. (a) RG plots using a Q 
range of 0.09-0.14 nm
-1 for the 50 mM and 350 mM NaCl buffers and pH 9.4, and 0.06-
0.13 nm
-1 for the 137 mM and 250 mM NaCl buffers and pH 7.4. (b) RXS-1 plots using a 
Q range of 0.17-0.27 nm
-1.     148
an assumption of the value of the maximum dimension Dmax. In buffers containing 50 
mM, 137 mM, 250 mM and 350 mM NaCl, the RG values were 9.17 nm, 8.57 nm, 9.68 
nm and 9.72 nm, which were generally slightly larger but consistent with the Guinier RG 
values, showing that the P(r) curves refer to the macromolecule being studied (Table 
5.1). The maximum M in the P(r) curve corresponds to the most frequently occurring 
interatomic distance within the FH structure. This main peak was almost unaffected in 
position at r values of 4.8 nm, 5.4 nm, 4.6 nm and 5.3 nm from 50 mM NaCl to 350 mM 
NaCl (Figure 5.9). The maximum dimension L of FH is determined from P(r) as the 
value of r when P(r) = 0 at large r. The L value increased from 33 nm in 50 mM NaCl to 
38 nm in 250 mM and 350 mM NaCl (Figure 5.9), again showing that the FH domain 
structure becomes more extended as the NaCl concentration is increased.  
pH effects on the X-ray data for FH were studied at pH 5.4 (PBS), pH 7.4 
(HEPES) and pH 9.4 (PBS). Limited data were measurable at pH 5.4. The Guinier fits 
for pH 9.4 showed a slight increase in non-specific aggregation similar to that seen in 50 
mM NaCl (Figure 5.7(a)). FH had an RG value of 9.58 nm and an RXS-1 value of 3.35 nm 
(two values), both of which were higher than at pH 7.4 (Table 5.1; Figure 5.8(a,b)). The 
RXS-2 value remained relatively unchanged at 1.91 nm at pH 5.4 and 2.00 nm at for pH 
9.4 (Table 5.1; Figure 5.8(c)). The P(r) curve resulted in an RG value of 9.55 nm at pH 
9.4, in good agreement with the Guinier analyses. The M value increased from 5.4 nm at 
pH 7.4 to 6.0 nm at pH 9.4, while L remained unchanged at 32 nm at pH 9.4 compared 
to pH 7.4 (Figure 5.9). The observed tendency for slight aggregation at the lowest Q 
values and the larger RG  and  RXS-1  values may explain the apparent predominantly 
dimeric FH structure that was first observed by X-ray scattering (Perkins et al., 1991). In 
the 1991 study, FH was eluted from the MRCOX23 monoclonal column using alkaline 
conditions. No information on the FH conformation at comparably high pH was 
available from the present data for analysis. 
To assess the effect of carbohydrate on the FH structure, deglycosylated FH was 
studied in 137 mM NaCl at pH 7.4. Linear Guinier analyses gave RG, RXS-1 and RXS-2 
values of 9.48 nm, 2.93 nm and 1.89 nm respectively (4-7 determinations) (Table 1; 
Figures 5.10(a,b)). The P(r) curve resulted in an RG value of 9.73 nm, and M and L 
values of 5.7 nm and 32 nm respectively (Figure 5.10(e)). The similarity with the    149
 
Figure 5.8 
NaCl concentration and pH dependence of the Guinier parameters for FH. The 
left and right sides of each panel correspond to NaCl concentrations and pH conditions 
respectively. Other details follow Figure 5.7.  
(a) Dependence of the RG values on NaCl concentration and pH.  
(b,c) Dependence of the RXS-1 and RXS-2 values on NaCl concentration and pH. 
The RXS-2 values were determined using a Q range of 0.50-0.80 nm
-1 (not shown).    150
corresponding Guinier values of 8.90 nm, 2.51 nm and 1.79 nm for FH and the M and L 
parameters of 5.7 nm and 32 nm for wild-type FH in 137 mM NaCl at pH 7.4 (Table 
5.1) indicated that FH adopted only a slightly more elongated structure after 
carbohydrate removal, and that its carbohydrate content plays no major role in 
determining the folded-back FH structure. This is in accord with the AUC data. 
 
(5.2.3) Constrained scattering modelling of monomeric Factor H  
Solution structures for FH in 50 mM, 137 mM and 250 mM NaCl were 
determined by constrained scattering modelling, where the constraints were provided by 
the use of nine updated SCR homology models and 11 crystal and NMR structures for 
the FH SCR domains (Section 5.4.4). These are the same as those used to model SCR-
1/5 and SCR-16/20 (Chapter 4). The original constrained modelling of FH was the first 
application of this method for any SCR protein (Aslam & Perkins, 2001). At that time, 
only three SCR structures were known, and the effect of FH oligomer formation and 
aggregation on the X-ray scattering curve was incompletely understood. Here, the 
experimental X-ray curves used for curve fitting utilised FH samples in which 
aggregation effects are absent, although FH oligomers are present and will contribute to 
the scattering curve. Conformational models for intact FH that best fitted the X-ray data 
were identified from trial-and-error searches of 5,000 randomised structures. These 
5,000 structures were generated using molecular dynamics simulations to create libraries 
of peptide linker conformations, which were sampled at random and joined with the 20 
SCR domain models. Calculation of scattering curves from the 5,000 models showed 
that a sufficient number of models had been tested (Figure 5.11(a,b)). The comparisons 
of the R-factor (goodness of fit) and RXS-1  values with the RG  values using  three 
experimental curves in 50 mM, 137 mM and 250 mM NaCl buffer, and including two 
more for a pH 9.4 buffer and deglycosylated FH for comparison (Figure 5.11(a,b)), 
showed that the models encompassed the experimental RG and RXS-1 values. This showed 
that the 5,000 models were sufficient to determine a best-fit FH solution structure. The 
best-fit structures were selected on the criteria that they satisfied the RG and RXS-1 values 
to within 5% and showed the lowest R-factor values. Here, unlike the original fits which    151
 
Figure 5.9 
Distance distribution function P(r) analyses for FH. The peaks in the P(r) curves 
are denoted by M1 and M2, and the maximum length is denoted by L1 and L2. Other 
details follow Figure 5.7.   152
 
Figure 5.10 
Comparison of the Guinier fits and distance distribution P(r) analyses for native 
(Gly) and deglycosylated (Degly) FH. The FH concentration is 0.4 mg/ml. Details of 
(a,b) follow Figure 5.7, (c,d) follow Figure 5.8 and (e) follows Figure 5.9.   153
showed 31 best-fit R-factors of 19 ± 3% (Aslam & Perkins, 2001), all best-fit structures 
resulted in R-factors of less than 10%. This reduction demonstrated the effect of using 
better experimental data and improved SCR domain models.  
The best-fit models for FH are partially folded-back and bent in appearance. The 
superimposition upon SCR-1 of the 17 best fit structures for 137 mM NaCl (Figure 
5.11(c)) showed that this feature is common in all the structures. The best-fit models 
showed that the RG values increased with [NaCl] from 8.79 nm and 8.44 nm to 9.67 nm 
as this increased from 50 mM and 137 mM to 250 mM, in agreement with experiment. 
The best-fit model from the five searches were in similar locations in the distributions of 
Figures 5.11(a,b), accordingly all five experimental curves resulted in similar overall 
structures for FH. This confirms that the conformational changes in FH between these 
experimental conditions, though significant, were not large enough to yield distinct 
groups of best-fit models (Table 5.1). Only the models for 50 mM, 137 mM and 250 
mM NaCl were deposited in the Protein Data Bank (PDB), with codes 3gau, 3gav and 
3gaw respectively. There is some partial overlap of the best-fit models. For example, 
five out of the 27 best-fit models for the 50 mM NaCl and 137 mM buffers were 
identical, while there was no overlap between the 137 mM and 250 mM NaCl models.  
For 137 mM NaCl and pH 7.4, the R-factor values for the 17 best-fit models 
(Figure 5.11(c)) ranged from 4.5-9.6 %. These values are much lower than those for the 
original four best-fit models in similar buffer that gave R-factor values of 12-15% 
(Aslam & Perkins, 2001). The visual comparison of the agreement between the 
experimental and modelled I(Q) curves showed a good fit from low Q out to a Q value 
of 1.5 nm
-1, in which the modelled I(Q) curve decayed uniformly as Q increased (Figure 
8(b)). The P(r)  curves (insets in Figure 5.12(b)) showed maxima M and maximum 
dimensions L at the same r values, in agreement with the experimental values (Figures 
5.9; 5.10(e)). This is much improved over the original fits for which the agreement 
extended to a Q value of only 0.4 nm
-1 and the modelled curves did not decay uniformly 
at large Q (Aslam & Perkins, 2001). The new FH curve fits show similar agreements in 
Q ranges with experiment as those for CR1 and CR2 (Gilbert et al., 2006; Furtado et al., 
2008).    154
 
Figure 5.11 
  Outcome of five constrained modelling searches to determine a FH solution structure. In 
each modelling search, a library of 5,000 conformationally-randomised models were fitted to a 
given FH scattering curve at 0.4 mg/ml in 50 mM NaCl (red), 137 mM NaCl (grey), 250 mM 
NaCl (green), pH 9.4 (black), and deglycosylated FH (white). In (a,b), the distribution of the fits 
to the five experimental curves is shown. The five highlighted symbols correspond to the best-fit 
model in each fit. (a) Comparison of the R –factor values with the RG values. (b) Comparison of 
the RXS values with the RG values. (c) The 17 best-fit models for the 137 mM NaCl fit are shown 
superimposed on SCR-1 (orange). For clarity, the 19 remaining SCR domains of the best-fit 
model are highlighted in black up to SCR-20 (labelled).    155
As an independent check of the scattering modelling, the sº20,w values of the best-
fit FH models were calculated using HYDROPRO (Table 5.1). For the best-fit models,  
the calculated sº20,w values ranged from 4.85-5.18 S for 50 mM and 137 mM NaCl 
buffers, and decreased to a range of 4.59-4.89 S for 250 mM NaCl buffer (Table 5.1). 
The best-fit models gave calculated sº20,w values of 4.91 S, 5.01 S and 4.59 S for 50 mM, 
137 mM and 250 mM NaCl buffers in that order. While the calculated values were 0.6-
0.8 S lower than the experimental values of 5.66 S, 5.56 S and 5.41 S respectively, the 
calculated  sº  20,w  values generally decreased with increase in NaCl concentration in 
agreement with the experimentally-observed trend. Since good agreements had 
previously been seen with the calculated and experimental sº20,w values for CR1and CR2 
(Gilbert et al., 2006; Furtado et al., 2008; Li et al., 2008), the discrepancy is most likely 
due to the influence of FH oligomers on the modelling of the X-ray scattering curves. 
The presence of these oligomers would result in good fits to FH models that are slightly 
longer with slightly increased calculated RG values. As such, the calculated sº20,w values 
of models would be slightly reduced. Hence the contribution of oligomers to the X-ray 
fits accounts for the discrepancy between experimental and calculated sº20,w values in 
Table 5.1. In this sense, the calculations support the outcome of the scattering modelling 
(Figure 5.12). The influence of oligomers on the FH curve fits suggests that the actual 
FH monomer conformation in solution may be more compact with an even lower RG 
value than those reported in Figures 5.7 and 5.8.  
The determination of five sets of best-fit FH models that showed partially folded-
back SCR arrangements (Table 5.1) permitted the evaluation of the inter-domain 
orientations that resulted in the formation of these FH structures. This evaluation is 
limited in scope by the algorithm used to generate the 5,000 randomised FH 
conformations, because this created the linkers in extended conformations that were 
permitted to reorientate themselves. The angle between the longest axes of two adjacent 
SCR domains shows the degree of bend between them (Fernando et al., 2007; Chapter 
4). For the 50 mM, 137 mM and 250 mM NaCl buffers, the mean inter-domain angle 
was similar at 119° ± 34°, 121° ± 32° and 119° ± 30° respectively in the eight best-fit 
models for each of these fit searches. As an entirely linear SCR arrangement 
corresponds to a mean angle of 180°, this shows that adjacent pairs of SCR domains in    156
 
Figure 5.12 
Best-fit FH X-ray scattering curve fit for the five experimental conditions. 
 (a) 50 mM NaCl; (b) 137 mM NaCl; (c) 250 mM NaCl; (d) pH 9.4; (e) deglycosylated 
FH. The left panels show the fitted experimental scattering data as black points for 0.4 mg/ml 
FH. The continuous lines correspond to the best-fit modelled curves. The Q ranges employed in 
the experimental RG and RXS analyses are denoted by horizontal bars. The insets at the upper 
right compare the modelled P(r) curves as a coloured or dashed line with the experimental P(r) 
curve in continuous black. The right panels show ribbon views of the best-fit FH model. 
Oligosaccharides where present are shown in orange. The positions of SCR-1 and SCR-20 are 
indicated, along with the maximum lengths of the FH models.   157
Table 5.1.  X-ray scattering and sedimentation coefficient data for monomeric FH and their modelling 
 
a The first value is from the Guinier RG analyses (Figures 5.7; 5.8 and 5.10(a-d); the second is from the GNOM P(r) analyses (Figures 5.9 and 5.10(e)).  
b The optimum number of hydrated spheres predicted from the sequence is 2074.       n.a. not available 
  Filter Models  Spheres  RG (nm)  RXS-1 (nm)  RXS-2 (nm)  Dmax (nm)  R factor (%)  s
0
20,w (S)  
Experimental data                 
FH in 50 mM NaCl buffer        8.57 ± 0.22;  
9.17 ± 0.12  
2.54 ± 0.07  1.43 ± 0.05  34    5.66 ± 0.05 
 
FH in 137 mM NaCl buffer       8.90  ± 0.19;  
8.57 ± 0.71 
a  
2.51 ± 0.06  1.79 ± 0.01  32    5.56 ± 0.08 
 
FH in 250 mM NaCl buffer       9.22 ± 0.56  
9.68 ± 0.49
 a   
2.31 ± 0.09  1.52 ± 0.09  38    5.41 ± 0.06 
 
FH in 350 mM NaCl buffer       9.28 ± 0.17  
9.72 ± 0.25
 a   
2.71 ± 0.13  1.82 ± 0.08  38    5.31 ± 0.06 
FH in pH 5.4 buffer       n.a   n.a  1.91 ± 0.11  n.a    5.54 ± 0.05 
FH in pH 9.4 buffer 
 
      9.58 ± 0.08 
9.55 ± 0.01 
a 
3.35 ± 0.12  2.00 ± 0.04  32    5.40 ± 0.05 
Deglycosylated FH        9.48 ± 0.29 
9.73 ± 0.14 
a 
2.93 ± 0.08  1.89 ± 0.11  32    5.34 ± 0.03 
Modelling of FH                
Library of 5,000 FH models  None  5,000  1948-2284
 b  4.88 - 12.83  0.08 - 6.00  0.04 - 2.65  n.a  3.6 - 30.1  n.a. 
FH in 50 mM NaCl buffer  RG, RXS-1 and R factor  10  2087-2170  8.18-8.99  2.42-2.66 1.46-1.84 30-34  7.8-9.9  4.86-5.18 
FH in 50 mM NaCl buffer  Best fit   1  2170  8.79  2.53  1.65  33  7.8  4.91 
FH in 137 mM NaCl buffer  RG, RXS-1 and R factor  17  2087-2220  7.84-8.59  2.41-2.62 0.89-2.19 27-34  4.5-9.6  4.85-5.18 
FH in 137 mM NaCl buffer  Best fit  1  2207  8.44  2.44  1.59  32  4.5  5.01 
FH in 250 mM NaCl buffer  RG, RXS-1 and R factor  8 2127-2254  9.26-9.67  2.21-2.38  1.40-1.80 35-38  6.4-9.2  4.59-4.89 
FH in 250 mM NaCl buffer  Best fit  1  2158  9.67  2.25 1.47 38  7.0  4.59 
FH in pH 9.4 buffer  RG, RXS-1 and R factor  4  2191-2212  9.17-9.55  3.26-3.39 1.72-1.77 29-34 7.0-10.0 4.61-4.73   
FH in pH 9.4 buffer  Best fit   1  2201 9.17  3.39  1.76    34 7.0  4.73 
Deglycosylated FH  RG, RXS-1 and R factor  10 2087-2230  9.05-9.82  2.80-3.06  1.69-2.04 30-36  4.8-9.8  4.07-4.33   
Deglycosylated FH  Best fit  1  2191  9.14  2.90 1.82 32  4.8  4.18   158
FH will be on average bent in their structure. These mean angles also show that the 
appearance of more elongated structures with increase in NaCl concentration will result 
from subtle changes in the inter-SCR angles, potentially involving very few residues 
(Figure 5.13). This is illustrated by ranking the inter-domain angles for the three best-fit 
models for each condition studied according to the spread between 0º-180º in contiguous 
bands of 45º (Figure 5.13; Table 5.2; Section 5.4.4). The six longest linkers with lengths 
of 5-8 residues occur in the central part of FH between SCR-7/8, SCR-10/15 and SCR-
18/19. The best-fit FH models suggest that some of these inter-SCR angles may be much 
reduced to less than 90° in order to form partially folded-back structures (Table 5.2; 
Figure 5.13). If so, these would be similar to the low inter-SCR angles seen in the crystal 
structures for CR2 SCR-1/2 and the three-SCR fragment of complement factor B 
(Szakonyi et al., 2001; Prota et al., 2001; Mildner et al., 2007).  
 
(5.3) Conclusions 
This study shows that the conformational and oligomeric properties of intact FH 
depend on NaCl concentration and pH, but less so for its glycosylation. Firstly, the 
partially folded-back arrangement of 20 SCR domains in FH shows a dependence on 
electrostatic effects that was previously unknown. This means that the FH conformation 
will depend on its local environment, and this may be important for the mechanism of its 
regulatory action through interaction with C3b. Secondly, FH is now shown to be 
oligomeric in a range of solution conditions. The extent of FH oligomerisation also 
depends on its local environment, and this may also be important for its role as a 
complement regulator. These observations appear to be unique to FH, as neither of these 
two features appears for two other large multi-SCR proteins, CR1 and CR2, both of 
which are membrane proteins unlike FH. For example, soluble recombinant CR2 shows 
no difference in conformation between 50 mM and 137 mM NaCl (Li et al., 2008). 
Charged groups in FH are able to mediate a slightly more compact arrangement 
of SCR domains within FH. This may be important for regulation. For example, the 
polyanionic host cell surface may cause FH to alter its conformation after FH is bound to 
it. The SCR-1/4 domains of FH interact with its ligand C3b, with a second binding site    159
 
Figure 5.13 
(Figure legend overleaf)   160
(Figure 5.13 legend) 
Summary of the effects of NaCl concentration, pH and deglycosylation on FH 
inter-domain orientation. Average inter-domain angles are shown for the three best-fit 
FH models at each condition. The angles are ranked 1, 2 or 3 according to the size 
ranges represented by the areas under the thick black lines R1, R2 and R3.  
(a) The average inter-domain angle distribution for models in 50 mM NaCl (▲), 
137 mM NaCl (■) and 250 mM NaCl (♦) buffers.  
(b) The corresponding ranking distributions of inter-domain angles for 50-250 
mM NaCl. A relative lack of change is indicated by superimposition of the symbols for 
each condition. The colour scheme follows that of (a).  
(c) A bar chart summarizing the ranking deviations from a normal orientation in 
137 mM NaCl buffer. The height of the bar corresponds to the degree of change. 
Positive and negative deviations indicate changes towards a more extended or more 
folded-back orientation respectively.  
(d-f) Inter-domain angle distributions, ranking distributions and ranking 
deviations at pH 7.4 (■) and 9.4 (●). The ranking deviations are shown as deviations 
from a normal orientation at pH 7.4.  
In (g-i) for the corresponding ranking analyses for native (■) and deglycosylated FH (  ), 
native FH is the normal orientation.   161
Table 5.2.  Summary of inter-SCR domain angles for the best-fit solution structures of monomeric FH 
 
a The ranking is defined as 0 if  0 º ≤ inter-SCR angle ≤ 45º, 1 if  45 º < inter-SCR angle ≤ 90º, 2 if  90 º < inter-SCR angle ≤ 
135º and 3 if  135 º < inter-SCR angle ≤ 180
Average inter-domain angles for best-fit FH models   
50 mM NaCl buffer  137 mM NaCl buffer  250 mM NaCl buffer  pH 9.4 buffer  Deglycosylated FH 
SCR 
domains 
Average 
angle (º) 
Ranking
a Average  angle 
(º) 
Ranking
a Average  angle 
(º) 
Ranking
a Average 
angle (º) 
Ranking
a   Average angle 
(º) 
Ranking
a 
1-2  141.3 ± 29.6  3  147.9 ± 22.9  3  140.5 ± 10.4   3  123.1 ± 10.2  2  135.6 ± 31.4  3 
2-3  123.3 ± 31.8  2  95.1 ± 20.0  2  101.6 ± 50.6   2  71.6 ± 49.5  1  103.0 ± 45.9  2 
3-4  141.4 ± 42.8  3  130.4 ± 19.6  2  132.3 ± 33.3   2  112.1 ± 6.6  2  128.3 ± 34.4  2 
4-5  136.1 ± 16.5  3  137.0 ± 14.7  3  143.0 ± 20.7   3  98.3 ± 4.1  2  149.7 ± 19.2  3 
5-6  121.2 ± 11.6  2  130.2 ± 10.4  2  127.4 ± 26.6   2  122.9 ± 25.4  2  131.9 ± 24.5  2 
6-7  121.9 ± 7.2  2  100.0 ± 44.4  2  108.0 ± 3.2   2  113.9 ± 21.5  2  110.0 ± 43.4  2 
7-8  126.9 ± 54.9  2  121.4 ± 18.0  2  118.8 ± 28.8   2  142.9 ± 4.2  3  167.2 ± 1.2  3 
8-9  112.5 ± 14.2  2  106.1± 6.6  2  94.6 ± 36.6   2  132.4 ± 37.1  2  127.8 ± 43.1  2 
9-10  119.2 ± 61.1  2  93.4 ± 32.7  2  106.2 ± 32.8   2  140.2 ± 26.5  3  140.2 ± 24.8  3 
10-11  99.6 ± 39.0  2  114.4 ± 22.8  2  104.8 ± 9.4   2  149.7 ± 14.2  3  121.2 ± 38.3  2 
11-12  127.7 ± 37.7  2  73.1 ± 32.1  1  113.4 ± 20.6   2  103.8 ± 11.2  2  104.5 ± 36.3  2 
12-13  115.5 ± 48.2  2  89.0 ± 12.3  1  107.0 ± 6.9   2  137.6 ± 40.7  3  125.8 ± 19.0  2 
13-14  139.1 ± 32.9  3  124.3 ± 31.4  2  133.1 ± 40.5   2  137.4 ± 7.0  3  109.7 ± 37.2  2 
14-15  128.9 ± 27.3  2  130.1 ± 18.9  2  132.6 ± 36.0   2  112.6 ± 36.5  2  113.1 ± 10.9  2 
15-16  122.0 ± 62.6  2  137.4 ± 18.5  3  129.8 ± 9.1   2  121.6 ± 62.4  2  119.4 ± 37.9  2 
16-17  118.1 ± 70.2  2  116.2 ± 63.2  2  99.0 ± 35.7   2  121.2 ± 57.8  2  89.3 ± 25.7  1 
17-18  127.2 ± 36.0  2  151.5 ± 11.0  3  142.5 ± 12.3   3  118.6 ± 71.9  2  121.7 ± 30.7  2 
18-19  89.8 ± 45.1  2  104.8 ± 56.8  2  147.2 ± 19.3   3  91.8 ± 57.9  2  155.5 ± 9.5  3 
19-20  122.5 ± 61.5  2  125.0 ± 24.7  2  143.9 ± 8.5   3  135.9 ± 21.3  3  107.0 ± 42.8  2   162
for C3b at SCR-20 (Jokiranta et al., 2006; Chapter 6), and charge effects at the FH-C3b 
interface may be important for the binding of FH. By this study, conformational changes 
with increase of NaCl concentration or pH indicate that the internal charge attractions 
within FH become weakened as these parameters increase. This conclusion presumes 
that there are no specific interactions between the protein and Na
+ or Cl
- ions, i.e. that 
the effect is due primarily to ionic strength. The constrained modelling of FH shows that 
the observed conformational changes can be rationalised by relatively minor alterations 
in a few salt bridges including His residues (given that generally similar SCR 
arrangements were determined in different NaCl concentrations). It is not known 
whether the effects are caused within a single inter-SCR linker region, or by interactions 
between two non-adjacent SCR domains. Electrostatic attractions are however not able 
to account fully for the folded-back structure for FH, and this implies that other 
contributions are present. Glycosylation and linker lengths are two possible contributory 
factors.  
The central region of FH is dominated by eight glycosylation sites between SCR-
9 to SCR-18, given that the putative site at SCR-4 is not glycosylated (Fenaille et al., 
2007). Here, it has been shown that the possible role of carbohydrate in causing FH to 
adopt a folded-back domain structure is unlikely. The centre is also dominated by long 
inter-SCR linkers, where six of the eight linkers between SCR-7 and SCR-15 are longer 
than the usual length of three or four residues (Aslam & Perkins, 2001). Long linkers 
facilitate the greater folding back of two adjacent SCR domains from an averaged inter-
SCR angle of about 120° seen in the best-fit FH models to the lower inter-SCR angles of 
37°, 40° and 69° seen in other SCR proteins. These lower values are found in three 
crystal structures showing folded-back SCR domains, namely CR2 SCR-1/2 with an 
eight-residue linker (Szakonyi et al., 2001; Prota et al., 2002), and the factor B SCR-2/3 
domains with a six-residue linker (Milder et al., 2007). It should be noted that longer 
linkers can also facilitate flexibility between adjacent SCR domains. This is shown by 
the comparison of the opened-up solution structure of CR2 SCR-1/2 (inter-SCR angle of 
63°-121°) with its folded-back crystal structure (inter-SCR angle of 37°-40°) (Gilbert et 
al., 2005).    163
The present conformational studies of FH provide further insight on the 
conformational properties of long SCR proteins. The original solution structure for FH 
was the first of its type and was limited by the quality of the scattering data and the SCR 
domain models (Aslam & Perkins, 2001). The new FH modelling curve fits from this 
current study are much improved compared to that of 2001. The fits are similar in 
agreement to those reported for scattering modelling structures for other SCR proteins, 
including CR1 and CR2 and the fragments of FH, and this shows that the “Randomised 
linker-3” method is generally useful for these medium resolution solution structure 
determinations (Fernando et al., 2007; Chapter 4; Gilbert et al., 2006; Furtado et al., 
2008). The comparison of SCR proteins in Table 2 of Furtado et al., 2008 can now be 
updated, in which the RG/RO ratio for FH is now 2.8-2.9 in place of 3.67 previously. This 
ratio is much lower than those of CR1 with a ratio of 3.76 and CR2 with a ratio of 4.1. 
Likewise the calculation of the f/fo ratio from the sedimentation coefficient of 5.56 S 
(Table 5.1) leads to 1.75 in place of 1.77 previously (Furtado et al., 2008). In distinction, 
CR1 has a larger f/fo ratio of 2.29 and CR2 has a larger f/fo ratio of 1.96. These ratios 
firmly place FH to possess a folded-back solution structure. Summation of the charged 
groups in FH, CR1 and CR2 shows small differences, where the composition-predicted 
pI of FH is lower at 6.1-6.3 compared to those of CR1 and CR2 which are 6.5-6.7 and 
7.8-8.5 respectively, and there is a higher proportion of charged groups in FH.
IV The 
slight decrease in pI and increase in charged groups for FH are consistent with a role for 
electrostatic effects in partly determining the FH domain arrangement. Mutations in FH 
that lead to aHUS occur throughout FH, even though the majority occur within the C-
terminal C3d- and heparin-binding SCR-20 domain. Of interest is that about half the 
known missense aHUS mutations in FH (26 out of 56) involve changes in charged 
residues, even though charged residues comprise only 27% of the residues in FH 
(Saunders et al., 2007). Charged residues are often found at protein surfaces and may be 
involved in direct interactions between FH and its ligands. Differences in residue charge 
                                                 
IV The net charge for FH is -2 out of 326 charged residues (27%) in a total of 1213 
amino acid residues. The net charge for CR1 is +11 out of 439 charged residues (23%; 
not counting the C-terminus) in a total of 1931 residues. The net charge for CR2 is +8 
out of 218 charged residues (23%; not counting the C-terminus) in a total of 951 
residues.   164
in aHUS mutations may therefore lead to functional alterations in FH, which in turn will 
facilitate the onset of aHUS, in addition to direct charged interactions between FH and 
its ligands. This may account in part for the occurrence of aHUS mutations in SCR 
domains other than that of SCR-20.  
While NaCl concentration-dependent FH conformations have been identified, it 
is stressed that scattering modelling is unable to specify proximity relationships between 
individual SCR domains, only that some domains will approach others. It should 
additionally be noted that, given the effect of electrostatic interaction between separated 
SCR domains in intact FH, crystal and NMR structural determinations of small FH 
fragments may give misleading inter-SCR domain conformations when considered in 
the context of intact FH. A typical range of FH conformations from scattering modelling 
is depicted in Figure 5.14. The single views of Figure 5.12 are not likely to represent any 
specific or actual FH conformation in solution.  
Previous knowledge of FH binding sites on C3b clarifies the FH interaction with 
C3b. When three FH-binding peptides in C3b are mapped onto the C3b crystal structure 
(Janssen et al., 2006), peptide H-1 is found to lie on the opposite face of C3b to those of 
H-2 and H-3 (Chapter 4). This indicates that the FH SCR domains will fold themselves 
around the C3b structure, thus FH is not wholly positioned on one side of C3b. 
Electrostatic views of FH and C3b can provide further insight into this interaction. 
Electrostatic surface maps reveal basic surfaces at SCR-7, SCR-13 and SCR-20, while 
acidic surfaces are revealed at SCR-9, SCR-12 and SCR-15 (Aslam & Perkins, 2001; 
Figure 5.15), while a similar varied range of differently-charged surfaces are visible in 
C3b (Figure 5.15). For FH, these correspond to the charge summations in Figure 5.1. 
These indicate that charge interactions will be important for the FH-C3b complex 
formation, and will facilitate any folding of the FH domains around C3b. The NaCl-
dependent conformational behaviour of FH observed in the absence of C3b in the 
present study is consistent with the folding of FH around C3b. It is therefore not 
surprising that the SCR domains of unbound FH will display NaCl-dependent 
conformations. Based on this observation, many more residues in FH outside SCR-19 
and SCR-20 are predicted to be important for the C3b-FH interaction. Such an extensive    165
 
Figure 5.14 
The best-fit FH models in 50 mM and 250 mM NaCl. The eight red models in order of 
R-factor correspond to the FH models in 50 mM NaCl that were deposited in the Protein Data 
Bank (PDB code 3gau), and the green models correspond likewise to those in 250 mM NaCl 
(PDB code 3gaw). The best-fit structure is asterisked. The maximum length of these models (± 
standard deviation) is shown above the best-fit model. The FH conformations shown do not 
predict any proximity relationships between neighbouring SCR domains; only that the best-fit 
models are partially folded back and that non-covalent contacts between two non-adjacent SCR 
domains are possible.   166
contact model offers a further explanation for the occurrence of aHUS mutations outside 
SCR-20 (Saunders et al., 2007; Chapter 4).  
Knowledge of the oligomeric state of FH is also crucial for understanding its 
function in complement regulation and its likely roles in AMD and aHUS disease. FH 
oligomerisation in solution was first identified in 1991 (Perkins et al., 1991), but it is 
only now that this feature of FH is becoming understood. The most recent study showed 
that a reversible monomer-dimer equilibrium exists at the lowest concentrations, and 
higher oligomeric structures that are not in equilibrium with each other exist at 
concentrations higher than physiological (Nan et al., 2008a). Oligomer formation has 
been attributed to dimerisation in each of SCR-6/8 and SCR-16/20 in physiologically-
relevant concentrations (Fernando et al., 2007, Chapter 4). A repeated alternation of 
dimerisation events will lead to the formation of an indefinite chain of FH oligomers. 
The present study extends these results by showing that FH oligomerisation persists in a 
range of NaCl concentrations and pH values at FH concentrations below and above its 
physiological concentration in plasma. The proportions of FH monomer, dimer and 
higher oligomers in the preparations used for this study are approximately 84%, 8% and 
8% (Figure 5.6). This is consistent with the previously-determined dissociation constant 
KD value of 28 µM at pH 7.4, 137 mM NaCl, which indicates that about 5% to 15% of 
FH in plasma will be dimeric, so long as no other factors require consideration (Nan et 
al., 2008a).  
Oligomer formation increases with a reduction in NaCl concentration or an 
increase in FH concentration. Again this indicates that the regulatory role of FH will be 
affected by the local environment. Depending on the progression of oligomer formation, 
ligand binding may be blocked or enhanced. For example, substantially larger FH 
oligomers form in the presence of at least 60 µM zinc and copper, and these inhibit the 
regulatory function of FH (Nan et al., 2008b). In addition, given the lack of reversibility 
of FH oligomer formation at high concentration, it may be important to use freshly gel-
filtrated FH samples stored below 1 mg/ml concentrations for complement regulatory 
functional studies. FH oligomers are potentially relevant for AMD, given that the hall 
mark of AMD is the formation of sub-RPE deposits (including drusen) at the retinal 
surface. Drusen are formed from about 120 aggregated proteins and oxidized lipids   167
adjacent to the Bruch’s membrane. Currently there is no detailed knowledge of the 
mechanism of drusen formation in AMD. It is possible that the local environment at the 
retina may facilitate the slow formation of protein precipitates, including FH, during the 
course of a lifetime.  
 
(5.4) Materials and Methods 
(5.4.1) Purification of Factor H 
Native FH was purified and concentrated from a pool of just-outdated 
anonymised human plasma using monoclonal MRC-OX23 Sepharose affinity column by 
Miss Ruodan Nan (Sim et al., 1993; Nan et al., 2008a; 2008b). FH samples were 
checked by SDS-PAGE before and after each X-ray scattering or AUC experiment. 
Samples were dialysed into a range of buffers by centrifugation at 2,000 g using four 
buffer changes in Millipore concentrators with a 50 kDa molecular weight cutoff. AUC 
and X-ray scattering FH data in 137 mM NaCl, pH 7.4 were collected by Miss Ruodan 
Nan in 10 mM HEPES, 0.5 mM EDTA (Nan et al., 2008a). All other 137 mM NaCl data 
for this thesis utilised phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 
mM NaH2PO4, 1.5 mM KH2PO4). Because no FH oligomerisation was seen with Zn or 
Cu below concentrations of 20 µM (Nan et al., 2008b), EDTA was not added to the PBS 
buffers. According to the manufacturer’s specifications, any trace amounts of copper in 
PBS was below 0.0005%. The NaCl concentration dependence experiments at pH 7.4 
were performed for this thesis by replacing 137 mM NaCl with 50 mM NaCl, 250 mM 
NaCl or 350 mM NaCl. The pH dependence was studied by resetting the pH of PBS to 
pH 5.4 and 9.4. Deglycosylated FH was prepared by enzymatic digestion using PNGase 
F in PBS at pH 7.4 (Fenaille et al., 2007). Briefly, 200 µg FH in 90 µl was mixed with 
10 µl of the detergent NP-40 (50% solution) and 2 µl of PNGase F solution prepared 
according to manufacturer’s instructions (Prozyme, San Leandro, CA, USA). The 
resulting mixture was incubated at 37ºC for 24 h. Deglycosylation was confirmed by 
SDS PAGE.  
The FH amino acid composition was taken from its sequence (SWISSPROT 
accession code P08603). The glycosylation of FH was taken to be eight biantennary 
oligosaccharides located at SCR-9, SCR-12, SCR-13, SCR-14, SCR-15 (two sites),   168
 
Figure 5.15 
Electrostatic views of the best-fit model of FH in 137 mM NaCl and its comparison with 
the crystal structure of C3b. Both FH and C3b are drawn to the same scale. Red denotes acidic 
regions while blue denotes basic regions. 
Upper: The ribbon view for the best fit FH model (PDB code: 3gav; Figure 5.12(b)) is 
numbered to indicate the positions of the SCR domains. The front and back views of its 
electrostatic surface are shown. No specific proximity arrangements between non-adjacent SCR 
domains in FH are implied by this view, only that the SCR domains are folded back. 
Lower: The ribbon view of the crystal structure of C3b (PDB code: 2i07) is colour 
coded to indicate the TED, CUB, C345C and MG1-MG8 domains.  
The blue ribbons highlight three previously-mapped peptides that bind to C3b and 
denoted by H1, H2 and H3. The front and back views of the C3b electrostatic surface are shown, 
with and without the ribbon view superimposed on this, for clarity. The positions of the H-1, H-2 
and H-3 binding peptides in C3b are arrowed.   169
SCR-17 and SCR-18 from the recent mass spectrometry determination; note that SCR-4 
is not glycosylated (Fenaille  et al., 2007; Figure 5.1). This resulted in a revised 
calculated FH molecular weight of 154.4 kDa (in place of 150.0 kDa used in our 
previous studies), an unhydrated volume of 193.1 nm
3, a hydrated volume of 256.2 nm
3 
(based on a hydration of 0.3g H2O/g of glycoprotein and an electrostricted volume of 
0.0245 nm
3 per bound water molecule), a partial specific volume v of 0.715 ml/g, and an 
absorption coefficient at 280 nm (1%, 1 cm path length) of 16.2 (in place of 16.7 used in 
our previous studies). The value of 16.2 is based on molar extinction coefficients of 
5665 M
-1cm
-1 for Trp residues, 1535 M
-1cm
-1 for Tyr residues, and 129 M
-1cm
-1 for Cys 
residues (Perkins, 1986). A similar value of 15.7 was calculated based on molar 
extinction coefficients of 5500 M
-1cm
-1 for Trp residues, 1490 M
-1cm
-1 for Tyr residues, 
and 125 M
-1cm
-1 for Cys residues (Pace et al., 1995), for which the evaluation of 93 Trp-
containing proteins showed a mean standard deviation of 3.167 % from the observed 
value. Other studies have reported a higher absorption coefficient of 19.5 (Hakobyan et 
al., 2008), or a lower one of 14.2 and 12.4 (Sim & DiScipio, 1982; Pangburn et al., 
2009). The value of 16.2 used here conveniently corresponds to the mean of these 
experimental determinations. All the buffer densities were measured at 20
oC using an 
Anton-Paar DMA5000 density meter to be 1.00169 g/ml (PBS using 50 mM NaCl), 
1.00488 g/ml (HEPES using 137 mM NaCl), 1.00541 g/ml (PBS using 137 mM NaCl), 
1.00995 g/ml (PBS using 250 mM NaCl), 1.01394 g/ml (PBS using 350 mM NaCl), 
1.00536 g/ml (PBS at pH 5.4) and 1.00554 g/ml (PBS at pH 9.4).  
 
(5.4.2) Sedimentation velocity data for Factor H  
AUC data for FH were obtained on two Beckman XL-I instruments equipped 
with AnTi50 and AnTi60 rotors. Sedimentation velocity data was acquired at 20
oC at 
rotor speeds of 40,000 r.p.m, 50,000 r.p.m. and 60,000 r.p.m. in two-sector  cells with 
column heights of 12 mm. Analysis was performed using direct boundary Lamm fits of 
up to 300 scans using SEDFIT version 11.0 (Schuck, 1998; 2000). SEDFIT resulted in 
size-distribution analyses c(s), the algorithm for which assumes that all species have the 
same frictional ratio f/fo. The final SEDFIT analyses used a fixed resolution of 200 and 
optimised the c(s) fit by floating f/fo until the overall root mean square deviations and   170
visual appearance of the fits were satisfactory (Figures 5.2-5.5). The percentage fraction 
of oligomers in the total loading concentration was derived using the c(s) integration 
function.  
 
(5.4.3) X-ray scattering data collection and analysis 
X-ray scattering data were obtained in three beam sessions in either four-bunch 
or sixteen-bunch mode at the European Synchrotron Radiation Facility (ESRF), 
Grenoble, France, operating with a ring energy of 6.0 GeV on the Beamline ID02 
(Narayanan et al., 2001). For data collection in this thesis, storage ring currents ranged 
from 32 mA to 75 mA. Data were acquired using a recently installed fibre optically-
coupled high sensitivity and dynamic range CCD detector (FReLoN). Together with a 
smaller beamstop, this allowed a shorter sample-to-detector distance of 2.0 m to be used 
and resulted in higher signal-to-noise ratios (Li et al., 2008). FH was studied at 0.4 
mg/ml to reduce the proportion of reversible oligomers. Samples of volume 100 µl were 
measured in flow cells to reduce radiation damage by moving the sample continuously 
during beam exposure. Sets of ten time frames each, with frames of duration 0.1 sec, 
0.25 sec, 0.5 sec or 1.0 sec each, were acquired. On-line checks during data acquisition 
confirmed the absence of radiation damage, after which the ten frames were averaged. 
Other details including the data reduction procedure are described elsewhere (Gilbert et 
al., 2005). 
In a given solute-solvent contrast, the radius of gyration RG is a measure of 
structural elongation if the internal inhomogeneity of scattering densities within the 
protein has no effect. Guinier analyses at low Q gives the RG, and the forward scattering 
at zero angle I(0) (Glatter & Kratky, 1982):  
ln I(Q) = ln I(0) - RG
2 Q
2/3. 
This expression is valid in a Q.RG range up to 1.5. If the structure is elongated, the mean 
radius of gyration of cross-sectional structure RXS and the mean cross-sectional intensity 
at zero angle [I(Q)Q]Q→0 is obtained from: 
ln [I(Q)Q] = [I(Q)Q]Q→0 - RXS
2Q
2/2. 
The RG and RXS analyses lead to the triaxial dimensions of the macromolecule if the 
structure can be represented by an elliptical cylinder, where L = √ 12(RG
2 - RXS
2) and L   171
is its length (Glatter & Kratky, 1982). The RG and RXS analyses were performed using an 
interactive PERL script program SCTPL7 (J. T. Eaton and S. J. Perkins, unpublished 
software) on Silicon Graphics O2 Workstations. Indirect transformation of the scattering 
data I(Q) in reciprocal space into real space to give the distance distribution function 
P(r) was carried out using the program GNOM (Semenyuk & Svergun, 1991): 
P(r) corresponds to the distribution of distances r between volume elements. For this, 
the X-ray I(Q) curve utilised up to 280 data points in the Q range between 0.06 nm
-1 and 
1.9 nm
-1. 
 
(5.4.4) Modelling of the Factor H solution structures 
  The first constrained modelling of the 20 SCR domains in FH used NMR 
structures for three SCR domains and homology models for the remaining 17 SCR 
domains (Aslam & Perkins, 2001). Here the remodelling of FH was based on NMR and 
crystal structures for 11 SCR domains and nine improved SCR homology models for the 
remainder. The homology models were taken from the website http://www.fh-hus.org 
(Saunders et al., 2006). NMR structures were used for SCR-5 (Barlow et al., 1992), 
SCR-15/16 (PDB code 1hfh; Barlow et al., 1993) and SCR-1/3 (PDB codes 2rlp and 
2rlq; Hocking et al., 2008). Crystal structures were used for SCR-19/20 (PDB code 2g7i; 
Jokiranta et al., 2006) and SCR-6/8 (PDB code 2uwn; Prosser et al., 2007). The FH 
sequence numbering was initiated from the N-terminus of the 18-residue signal peptide, 
not that of the mature protein. Twenty peptides that corresponded to the N-terminus (19-
ED-20) and the 19 inter-SCR linkers were created in extended β-strand conformations 
using INSIGHT II 98.0 molecular graphics software (Accelrys, San Diego, CA, USA) 
on Silicon Graphics OCTANE Workstations (Aslam & Perkins, 2001). Libraries of 
1,000 randomised conformations were generated for each peptide using molecular 
dynamics simulations. This procedure followed the Randomised Method 3 used for 
intact FH, in which the peptides are constrained to be almost fully extended in length 
(Aslam & Perkins, 2001).  
dQ   (Qr)   Qr   I(Q)    
2
1
  =   P(r)
o
2 sin ∫
∞
π
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One conformation was randomly selected from each library for each linker in 
order to join the 20 SCR domains to assemble 5,000 full FH models. Further details are 
given elsewhere (Aslam & Perkins, 2001; Gilbert et al., 2005). The inter-SCR domain 
angle is defined as the angle between the two longest axes of two adjacent SCR 
domains, where each axis is the line between the midpoint of the two αC atoms in the 
disulphide bridges at the two ends of the SCR domain. At the N- and C-termini, the axes 
were redefined using the αC atoms at 19-E and C-21, and at 1228-C and 1231-R 
respectively. In other analyses, the ranking R for averaged inter-domain angles is 
defined for the values 0, 1, 2 and 3 as follows: R = 0 if 0 º ≤ inter-SCR angle ≤ 45º; R = 
1 if 45 º < inter-SCR angle ≤ 90º; R = 2 if 90 º < inter-SCR angle ≤ 135º; R = 3 if 135 º < 
inter-SCR angle ≤ 180º (Table 5.2). 
  
(5.4.5) Debye scattering and sedimentation coefficient modelling  
Each full FH molecular model was used to calculate its X-ray scattering curve 
for comparison with five experimental FH curves (Table 5.1) using Debye sphere 
models (Gilbert et al., 2005). A cube side length of 0.498 nm in combination with a 
cutoff of 3 atoms was used to convert the coordinates into Debye sphere models with 
1485 spheres that corresponded to the unhydrated structure. The hydration shell was 
created using HYPRO, (Ashton et al., 1997) where the optimal total of hydrated spheres 
in the FH model is 2074 (Table 5.1). The X-ray scattering curve I(Q) was calculated 
using the Debye equation adapted to spheres (Perkins & Weiss, 1983). Other details are 
given elsewhere (Perkins, 2001). Steric overlap between the SCR domains in the models 
was assessed using the number of spheres N in the models after grid transformation, 
where models showing less than 95% of the required total of 1485 spheres were 
discarded. Over 99% of the 5,000 models met this “absence of steric overlap” criterion. 
Next, the X-ray RG and RXS-1 values were calculated from the modelled curves in the 
same  Q ranges used for the experimental Guinier fits. This allowed for any 
approximations inherent in the use of the Q.RG fit range up to 1.5. Models that passed 
the N, RG and RXS-1 filters were then ranked using a goodness-of-fit R factor defined by 
analogy with protein crystallography and based on the experimental curves in the Q 
range extending to1.8 nm
-1 (Table 5.1).   173
   Sedimentation coefficients s
0
20,w were calculated  directly from the atomic 
coordinates in the HYDROPRO shell modelling program using the default value of 0.31 
nm for the atomic element radius for all atoms to represent the hydration shell (Garcia de 
la Torre et al., 2000). 
 
(5.4.6) Protein Data Bank accession number 
 The  best-fit  FH  α-carbon co-ordinate models have been deposited in the Protein 
Data Bank with the accession codes 3gau (50 mM NaCl buffer), 3gav (137 mM NaCl 
buffer), and 3gaw (250 mM NaCl buffer).   174
Chapter Six 
 
Multimeric interactions between complement Factor H and its C3d ligand 
provide new insight on complement regulation 
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(6.1) Introduction 
The interaction between FH and C3b involves multiple SCR sites within FH. 
In studies using buffers with 50-75 mM NaCl, the four N-terminal domains SCR-1/4 
have been shown to bind to intact C3b, a second site in SCR-6/10 binds to the C3c 
region of C3b, and a third site within SCR-16/20 binds to the C3d region of C3b 
(Lambris et al., 1988; Sharma & Pangburn, 1996; Jokiranta et al., 2000; 2001). A 
molecular understanding of the FH-C3b complex requires the dissection of the role 
of each of these C3b sites on FH. This chapter focuses on the C3d fragment and its 
interaction with SCR-16/20 and FH. Ligand-binding assays in 137 mM NaCl buffer 
first revealed that a peptide derived from C3d inhibits FH binding to C3b (Lambris 
et al., 1988). SPR analysis in 50 mM and 75 mM NaCl indicate that C3d binds to FH 
and also to the FH-related proteins FHR-3 and FHR-4 with dissociation constants KD 
of 0.09-0.36 µM (Hellwage et al., 1999; 2002). The FH-C3d interaction in 50 mM 
and 75 mM NaCl was confirmed, and the binding site was localised to SCR-20 
(Jokiranta et al., 2000; Hellwage et al., 1999). Mutations in SCR-20 lead to reduced 
binding to C3d and heparin (Manuelian et al., 2003; Jokiranta et al., 2005). The FH 
binding sites for C3d and heparin partially overlap and lead to a ternary complex of 
FH-C3d-heparin in 70 mM NaCl (Hellwage et al., 2002; Jokiranta et al., 2005). 
Interestingly, other studies showed that dimeric C3dg remains bound to IgG after 
C3b inactivation, suggesting that dimeric C3d is required for efficient binding to 
CR2 and that C3d oligomers may be physiologically important (Arnaout et al., 1983; 
Dempsey et al., 1996; Jelezarova et al., 2003).  
Structural studies on intact FH are hindered by its large size, glycosylation 
and inter-SCR flexibility, and a multidisciplinary approach has been required to 
elucidate its structure. Medium resolution solution scattering structures based on 
homology models and high resolution NMR and crystal structures have shown that 
FH possesses a partly folded-back SCR arrangement (Aslam & Perkins, 2001; 
Soares & Barlow, 2005; Jokiranta et al, 2006; Herbert et al., 2006; Prosser et al., 
2007; Hocking et al., 2008; Chapter 5). In contrast, structural studies of FH-ligand 
complexes are more limited. It was previously shown that SCR-6/8 has a bent 
solution structure, is weakly dimeric, and forms a 1:1 complex with heparin 
(Fernando et al., 2007). The solution structure for SCR-16/20 (Chapter 4; Figure 6.1) 
shows that this is partially folded-back and partly dimeric. Native FH exists in 
oligomeric forms (Chapter 5; Nan et al, 2008a). The solution and crystal structures  176
for C3d have been reported (Nagar et al., 1998; Gilbert et al., 2005; Li et al., 2008), 
and C3d binds to SCR-20 (Jokiranta et al., 2000; Hellwage et al., 1999). Together, 
these studies now make possible the investigation of the SCR-16/20 and FH 
complexes with C3d, where it can be predicted that the complexes do not show a 1:1 
stoichiometric ratio (Figure 6.1).This chapter presents solution structures for the 
SCR-16/20- and FH-C3d complexes using AUC, SPR, X-ray scattering and 
molecular modelling. The hypothesis that the FH-C3d complexes do not exhibit the 
1:1 stoichiometry that had been commonly assumed previously is confirmed here. It 
is also shown that ionic interactions play a major role in FH-C3d complex formation. 
This observation of C3d-FH multimers provides new insights into the mechanism of 
complement regulation at host cell surface and contributes to the understanding of 
aHUS.  
 
(6.2) Results and Discussion 
(6.2.1) Solution structural data for the Factor H-C3d complex 
To test the hypothesized spatial arrangement of the individual components 
within the FH-C3d complexes (Figure 6.1), the approaches used previously to 
characterize each of unbound SCR-16/20, native FH and C3d in solution (Gilbert et 
al., 2005; Li et al., 2008; Section 6.2.2; Chapter 4; Chapter 5) were now applied to 
obtain structural data for their complexes. These data were then fitted using the 
structural models for SCR-16/20, FH and C3d. Experiments on C3d were performed 
jointly with Miss Keying Li (Li et al., 2008), and this is acknowledged accordingly 
in relevant figure legends. The sedimentation velocity data on C3d in HEPES buffer 
presented here include reanalyses of data previously collected by Dr. Hannah Gilbert 
(Gilbert et al., 2005). 
Native FH, recombinant SCR-16/20, SCR-1/5 and C3d were expressed and 
purified (Section 6.4.1; Chapter 4) and analysed by size-exclusion chromatography. 
While C3d and SCR-1/5 are unglycosylated, at least one of the two putative 
glycosylation sites of SCR-16/20 is occupied (Chapter 4). C3d eluted as a single 
homogeneous peak by gel filtration, but with a sharp leading edge and a skewed 
trailing edge that indicated self-association (Figure 6.2(a)), and showed a single band 
on non-reducing SDS-PAGE with an apparent molecular weight of 30 kDa (not 
shown). SCR-16/20 reproducibly eluted as a broad peak with a trailing edge that was 
occasionally partly-resolved into two components (Figure 6.2(a)) and ran as a single   177
 
 
Figure 6.1 
Schematic cartoon of the SCR arrangement in the monomer and dimer of 
SCR-16/20. The length of the monomer is 17 nm, while that of the dimer is 26 nm. 
The location of C3d (dashed outline) on SCR-20 is predicted to lead to no changes in 
these lengths if no conformational change occurs in SCR-16/20 after C3d binding. 
The residue lengths of the four inter-SCR linkers of SCR-16/20 are indicated by 
numbers. The two predicted N-linked oligosaccharide chains at Asn1029 (SCR-18) 
and Asn1095 (SCR-19), at least one of which is occupied, are indicated by Ψ-like 
symbols.  
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Figure 6.2  
Size-exclusion chromatography of unbound SCR-16/20, C3d and their 
complex. The elution positions of four standards are shown in kDa. The elution 
positions of unbound C3d, SCR-16/20 monomer (M) and dimer (D), and complex 
are labelled as shown.   
(a) In 50 mM NaCl buffer, unbound C3d eluted as a single peak (full line), 
while unbound SCR-16/20 eluted as a peak partly resolved into two components 
designated as monomer (M) and dimer (D) (dashed line).  
   (b) A 1:1 mixture of SCR-16/20 and C3d at 1.6 mg/ml was loaded onto a 
Superdex-200 prep grade XK 16/60 column in 50 mM NaCl HEPES buffer (dashed 
line) and 137 mM NaCl PBS buffer (full line).  The peak for the complex at 50 ml is 
absent in 137 mM NaCl PBS buffer.   179
major band on non-reducing SDS-PAGE with an apparent molecular weight of 37 
kDa (not shown). Complexes were prepared by mixture of C3d and SCR-16/20 in the 
appropriate molar ratio. HEPES buffer was used in continuation of the studies with 
C3d (Gilbert et al., 2005; Li et al., 2008), while PBS was previously used with SCR-
16/20 (Chapter 4). No difference was observed in the behaviour of FH in HEPES or 
PBS buffers at similar NaCl concentrations (Nan et al., 2009b). Hence HEPES buffer 
was used for SPR, and both HEPES and PBS buffers were used for AUC and X-ray 
scattering experiments. 
By gel filtration, the formation of a weak complex in 50 mM NaCl HEPES 
buffer was indicated for an equimolar mixture by the appearance of an early peak 
that eluted at 50 ml in addition to the peaks for SCR-16/20 and C3d (Figure 6.2(b)). 
The observation of three peaks indicated a micromolar dissociation constant KD. Two 
peaks were observed when 137 mM NaCl PBS buffer was used, indicating that the 
complex had weakened and that there is a strong ionic strength dependence of 
complex formation (Figure 6.2(b)).  
 
(6.2.2) Analytical ultracentrifugation of C3d 
(6.2.2.1) Sedimentation velocity data for C3d 
Previously, C3d was observed to undergo what was assumed to be a 
concentration-dependent monomer-dimer equilibrium with a KD value of 40 µM in 10 
m M  H E P E S ,  5 0  m M  N a C l  ( Gilbert  et al., 2005). Here, this was reinvestigated by 
sedimentation velocity at concentrations from 0.3 mg/ml to 8.3 mg/ml in both 137 mM 
(PBS) and 50 mM (HEPES) NaCl buffers (Section 6.4.1). Interference optics data were 
used throughout, together with absorbance data below 0.8 mg/ml, due to the saturation of 
the absorbance optics at C3d concentrations above 0.8 mg/ml. Unlike the previous 
DCDT+ analyses, size-distribution c(s) analyses using SEDFIT were now used for data 
analyses, and resulted in good boundary fits (Figure 6.3(a,b)). In 137 mM NaCl, a single 
predominant species was observed at an s
o
20,w value of 2.95 ± 0.05 S between 0.5-7.5 
mg/ml (10 determinations) (Figure 6.3(c)). The c(M) size distribution plot showed that 
this corresponded to a molecular mass of 39 ± 4 kDa. This was accordingly assigned to 
C3d monomers with a molecular mass of 34.6 kDa calculated from its composition. 
Trace amounts of higher oligomers were visible at higher C3d concentrations (Figure 
6.3(c)). In 50 mM NaCl, the c(s) distributions showed a concentration dependence   180
 
Figure 6.3  
Concentration dependence of the sedimentation velocity data for unbound C3d in 
137 mM NaCl (green) and 50 mM NaCl (red) buffers. Figures (a) and (c) are used with 
permission from Miss Keying Li (Li et al., 2008). (a) The boundary fits for C3d at 1.1 mg/ml 
in 137 mM NaCl at 32,000 r.p.m. are from interference data. Only every sixth scan in a total of 
200 scans is shown for reason of clarity. (b) The boundary fits for C3d at 1.2 mg/ml in 50 mM 
NaCl at 40,000 r.p.m. are from interference data. Only every fourth scan of the first 80 scans is 
shown for reason of clarity. (c) The concentration dependence of the c(s) size distributions for 
0.6 mg/ml, 1.1 mg/ml (green), 3.6 mg/ml and 7.4 mg/ml of C3d in 137 mM NaCl is shown. A 
single species is observed at 2.9 S and labelled M (monomer).    
(d) The concentration dependence of the c(s) size distributions for 0.3 mg/ml, 0.7 mg/ml, 
0.8 mg/ml, 1.2 mg/ml, 2.1 mg/ml, 2.8 mg/ml and 8.3 mg/ml of C3d in 50 mM NaCl is shown. 
The peaks are labelled as M (monomer), D (dimer) and T (trimer) in increasing order of S values, 
where the values shown correspond to 8.3 mg/ml.   181
between 0.3-8.3 mg/ml, and three peaks indicating three oligomer species were visible 
(Figure 6.3(d)). At 0.3 mg/ml, only the monomer (M) was present at 2.9 S.   
The mean value is 2.99 ± 0.10 S (21 determinations). Above 0.7 mg/ml, a second 
peak (D) was observed at 4.28 ± 0.29 S (16 determinations) and its intensity increased 
with concentration. A third peak (T) appeared above 2.1 mg/ml, whose s
o
20,w value 
increased from 5.4 S to 6.8 S as the concentration increased from 2.1 mg/ml to 8.3 
mg/ml. The mean value is 5.99 ± 0.59 S (11 determinations). The c(M) distribution plots 
showed that peaks M, D and T correspond to molecular masses of 34 ± 4 kDa, 59 ± 10 
kDa and 95 ± 18 kDa respectively, assuming that the frictional ratio f/fo remained 
unchanged for these species. These masses are consistent with the formation of C3d 
dimers and trimers of sizes 70 kDa and 105 kDa. The rate of interconversion between the 
three species was slow enough during the velocity runs for these peaks to be visible in 
the c(s) plots. Previous study of C3d in 50 mM buffer using DCDT+ fits of 10-20 scans 
gave s
o
20,w values that ranged between 3.26 S to 4.85 S. (Gilbert et al., 2005) This 
range of s
o
20,w values is consistent with the range seen in Figure 6.3, and reanalyses of 
the previous data using SEDFIT confirmed the occurrence of three species in Figure 
6.3(d).  
 
(6.2.2.2) Sedimentation equilibrium data for C3d  
Sedimentation equilibrium experiments in both 137 mM and 50 mM NaCl 
were performed to explore C3d oligomer formation over a ten-fold concentration 
range. Absorbance data were not fitted because of the saturation of the optics above 
0.8 mg/ml. The individual fits of the equilibrium curves at different speeds and 
concentrations gave the molecular weights shown in Figure 6.4(c). Thus C3d in 50 
mM NaCl showed a concentration dependent mass, while this was not seen in 137 
mM NaCl. The final global fit of each multispeed experiment were performed using 
rotor speeds of 19k, 28k and 35k r.p.m. (Section 6.4.2.2).  
For C3d in 137 mM NaCl PBS buffer, the mass was determined using a 
global fit of 15 curves at five concentrations (Figure 6.4(a)) on the basis of a 
monomer-dimer-trimer model (Figure 6.3). Low random residuals, a low reduced χ
2 
value of 8.0, and good visual fits were obtained. A C3d monomer mass of 34.1 ± 1.6 
kDa was determined, in good agreement with the composition-determined value of 
34.6 kDa. The monomer-dimer and monomer-trimer dissociation constants KD were   182
 
Figure 6.4 
Multispeed global fit sedimentation equilibrium analyses of C3d in 137 mM NaCl 
(green) and 50 mM NaCl (red) buffers.  The fit residuals are shown above each panel. Figure 
(a) is used with permission from Miss Keying Li (Li et al., 2008). (a) The five panels show 
the multispeed global fit analysis of interference data for C3d (fitted line in green) at five 
concentrations (0.64 mg/ml, 1.20 mg/ml, 3.63 mg/ml, 4.20 mg/ml and 7.01 mg/ml). Within 
each panel, the rotor speeds were 19k r.p.m. (○), 28k r.p.m. (∆) and 35k r.p.m. (□). The 
global fits gave a monomer mass of 34.1 kDa. (b) The six panels show the multispeed global 
fit analysis of interference data for C3d (fitted line in red) at six concentrations (0.26 mg/ml, 
0.81 mg/ml, 1.77 mg/ml, 2.84 mg/ml, 3.63 mg/ml and 5.50 mg/ml). The rotor speeds are the 
same as in (a). (c) Concentration dependence of the molecular mass of C3d in 137 mM 
(green) and 137 mM (red) NaCl buffers. For 137 mM NaCl, the green line corresponds to a 
mass of 35 kDa. For 50 mM NaCl, the red line corresponds to the regression line drawn 
using data from 0.11, 0.26, 0.81, 1.77, 2.84, 3.63, 4.49 and 5.5 mg/ml.  183
high at 61 mM and 1.4 mM
2 respectively, indicating that no dimer or trimer had 
formed. This outcome was confirmed by a global fit based on a single species only, 
which gave a similar mass of 35.1 ± 0.3 kDa and an almost unchanged reduced χ
2 
value of 9.7 (fits not shown). Hence C3d in physiological buffer was concluded to be 
monomeric.  
For C3d in 50 mM NaCl HEPES buffer, the same rotor speeds and 
concentration range also gave good fits to a monomer-dimer-trimer association 
model. This fit required that equilibrium had been reached, and this was confirmed 
using overlays of runs (Section 6.4). The global fit based on a monomer-dimer-trimer 
association model of 18 curves at six concentrations with a fixed monomer mass of 
34.6 kDa gave low residuals (Figure 6.4(b)) and a global reduced χ
2 value of 3.5. The 
KD values of the monomer-dimer and monomer-trimer equilibria were determined to 
be 360 ± 0.01 µM and 0.070 ± 0.003 µM
2 respectively. Global fits based on a single 
species gave much worsened reduced χ
2 values of 60 to 223. A monomer-dimer 
model gave a poorer reduced χ
2 value of 12.9 but gave a KD value of 210 µM that 
was comparable with the previous estimate of 40 µM (Gilbert et al., 2005). Overall, 
C3d at 8.3 mg/ml in low salt will form more trimer than dimer, and this agrees with 
the c(s) analyses of the sedimentation velocity data (Figure 6.3(d)).  
 
(6.2.3) Analytical ultracentrifugation of the SCR-16/20 and Factor H complexes 
with C3d 
(6.2. 3.1) Sedimentation velocity data for the SCR-16/20 complex with C3d  
AUC studies macromolecular structures in solution by following their 
sedimentation behaviour under a high centrifugal force (Cole  et al., 2008). The 
observed sedimentation boundaries were fitted to yield a sedimentation coefficient 
distribution, c(s) according to the Lamm equation using SEDFIT (Section 6.4.2.1). 
This takes into account all the species present in the sample, although the algorithm 
assumes that the same frictional ratio applies for all the sedimenting species. 
Macromolecular elongation is monitored through changes in the sedimentation 
coefficient s
0
20,w values, and sample polydispersity is determined from the number of 
peaks observed in the c(s)  plot. AUC sedimentation velocity experiments were 
carried out for SCR-16/20 and C3d. Only interference optics data were used due to 
saturation of the absorbance optics at 280 nm in the concentration range used. Free   184
 
Figure 6.5 
Size distribution c(s) analyses of SCR-16/20 and C3d mixtures in 50 mM 
NaCl HEPES buffer. The SEDFIT analyses correspond to a rotor speed of 50,000 
r.p.m. in which C3d was titrated against 1.0 mg/ml SCR-16/20. Representative 
boundary fits are shown in the two upper panels. The lower panels show nine c(s) 
analyses. For clarity, the c(s) plots were displaced arbitrarily along the c(s)-axis. 
Eight peaks were labelled 1-8 in order of increasing S value. (a) The two unbound 
proteins were assigned as peaks 1 and 3 (SCR-16/20) and peak 2 (C3d at low 
concentration) at 2.60 S, 2.91 S and 3.30 S in that order. Low molar ratios of C3d 
(0.3:1, 0.6:1 and 1:1) resulted in complex formation which was suggested by the 
appearance of peaks 6 and 7. (b) C3d at high concentration was assigned to peaks 2, 
4 and 5, and complex formation in high molar ratios of C3d (1.5:1, 2:1 and 3:1) was 
suggested by the additional peaks labelled 6, 7 and 8.  185
C3d and SCR-16/20 were used as reference (Figure 6.5(a)). Analysis of up to 300 
scans revealed excellent boundary fits (Figure 6.5). In the c(s) distribution of Figure 
6.5(a), peak 2 for unbound C3d at 0.3 mg/ml in Figure 6.5(a) shows a s20,w value of 
2.99 (± 0.08) S, and this single peak is unchanged up to 0.8 mg/ml (Figure 6.3(c,d)). 
When C3d is in excess of 1 mg/ml in Figure 6.5(b), peaks 4 and 5 correspond to the 
previously-suggested C3d dimer and trimer respectively (Figure 6.3(d)). It should be 
noted that the c(s) analysis will provide peaks for reversibly reacting systems, but 
these peaks correspond to reaction boundaries and not to distinct species. 
Accordingly molecular weight analyses may not be justified in the absence of other 
evidence (Section 3.2.5.3). Figure 6.5(b) thus shows that C3d undergoes an unusual 
co-operative association to states larger than dimer, where the lack of baseline 
resolution between peaks 4 and 5 is consistent with C3d undergoing mass action 
association. Peaks 1 and 3 for SCR-16/20 in Figure 6.5(a) show s20,w values of 2.69 S 
and 3.30 S respectively which are consistent with a slow monomer-dimer 
equilibrium (Chapter 4). The possibility that SCR-16/20 dimerisation occurred as a 
result of the C-terminal hexahistidine tag was excluded by control AUC experiments. 
The study of SCR-16/20 using imidazole concentrations of 0.1 M, 0.3 M and 0.5 M 
showed that dimer was formed in similar amounts to that observed in PBS buffer 
(not shown).  
Because weak complexes were identified by gel filtration (Figure 6.2(b)), the 
complex was investigated in 50 mM NaCl HEPES buffer by titrating C3d against a 
fixed concentration of 1.0 mg/ml SCR-16/20 (25.2 µM) (Figure 6.5). The C3d molar 
ratios ranged from 0.3:1 to 3:1. In the c(s) plots, five additional peaks numbered 4 to 
8 were observed that indicated the formation of a series of reversibly reacting SCR-
16/20 and C3d complexes (Figures 6.5(a,b)). The underlying model for c(s) analysis 
assumes the same frictional ratio for all sedimenting species. In addition, while c(s) 
analysis is suitable for studying homogeneous or heterogeneous non-interacting 
systems, it has not been shown to be appropriate for solutions containing interacting 
components with multiple assembly states. Thus for the reversibly-interacting system 
described by this experiment, the c(s) peaks for the complexes will generally 
correspond to reaction boundaries and not to distinct molecular species. For the 
molar ratios up to 1:1 (Figure 6.5(a)), at least four additional peaks (numbered 4 to 7) 
could be resolved. Peaks 1-5 for unbound C3d and SCR-16/20 did not completely 
disappear in these mixtures, indicating that SCR-16/20 self-  186
    
 Figure 6.6 
Size distribution c(s) analyses of SCR-16/20, FH and C3d mixtures in 137 
mM NaCl PBS or HEPES buffer.  
(a) The unbound proteins in PBS buffer were assigned as peaks 1 and 3 
(SCR-16/20 at 1.0 mg/ml) and peak 2 (C3d at 0.6 mg/ml) at 2.60 S, 2.91 S and 3.30 
S in that order. Their 1:1 mixture at 1.8 mg/ml shows additional weak peaks 6, 7 and 
8.  
(b) The unbound proteins in PBS buffer were assigned as peak 2 (C3d at 0.6 
mg/ml) and peaks A and B (FH monomer and dimer respectively at 1.53 mg/ml) in 
137 mM NaCl HEPES buffer. Their 1.5:1 ratio of C3d: FH showed additional weak 
peaks labelled C, E and F. The presence of Peak X is artefactual.  187
interaction and C3d oligomerisation occur, even though SCR-16/20 binding to C3d 
has taken place. The relative stability of peaks 1-5 suggests a slow interaction. For 
the molar ratios above 1:1 (Figure 6.5(b)), the resolution and positions of peaks 6 and 
7 changed, and another peak 8 became visible. This concentration dependence of 
peaks 6-8 is indicative of a faster equilibrium (Balbo & Schuck, 2005).  
While it is impossible to determine exact peak positions for larger 
sedimenting species in fast-interacting systems, it is nonetheless possible to infer 
peak positions for smaller species with slow interactions (Balbo & Schuck, 2005). 
Hence the positions of peaks 1-5 can be deduced since these did not alter in their s20,w 
values with concentration. Peak 4 with a mean s20,w value of 4.25 (± 0.07) S was seen 
at all molar ratios, and is assigned to the C3d dimer and possibly to complex 
formation between SCR-16/20 and C3d. Peak 5 with a mean s20,w value of 5.55 (± 
0.12) S was seen clearly only at the higher C3d concentrations, and corresponds to 
the putative C3d trimer and possibly to further complex formation. In contrast, the 
s20,w value of peak 6 ranged from 6.23 S to 8.43 S in the titration. Peak 7 with a mean 
s20,w value of 10.49 (± 0.08) S showed no concentration dependence up to a 1:1 molar 
ratio, and varied between 9.93 S to 10.66 S at higher molar ratios. Peak 8 was seen 
only at high molar ratios above 1:1, and has an s20,w value of 11.90 S to 12.66 S. 
Even though precise s20,w values could not be determined, the existence of the peaks 
shows that a series of large multimeric complexes have formed.  
The conversion of the observed c(s) peaks into molecular weights provides 
some insight into the SCR-16/20 complex with C3d in 50 mM NaCl. Such an 
analysis assumes that all the sedimentation species possess the same frictional ratio 
f/fo (where fO is the frictional coefficient of the sphere with the same volume as the 
hydrated glycoprotein) and that the peaks do not correspond to reaction boundaries. 
The f/fo ratio is a measure of structural elongation. The f/fo values for the elongated 
SCR-16/20 monomer and dimer are 1.4 and 1.6 respectively (Chapter 4), while that 
for the globular C3d monomer is 1.1 (Li et al., 2008), showing that such an analysis 
will be limited. The conversion of c(s) plots to c(M) plots (not shown) using a low 
f/fo ratio of 1.185 suggested that peaks 1 and 3 corresponded to putative molecular 
weights of 29 kDa and 42 kDa. These values are less than the expected molecular 
weights for the SCR-16/20 monomer (40 kDa) and dimer (79 kDa) because of the 
low f/fo ratio. Peaks 2, 4 and 5 correspond to molecular weights of 31 (± 3) kDa, 55 
(± 6) kDa and 70 (± 9) kDa respectively, which are also less than the expected  188
molecular weights for the C3d monomer, dimer and trimer of 35 kDa, 70 kDa and 
105 kDa respectively. As the molecular weight for a 1:1 complex is 74 kDa, the 
discrepancies for peaks 4 and 5 may be explained by complex formation with low 
stoichiometric ratios. The putative molecular weights of peaks 6-8 are in a range of 
111 (± 9) to 222 (± 20) kDa with a f/fo ratio close to 1.1, while complexes with a 2:2 
or 4:4 stoichiometry will have predicted molecular weights of 149 kDa or 297 kDa 
respectively. If peaks 6-8 are assigned to molecular species, the existence of peaks 6-
8 shows that a range of multimeric FH-C3d complexes have been formed, although 
their stoichiometry cannot be determined because of the uncertainty over the f/fo 
ratio.   
The velocity data were repeated using physiological 137 mM NaCl PBS 
buffer (Figure 6.6(a)). Peaks 1, 2 and 3 were identified again in the c(s) analyses, 
although peaks 1 and 3 were slightly shifted in position with s20,w values of 2.81 S 
and 3.89 S respectively, compared with those of 2.60 S and 3.30 S in 50 mM NaCl 
HEPES buffer. The putative molecular weights of 38 kDa (peak 1) and 67 kDa (peak 
3) are comparable with the expected molecular weights of 40 kDa, and 79 kDa 
respectively. For the 1:1 mixture at 1.8 mg/ml, additional peaks 6, 7 and 8 were 
observed, showing that multimeric complex formation had occurred. Integration of 
the c(s) analyses showed that peaks 4-8 comprised 42% of the total signal area for 
the 1:1 mixture in 50 mM NaCl buffer, while this was reduced to 24% in 137 mM 
NaCl buffer. This decrease indicated a salt-dependence of complex formation.  
 
(6.2.3.2) Sedimentation velocity data for the complex of native Factor H with 
C3d 
In order to assess the physiological relevance of multimeric SCR-16/20 
complexes with C3d, the same AUC titrations were performed with native FH and 
C3d in 137 mM NaCl PBS buffer. Previously with native FH, oligomers in slow 
exchange were detected in the c(s) plot, of which the monomer and dimer were 
prevalent at 1.0 mg/ml FH (Nan et al., 2008a). The monomer and dimer (peaks A 
and B respectively) were observed for FH at 1.53 mg/ml (Figure  6.6(b)). The 
addition of a 50% molar excess of C3d to 1.0 mg/ml FH resulted in multimers as 
evidenced by the appearance of peaks C, E and F (Figure 6.6(b)).  
The FH complex was investigated in 50 mM NaCl HEPES buffer using a 
titration of C3d against a fixed concentration of 1.0 mg/ml FH (6.7 µM). Good   189
 
Figure 6.7 
Size distribution c(s) analyses of native FH and C3d mixtures in 50 mM NaCl 
HEPES buffer. The SEDFIT analyses correspond to a rotor speed of 40,000 r.p.m. 
Representative boundary fits are shown in the two upper panels. The lower panels 
show nine c(s) analyses. For clarity, the plots were displaced arbitrarily along the 
c(s)-axis. Peaks 2 and 4 were assigned to C3d to follow Figures 6.5 and 6.6. Peaks A 
and B were assigned as the FH monomer and dimer respectively. Other peaks were 
labelled C to G in order of increasing S value.   190
boundary fits were obtained in all cases (Figure 6.7). The c(s) plots revealed the 
more prominent presence of C3d-induced multimers at lower ionic strength (Figure 
6.7). Unbound FH at 1.0 mg/ml exhibited at least seven oligomeric forms labelled A 
to G in slow exchange, and these have been assigned as predominantly FH 
monomers (peak A) with small amounts of FH dimers increasing to heptamers 
(peaks B to G) (Nan et al., 2008a). The addition of C3d up to a 1:1 molar ratio 
showed that peaks B to G either shift to larger S values or increase in their size. If the 
peaks correspond to distinct species and/or reaction boundaries, this indicates that 
complexes had formed. Peak 2 that corresponded to monomeric unbound C3d was 
also observed in Figure 6.7 (a), indicating that C3d bound incompletely and weakly 
to FH.  Above a 1:1 molar ratio, further changes in the FH peaks B to G positions 
and intensities occur, together with large increases in peak 2 for C3d (Figure 6.7 (b)). 
Unlike the case of SCR-16/20, more detailed analyses of the C3d and FH interaction 
were precluded by the complexity of the system under investigation.   
 
(6.2.4) Surface plasmon resonance studies of the complexes of Factor H and 
SCR-16/20 with C3d 
SPR monitors the interaction between a binding partner in solution (analyte) 
and a partner (ligand) attached to the surface of a sensor chip (Tanious et al., 2008). 
Previous SPR studies of the FH-C3d interaction using immobilised C3d did not 
report multimer formation (Hellwage et al., 1999, 2002; Jokiranta et al., 2000, 2005; 
Manuelian et al., 2003). Accordingly C3d binding to immobilised FH was studied in 
duplicate runs. The binding response decreased approximately five-fold from 50 mM 
NaCl HEPES to 137 mM NaCl HEPES buffers (Figure 6.8(a)), confirming the ionic 
strength-dependent nature of this interaction. In both buffers, steady-state affinity 
studies revealed that C3d bound to immobilised FH in two stages. The equilibrium 
dissociation constant KD1 for the first stage was well-determined between C3d 
concentrations of 0.1-7 µM in 50 mM NaCl and 0.1-30 µM in 137 mM NaCl 
(Figures 6.8(b,c)). In 50 mM NaCl buffer, the KD1 value was 1.0 µM (Figure 6.8(b)), 
while this was increased to 2.6 µM in 137 mM NaCl buffer (Figure 6.8(c)). A second 
association phase was indicated by a significant increase in the response above 7 µM 
C3d in 50 mM NaCl buffer (Figure 6.8(b)) and above 30 µM in 137 mM NaCl buffer 
(Figure 6.8(c)). However KD2 values could not be well determined for the responses   191
 
Figure 6.8  
SPR analysis of C3d binding to immobilised FH.  
(a) Approximately five-fold more C3d binds to FH in 50 mM NaCl buffer compared to 137 
mM NaCl buffer. (b) Steady-state affinity analyses for C3d binding to FH in 50 mM NaCl 
buffer. A secondary increase in the binding response occurred at concentrations above 7 µM 
C3d (0.2 mg/ml). The equilibrium dissociation constant KD1 was determined for C3d 
between 0-7 µM (see inset for greater clarity). (c) In 137 mM NaCl buffer, the KD1 value was 
determined for C3d between 0-30 µM. (d) Sensorgram overlays showing the data points 
used in the affinity studies of (b) and (c).  192
in this second phase because steady-state saturation could not be fully attained. The 
existence of two KD values would be consistent with the presence of both a FH-C3d 
complex and a multimer complex.  
Overlay experiments were performed in order to test further the hypothesis 
that the C3d interaction with FH is not a simple 1:1 binding reaction. C3d at 7 µM in 
both 50 mM and 137 mM NaCl buffers was injected onto immobilised FH for 
increasing amounts of time from 15 sec to 180 sec. The data were overlaid at the start 
of the dissociation phase (Figure 6.9). A simple binding reaction would be revealed 
by the dissociation phases lying on top of each other. Instead of this, it was observed 
in both buffers that, the longer the contact time became, the slower the dissociation 
time became. This indicated a linked reaction caused by C3d multimer formation on 
immobilised FH. While alternative explanations based on (i) conformational 
rearrangements in C3d, or (ii) the presence of a secondary C3d-binding site in 
immobilised FH are possible, these alternatives are unlikely because (i) C3d 
possesses a compact domain structure that is unlikely to undergo conformational 
rearrangement on ligand-binding (Gilbert  et al., 2005; Li et al., 2008) and (ii) 
previous studies show that FH possesses a single C3d-binding site (Sharma & 
Pangburn, 1996; Jokiranta et al., 2000; Lambris et al., 1988; Jokiranta et al., 2001). 
The maximum response in this experiment is given by the molecular weight ratio of 
analyte to ligand (36/154) multiplied by the stoichiometry of 1 and the amount of 
immobilised FH ligand (700 RU). The observed response of over 200 RU at first-
stage saturation in Figures 6.8(b) exceeds the predicted maximum response of 164 
RU, which may suggest that C3d multimerisation on immobilised FH has occurred in 
this buffer. In the light of this observation, the weaker saturation of 40 RU and the 
changes above 30 µM C3d in 137 mM NaCl (Figures 6.8(c)) are best explained by 
the occurrence of C3d multimerisation in preference to the FH-C3d interaction in this 
buffer.  
Next, the formation of multimeric FH-C3d complexes in physiological buffer 
conditions (137 mM NaCl buffer) was studied in more detail using SCR-16/20 or 
SCR-1/5 fragments with or without C3d as the analyte (Figure 6.10). First, 5 µM of 
C3d and SCR-16/20 were each passed over immobilised FH (Figure 6.10(a)). Each 
protein bound to FH. For SCR-16/20, this was in agreement with the monomer-dimer 
equilibrium for SCR-16/20 shown by AUC (Chapter 4). Next, an equimolar mixture 
of C3d and SCR-16/20 was flowed over immobilised FH (Figure 6.10 (a)). Note that  193
the concentration of each protein in the mixture is reduced by half when compared to 
the unbound proteins in Figure 6.10(a), due to the doubling of the volume on mixing. 
Given the similar molecular weights of both proteins, the total response of this 
mixture would be similar to that of either C3d or SCR-16/20 if the proteins compete 
for binding. The doubling of the response in Figure 6.10(a) therefore indicated the 
formation of a ternary complex (Jokiranta  et al., 2005). As a control, the 
corresponding equimolar mixture of SCR-1/5 and C3d showed a reduction in signal 
response, as expected (Figure 6.10(b)). This shows that SCR-16/20 dimerisation 
occurs even when C3d is bound, in agreement with the observation of multimeric 
species in the AUC data of Figure 6.5.  
Final experiments in 137 mM NaCl HEPES buffer studied two concentrations 
of FH in the presence of increasing amounts of C3d (both proteins in the analyte) and 
using immobilised FH as ligand. Thus C3d in molar ratios ranging from 0:1 to 10:1 
was mixed with native FH at two starting concentrations of 0.08 mg/ml (0.5 µM) and 
0.8 mg/ml (5 µM) (Figure 6.11(a,b)). FH self-associates in a concentration-
dependent manner through at least two sites localised within SCR-6/8 and SCR-
16/20, with the associated forms being more stable at higher FH concentrations 
(Fernando et al., 2007; Chapter 4; Nan et al, 2008a). Because of the approximately 
four-fold mass difference between FH and C3d, a FH-C3d complex will exhibit a 
lower response than a FH-FH dimer. In the absence of C3d, a high response was 
observed to show that FH forms at least some FH-FH dimer and possible higher 
oligomers (Nan et al, 2008a). On addition of an equal volume of C3d to FH in the six 
C3d:FH ratios, the halved FH concentration to 2.5 µM (from 5 µM) and 0.25 µM 
(from 0.5 µM) leads to a decreased response compared to the start of Figures 
6.11(a,b) for reason of reduced FH-FH association. At these two FH concentrations, 
the six responses generally decreased with increased C3d concentration. This was 
more pronounced for 2.5 µM FH (from 100 RU to 79 RU) than 0.25 µM FH (from 
30 RU to 25 RU). This reduction is attributed to the reduced formation of FH-FH 
associated forms as C3d increases. This shows that C3d partially competes with FH-
FH association, although this is more likely to involve higher oligomers given the 
outcome of Figure 6.10(a). As a non-FH binding benchmark, the 2.5 µM FH analyte 
was replaced by 2.5 µM SCR-1/5 in the same C3d titration. This yielded a baseline 
value for the C3d interaction with immobilised FH that increases with C3d   194
 
 
 
Figure 6.9  
Time-resolved SPR analysis of C3d binding to immobilised FH. 
(a) In 50 mM NaCl buffer, 7 µM of C3d analyte was flowed over 
immobilised FH for 15 sec, 30 sec, 60 sec and 120 sec. The data were overlaid at the 
start of the dissociation phase.   
(b) As for (a) but using 137 mM NaCl buffer.  195
  
Figure 6.10   
    SPR analyses of ternary complexes formed between C3d, SCR-16/20 and 
immobilised FH in 137 mM NaCl buffer. Bar charts of the binding response are inset 
for clarity.  
(a) SCR-16/20 and C3d bound to immobilised FH with similar responses, and 
their equimolar mixture showed a doubled response.   
(b) C3d bound to immobilised FH, while SCR-1/5 showed no binding, even 
when both proteins were present as an equimolar mixture.   196
 
Figure 6.11 
SPR analyses of ternary complexes formed between C3d and FH in the 
presence of immobilised FH in 137 mM NaCl buffer. Binding responses are shown 
as bar charts for clarity.  
(a) In the presence of a starting concentration of 0.5 µM FH (0.08 mg/ml), the 
response decreased from 47 to 25 RU as the C3d:FH ratio increased from 0:1 to 10:1.  
(b) In the presence of a starting concentration of 5 µM FH, the response 
decreased from 138 to 79 RU as the C3d:FH ratio increased from 0:1 to 10:1. If FH 
was replaced by SCR-1/5 with a starting concentration of 5 µM, the response is 
much reduced as the C3d:FH ratio increased (hatched bars).   197
concentration (hatched in Figure 6.11(b)). Compared to this baseline, the FH-C3d 
signal is larger than a C3d-only binding event, even at the highest C3d 
concentrations. This shows that the FH analyte binds to immobilised FH even in the 
presence of C3d, in accordance with Figure 6.10(a). The higher signal response of 79 
RU for the 10:1 mixture in Figure 6.11(b) c o m p a r e d  t o  t h a t  o f  3 8  R U  f o r  t h e  
corresponding C3d concentration of 25 µM in Figure 6.8(c) supports this conclusion. 
These experiments support the AUC observations of multimeric FH-C3d complexes 
in 137 mM NaCl (Figures 6.6(b); 6.7).  
 
(6.2.5) X-ray scattering data of the SCR-16/20 complex with C3d 
Solution scattering is a diffraction technique that studies the overall structure 
of biological macromolecules in solution (Perkins et al., 2008). The C3d-SCR-16/20 
complexes were analysed by synchrotron X-ray scattering. Time frame analyses 
showed that the X-ray radii of gyration (RG) were affected by minor radiation 
damage only by the longest exposure times of 0.5 sec per frame. To eliminate these 
effects, data were therefore collected using a flow cell with ten exposures of 0.1 
sec/frame, and the ten time frames were averaged to improve the signal-noise ratio. 
In Guinier analyses of ln I(Q) vs. Q
2 to determine the RG (a measure of elongation)  
and the intensity of forward scattering I(0)/c (a measure of molecular weight; c = 
concentration), the fits were linear within satisfactory Q.RG  limits (Q = 4 π sin 
θ /λ; 2θ = scattering angle; λ = wavelength) (Figure 6.12). This indicates the 
monodispersity of the proteins and the absence of non-specific aggregates. SCR-
16/20 at 1.0 mg/ml was titrated with C3d at six molar ratios of 0.3:1, 0.6:1, 1:1, 
1.5:1, 2:1 and 3:1 in 50 mM NaCl HEPES buffer (Figures 6.12; 6.13). Unbound 
SCR-16/20 and C3d were used as controls (Gilbert et al., 2005; Chapter 4). In the 
titration, the I(0)/c values decreased linearly from 0.0237 (± 0.0007) for unbound 
SCR-16/20 to 0.0167 (± 0.0002) for the mixture at a molar ratio of 3:1 (not shown). 
This decrease is consistent with weak complex formation between SCR-16/20 and 
C3d.  
The analysis of changes in the RG  values indicated complex formation. 
Unbound SCR-16/20 had a mean RG value of 8.05 (± 0.36) nm (4 determinations), in 
good agreement with the RG of 8.09 ± 0.21 nm for its dimeric form between 0.7-1.2 
mg/ml in 137 mM NaCl PBS buffer (Chapter 4). Unbound C3d showed a 
concentration-dependent increase in its RG value from 1.8 nm to 3.5 nm,   198
 
Figure 6.12 
X-ray Guinier RG analyses for SCR-16/20 and C3d mixtures in 50 mM NaCl 
HEPES buffer. The SCR-16/20 concentration is 1.0 mg/ml. From bottom to top, the 
molar ratios of C3d: SCR-16/20 are 0:1, 0.3:1, 0.6:1, 1:1, 1.5:1 and 3:1. The Guinier 
RG plots are displaced vertically for clarity. The filled circles between the arrowed 
Q.RG ranges correspond to the RG fits using a Q range of 0.09-0.14 nm
-1. The straight 
line corresponds to the best fit through the filled circles.   199
 corresponding to its monomeric, dimeric and trimeric forms (Gilbert et al., 2005; Li 
et al., 2008). In the titration using 50 mM NaCl buffer, the mean RG value increased 
from 8.05 (± 0.36) nm (ratio of 0:1 C3d:SCR-16/20) and 8.26 (± 0.25) nm (ratio of 
0.3:1) to 8.54 (± 0.12) nm (ratio of 1.5:1), after which it decreased to 8.10 (± 0.10) 
nm (ratio of 3:1) (Figure 6.12). The increases indicated complex formation. In the 
titration with 137 mM NaCl PBS buffer, the RG value of the 1:1 mixture was lower at 
6.89 (± 0.26) nm (3 values), and corresponds to the weighted sum of the RG values 
for unbound monomeric and dimeric SCR-16/20 and monomeric C3d (Perkins et al., 
1985). This shows that complex formation is much reduced in 137 mM NaCl buffer.  
The distance distribution function P(r) calculated from the full I(Q) curve 
(Section 6.4.4) allows the determination of overall lengths following the assumption 
of the value of the maximum dimension L (Figure 6.13). The P(r) curve provides an 
independent verification of the Guinier RG values and this gave 8.33 (± 0.05) nm for 
unbound SCR-16/20. This is comparable with that of 8.05 (± 0.36) nm from the 
Guinier analysis, showing that the P(r)  curves refer to the macromolecule being 
studied. In the titration with C3d, RG values that increased from 8.32 nm to 8.88 nm 
were obtained again. The maximum macromolecular dimension L was determined 
from the value of r when P(r) = 0 at large r. The L value for unbound SCR-16/20 in 
50 mM NaCl was 29 nm (Figure 6.13(a)), again similar to that of 27 nm in 137 mM 
NaCl (Chapter 4). Even though the P(r) analyses were not precise at large r value, 
the L values for all molar ratios for the complex ranged between 30 to 33 nm (Figure 
6.13(a)). This shows that no major conformational change had occurred on complex 
formation. Since the maximum length of C3d from its crystal structure is measured 
to be 7 nm, the lack of change from the unbound L value of 27-29 nm for the 
mixtures shows that C3d is incorporated within the length of dimeric SCR-16/20 in 
its complex. An end-to-end arrangement with SCR-16/20 would have increased the 
overall length, but this was not observed. As it is known that C3d binds to SCR-20 
(Jokiranta et al., 2000; Hellwage et al., 2002), the lack of change in the L value 
suggests that the SCR-16/20 dimer is formed by contacts between the two SCR-20 
domains, and not between the two SCR-16 domains. The location of the dimer site 
could not be determined previously (Chapter 4). 
Changes in the P(r) curves demonstrated the occurrence of complex 
formation (Figure 6.13(a)). The maximum M corresponds to commonly occurring 
interatomic distances within the structure. Peak M1 with r = 3.3 nm is unique and   200
 
Figure 6.13 
X-ray distance distribution functions P(r) for SCR-16/20 and C3d mixtures. The 
SCR-16/20 concentration is 1.0 mg/ml.  
(a) X-ray distance distribution functions for five of the analyses in Figure 6.12. The 
curves are shown as dashed and full lines for clarity. The maxima M1, M2 and M3 represent 
commonly occurring distances within the macromolecules, and were 2.8 nm, 5.5 nm and 6.6 
nm in that order. The maximum dimension is denoted by L and was 30 nm in all cases.  
(b) Comparison of the P(r) curves for unbound SCR-16/20 and C3d with their 1:1 
mixtures in 50 mM NaCl HEPES and 137 mM NaCl PBS buffers. The intensities of M1 and 
M2 for the two unbound proteins were set equal for clarity, and their sum is labelled 1+1 
(dashed line). The P(r) curves in 50 mM NaCl HEPES and 137 mM NaCl PBS buffers are 
denoted by full lines. The maximum of the latter three P(r) curves at r = 3 nm were set equal 
for clarity.  201
corresponds to unbound C3d (Gilbert et al, 2005). Peak M1 was visible in mixtures 
with molar ratios from 0.6:1 to 3:1, indicating that unbound C3d was present and that 
weak complex formation has occurred in these mixtures (Figure 6.13(a)). Peak M2 
with r = 5.5 nm corresponds to the unbound SCR-16/20 dimer (Chapter 4). Peak M2 
weakened during the titration. In 50 mM NaCl, peak M3 with r = 6.6 nm indicates 
complex formation, because this peak was not seen for unbound C3d or SCR-16/20 
(Figure 6.13(b)). In 137 mM NaCl, peak M3 was not visible, showing that complex 
formation had been reduced. The 50 mM and 137 mM NaCl P(r) curves can be 
compared with the sum of the unbound C3d and SCR-16/20 P(r) curves (1+1 in 
Figure 6.13(b)). The intensities in the P(r) curve increased more for 50 mM NaCl 
than for 137 mM NaCl for r values above 7 nm. This agrees with the greater complex 
formation in 50 mM NaCl compared to 137 mM NaCl.  
 
(6.2.6) Molecular modelling of SCR-16/20 complexes with C3d 
Constrained modelling was performed in order to provide insight into the s
0
20,w values observed in the AUC titrations. The constraints were the crystal structure 
of C3d (Nagar et al., 1998) and the best-fit model for the SCR-16/20 dimer (Chapter 
4). C3d and SCR-16/20 were assumed to form only symmetric dimers in its 
complexes with SCR-16/20. The calculation of sedimentation coefficients for Peaks 
1-5 gave reasonable agreements for these five molecular species to within 0.3 S, and 
the f/fo ratios ranged between 1.1 and 2.0 (Table 6.1(a)). For the additional peaks 6-8, 
it was assumed that C3d interacted with SCR-20, and that no conformational change 
occurs in SCR-16/20 during complex formation. This C3d location is similar to two 
alternative hypothetical docking models for SCR-20 and C3d, in which C3d was 
located at one side of SCR-20 near its C-terminal tip (Jokiranta et al., 2006; Herbert 
et al., 2006). A range of stoichiometries was explored.  
The simplest scheme was based on equimolar stoichiometries of 1:1, 2:2, 4:4, 
6:6 and 8:8 (Figure 6.14). If peaks 4 to 8 were assigned to these, the comparison 
between the pairs of experimental and mean predicted s
0
20,w values were respectively 
in reasonable agreement with each other at 4.3 S and 3.6 S (1:1 complex), 5.6 S and 
5.4 S (2:2 complex), 6.2-8.4 S and 8.0 S (4:4 complex), 9.9-10.7 S and 9.8 S (6:6 
complex), and 11.9-12.7 S and 11.7 S (8:8 complex) (Table 6.1(b)). The comparison 
between the calculated and the mean predicted f/fo ratios likewise gave reasonable 
agreements at 1.33 and 1.56 (1:1), 1.61 and 1.65 (2:2), 1.68 and 1.77 (4:4), 1.75 and  202
 
Figure 6.14  
Molecular models for unbound SCR-16/20 and C3d and their complexes. C3d 
is shown in red and bound to SCR-20, and SCR-16/20 is shown in green and blue. 
(a) Unbound proteins; (b) Models for their putative 1:1, 2:2 and 4:4 complexes. The 
6:6 and 8:8 complexes noted in Table 1 were constructed in a similar manner to that 
of the 2:2 and 4:4 complexes.  203
 
Figure 6.15 
X-ray scattering fits for SCR-16/20 and its C3d complex.  
(a) The X-ray curve for SCR-16/20 was fitted to 80% monomer and 20% 
dimer to follow Figure 6.14. The Q  range for the RG  analyses is denoted by a 
horizontal bar. The inset shows the comparison of the modelled (dashed) and 
experimental (full) P(r) curves. 
(b) The X-ray curve fit for a 0.3:1 mixture of C3d and SCR-16/20 was 
achieved assuming 10% of a 1:1 complex, 7% of a 2:2 complex, 7% of a 4:4 
complex, and 3% of a 6:6 complex to follow Figure 6.14.    204
Table 6.1.  Sedimentation coefficient data and their modelling   
 
 
                                                 
a The first value is calculated from the sphere model using HYDRO; the second is calculated from the coordinate model using HYDROPRO.   
b These putative values are calculated assuming each peak represents a single sedimenting species. 
  Observed  
s
0
20,w (S) 
Modelled  
s
0
20,w (S)
a  
Hydrated 
spheres 
f/fo (observed) 
b  f/fo (model) 
(a)  Unbound  proteins       
SCR-16/20 monomer (Peak 
1) 
2.69   2.29, 2.17  446  1.35  1.69-1.78 
C3d monomer (Peak 2)  2.99 ± 0.08  3.14, 2.91  330  1.00  1.01-1.10 
SCR-16/20 dimer (Peak 3)  3.30   3.20, 3.06  857  1.58  1.92-2.00 
C3d dimer   (Peak 4)  4.25 ± 0.07  4.67, 4.54  654    1.08-1.11 
C3d trimer   (Peak 5)  5.55 ± 0.12  5.88, 5.78  970    1.13-1.15 
(b)  Putative  complexes       
1:1 complex (Peak 4)  4.25 ± 0.07  3.73, 3.49   772  1.33  1.51-1.61 
2:2 complex (Peak 5)  5.55 ± 0.12  5.59, 5.29   1565  1.61  1.60-1.69 
4:4 complex (Peak 6)  6.23 – 8.43  n.a , 8.03  3005  1.68  1.77 
6:6 complex (Peak 7)  9.93 – 10.66  n.a , 9.75   4662  1.75  1.91 
8:8 complex (Peak 8)  11.90 – 12.66  n.a , 11.71  6098  1.86  1.93  205
1.91 (6:6), and 1.86 and 1.93 (8:8) (Table 6.1). While no unambiguous peak 
assignments could be made, and while it is stressed that the modelling assumed that 
peaks 4 to 8 correspond to molecular species and not to reaction boundaries, the 
calculation indicate that a range of multimeric complexes may account for the 
appearance of additional peaks in the c(s) fits of Figure 6.5.  
Constrained modelling also provided insight into the X-ray scattering analyses. The 
overall length of the SCR-16/20 complexes was not greatly increased in the C3d 
titration (Figure 6.13(a)). In agreement with this, the overall length of 25 nm for the 
model of the SCR-16/20 dimer was only slightly increased to 29 nm for the model of 
the 6:6 complex. Scattering curve fits for the unbound SCR-16/20 monomer and 
dimer at 1.0 mg/ml was best achieved with a composition of 20% monomer: 80% 
dimer, giving a low goodness of fit R-factor of 4.9 % (Figure 6.15(a)). The scattering 
curve fits for the 0.3:1 molar ratio assumed that all the C3d was bound to SCR-16/20. 
The relative proportion of unbound SCR-16/20 monomer and dimer was taken to be 
9% and 36% respectively, and that for the 1:1, 2:2, 4:4 and 6:6 complexes was taken 
to be 20%, 14%, 14% and 6% in that order from integration of the c(s) fits. The 
weighted summation of the scattering curves from this resulted in a low R-factor of 
4.2 % in the curve fit (Figure 6.15(b)). While the agreement of the experimental and 
predicted RG values were not close, the achievement of these X-ray fits indicated that 
a mixture of multimeric species was likely to be present.  
 
(6.3) Conclusions  
This study of the interaction of the major complement regulator FH with C3d, 
a functionally relevant cleavage fragment of C3b, has revealed unexpected 
multimerisation properties. Multimerisation can be significant, in that oligomer 
formation can enhance or inhibit protein-protein interactions during complement 
activation. In this context, FH can be either immobilised on the host cell surface or in 
fluid phase as an abundant soluble plasma protein. One major feature of this study is 
that physiologically-appropriate protein concentrations were studied in 137 mM 
NaCl buffer. FH plasma concentrations range between 0.235 and 0.810 mg/ml (1.6 
µM to 5.4 µM) (Saunders et al., 2007). At these concentrations, an estimated 5% to 
15% of FH will be dimeric, if no other factors require consideration (Nan et al., 
2008a). The molar equivalent physiological concentration of SCR-16/20 would be 
between 0.06 and 0.2 mg/ml.  The normal C3 concentration range in plasma is  206
between 1 and 1.5 mg/ml (6.3 µM to 7.9 µM)  (Law & Reid, 1995; Morley & 
Walport, 2000). If all the C3 is fully cleaved, the maximum C3d concentration would 
be 0.27 mg/ml (7.9 µM). However, as C3 is an acute-phase reactant, its concentration 
can potentially increase much more during inflammation, and any localised 
production of C3 could also result in high C3 concentrations at inflammatory sites. 
The other major feature of this study is the use of both 50 mM NaCl and 137 mM 
NaCl buffers. The studies in 50 mM NaCl produce comparatively strong binding 
effects, but these are much reduced in physiological 137 mM NaCl. Using both AUC 
and SPR, studies using 50 mM NaCl show whether or not any interaction occurs, and 
studies in 137 mM NaCl show whether or not these are biologically significant. In 
this study, observations of FH-C3d multimers occur in physiologically-relevant 
concentration ranges in a physiological 137 mM NaCl buffer. 
The SCR-16/20 multimeric interaction with C3d was identified by a 
combination of size-exclusion chromatography, AUC, SPR, X-ray scattering and 
molecular modelling. Size-exclusion chromatography identified the occurrence of 
complex formation in 50 mM NaCl buffer but less so in 137 mM NaCl, however this 
is a qualitative method (Figure 6.2). In distinction, multimerisation events were more 
clearly detected by AUC. While it was not possible to distinguish between the 
observation of distinct multimeric species or reaction boundaries from the 
appearance of peaks 6, 7 and 8 (Figure 6.5), AUC clearly showed that a simple 1:1 
complex cannot account for the interaction between SCR-16/20 and C3d. The 
binding is weak in 50 mM NaCl, and is weaker but observable in physiological 137 
mM NaCl (Figures 6.5; 6.6(a)). Structural modelling showed no indication of large 
conformational changes when SCR-16/20 binds to C3d. This is because the s
0
20,w 
values of the putative complexes could be replicated starting from previously-
determined structures for unbound SCR-16/20 and C3d (Table 6.1). Thus there is no 
indication of any allosteric mechanism involving conformational changes upon C3d 
binding to FH. Further insight was obtained from SPR studies using immobilised FH, 
where ternary complex formation between C3d, SCR-16/20 and FH was detectable, 
i.e. this was not limited to a 1:1 complex (Figure 6.10(a)). X-ray scattering also 
showed that complex formation was detectable from the observed large alterations in 
the P(r) curves for the mixtures of C3d and SCR-16/20 when compared to the two 
proteins on their own (Figures 6.13(a,b)). The changes were seen in both 50 mM 
NaCl and 137 mM NaCl (Figure 6.13(b)). By X-rays, the existence of multimeric  207
C3d and SCR-16/20 complexes in 50 mM NaCl was also revealed by the inability to 
fit the scattering curve according to a 1:1 model. Instead, the use of multimeric 
complexes offered a much improved fit, although the nature of these multimers could 
not be unambiguously determined (Figure 6.15(b)).  
The multimeric interaction between native FH and C3d was identified using 
AUC and SPR. AUC revealed weak complex formation for FH-C3d in both 50 mM 
and 137 mM NaCl (Figures 6.6(b) and 6.7). The stronger association in 50 mM NaCl 
is in agreement with the results for SCR-16/20. However the complexity of the 
changes seen in the c(s) plots do not permit a simple interpretation. This aspect was 
clarified by SPR studies of C3d binding to immobilised FH, in which KD fits could 
not be achieved with a 1:1 binding model for FH-C3d. As the C3d concentration 
increased, the amount of C3d bound to FH in both 50 mM NaCl and 137 mM NaCl 
increased beyond that expected from a 1:1 interaction (Figure 6.8(b,c)). This 
indicated a multimeric interaction. The strength of this binding was again weaker in 
137 mM NaCl compared to 50 mM NaCl.  
The multimeric interaction between native FH and C3d was identified using 
AUC and SPR. AUC revealed weak complex formation for FH-C3d in both 50 mM 
and 137 mM NaCl. The stronger association in 50 mM NaCl is in agreement with the 
results for SCR-16/20 (Figures 6.6(b) and 6.7). However the complexity of the 
changes seen in the c(s) plots do not permit a simple interpretation. This aspect was 
clarified by SPR studies of C3d binding to immobilised FH, in which KD fits could 
not be achieved with a 1:1 binding model for FH-C3d. As the C3d concentration 
increased, the amount of C3d bound to FH in both 50 mM NaCl and 137 mM NaCl 
increased beyond that expected from a 1:1 interaction (Figure 6.8(b,c)). This 
indicated a multimeric interaction. The strength of this binding was again weaker in 
137 mM NaCl compared to 50 mM NaCl. 
The SCR-16/20 self-dimerisation site is independent of the SCR-16/20 
binding site for C3d. Size-exclusion chromatography showed that the monomer and 
dimer peaks for SCR-16/20 were still observed, even in the presence of C3d (Figure 
6.2(b)). AUC showed that the relative sizes of the double c(s) peaks for the monomer 
and dimer of SCR-16/20 were unchanged in the presence of C3d (Figure 6.5).  By 
SPR, the binding of C3d and SCR-16/20 to immobilised FH are seen to occur as 
independent events (Figure 6.10(a)). The self-association of FH to form dimers and 
higher oligomers is likewise not significantly perturbed by C3d binding. By AUC,  208
the c(s) peaks for these FH oligomers were still mostly observed in the presence of 
C3d, even though their positions and intensities altered (Figure 6.6). By SPR, FH is 
seen to self-associate with immobilised FH, and the addition of increasing amounts 
of C3d did not eliminate this (Figure 6.11).  
The observation of FH-C3d multimers in both the solution and surface phases 
using physiologically-relevant concentrations and buffers adds another layer of 
complexity to the mechanism of complement activation and control. Unbound FH 
has often been considered to be a monomer in plasma (Sim & DiScipio, 1982; 
DiScipio, 1992). Dimeric forms of FH have however been identified (Jokiranta et al., 
2000, 2006; Oppermann et al., 2006; Perkins et al., 1991). Weak dimerisation sites 
have been found in each of the SCR-6/8 and SCR-16/20 fragments but not in the 
SCR-1/5 fragment  (Fernando  et al., 2007; Chapter 4) and this observation was 
confirmed here using FH, SCR-1/5 and SCR-16/20 by SPR experiments (Figure 
6.10). The presence of multiple self-association sites explains the ability of FH to 
form a series of higher oligomers at concentrations above 1 mg/ml  (Nan  et al., 
2008a; Perkins et al., 1991). Unbound C3 itself is also usually considered to be 
monomeric, with the exception of its disulphide-linked dimers (Perkins & Sim, 
1986). In 50 mM NaCl, unbound C3d exhibits monomer, dimer and trimer forms 
above 2.8 mg/ml (80 µM), while in 137 mM NaCl, only the C3d monomer is 
observed (Gilbert et al., 2005; Li et al., 2008). The KD values of 16 µM for SCR-
16/20 dimerisation and 360 µM for C3d dimerisation show that FH dimerisation 
takes priority over C3d dimerisation in 50 mM NaCl (Chapter 4; Li et al., 2008). 
These multimers will complicate structural studies of complexes between SCR-20 
and C3d by NMR or crystallographic approaches, as these methods require high 
protein concentrations.  
The observations for SCR-16/20 in 50 mM NaCl are most simply explained 
by the formation of an indefinite series of complexes of alternating dimers of C3d 
and SCR-16/20 as suggested from the AUC and scattering modelling (Figure 6.14). 
The interaction sites that lead to these complexes are independent of each other. 
These multimers are formed more weakly in 137 mM NaCl with possible 
stoichimetries of 1:1, 2:1 or 2:2, because C3d does not form oligomers in this buffer. 
The observations of FH and C3d multimers in 50 mM NaCl are likewise most simply 
explained by the existence of FH oligomers, where each FH monomer is able to bind 
at least one C3d monomer or C3d dimer in addition to the formation of FH  209
oligomers. In 137 mM NaCl, these form more weakly. Three previous SPR studies 
did not report multimeric species of FH and C3d complexes (Hellwage et al., 2002; 
Manuelian et al., 2003; Jokiranta et al., 2005). This is attributable to (i) the use of 
low FH concentrations of either 2-3 µg/ml, 100-125 µg/ml or 100-150 µg/ml, that are 
much less than the physiological range of 235-810 µg/ml, and (ii) the immobilisation 
of C3d on the chip. Both factors would reduce or eliminate FH or C3d dimerisation. 
Interestingly, the formation of C3d dimer and trimer in 50 mM NaCl is inhibited by 
the complex formed with SCR-1/2 of CR2 (Gilbert et al., 2005; Li et al., 2008). This 
indicates that the C3d surfaces that interact with FH and CR2 are distinct.   
The ionic strength dependence of the SCR-16/20-C3d and FH-C3d 
interaction is explained by the overall negative charge of C3d and the overall positive 
charge of SCR-20. C3d binding to CR2 also shows a strong ionic strength 
dependence (Li et al., 2008). Radioactivity assays in 150 mM NaCl indicated that 
dimeric or oligomeric C3b may form multimeric interactions with CR1, and these 
interactions were found to be ionic strength dependent (Arnaout et al., 1983). Hence 
the ionic strength dependence of the interactions between C3 and the complement 
regulatory proteins appears to be a general phenomenon. Other FH-C3d studies also 
report similar observations, but did not compare the use of 50-75 mM NaCl buffers 
with 137 mM NaCl buffers. SPR showed that immobilised C3d did not bind in 75 
mM NaCl to a recombinant SCR-15/20 fragment with the SCR-20 substitutions 
R1203E, R1206E, R1210S, K1230S and R1231A in 75 mM NaCl (Hellwage et al., 
2002;  Table 6.2).  Similarly, an SCR-8/20 fragment with two aHUS mutations 
R1210C or R1215G in SCR-20 showed reduced binding to immobilised C3d 
(Manuelian et al., 2003; Table 6.2). The crystal structures for SCR-19/20 and C3d 
have been used to predict ion-pairs that included residues E1032, R1042, E1047 and 
K1264 in C3d and residues R1182, K1186, K1188, E1198 and R1215 at the tip of 
SCR-20 (Jokiranta et al., 2006). Solution studies that utilise low salt buffer (50 mM 
NaCl) and high protein concentrations in equimolar conditions (ca: 1 mg/ml or 25 
µM) amplify the molecular interactions seen between FH and C3d. This accounts for 
the use of 50-75 mM NaCl buffers in previous SPR studies (Hellwage et al., 2002; 
Manuelian et al., 2003; Jokiranta et al., 2005; Table 6.3). However observations of 
binding using both AUC in the solution phase and SPR at a surface in physiological 
137 mM NaCl buffer in this thesis confirm the biological relevance of these 
interactions. The observation of multimeric complexes between 1 mg/ml native FH  210
with 0.3 mg/ml C3d in 137 mM NaCl PBS buffer occurs in conditions close to 
physiological (Figure 6.6(b)).  
The multimeric SCR-16/20 and C3d interaction provides a fresh insight into 
the mechanism of C3b regulation by FH. Predominantly monomeric FH together 
with 5-15% of dimeric and oligomeric FH circulate in plasma (Nan et al., 2008a). FH 
recognizes the anionic cell surface glycans (glycosaminoglycans and sialic acids) 
decorating all host cells which present heparin-like structures, but not pathogenic 
bacteria on which these are absent. This initial contact of FH with host cells is via 
SCR-20 (Figure 6.16(a)), followed by N-terminal regulatory activity, and this 
mechanism is the main focus of the recent literature (Oppermann  et al., 2006; 
Ferreira et al., 2006). The steady tick-over activation of C3 to C3b means that C3b 
activation requires continuous control in the host, as C3b can bind indiscriminately to 
any cell surface and could, if unregulated, trigger a rapid and uncontrolled 
inflammatory response. The degradation of cell surface-bound C3b to C3c and C3dg 
by FH and factor I will leave the host cell surface decorated by C3d covalently linked 
through its thioester (Figure 6.16(b)). Surface-bound C3d on host cells will present a 
FH binding site, and this FH-C3d binding will complement the binding of FH to 
heparin analogues on host cells (Figure 6.16(c)), but not on microbial pathogens. 
Weak FH dimerisation will potentially maximise FH localisation and complement 
regulation on host cells.  
Furthermore, under inflammatory conditions where high rates of complement 
activation occur, the observation of FH-C3d multimers offers a mechanism for a 
further increase in host cell protection, as increased amounts of fluid-phase or 
surface-bound C3d will lead to the formation of higher multimers of FH-C3d 
complexes on host cell surfaces (Figure 6.6(b)). The binding of these multimeric FH-
C3d complexes to host cells will afford a greater level of protection to the host 
through the increased concentration of the regulatory FH N-terminal SCR domains at 
the host cell surface (Figure 6.16(d)). These observations provide further insight into 
the pathogenic mechanisms underlying aHUS. aHUS mutations occur mostly 
between SCR-16 and SCR-20 and generally lead to dysfunctional FH molecules 
(Saunders  et al., 2007). Mutations in SCR-20 that affect either C3d or heparin 
binding or FH dimerisation will directly lead to the impaired protection of host cells. 
The occurrence of further mutations between SCR-16 to SCR-19 may correspond to  211
the need for these residues to orientate correctly FH on the host cell surface in order 
to bind to surface-bound C3b in order to degrade this.  
 
(6.4) Materials and Methods 
(6.4.1) Protein expression and purification 
SCR-16/20 and SCR-1/5 were expressed as hexaHis-tagged products in Pichia 
pastoris and purified using nickel affinity chromatography (Chapter 4). Native FH 
was purified from just-outdated pooled plasma using MRC-OX23 affinity 
chromatography and used while freshly purified to minimise the occurrence of FH 
aggregates (Sim et al., 1993; Nan et al., 2008a; 2008b; Chapter 5). Human C3d 
(sequence 994-AVDAE… to …QLPSR-1303 of the mature protein C3 with 
SWISSPROT accession code P01024) containing the free cysteine of the thioester 
was expressed in Escherichia coli BL21 transformed with the PGEX-2T vector, as 
provided by Prof. V. M. Holers and Dr. J. P. Hannan of the University of Colorado 
School of Medicine, Denver, Colorado, USA. Expression and purification were 
carried out in conjunction with Miss Keying Li (Li et al, 2008) as described below.  
Ampicillin-resistant colonies were used to produce starter cultures, which 
were then expanded to five litres and grown at 37°C until an absorbance at 600 nm of 
0.3 was attained, then cooled to 23°C and incubated to an absorbance of 0.4. Samples 
were then induced with 0.5 mM IPTG and shaken overnight at 25°C. The culture was 
lysed in the presence of protease inhibitors by sonication, and after clarification 
applied to a GSTrap FF column equilibrated in 25 mM Tris, 0.5 M NaCl, 1 mM 
EDTA, 1 mM DTT, pH 8.0. After washing to remove unbound protein, thrombin was 
added to the column. After an overnight incubation at 4ºC, the thrombin was inactivated 
and the cleaved C3d was eluted by further washing. Reduced glutathione was added to 
the buffer in further washes to elute GST and uncleaved GST-C3d. The C3d was 
concentrated using Amicon® Ultra-15 centrifugal filter devices with a molecular mass 
cut-off of 10 kDa at 4500 g, and size exclusion chromatography using a Superdex-200 
Prep Grade XK 16/60 column resulted in the C3d samples used for data acquisition 
Briefly, the C3d-GST cell supernatant was passed over a GSTrap FF column, 
followed by cleavage using thrombin and size-exclusion chromatography using a 
Superdex 200 prep grade XK 16/60 column (Figure 6.2). The purified proteins were 
stable upon storage at 4
oC. Experiments were performed using either 10 mM HEPES  212
 
 
Figure 6.16           
Schematic cartoons of FH multimer binding to cell surfaces in the presence of 
surface-bound C3d and heparin-like analogues. (a) Monomeric FH is bound via SCR-20 via 
anionic oligosaccharides to the host cell, together with C3b covalently bound through its 
thioester to the host cell. Small amounts of dimeric FH are also present. (b) FH degrades 
surface-bound C3b through factor I cleavage to leave C3d bound to the host cell surface. 
SCR-7 also binds to anionic oligosaccharides. (c) FH forms a 1:1 complex with host cell-
bound C3d. (d) A schematic multimeric 4:4 complex of FH:C3d illustrates how high 
amounts of soluble and cell-bound C3d will lead to FH multimerisation on the host cell 
surface, thereby enhancing the protection of the host cell.    213
Table 6.2. Electrostatics of FH-C3d interactions 
 
 
 
                                                 
* Mutation often found in familial HUS. 
FH protein   Ligand   Conditions  Effect  Reference/ Method 
SCR-15/20  C3d  One mutant protein (all residues on 
SCR-20): R1203E, R1206E, 
R1210S*, K1230S, R1231A 
Mutant showed much reduced binding to C3d. While 
KD of wild-type binding was 0.09 µM, it was 
impossible to calculate rate constants for the mutant 
under the same conditions because binding was too 
weak to obtain reliable results. Half-life of the complex 
was reduced to 34.2% of that for wild-type complex.  
Hellwage et al., 2002/ 
SPR  
SCR-8/20  C3d  Two mutant proteins  (all residues on 
SCR-20): 1) R1210C
*,  2) R1215G*  
Weak binding of mutants to C3d.  Manuelian et al., 
2003/ SPR   214
Table 6.3.  Ionic strength conditions used for C3 binding studies 
                                                 
* Used an ionic strength titration series between high and low NaCl conditions; ** HEL – Hen egg lysozyme; C3d1-3 – C3d monomers to trimers; *** For C3d 
binding to the specified fragment of FH. 
C3 protein   Ligand  Buffer  Experimental KD  Reference 
Low NaCl (~50 mM)         
C3b  CR1  5 mM Veronal, 50 mM NaCl    Arnaout et al., 1983
* 
C3b  FH  2.5 mM Veronal, 70 mM NaCl    Sharma & Pangburn, 1996 
C3b  FHR-3, FHR-4  1.7 mM Veronal, 50 mM NaCl  0.13-0.34 µM  Hellwage et al., 1999 
C3d  FH, FHR-3, FHR-4  1.7 mM Veronal, 50 mM NaCl  0.09-0.36 µM  Hellwage et al., 1999 
C3b  FH  1.7 mM Veronal, 50 mM NaCl    Jokiranta et al., 2000 
C3b, C3c, C3d  Factor B, FH, C5, sCR1  1.7 mM Veronal, 50 mM NaCl   Jokiranta et al., 2001 
C3b, C3d  FH, SCR-15/20  5 mM Veronal, 75 mM NaCl  0.09 µM***  Hellwage et al., 2002 
C3d  FH  7.5 mM Veronal, 68 mM NaCl   Jokiranta et al., 2005 
C3b   FH  2.5 mM Veronal, 70 mM NaCl    Ferreira et al., 2006 
C3d  CR2  10 mM HEPES, 50 mM NaCl  < 0.28 µM  Li et al., 2008 
C3d  FH  10 mM HEPES, 50 mM NaCl  1.0 µM***  Present study  
High NaCl (> 100 mM)        
C3b  CR1  5 mM Veronal, 150 mM NaCl    Arnaout et al., 1983* 
C3b  FH  10 mM Phosphate, 137 mM NaCl    Lambris et al., 1988 
C3d1-3-HEL**  CR2  10 mM Phosphate, 137 mM NaCl    Dempsey et al., 1996 
C3b  FH  10 mM Phosphate, 137 mM NaCl    Manuelian et al., 2003 
C3b, C3dg  IgG  4.6 mM Veronal, 150 mM NaCl    Jelezarova et al., 2003 
C3b  FH  10 mM Phosphate, 137 mM NaCl    Opermann et al., 2006 
C3d  CR2  10 mM Phosphate, 137 mM NaCl  > 6.9 µM  Li et al., 2008 
C3d  FH  10 mM Phosphate, 137 mM NaCl  2.6 µM***  Present study  215
50-137 mM NaCl, pH 7.4 or Dulbecco’s phosphate buffered saline (137 mM NaCl, 
2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.3). Compositional data for 
the data analyses are reported elsewhere (Perkins, 1986). SCR-16/20 is assumed to 
be glycosylated at either of two putative sites in SCR-17 and SCR-18, while C3d is 
unglycosylated (Figure 6.1). In summary, SCR-16/20 has a calculated molecular 
weight of 39.7 kDa, an unhydrated volume of 50.1 nm
3, a hydrated volume of 66.3 
nm
3, a partial specific volume v of 0.719 ml/g, and a 280 nm absorption coefficient 
(1%, 1 cm path length) of 15.7 (Chapter 4). Native FH has a calculated molecular 
weight of 150.0 kDa (assuming six N-linked oligosaccharide chains), an unhydrated 
volume of 188.4 nm
3, a hydrated volume of 249.7 nm
3, a partial specific volume v of 
0.717 ml/g, and a 280 nm absorption coefficient (1%, 1 cm path length) of 16.7 
(Aslam & Perkins, 2001). While the recent mass spectroscopic study of FH revealed 
eight N-linked predominantly biantennary oligosaccharides, the compositional 
parameters are minimally affected by this (Fenaille  et al., 2007). C3d has a 
calculated molecular weight of 34.6 kDa, an unhydrated volume of 45.5 nm
3, a 
hydrated volume of 59.6 nm
3, a v of 0.746 ml/g, and an absorption coefficient of 
13.1. The HEPES and PBS buffer densities were measured as 1.00139 g/ml and 
1.00534 g/ml at 20
oC using an Anton-Paar DMA 5000 density meter.  
 
(6.4.2) Analytical ultracentrifugation data and analysis  
(6.4.2.1) Sedimentation velocity data for C3d and its complexes with Factor H 
and SCR-16/20  
Sedimentation velocity data were acquired on two Beckman XL-I instruments 
with AnTi50 or AnTi60 rotors at 20
oC at a rotor speed of 50,000 r.p.m. in two-sector 
cells with column heights of 12 mm. The SCR-16/20 and FH concentrations were 
held fixed at 1.0 mg/ml, into which C3d was added at molar ratios of 0:1, 0.3:1, 
0.6:1, 1:1, 1.5:1, 2:1 and 3:1 in 10 mM HEPES buffer (50 mM NaCl), and a molar 
ratio of 1:1 in PBS buffer (137 mM NaCl). Analyses to determine sedimentation 
coefficients s
0
20,w were performed using direct boundary Lamm fits of up to 300 scans 
for size-distribution analyses c(s) in SEDFIT (version 11.0) that assumed that all 
species have the same frictional ratio f/fo ( Schuck, 1998; 2000). The c(s) fits 
employed a resolution of 200 and were optimised by floating the frictional ratio and 
baseline until the overall root mean square deviations and visual appearance of the  216
fits were satisfactory (Figures 6.5 and 6.7). Other analyses utilised the c(s,f/fo) model 
to allow for variable frictional ratios and permit more accurate molecular weight 
determinations. 
 
(6.4.2.2) Sedimentation equilibrium data for C3d 
Sedimentation equilibrium experiments resulted in molecular weight and 
dissociation constant KD determinations. C3d data were obtained in PBS and HEPES 
buffers at 20ºC over 30 h at each speed using six-sector cells with column heights of 
2 mm and rotor speeds of 19k r.p.m., 24k r.p.m., 28k r.p.m., 30k r.p.m. and 35k 
r.p.m. Experiments in PBS were performed by Miss Keying Li (Li et al., 2008). The 
existence of equilibrium conditions after at least 10 h in PBS buffer and at the lowest 
concentrations and after at least 30 h at the highest concentrations in HEPES buffer 
was confirmed using overlays of runs measured at 3 h intervals in SEDFIT. In PBS 
buffer, nine concentrations between 0.04 mg/ml to 7.01 mg/ml were used, while in 
HEPES buffer, nine concentrations between 0.11 mg/ml to 5.50 mg/ml were used. 
Data analyses utilised SEDPHAT version 5.01 (Schuck, 2003). First, multispeed fits 
assuming a single species were performed individually. Next, the best interference 
optics fits from 19k r.p.m., 28k r.p.m., and 35k r.p.m. were used for global fits using 
the monomer-‘m-mer’-‘n-mer self-association model with m = 2 (dimer) and n = 3 
(trimer) in SEDPHAT (Figure 6.4). The global fits utilised a common baseline, 
meniscus, cell bottom, extinction coefficient, and loading concentration.  Fits used 
the M and s, simplex and Marquardt-Levenberg fitting routines, while floating the 
baseline and the cell bottom of the cell. Statistical error analyses employed the 
Monte-Carlo approach. 
  
(6.4.3) Surface plasmon resonance data for Factor H and C3d 
The interactions between FH, SCR-16/20, SCR-1/5 and C3d were analysed 
by SPR using Biacore X100 instrument and version 1.1 of its evaluation software 
(GE Healthcare, Uppsala, Sweden). Native FH was coupled to the flowcell of a 
carboxylated dextran (CM5) research grade sensor chip via a standard amine 
coupling procedure according to the manufacturer’s protocol. 10 µg/ml of FH in 10 
mM acetate buffer (pH 5.5) was injected over flowcell 2 until the appropriate level of 
response units for kinetic analyses (~ 700 response units (RU)) was attained. A 
control surface cell was prepared identically on flow cell 1 but without immobilising  217
FH. Binding and steady-state analysis with C3d, FH, SCR-16/20 and SCR-1/5 were 
performed at 25º C using the appropriate Biacore X100 wizards at flow rates of 10-
30 µl/min. Regeneration after each run was achieved by pulsing 10 mM acetate 
buffer, 2 M NaCl (pH 4.6) across both flow cells twice for 30 sec each.  
For binding analyses, the appropriate concentration of each analyte was 
passed over the chip surface in 50 mM NaCl or 137 mM NaCl HEPES buffers. For 
steady-state analysis of C3d binding to FH, 0.01-50 µM (0.03-1.7 mg/ml) C3d was 
passed over the chip surface in 50 mM NaCl or 137 mM NaCl HEPES buffer 
respectively. For binding assays of C3d-FH ternary complex formation in 137 mM 
NaCl HEPES buffer, increasing concentrations of C3d were added to 0.5 or 5 µM 
(0.08 or 0.8 mg/ml) FH in ratios of 0:1, 0.2:1, 0.4:1, 1:1, 2:1, 4:1 and 10:1 before 
injection. Control experiments using 5 µM (0.2 mg/ml) SCR-1/5 were run at ratios of 
0:1, 0.2:1, 2:1 and 4:1.  
 
(6.4.4) X-ray scattering data collection and analysis  
X-ray scattering data were obtained in one beam session at the European 
Synchrotron Radiation Facility, Grenoble, France operating in sixteen bunch mode 
with a ring energy of 6.0 GeV on the Beamline ID02 (Narayanan  et al., 2001). 
Storage ring currents ranged from 66 mA to 76 mA. Data were acquired using an 
improved fibre optically-coupled high sensitivity and dynamic range CCD detector 
(FReLoN) with a smaller beamstop, which allowed a shorter sample to detector 
distance of 2.0 m to result in a better signal-to-noise ratio. Sample concentrations 
were the same as those used in AUC and employed 50 mM NaCl HEPES or 137 mM 
NaCl PBS buffer. All samples were measured in a flow cell which moved the sample 
continuously during beam exposure in 10 time frames of duration 0.1 sec each to 
confirm the absence of radiation damage. This exposure was optimised using on-line 
checks for the absence of radiation damage, after which the frames were averaged. 
Other details including the data analysis procedure to determine the radius of 
gyration  RG from Guinier plots and the distance distribution function P(r) are 
described elsewhere (Gilbert et al., 2005). The X-ray curves contained 541-544 data 
points in the Q range between 0.09 nm
-1 and 1.89 nm
-1.  218
(6.4.5) Molecular modelling of the SCR-16/20:C3d complexes 
Modelling was based on the crystal structure for C3d and the scattering 
solution structure for the SCR-16/20 dimer as constraints (Nagar  et al., 1998; 
Chapter 4). To model the complex, C3d was positioned adjacent to SCR-20 in an 
arbitrary location that did not lead to steric clashes with other SCR domains. Further 
symmetry-based manipulations generated compact yet planar models. The 
calculation of scattering curves for comparison with the experimental X-ray curves 
used hydrated spheres (Gilbert et al., 2005). Starting from each model, cube side 
lengths of 0.543 nm (1:1 complex), 0.537 nm (2:2 complex), 0.545 (4:4 complex), 
0.537 nm (6:6 complex) and 0.541 nm (8:8 complex) in combination with a cutoff of 
4 atoms produced 579-, 1192-, 2286-, 3552-, and 4667-sphere models respectively, 
each within 95% of the total unhydrated volume calculated from its composition. The 
hydration shell was added using HYPRO (Ashton et al., 1997), and the models were 
confirmed to be within 95% of the optimal total of hydrated spheres of 786 (1:1 
complex), 1626 (2:2 complex), 3111 (4:4 complex), 4879 (6:6 complex) and 6362 
(8:8 complex). Each X-ray scattering curve I(Q) was calculated using the Debye 
equation adapted to spheres (Perkins & Weiss, 1983; Perkins et al., 2008). The final 
calculated curve was summed from a linear combination of the individual scattering 
curve for each molecular species, weighted in the proportions derived from the 
SEDFIT c(s) analysis. From this, the RG value was calculated in the same Q range 
used for the experimental Guinier RG fits in order to allow for any approximations 
inherent in this procedure. The goodness of fit between the calculated and 
experimental curves was assessed using the R factor, defined by analogy with protein 
crystallography from the experimental curve in the Q range extending to 1.8 nm
-1. 
The s
0
20,w values were calculated from the X-ray hydrated sphere models using the 
HYDRO program (Garcia de la Torre et al., 1994; Ashton et al., 1997), and also 
from the crystal coordinates using the HYDROPRO shell modelling program using 
the default value of 0.31 nm for the atomic element radius for all atoms to represent 
the hydration shell (Garcia de la Torre et al., 2000).  
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Chapter Seven 
 
C-reactive protein exists in an NaCl-concentration dependent pentamer-
decamer equilibrium in physiological buffer containing calcium  220
(7.1) Introduction 
C-reactive protein (CRP) is a 115 kDa acute-phase protein of the pentraxin 
family of calcium-dependent ligand-binding proteins in serum (Pepys & Hirschfield, 
2003; Section 2.3.3.1).  
Native CRP is unglycosylated and consists of five identical subunits arranged 
non-covalently as a cyclic pentamer with a central pore. When co-crystallised with 
Ca
2+ and phosphorycholine, each subunit has a phosphocholine ligand-binding site 
proximate to two bound Ca
2+ ions held 0.4 nm apart by acidic side chains on the B 
(binding) face of the pentamer (Thompson et al., 1999; Pepys & Hirschfield, 2003). 
The other A (alpha) face of the protomer possesses the single α-helix of CRP and 
binds to ligands such as C1q (Gaboriaud et al., 2004). The B face of the pentamer is 
negatively charged, while the A face showed a more varied charge distribution with a 
ring of negative charge at the central pore (Thompson et al., 1999; Ramadan et al., 
2002). This suggests a role for electrostatic effects in both lipid binding at the B face 
and C1q binding at the A face (Gaboriaud  et al., 2004). Native CRP with Ca
2+ 
present exists physiologically as a pentamer according to electron microscopy, gel 
chromatography and crystallography (Osmand et al, 1977; Volanakis et al., 1978; 
Shrive et al., 1996; Thompson et al., 1999). However, in the presence of Ca
2+, CRP 
shows a marked concentration dependence in its scattering and sedimentation 
properties, showing that self-association had occurred (Perkins & Pepys, 1986; 
Blizniukov et al., 2003). Ca
2+ depletion leads to monomeric CRP (Motie et al., 1996; 
Wu et al., 2002). In contradiction to this, crystallographic studies in 100 mM NaCl in 
the absence of calcium suggested that CRP may be a decamer formed by the A face-
A face association of two pentamers (Ramadan et al., 2002). While the unfolding of 
a large Ca
2+-binding loop on the B face after Ca
2+ depletion may explain the Ca
2+-
dependent affinity of CRP for lipids, this Ca
2+ site is neither located at the protomer 
interface nor at the A face. Even though Ca
2+ is present in at least 2 mM in plasma 
(Hurwitz, 1996), there is much emphasis in the structural literature on the effect of 
Ca
2+ depletion on CRP, even though Ca
2+ depletion is highly unlikely to occur in 
vivo.  
  In this thesis, a multidisciplinary strategy based on AUC, X-ray scattering, 
and SPR established the association state of CRP at concentrations of 0.1-5.4 mg/ml 
in 2 mM Ca
2+. CRP normally circulates in blood at 0.0008 mg/ml, but this increases 
to over 0.5 mg/ml following an acute phase stimulus (Pepys & Hirshfield 2003).   221
Size-distribution analyses c(s) from AUC identified pentamers and decamers of CRP, 
while constrained scattering modelling based on crystal structures quantified the 
amounts of pentamers and decamers (Cole et al., 2008; Perkins et al., 2008). It is 
shown here that SPR is able to detect similar degrees of CRP self-association 
(Tanious  et al., 2008). In distinction to previous size-exclusion chromatography 
studies, the improved resolution of AUC, scattering and SPR shows that under 
physiological conditions CRP with Ca
2+ present exists in a rapid NaCl-concentration 
dependent pentamer-decamer equilibrium. Molecular modelling accounted for the 
formation of decamers. In order to resolve discrepancies in previous CRP functional 
studies without Ca
2+, it is shown that this artefactual removal of Ca
2+ leads to the 
reduced formation of decamers and the dissociation of pentamers into monomers. 
These studies clarify the molecular interaction of CRP with its ligands, and 
emphasize the importance of working with CRP in buffers containing Ca
2+.  
 
(7.2) Results and Discussion 
(7.2.1) Size exclusion chromatography of CRP 
Size exclusion chromatography measures the effective hydrodynamic volume 
of a protein (Mori & Barth, 1999). CRP may self-associate into decamers (Ramadan 
et al., 2002) and/or dissociate into protomers when stored in the absence of Ca
2+ 
(Motie et al., 1996; Wu et al., 2002). These observations were investigated by size 
exclusion chromatography of CRP in 140 mM NaCl buffer. CRP stored at 1.0 mg/ml 
at 4
oC in the presence of 2 mM Ca
2+ eluted as a single clean peak in both the 
presence and absence of Ca
2+  (Figure 7.1). Molecular weight standards indicated that 
this peak corresponded to an apparent molecular weight of 80-94 kDa, and was 
therefore assigned to the pentamer. However, when CRP was stored at 4
oC in a 
buffer lacking Ca
2+ for 12 weeks, a second peak was observed at a later elution 
volume (Figure 7.1), in agreement with earlier observations (Wu et al., 2002). This 
second peak had an apparent molecular weight of 23 kDa and corresponded to 
approximately 10% of the total eluted protein. This indicated that partial dissociation 
into CRP monomers or other lower molecular-weight forms had occurred slowly in 
the absence of Ca
2+. Small shifts in the elution position of CRP to earlier elution 
positions were observed with increased storage periods in Ca
2+-depleted buffer 
(Figure 7.1). This may correspond to small increases in the amounts of aggregated   222
  
 
Figure 7.1. 
Size-exclusion chromatography of 1 mg/ml CRP in 140 mM NaCl buffers. 
The elution positions of four globular standards are shown in kDa. CRP stored for 
over 12 weeks in Ca
2+-containing buffer eluted as a single peak (solid black line). A 
fresh sample of CRP eluted with Ca
2+-depleted buffer eluted earlier (dashed grey 
line). CRP stored for 12 weeks in Ca
2+-depleted buffer (solid grey line) eluted earlier 
still, and showed an additional smaller peak at 90 ml.     223
forms of CRP.  
 
(7.2.2) Sedimentation velocity analyses of CRP 
AUC studies macromolecular structures in solution by following their 
sedimentation behaviour in a high centrifugal force (Cole et al., 2008). The much 
improved resolution of size distribution analyses c(s) from sedimentation velocity 
experiments performed on a Beckman Proteomelab XL-I instrument was used to 
monitor CRP. The observed sedimentation boundaries in sedimentation velocity 
experiments were fitted to yield a c(s) plot according to the Lamm equation using 
SEDFIT (Section 7.4.2). This takes into account all the species present in the sample, 
although the algorithm assumes that the same frictional ratio applies for all the 
sedimenting species. Macromolecular elongation is monitored through the 
sedimentation coefficient s
0
20,w values. The number of species is determined from the 
peaks observed in the c(s) plot. The effect of NaCl concentration on CRP was studied 
in the concentration range of 0.2 mg/ml to 2.5 mg/ml in 50 mM, 140 mM and 250 mM 
NaCl buffers, all containing 2 mM Ca
2+. The c(s) analyses of interference optics data 
using SEDFIT resulted in good sedimentation boundary fits (top of Figure 7.2). In all 
three buffers, a single species was observed at the lowest concentration of 0.2 mg/ml, 
while two species were observed above 1 mg/ml. The c(M) mass distribution plot 
showed a molecular weight of 118 ± 23 kDa for the single species. This was accordingly 
assigned to pentameric CRP which has a sequence-calculated molecular weight of 115.0 
kDa. The pentamer was consistently observed at s
o
20,w values of 6.5 ± 0.1 S, 6.4 ± 0.2 S 
and 6.4 ± 0.3 S at all concentrations in 50 mM, 140 mM and 250 mM NaCl buffers 
respectively, indicating that the NaCl concentration does not affect the CRP 
conformation (Figure 7.2; Table 7.1). These values agree with the value of 6.6 S for 
pentameric CRP in 2 mM Ca
2+ obtained using older Beckman Model E technology 
(Blizniukov et al., 2003).  
A pentamer-decamer equilibrium was identified from the c(s) plots. Above 0.2 
mg/ml in 50 mM NaCl, 0.8 mg/ml in 140 mM NaCl and 1.0 mg/ml in 250 mM NaCl, 
the c(s) distributions showed the steady growth of a second species indicating a higher 
oligomer in equilibrium with the pentamer (Figure 7.2). This peak was attributed to the 
formation of decameric CRP. However the s
o
20,w value for this peak is variable in 
ranges from 7.7-8.4 S in 50 mM NaCl, 7.6-8.2 S in 140 mM NaCl and 7.5-7.7 S in 
250 mM NaCl. The molecular weight of 138 ± 10 kDa of this peak from c(M)   224
 
 
Figure 7.2 
NaCl concentration dependence of CRP decamer formation by AUC in the 
presence of Ca
2+. Protein concentrations ranged from 0.2 to 2.5 mg/ml, and are 
labelled at the right of each c(s) plot. The c(s) plots are displaced vertically and the 
peak intensities are normalised for clarity. The boundary fits corresponding to 0.8 
mg/ml or 0.6 mg/ml are shown in the upper panels, where only every tenth scan is 
shown for reason of clarity. Experiments were performed at a rotor speed of 50,000 
r.p.m. In Figures 7.2-7.9, data measured in 50 mM NaCl is denoted by red, 140 mM 
NaCl by black and 250 mM NaCl by green.  
(a-c) Buffers containing 2 mM Ca
2+ and 50 mM NaCl, 140 mM NaCl and 
250 mM NaCl.  
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analyses is too low compared to the expected value of 230 kDa. The variation in s
o
20,w 
values and the low molecular weight indicate that this peak is not a second CRP 
species but is instead a reaction boundary corresponding to a rapid equilibrium 
between pentameric and decameric CRP on the time scale of sedimentation (Dam & 
Schuck, 2005). A s
o
20,w value of 9.5 S has been reported for cross-linked decameric 
CRP (Blizniukov et al., 2003). Integration of the two c(s) peak areas resulted in an 
estimated dissociation constant KD value of 19 µM for the CRP pentamer-decamer 
equilibrium in 50 mM NaCl, 2 mM Ca
2+ buffer (Figure 7.4(a)). Estimates of the KD 
values in 140 mM NaCl and 250 mM NaCl buffers were not possible for reason of 
the poor resolution of the two peaks at lower concentrations.  
The removal of Ca
2+ at CRP concentrations of 0.1 mg/ml to 2.4 mg/ml in 50 
mM and 140 mM NaCl buffers revealed the presence of smaller oligomers of CRP, 
together with pentamers and decamers by AUC. Good boundary fits were obtained 
(Figure 7.3). At all concentrations, pentamers were clearly observed to dominate the c(s) 
analyses with mean s
o
20,w values of 6.4 ± 0.1 S in 50 mM NaCl and 6.3 ± 0.1 S in 140 
mM NaCl (Table 7.1).  These values were unchanged from those obtained in the 
presence of Ca
2+ (Table 7.1). The c(M) analyses yielded a mean molecular weight of 119 
± 26 kDa in agreement with the assignment as pentamers. It was concluded that the loss 
of Ca
2+ leads to only small effects in pentameric CRP, in agreement with size exclusion 
chromatography (Figure 7.1). Two further observations were made. Firstly, at all 
concentrations, one or two additional c(s) peaks were seen at 2.8 ± 0.2 S and 4.3 ± 0.3 S 
in 50 mM NaCl, and at 3.0 ± 0.2 S and 4.0 ± 0.3 S in 140 mM NaCl (Figure 7.3).  The 
absence of a concentration dependence showed that these peaks were not in equilibrium 
with the pentamer. Since the c(M) analyses yielded mean molecular weights of  37 ± 5 
kDa and 72 ± 7 kDa, these peaks are possible dimer (46 kDa) and trimer (69 kDa) forms 
of CRP. Thus in the absence of Ca
2+, CRP partially dissociates into lower molecular-
weight oligomers. This is consistent with size exclusion chromatography results after 
storage in the absence of Ca
2+ (Figure 7.1). Secondly, at 1.0 mg/ml and above, the CRP 
decamer was observable with s
o
20, w values ranging from 7.5-8.9 S and 7.3-7.7 S in 50 
mM and 140 mM NaCl buffers respectively, and a mean apparent molecular weight of 
172 ± 59 kDa (Figure 7.3). Peak integrations showed that the apparent KD for the 
pentamer-decamer equilibrium is much weakened in higher salt (Figure 7.4(b)). No KD 
values could be estimated for reason of the presence of 2% to 33% of the lower 
molecular-weight oligomers. It is concluded that Ca
2+ is essential to stabilise the CRP   226
pentamer and the formation of decamers.  
 
(7.2.3) X-ray scattering analyses of CRP  
X-ray scattering is a diffraction technique that studies the overall structure of 
biological macromolecules in random orientations in solution (Perkins et al., 2008). 
This was used to observe the self-association and conformation of CRP in the 
presence and absence of Ca
2+. Previous X-ray experiments with 2-6 mg/ml CRP 
were performed on Station 7.3 at the Synchrotron Radiation Source at Daresbury, 
Cheshire, which utilised a linear detector with a limited Q range (Q = 4π sin θ /λ; 2θ  
= scattering angle; λ = wavelength) (Perkins & Pepys, 1986). In comparison, 
Instrument ID02 at the European Synchrotron Radiation Facility in Grenoble, France 
enabled much improved experiments. ID02 was equipped with a flow cell to 
eliminate possible radiation effects and a two-dimensional detector with better 
sensitivities and larger Q  range (Section 7.4.3). The improvements permitted a 
detailed study of a more extended CRP concentration range of 0.3-5.4 mg/ml.  
The X-ray Guinier analysis confirmed CRP self-association in 140 mM NaCl 
buffer with 2 mM Ca
2+, and provided information on the decamer conformation. 
Guinier analyses of the scattering data I(Q) at low Q values yielded the forward 
scattered intensity I(0) at zero Q and the radius of gyration RG.  The I(0)/c value is 
proportional to molecular weight (where c is the CRP concentration in mg/ml) and 
RG monitors the degree of overall macromolecular elongation. Guinier plots gave 
linear  RG fits within appropriate Q.RG limits (Figure 7.5(a)). The I(0)/c values 
increased from 14.2 to 21.9 units between CRP concentrations from 0.3 to 5.4 mg/ml 
(Figure 7.6(a)), in agreement with a self-association equilibrium. Assuming that this 
is a pentamer-decamer equilibrium, extrapolation of I(0)/c to zero concentration gave 
a value of 13.1 units for the pentamer, thus assigning 26.2 units for the decamer 
I(0)/c value, and leading to a KD value of 26 µM (3.0 mg/ml) from the mid-point. 
The concentration dependence of the RG values ranged from 3.8 ± 0.1 nm to 4.5 ± 0.2 
nm (Figure 7.6(c)). Extrapolation to zero concentration yielded an RG value of 3.7 
nm for the pentamer. The RG values agreed with the previously-reported values of 
4.1-4.5 nm for CRP concentrations of 2-6 mg/ml (Perkins & Pepys, 1986).  
The distance distribution function P(r) in real space was calculated from the 
I(Q) data, following an assumption of the value of the maximum dimension Dmax. 
The  P(r) curve represents all the distances between pairs of atoms within CRP,   227
 
Figure 7.3  
NaCl concentration dependence of CRP decamer formation by AUC in the 
absence of Ca
2+. Protein concentrations ranged from 0.1 to 2.4 mg/ml. All other 
details follow Figure 7.2. 
(a,b) Buffers without Ca
2+ and containing 50 mM NaCl and 140 mM NaCl. 
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Figure 7.4.  
NaCl concentration and Ca
2+ dependence of CRP pentamer-decamer 
equilibrium by AUC. At each CRP concentration, the relative percentage of 
pentamer (solid lines) and decamer (dashed lines) corresponds to data obtained at 
50,000 r.p.m. The apparent KD value (KD-app) in 50 mM NaCl is estimated as the 
point of intersection of the two data sets when fitted to a non-linear regression for an 
exponential rise (decamer: y = y0 + a(1-b
x)) or decay (pentamer: y = y0 + a(10)
-bx) as 
appropriate. The colours are defined in Figure 7.2. 
(a) Data correspond to 50 mM NaCl, 140 mM NaCl and 250 mM NaCl in the 
presence of 2 mM Ca
2+. 
(b) Data correspond to 50 mM NaCl and 140 mM NaCl in the absence of 
Ca
2+. The inset shows the percentage contribution of lower oligomers of CRP, which 
was not seen with Ca
2+ present.    229
and provides an independent verification of the Guinier RG values. The P(r) curves 
from Figure 7.7(a) yielded mean RG values of 3.8 ± 0.1 nm to 4.3 ± 0.1 nm, in good 
agreement with the Guinier values. Two maxima M1 at r = 3.1 nm and M2 at r = 5.7 
nm correspond to the most frequently occurring interatomic distances within CRP. 
Comparison with the pentamer and decamer crystal structures (PDB codes 1b09 and 
1lj7) (Thompson et al., 1999; Ramadan et al., 2002) showed that M1 and M2 could 
be assigned to the CRP pentamer and decamer respectively. While the r values of M1 
and M2 remained unchanged with concentration, the intensity of M2 relative to M1 
increased with CRP concentration. This means that the proportion of decameric CRP 
increases with concentration, which is as expected from the pentamer-decamer 
equilibrium. The maximum dimension L of CRP is the r value when P(r) decreases 
to 0 at large r. The L values were unchanged with concentration at 11-13 nm (Figure 
7.7(a)). The outermost ring diameter of the CRP pentamer is 11-13 nm by electron 
microscopy (Osmand  et al., 1977). Both are in good agreement with the longest 
dimensions measured from the unhydrated pentamer and decamer crystal structures 
of 10.5 nm and 11.9 nm respectively, provided that these were increased to 11.1 nm 
and 12.5 nm respectively by the addition of a uniform shell of water molecules of 
thickness 0.3 nm on all surfaces (Thompson et al., 1999; Ramadan et al., 2002; 
Perkins, 2001). The lack of significant change in L on decamer formation shows that 
the pentamers are arranged face-to-face within the decamer.  
X-ray scattering showed that Ca
2+ removal from CRP promoted some self-
aggregation, and reduced the proportion of CRP decamer, but left the CRP 
conformation largely unchanged. Ca
2+ removal was studied using a CRP 
concentration range of 0.1-2.5 mg/ml using 50 mM and 140 mM NaCl buffers 
without Ca
2+. Trace amounts of non-specific aggregation were readily visible in the 
Guinier plots as non-linear increases in the I(Q) values at very low Q values. 
Accordingly a reduced Q range was employed for the RG fits (Figure 7.5(b)).  The 
I(0)/c values showed a reduced concentration dependence compared to that in the 
presence of Ca
2+, increasing from 11.7 to 12.9 units and from 8.6 to 11.6 units in 50 
mM NaCl and 140 mM NaCl respectively (Figure 7.6(b)). This small increase 
showed that, even though the pentamer-decamer association is weakened compared 
to studies in the presence of Ca
2+, the pentamer-decamer equilibrium is not 
eliminated by the removal of Ca
2+. The RG values of CRP likewise increased in 
smaller ranges from 3.8 ± 0.0 nm to 4.1 ± 0.0 nm in 50 mM NaCl, and from 3.6 ±   230
 
Figure 7.5  
X-ray scattering Guinier RG analyses for CRP.  
(a) The filled circles correspond to the data points used to obtain RG values 
using a Q range of 0.06-0.36 nm
-1 and the straight lines correspond to the best fit 
through these points. The Q.RG fit range is arrowed. In the presence of 2 mM Ca
2+, 
from bottom to top, concentrations of 0.3 mg/ml, 1.3 mg/ml, 2.7 mg/ml, 4.0 mg/ml 
and 5.4 mg/ml were used. 
(b) In the absence of Ca
2+, the Guinier fits were made in a Q range of 0.18 - 
0.36 nm
-1. From bottom to top, the CRP concentrations were 0.1 mg/ml, 0.3 mg/ml, 
0.6 mg/ml and 2.4 mg/ml.    231
 
Figure 7.6  
Concentration dependence of X-ray scattering Guinier RG analyses for CRP.  
 (a) Concentration dependence of the Guinier I(0)/c parameter in 140 mM 
NaCl buffer containing 2 mM Ca
2+. The KD value was determined by a non-linear 
regression fit (solid line) for an exponential rise to a maximum (y = y0 + a(1-b
x)), and 
the vertical dashed line corresponds to 26 µM. Error bars are shown where visible. 
(b) Concentration dependence of the Guinier I(0)/c parameter in 50 mM NaCl 
(●) and 140 mM NaCl buffer (○) without Ca
2+. Note that the I(0)/c values here were 
obtained in a different beam session from that of (a), therefore the I(0)/c values are 
not comparable. No KD value could be determined. 
(c,d) The corresponding Guinier RG values for CRP in 140 mM NaCl buffer 
containing 2 mM Ca
2+, and in 50 mM NaCl (●) and 140 mM NaCl buffer (○) without 
Ca
2+.    232
0.1 nm to 4.1 ± 0.0 nm in 140 mM NaCl buffers (Figure 7.6(d)). Extrapolation to 
zero concentration yielded an RG value of 3.5 nm for the pentamer in 140 mM NaCl 
(Figure 7.6(d)); this is similar to the RG value of 3.7 nm for the pentamer in 140 mM 
NaCl with Ca
2+ present (Figure 7.6(c)). The P(r) curves yielded RG values of 3.7-4.1 
nm in 50 mM NaCl (data not shown) and 3.6-4.0 nm in 140 mM NaCl (Figure 
7.7(b)), in agreement with the Guinier analyses. The r values of the peaks M1 (r = 3.1 
nm) and M2 (r = 5.7 nm) were unchanged on Ca
2+ removal, although the increase in 
the intensity of the M2 peak relative to M1 was now reduced. The L values of 10-13 
nm showed no change from the L values in buffers containing Ca
2+. Thus no 
conformational change in CRP occurred on Ca
2+ removal. 
 
(7.2.4) Modelling of pentameric and decameric CRP 
 Constrained  modelling  starting from crystal structures permits the molecular 
interpretation of scattering curves (Perkins  et al., 2008). Here, this was used to 
determine a KD value for the CRP pentamer-decamer equilibrium and establish the 
similarity of the solution structure of the CRP decamer to its crystal structure. The 
scattering curve for the CRP pentamer was calculated from its crystal structure with 
Ca
2+ (PDB code 1b09)(Thompson  et al., 1999). Because several residues were 
missing and Ca
2+ was not present in the CRP decamer crystal structure (PDB code 
1lj7) (Ramadan et al., 2002), the  decamer scattering curve with Ca
2+ was calculated 
after superimposition of two pentamer crystal structure onto the decamer crystal 
structure. The modelled pentamer and decamer scattering curves resulted in RG 
values of 3.7 nm and 4.2 nm respectively (Table 7.1). These agree well with the 
experimental RG value of 3.7 nm on extrapolation for the pentamer and the observed 
range of 3.8 ± 0.1 nm to 4.5 ± 0.2 nm for the pentamer-decamer equilibrium (Figure 
7.6(c)). The amounts of pentamer and decamer in each X-ray curve was computed 
from 101 combinations of the modelled pentamer and decamer curves in 1% 
increments from 0%-100% to 100%-0% respectively. A total of nine experimental 
X-ray curves at different concentrations in 140 mM NaCl with Ca
2+ were assessed 
using a goodness-of-fit R-factor (Figure 7.8(a)). Excellent R-factors of 2.0% to 3.7% 
were obtained for pentamer-decamer ratios that ranged from 74%-26% at 0.3 mg/ml 
to 28%-72% at 5.4 mg/ml (Figure 7.9(a)). In comparison, the worst possible R-factor 
was 15.0%. The pentamer-decamer ratios resulted in a KD value of 16 µM (Figure 
7.9(a) which agrees well with the Guinier-determined value of 26 µM (Figure   233
 
Figure 7.7.  
   Concentration dependence of the X-ray distance distribution P(r) for CRP. 
CRP was studied in 140 mM NaCl buffers (a) containing 2 mM Ca
2+ and (b) without 
Ca
2+. The two maxima in P(r) are denoted by M1 and M2 at 3.1 nm and 5.7 nm 
respectively, assigned to pentamer and decamer respectively. The maximum 
dimension is denoted by L. The CRP concentrations correspond to those in Figures 
7.5(a,b). The dashed line in (a) corresponds to 2.7 mg/ml; in (b), this is shown again 
and normalised to M2 using that at 2.4 mg/ml in order to compare the effect of Ca
2+ 
removal.    234
7.6(a)). The modelled and experimental P(r) curves likewise agree well (Figure 
7.9(c)). The success of these curve fits shows that the decamer crystal structure with 
the two A-faces facing each other at the centre is a good model for its solution 
structure.  
  Constrained fits confirmed the NaCl concentration dependence of the 
pentamer-decamer equilibrium in the absence of Ca
2+ that was seen by AUC and 
Guinier analyses, and the decreased formation of decamer. The comparison of the 
101 pentamer/decamer curves with five experimental X-ray curves in 50 mM NaCl 
again resulted in excellent best-fit R-factors of 1.8% to 3.5% (Table 7.1). The good 
quality of the curve fits indicated the absence of large conformational change in CRP 
upon Ca
2+ removal. The best-fit ratios ranged from 100%-0% to 56%-44% of 
pentamer/decamer (Figure 7.9(b)). Likewise the four experimental curves in 140 mM 
NaCl buffer resulted in excellent best-fit R-factors of 1.7% to 2.8% (Figure 7.8(b); 
Table 7.1). The best-fit ratios of 100%-0% to 71%-29% showed that the proportion 
of decamer had decreased in 140 mM NaCl after Ca
2+ removal (Figure 7.9(b)). No 
KD values were determined because these were too large to be measured. The 
modelled  P(r) analyses showed good agreement with experimental data (Figure 
7.9(d)). Even though lower molecular-weight CRP oligomers will be present 
according to the c(s) plots (Figure 7.4(b)), these will have a small effect on curve fits 
because the scattered intensities are proportional to the square of the molecular 
weight.  
    The CRP scattering curves show a minimum at a Q value of 0.87 nm
-1 
(Figure 7.10(a)). This minimum is more prominent in the decamer than the pentamer. 
The mean diameter of the pentameric ring is given by 2π/Q as 7.2 nm, which is in 
good agreement with the neutron value of 7.4 nm (Perkins & Pepys, 1986) and a 
value of 7.5 nm measured from the pentamer and decamer crystal structures (Figure 
7.10(b)). The agreements support the face-to-face crystallographic model for the 
CRP decamer, in which one pentamer is rotated relative to the other by about 20
o, 
then brought into contact at their A faces (Ramadan et al., 2002). 
Sedimentation coefficients sº20,w  for the pentamer and decamer were 
calculated from their crystal structure models (Table 7.1). Those for pentameric CRP 
were 6.0-6.2 S, in good agreement with the experimental value of 6.4 S. That for the 
decamer was 9.8 S, for which no experimental value from this study was available 
for comparison. The value of 9.8 S is in good agreement with the experimental value    235
 
Figure 7.8.  
X-ray scattering curve fits for the CRP pentamer and decamer in the presence 
and absence of Ca
2+. The Q range for the RG analyses is denoted by a horizontal bar. 
(a) In buffer with 2 mM Ca
2+, representative best-fit curves are shown for 
CRP concentrations of 1.3 mg/ml (54% pentamer/ 46% decamer), 2.7 mg/ml (41% 
pentamer/ 59% decamer) and 5.4 mg/ml (28% pentamer/ 72% decamer) from bottom 
to top.  
(b) In Ca
2+-depleted buffer, representative best-fit curves are shown for CRP 
concentrations of 0.3 mg/ml (99% pentamer/ 1% decamer), 0.6 mg/ml (96% 
pentamer/ 4% decamer) and 2.4 mg/ml (71% pentamer/ 29% decamer).    236
 
Figure 7.9.  
Concentration dependence of X-ray scattering curve fits for the CRP 
pentamer and decamer in the presence and absence of Ca
2+.  
(a)  KD determination for the CRP pentamer/decamer equilibrium in the 
presence of 2 mM Ca
2+. Data points correspond to the best-fit pentamer/decamer 
ratio for each CRP concentration between 0.3-5.4 mg/ml in 140 mM NaCl buffer. 
The data were fitted according to Figure 7.6(a), and the vertical dashed line 
corresponds to a KD of 16 µM. 
(b) In Ca
2+-depleted buffer, no KD value could be determined as this was 
outside the concentration range studied.  
(c,d) Comparison of the modelled (dashed lines) and experimental (full lines) 
P(r) curves in the (c) presence and (d) absence of Ca
2+.   237
of 9.5 S for the cross-linked CRP decamer (Blizniukov et al., 2003).  
 
(7.2.5) Surface plasmon resonance (SPR) analyses of CRP 
SPR monitors the interaction between a binding partner in solution (analyte) 
and a partner (ligand) immobilised at the surface of a sensor chip (Tanious et al., 
2008). CRP accumulates at damaged and apoptotic cells by binding to charged 
groups at their cell surfaces (Volanakis, 1982; De Beer et al., 1982; Rowe et al., 
1984). Accordingly the self-association of CRP in solution with CRP immobilised on 
a sensor chip can provide insight on this interaction, provided that Ca
2+ is present 
throughout the SPR experiments.  
The NaCl concentration dependence of CRP self-association seen by AUC 
and scattering was confirmed by SPR. CRP was flowed across a sensor chip surface 
containing 150 resonance units (RU) of immobilised CRP which was prepared in the 
presence of Ca
2+ (Section 7.4.5).  The binding analysis of 50 µM (5.8 mg/ml) CRP in 
50 mM NaCl buffer in the presence of Ca
2+ showed that CRP aggregated on the chip 
surface, as evidenced by the extremely high binding response to greater than 15,000 
RU. This was rapidly followed by CRP dissociation to baseline levels (Figure 
7.11(a)). On increasing the salt to 140 mM NaCl, the corresponding analysis of 50 
µM CRP resulted in a much-reduced but more rapid binding response of 34 RU, 
followed by its rapid dissociation (Figure 7.11(b)). This represents 23% saturation of 
immobilised CRP. At a lower CRP concentration of 20 µΜ (2.3 mg/ml), the binding 
responses were reduced to 245 RU in 50 mM NaCl and to 24 RU in 140 mM NaCl 
(Figures 7.11(c,d)).  
Dissociation constants KD for CRP self-association were determined. 
Equilibrium SPR studies in 50 mM NaCl and 140 mM NaCl buffers with Ca
2+ 
present supported these binding analyses. At concentrations of 1-20 µM in 50 mM 
NaCl buffer, CRP showed a continuously increasing binding response consistent 
with aggregate formation (Figure 7.12(a,c)). A KD value could not be determined 
because binding saturation was not attained. In 140 mM NaCl buffer, a KD of 23 µM 
was determined using CRP concentrations between 1-35 µM (Figure 7.12(b,d)). This 
agrees well with the values of 26 µM and 16 µM in 140 mM NaCl from the X-ray 
analyses above, showing that immobilised CRP behaves in the same way as CRP in 
solution.     238
 
Figure 7.10. 
Comparison of the X-ray scattering curves for CRP pentamer and decamer. 
The arrow corresponds to the position of the minimum in the scattering curve. 
(a) Comparison of the experimental scattering curves for CRP at 2.7 mg/ml in 
2 mM Ca
2+ buffer (black) and 2.4 mg/ml in Ca
2+-depleted buffer (white). The 
intensity of I(Q) at the minimum (arrowed) is lower in the presence of Ca
2+, showing 
that more decamer has formed  
(b) Comparison of the scattering curves for CRP for mixtures of pentamer 
and decamer calculated from crystal structures. The intensity of the I(Q) minimum 
decreases as the proportion of decamer increases from 0% to 100%.   239
The corresponding experiments in the absence of Ca
2+, but using the same 
immobilised CRP sensor chip, showed that CRP binding to immobilised CRP was 
much reduced. Using 20 µΜ CRP, the binding responses were reduced from 245 RU 
to 115 RU in 50 mM NaCl buffer, and from 24 RU to 19 RU in 140 mM buffer 
(Figures 7.11(c,d)). Interestingly, with both buffers, CRP did not completely 
dissociate from immobilised CRP on the sensor surface back to baseline levels when 
this was compared with buffers containing Ca
2+ (dashed lines in Figures 7.11(c,d)). 
This suggested that, in the absence of Ca
2+, lower molecular-weight oligomers of 
CRP bind irreversibly to partially-dissociated immobilised CRP on the sensor chip 
surface to form aggregates. This is consistent with the AUC results showing reduced 
CRP decamer formation and partial dissociation of CRP in Ca
2+-depleted buffers.  
 
(7.3) Conclusions 
In this study, it has been shown that CRP in 2 mM Ca
2+ exists in a rapid 
pentamer-decamer equilibrium in solution using three different analytical 
instrumentation methods with improved resolutions compared to previous studies. 
This equilibrium is dependent on NaCl concentration. As far as could be determined, 
this is the first evidence for decameric CRP in physiologically-relevant buffer 
conditions. The CRP concentration in plasma ranges from 0.8 µg/ml (0.01 µM) at 
normal levels to over 0.5 mg/ml (4.4 µM) during acute phase conditions (Pepys & 
Hirschfield, 2003). Calcium is present in plasma at 2.5 mM, of which ionic Ca
2+ is 
present at 1.18 mM (Hurwitz, 1996). Only CRP pentamers and decamers were 
observed in 2 mM Ca
2+ in CRP concentrations between 0.1-5.4 mg/ml (0.9-47 µM), 
where these concentrations include the physiological range of the CRP acute phase 
response. The formation of decameric CRP with a mean KD value of 22 ± 5 µM can 
be relevant for the interaction of CRP with its ligands in plasma. However, as plasma 
contains at least 70 mg/ml of other proteins, more detailed knowledge of how CRP 
behaves in this milieu will be required before these findings can be extrapolated to 
CRP in plasma. Most importantly, the AUC data shows that the non-physiological 
removal of Ca
2+ causes CRP to dissociate into lower oligomers and reduces the 
proportion of decamers. Many previous functional studies of CRP have reported the 
existence of denatured or monomeric forms of CRP in the absence of Ca
2+, and have 
suggested that these are functionally relevant (Pepys & Hirschfield, 2003). There is   240
 
Figure 7.11.  
SPR binding analysis of CRP self-association. Data correspond to buffers 
containing 2 mM Ca
2+ unless stated otherwise. 
(a,b) 50 µM CRP was flowed over immobilised CRP in (a) 50 mM NaCl and 
(b) 140 mM NaCl buffer. An abnormally high response (> 15000 RU) was observed 
in 50 mM NaCl, while that in 140 mM NaCl was normal (~35 RU). 
(c,d) Comparison of the binding of CRP in the presence of Ca
2+ (solid lines) 
and absence of Ca
2+ (dotted lines). 20 µM of CRP was flowed over immobilised 
CRP in buffers containing (c) 50 mM NaCl buffer and (d) 140 mM NaCl. 
Approximately ten-fold more response was observed in (c) than (d). The dotted lines 
did not return to baseline levels in (c) and (d).   241
 
Figure 7.12.  
SPR equilibrium analysis of CRP self-association. Data correspond to buffers 
containing 2 mM Ca
2+.  
(a,b) Equilibrium analyses for CRP self-association in (a) 50 mM NaCl and 
(b) 140 mM NaCl buffer. The binding response increased continuously between 1-20 
µM in (a) while saturation was approached in (b) from which a KD value of 23 µM 
was determined from CRP concentrations between 1-35 µM.   
(c,d) Sensorgrams used for the equilibrium analyses, where panel (c) 
corresponds to the data in (a), and panel (d) corresponds to the data in (b).    242
no rigorous evidence for the existence of monomeric (i.e. denatured) CRP in vivo. 
Standard preparation protocols for CRP involve 2 mM Ca
2+ throughout (De Beer & 
Pepys, 1982). Because the AUC data confirm that pentameric CRP is very stable in 
the presence of Ca
2+, functional or structural experiments with CRP in which Ca
2+ is 
omitted have little or no physiological or pathophysiological relevance.   
The CRP pentamer-decamer equilibrium was previously unknown. The self-
association of pure CRP had been previously reported by X-ray and neutron 
scattering and by AUC, but was not explained (Perkins & Pepys, 1986; Blizniukov et 
al., 2003). Here, the molecular basis of this self-association was identified by the 
combination of the c(s) analyses from AUC and X-ray scattering modelling. The 
AUC data revealed a weak pentamer-decamer equilibrium in three NaCl 
concentrations in the presence of Ca
2+. While pentamers were unambiguously 
identified as the 6.4 S c(s) peak, the second c(s) peak corresponds to a reaction 
boundary that could not be assigned to a decamer. This ambiguity was resolved by 
the excellent X-ray curve fits based on the pentameric and decameric CRP crystal 
structures. The KD values of 19 µM (50 mM NaCl) by AUC, 26 µM and 16 µM (140 
mM NaCl) by X-ray Guinier fits and modelling, and 23 µM (140 mM NaCl) by SPR 
show consistency. The mean KD value of 22 ± 5 µM (140 mM NaCl) suggests that 
0% to 15% of CRP will be decameric in its physiological concentration range of 
0.01-4.4 µM if no other factors are involved. There were no indications of any 
indefinite self-association of CRP. The decamer is therefore formed from contacts 
between either the two A faces or the two B faces of the pentamers. The A faces are 
preferred as the buried interface because this is observed in the Ca
2+-free CRP 
decamer crystal structure, excellent X-ray modelling fits were obtained with the 
decamer crystal structure (Ramadan et al., 2002), and ionic interactions at the A 
faces were observed that account for the NaCl concentration dependence of decamer 
formation (see below). If CRP decamers are formed in plasma, the B faces will 
remain exposed for lipid binding at damaged host cells or bacterial surfaces and will 
not be affected. Given that CRP interacts with C1q of complement at its A face, CRP 
decamer formation may potentially inhibit C1q binding to CRP during a heightened 
acute phase response. The observation of a pentamer-decamer equilibrium and the 
absence of any observed 15-mers of CRP indicates that functional studies of 
chemically cross-linked 15-mers of CRP are not physiologically relevant (Jiang et 
al., 1991).    243
The reduced formation of CRP decamer with increase in NaCl concentration 
is explained by the CRP crystal structures. This dependence indicates that the A face-
A face interface in the decamer is stabilised by ionic interactions. The partially-
disordered decamer crystal structure suggested that ten pairs of Thr173 and Pro179 
sidechains form the closest contact between the A faces (Ramadan et al., 2002). If 
the Ca
2+-bound pentamer crystal structure at higher resolution was superimposed 
onto the decamer crystal structure (Thompson et al., 1999), it turns out that ten pairs 
of Asp169 and Arg188 residues on the A faces are well positioned to form the 
requisite ionic bridges (Figure 7.13(a)). There are no clear candidates for ionic 
bridges between the B faces. There are Lys69-Asp70 and Glu14-Arg47 pairs within 
each B face which cancel each other out. Additionally, there is a surplus of acidic 
residues on the B face (in addition to those involved with Ca
2+ and phosphocholine 
binding) which may repel each other. The NaCl concentration dependence of 
decamer formation shows that this may be affected by the local environment. For 
example, CRP binding to ligands at the exposed B faces may influence the pentamer-
decamer association. In this context, CRP is known to interact with a variety of 
polycations, as well as with polyanion-polycation complexes (Siegel et al., 1974; 
1975; Claus et al., 1975).  
Previous high resolution CRP crystallographic studies have highlighted the 
role of Ca
2+ in the formation of its structure. This emphasis is justified by the 
presence of at least 2 mM Ca
2+ in plasma, which is well in excess of the KD for Ca
2+ 
binding to CRP. Both Ca
2+-binding sites in CRP possess equal affinity for Ca
2+ in 
solution with a KD of 60 µM (Kinoshita et al., 1989). While two CRP pentamer 
crystal structures were reported in the presence of Ca
2+  (Shrive  et al., 1996; 
Thompson et al., 1999), CRP was crystallised as decamers in 100 mM NaCl buffer 
without Ca
2+ (Ramadan et al., 2002). The AUC data explains the crystallisation of 
decamers without Ca
2+ present, simply because decamers were still observable under 
these conditions. The AUC and gel filtration data also provide insight on the effect of 
Ca
2+ removal on CRP. In the crystal structure, Ca
2+ binds at a double site on the B 
face (Figure 7.13(b)). Ca
2+ site 1 is coordinated by amino acids Asp60, Asn61, 
Glu138, Asp140 and Leu139 (a total of five ligands), while Ca
2+ site 2 is coordinated 
by Gln138, Asp140, Gln150 and possibly Glu147 (Shrive et al., 1996; Thompson et 
al., 1999). The two Ca
2+-binding sites in CRP are therefore differentiated by one 
coordinating amino acid, even though they are equally occupied in the crystal   244
structure. Thus Ca
2+ is not structurally involved with decamer formation that 
probably occurs through A face contacts. In addition, Ca
2+ is not structurally related 
to the contacts between the five protomers in the pentamer, each of which is 
stabilised by four ionic bridges that span the interface (Glu42-Lys119; Glu101-
Lys201; Asp155-Arg118; Glu197-Lys123). Accordingly the AUC- and gel filtration-
observed weakening of decamer formation and the dissociation of smaller oligomers 
on the removal of Ca
2+ are best explained by a destabilisation of the entire double β-
sheet structure of the CRP protomer. Indeed, comparisons of CRP crystal structures 
with and without Ca
2+ bound (Figure 7.13(b)) show that there is a 0.174 nm root 
mean square difference in residue positions (Thompson  et al., 1999). This 
conformational sensitivity of the β-sheets to residue change provides an explanation 
for the notable absence of polymorphic forms of CRP (Pepys & Hirschfield, 2003).  
Several CRP studies have proposed that alterations in Ca
2+ binding are 
important for the mechanism of CRP action, however this view is not supported by 
this study. In the absence of Ca
2+, CRP is partially dissociated to form lower 
molecular-weight oligomers (Figure 7.13(c)). By the current AUC studies, these 
smaller oligomers were not in equilibrium with pentameric CRP. The existence of 
these lower oligomers of CRP consisting of monomers to trimers (mCRP) has been 
reported previously in functional studies under conditions of denaturing pH, 
temperature (Potempa et al., 1983; 1987) or Ca
2+-depletion (Motie et al., 1996; Wu 
et al., 2002). Given the high stability of CRP pentamers in the presence of Ca
2+, their 
functional relevance is questionable. AUC and X-ray data from this thesis show that 
the CRP pentamer does not undergo large conformational changes with NaCl 
concentration or Ca
2+-depletion and is highly stable. Given the prevalence of Ca
2+ in 
plasma, no allosteric mechanism involving the removal or addition of Ca
2+ during 
CRP function is likely, as proposed in earlier studies (Ramadan  et al 2002; 
Blizniukov et al., 2003). The existence of monomeric CRP with a functional role is 
likewise questionable (Wu et al., 2002; Wang & Sui, 2001; Taylor & van den Berg, 
2006). 
The understanding of the solution structural behaviour of CRP from this 
study is relevant to the elucidation of its function in complement activation and host 
acute-phase response. The main results show that CRP exists as very stable 
pentamers in a rapid equilibrium with decamers in 2 mM Ca
2+ (Figure 7.13). On the 
other hand, the spontaneous formation of lower molecular-weight oligomers of CRP   245
 
Figure 7.13. 
   Pentamers and decamers of CRP as a function of NaCl concentration and Ca
2+. 
   (a) Crystal structures for pentameric CRP with bound Ca
2+ (cyan and green ribbons) 
were superimposed onto the crystal structure of decameric CRP without Ca
2+ to reveal ten 
pairs of Arg188 (blue) -Asp169 (red) ionic bridges that are proposed to stabilise CRP 
decamer formation between the two A faces. Three pairs of bridges are shown in this view. 
(b) The B face of pentameric CRP is viewed in blue with bound Ca
2+, and in magenta  
without Ca
2+. The Ca
2+ -binding loop comprising amino acid residues 138-150 in each 
protomer is coloured red (with Ca
2+) or orange (without Ca
2+). (c) Pentameric CRP (blue, 
with bound Ca
2+ shown as yellow spheres) self-associates in a rapid equilibrium in the 
presence or absence of Ca
2+ to form decamer (green and cyan) through contacts between the 
A faces in an NaCl concentration-dependent manner. This has a mean dissociation constant 
KD value of 22 µM determined in 140 mM NaCl containing Ca
2+. In the absence of Ca
2+, 
CRP irreversibly dissociates into individual protomers (magenta) and decamer formation is 
reduced. When Ca
2+ is present, pentameric CRP binds to macromolecular ligands to form 
complexes that interact with C1q to activate the classical pathway of complement.   246
(termed mCRP) under conditions of Ca
2+-depletion was readily seen by AUC. SPR 
studies indicated that these lower molecular-weight CRP oligomers can bind to 
immobilised CRP, i.e. these lower molecular-weight oligomers can associate with 
ligand-bound CRP in vivo and may modify its biological activity. These results are 
cautionary in the sense that experimental work with CRP readily leads to artefactual 
observations; this most probably results from the ease with which Ca
2+ can be 
removed from CRP during experimental studies. Indeed CRP becomes denatured and 
shows subunit rearrangement on binding to membranes (Wang & Sui, 2001). Studies 
have suggested that mCRP may be produced in normal or inflamed human and 
animal tissue (Samols et al., 1985; Rees et al., 1988; Egenhofer et al., 1993; Diehl et 
al., 2000), and that mCRP possesses distinct antigenic properties from native CRP 
(Potempa et al., 1983; 1983; 1987; Khreiss et al., 2002). There is no robust evidence 
for these observations (Pepys & Hirschfield, 2003). This present study emphasizes 
the stability of CRP pentamers and the occurrence of an equilibrium with decamers, 
and the instability of other different oligomeric forms of CRP. The proper 
appreciation of this will open the way for a more rational understanding of the role of 
CRP in the acute phase response and in complement activation.  
 
(7.4) Materials and Methods. 
(7.4.1) Purification of CRP 
Human CRP was isolated and purified as described previously (De Beer & 
Pepys, 1982). Samples were extensively dialysed into 10 mM Tris buffers (with or 
without 2 mM CaCl2) containing 50 mM NaCl, 140 mM NaCl, or 250 mM NaCl, all 
at pH 8.0, for AUC and X-ray scattering data acquisition. Size exclusion 
chromatography was carried out using HEPES buffers (10 mM HEPES, 140 mM 
NaCl, pH 8.0), with or without 2 mM CaCl2. Samples were routinely analysed by 
SDS-PAGE before and after experiments to confirm their integrity. CRP 
concentrations were determined using an absorption coefficient of 17.5 (1%, 280 nm, 
1 cm path length), which agrees well with a value of 19.2 calculated from its 
composition (Nelson  et al., 1991; Perkins, 1986). CRP is unglycosylated and its 
composition resulted in a calculated molecular weight of 115.0 kDa, an unhydrated 
volume of 150.3 nm
3, a hydrated volume of 197.3 nm
3 and a partial specific volume 
v of 0.7408 ml/g (Perkins, 1986). The buffer densities for AUC were measured at 
20
oC using an Anton-Paar DMA5000 density meter to be 1.00096 g/ml or 1.00092   247
g/ml (50 mM NaCl), 1.00482 g/ml or 1.00455 g/ml (140 mM NaCl), with or without 
2 mM CaCl2 in that order, and 1.00934 g/ml (250 mM NaCl). 
 
(7.4.2) Analytical ultracentrifugation data and analyses  
AUC data for CRP were obtained on two Beckman XL-I instruments 
equipped with AnTi50 and AnTi60 rotors. Sedimentation velocity data was acquired 
at 20
oC at a rotor speed of 50,000 r.p.m. in two-sector  cells with column heights of 
12 mm. Sedimentation analysis was performed using direct boundary Lamm fits of 
up to 300 scans using SEDFIT (version 11.0) (Schuck, 1998; 2000). SEDFIT 
resulted in size-distribution analyses c(s) that assume that all macromolecular species 
have the same frictional ratio f/fo. The final SEDFIT analyses used a fixed resolution 
of 200 and optimised the c(s) fit by floating f/fo and the baseline until the overall root 
mean square deviations and visual appearance of the fits were satisfactory (Figure 
7.2). The percentage fraction of pentamers, decamers or lower oligomers in the total 
loading concentration was derived using the c(s) integration function (Figure 7.4).  
 
(7.4.3) X-ray scattering data collection and analysis 
X-ray scattering data were obtained in two beam sessions in sixteen-bunch 
mode at the European Synchrotron Radiation Facility (ESRF), Grenoble, France, 
operating with a ring energy of 6.0 GeV on the Beamline ID02 (Narayanan et al., 
2001). Storage ring currents ranged from 68 mA to 77 mA (session 1) and from 70 
mA to 92 mA (session 2). Data were acquired using a recently installed fibre 
optically-coupled high sensitivity and dynamic range CCD detector (FReLoN). 
Together with a smaller beamstop, this allowed a shorter sample-to-detector distance 
of 2.0 m to be used and resulted in higher signal-to-noise ratios (Li et al., 2008). CRP 
was studied at concentrations between 0.3 mg/ml and 5.4 mg/ml (with 2 mM Ca
2+) 
or between 0.1 mg/ml and 2.5 mg/ml (without Ca
2+). Samples of volume 100 µl were 
measured in flow cells to reduce radiation damage by moving the sample 
continuously during beam exposure. Sets of ten time frames, with frames of duration 
0.2 sec, 0.3 sec or 0.5 sec each were acquired. Buffers were measured using the same 
exposure times in alternation with the samples to eliminate background subtraction 
errors. On-line checks during data acquisition confirmed the absence of radiation 
damage, after which the ten frames were averaged. Sample temperature 
corresponded to ambient conditions at 20ºC. Other details including the data   248
reduction procedure are described elsewhere (Gilbert et al., 2005). 
In a given solute-solvent contrast, the radius of gyration RG is a measure of 
structural elongation if the internal inhomogeneity of scattering densities within the 
protein has no effect. Guinier analyses at low Q gives the RG and the forward 
scattering at zero angle I(0) (Glatter & Kratky, 1982): 
  
ln I(Q) = ln I(0) - RG
2 Q
2/3. 
 
This expression is valid in a Q.RG range up to 1.5. The RG analyses were performed 
using an interactive PERL script program SCTPL7 (J. T. Eaton and S. J. Perkins, 
unpublished software) on Silicon Graphics O2 Workstations. Indirect transformation 
of the scattering data I(Q) in reciprocal space into real space to give the distance 
distribution function P(r) was carried out using the program GNOM (Semenyuk & 
Svergun, 1991): 
P(r) corresponds to the distribution of distances r between volume elements. For this, 
the X-ray I(Q) curve utilised up to 562 data points in the Q range between 0.05 nm
-1 
and 1.9 nm
-1. 
 
(7.4.4) Modelling of CRP 
All the CRP modelling was based on the crystal structure for the pentamer in 
the presence of Ca
2+ (PDB code 1b09) (Thompson et al., 1999). The CRP decamer 
was formed by the superimposition of two pentamers face-to-face upon the Ca
2+-
depleted decamer structure (PDB code 1lj7) (Ramadan  et al., 2002). The 
superimposition resulted in an r.m.s.d of 0.460 nm in α-carbon atoms, and overcame 
the issue of missing residues in the Ca
2+-depleted crystal structure. Insight II 98.0 
(Accelrys, San Diego, CA) software on Silicon Graphics workstations was used for 
manipulations. A cube side length of 0.532 nm in combination with a cutoff of 4 
atoms was used to convert the coordinates into Debye sphere models with 998 and 
1997 spheres that corresponded to the unhydrated pentamer and decamer structures 
respectively. The hydration shell was created using HYPRO, (Ashton et al., 1997) 
dQ   (Qr)   Qr   I(Q)    
2
1
  =   P(r)
o
2 sin ∫
∞
π
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where the optimal total of hydrated spheres in the CRP models were 1310 (pentamer) 
and 2620 (decamer) (Table 7.1). The X-ray scattering curves I(Q) for CRP were 
calculated using the Debye equation adapted to spheres (Perkins & Weiss, 1983). 
Other details are given elsewhere (Perkins, 2001). The pentamer and decamer curves 
were merged in increments of 1% from 0% to 100% of  the decamer for comparison 
with nine X-ray curves in 140 mM NaCl buffer containing 2 mM Ca
2+, and six (50 
mM NaCl) or four (140 mM NaCl) curves in buffers without Ca
2+. Sedimentation 
coefficients were calculated from the X-ray hydrated sphere models using the 
HYDRO program (Garcia de la Torre et al., 1994; Ashton et al., 1997), and also 
from the crystal coordinates using HYDROPRO software (Garcia de la Torre et al., 
2000). The default value of 0.31 nm was used to represent the hydration shell. To 
generate a putative decamer with the B faces now in contact with each other, one 
pentamer in the decamer model was translated by 7.4 nm relative to the other along 
its central symmetry axis.  
 
(7.4.5) Surface plasmon resonance data  
The self-association of CRP was analysed by SPR using a Biacore X100 
instrument and version 1.1 of its evaluation software (GE Healthcare, Uppsala, 
Sweden). Native CRP was coupled to the flow cell of a carboxylated dextran (CM5) 
research grade sensor chip via a standard amine coupling procedure according to the 
manufacturer’s protocol. 10 µg/ml of CRP in 10 mM acetate buffer (pH 4.3) in the 
presence of Ca
2+ was injected over flowcell 2 until 150 response units (RU) was 
attained. A control surface cell was prepared identically on flow cell 1 but without 
protein immobilisation. Binding and equilibrium analyses using these CRP-
immobilised chips were performed at 25º C in duplicate or triplicate runs using the 
appropriate Biacore X100 wizards at flow rates of 10-30 µl/min. Regeneration after 
each run was achieved by pulsing 10 mM acetate buffer, 2 M NaCl (pH 4.6) across 
both flow cells once for 30 sec. Running buffer was either TBS (Tris-buffered saline, 
10 mM Tris, 140 mM NaCl, 0.005% P20 surfactant, pH 8.0) or HBS (HEPES-
buffered saline, 10 mM HEPES, 50 mM NaCl, 0.005% P20 surfactant, pH 8.0), with 
or without 2 mM CaCl2. 
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Table 7.1.  X-ray scattering and sedimentation coefficient data and modelling of CRP 
 
a The experimental value corresponds to the decamer reaction boundary (Figures 7.2; 7.3).  
b The first value is from the Guinier RG analyses (Figures 7.5(a,b); the second is from the GNOM P(r) analyses (Figure 7.7).  
c The optimum number of hydrated spheres predicted from the sequence are 1310 and 2620 for pentamer and decamer respectively.  
 
d The first value is for 50 mM NaCl; the second is for 140 mM NaCl.         
 
n.a. not available 
    RG (nm)    s
0
20,w (S)  s
0
20,w (S)   KD (µM) 
Experimental buffer        Pentamer Decamer 
a   
50 mM NaCl, 2 mM Ca
2+       6.5 ± 0.1  7.7 – 8.4  19 
140 mM NaCl, 2 mM Ca
2+    3.8 – 4.5; 3.8 – 4.3 
b   6.4 ± 0.2  7.6 – 8.2  22 ± 5 
250 mM NaCl, 2 mM Ca
2+         6.4 ± 0.3  7.5 – 7.7  n.a. 
50 mM NaCl buffer, no Ca
2+    3.8 – 4.1; 3.7 – 4.1 
b    6.4 ± 0.1  7.5 – 8.9  n.a 
140 mM NaCl buffer, no Ca
2+    3.6 – 4.1; 3.6 – 4.0 
b    6.3 ± 0.1  7.3 – 7.7  n.a 
Scattering modelling   Spheres    R factor (%)     
CRP pentamer  1256
 c 3.7    6.0 – 6.2     
CRP decamer  2492
 c 4.2     9.8   
Best-fit scattering curves (2 mM  Ca
2+)       2.0 - 3.7      23 
Best-fit scattering curves (no  Ca
2+)       1.8 - 3.5; 1.7 - 2.8
 d        251
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Chapter Eight 
 
Complement Factor H binds at two distinct sites to C-reactive protein in 
solution and on surfaces in an NaCl concentration-dependent manner   252
(8.1) Introduction 
Mutations and polymorphisms in FH are associated with atypical haemolytic 
uraemic syndrome (aHUS) and age-related macular degeneration (AMD), suggesting 
that the impaired control of complement activation in the kidney endothelium and the 
retina respectively are involved in these diseases (Section 2.4). The distribution of 
over 100 genetic alterations in FH leading to AMD or aHUS are summarised at 
http://www.fh-hus.org ( Saunders  et al., 2007). In physiological buffer, FH is 
principally monomeric and co-exists with as much as 15% of dimeric FH in a rapid 
equilibrium that is NaCl-concentration dependent; in addition FH forms less 
reversible higher oligomers at high FH concentrations (Nan et al., 2008; Chapter 5).  
Native CRP is unglycosylated and is a stable pentamer (Figure 8.1) formed 
by non-covalently-linked protomers whose assembly is stabilised by 2.5 mM Ca 
2+ 
present in plasma (Hurwitz, 1996;  Thompson  et al., 1999; Pepys & Hirschfield, 
2003; Chapter 7). In physiological buffer, CRP forms a rapid NaCl-concentration 
dependent pentamer-decamer equilibrium (Chapter 7). CRP binds phosphocholine at 
its Ca
2+ binding site (Thompson et al., 1999), and to phosphoethanolamine, microbial 
surface proteins, chromatin, histones, fibronectin, small nuclear ribonucleoproteins, 
laminin and polycations (Black  et al., 2004;  Section 2.3.3). These CRP-ligand 
interactions recognise damaged or apoptotic cells and bacterial pathogens (Black et 
al.,  2004; Thompson et al., 1999). CRP activates complement by the classical 
pathway (Kaplan & Volanakis, 1974), but inhibits alternative pathway activation by 
upregulating complement regulators and inhibitors at host cell surfaces (Mold et al., 
1999; Li et al., 2004). A common Tyr402His FH polymorphism is an established risk 
factor for AMD, however the molecular mechanism of the polymorphism in causing 
AMD remains unclear (Saunders et al., 2007). Individuals who are homozygous for 
the AMD-risk His402 FH allotype show a 2.5-fold higher level of CRP in the retinal 
pigmented epithelium (Johnson et al., 2006).  
A FH-CRP interaction would explain how CRP inhibits complement 
activation. Large basic surfaces exist on FH at SCR-7, SCR-13 and SCR-20 that may 
interact with acidic surfaces on CRP (Figure 8.1). However studies with CRP are 
readily affected by the ease with which CRP is denatured by the removal of Ca
2+, 
given that Ca
2+ binds to CRP with a moderate dissociation constant KD of 60 µM 
(Kinoshita et al., 1989). The assembly of the CRP pentamer is sensitive to small 
conformational perturbations such as those caused by Ca
2+ removal (Chapter 7). The   253
abnormally modified forms of CRP created by Ca
2+ removal have very different 
functional properties from the highly stable CRP pentamer, and there is no firm 
evidence for the persistence of any denatured CRP forms in vivo ( Pepys & 
Hirschfield, 2003). The first evidence for a FH-CRP interaction was provided by an 
ELISA assay of FH binding to plastic-immobilised CRP, and SPR analyses showing 
that FH SCR-7 and SCR-8/11 bind to immobilised CRP (Mold et al., 1999; Jarva et 
al.,  1999). FH binding to immobilised CRP has since then been demonstrated 
repeatedly, in all of which the Tyr402 allotype binds more strongly to CRP than the 
His402 allotype (Laine et al. 2007; Sjöberg et al., 2007; Skerka et al., 2007; Yu et 
al., 2007; Herbert et al., 2007). The stronger binding of FH Tyr402 to CRP would be 
more effective in protecting CRP-decorated host cells, and this may contribute to the 
molecular mechanism of AMD. However recent ELISA and AUC analyses 
suggested instead that the observed FH-CRP interactions result from the use of 
denatured CRP in earlier studies (Bíró et al., 2007; Hakobyan et al., 2008).  
   In this thesis, the conditions in which the molecular interaction between FH 
and CRP takes place in solution and on surfaces are defined using a combination of 
AUC, SPR and X-ray scattering (Cole et al., 2008; Perkins et al., 2008; Tanious et 
al., 2008). The discrepancy between the studies that report or refute the FH-CRP 
interaction was re-examined in physiological buffer conditions and protein 
concentrations, being careful to work in conditions when CRP forms its native stable 
pentamer. It is shown here that FH binds to CRP in both the solution and surface 
phases in a NaCl-concentration dependent manner with Ca
2+ present. A previously-
unknown second CRP binding site is identified at the C-terminus of FH. These 
results provide further insight into the multivalent interaction of CRP with ligands at 
the host cell surface and the involvement of FH in AMD and aHUS diseases.  
 
(8.2) Results and Discussion 
(8.2.1) Sedimentation velocity studies of the Factor H-CRP complex  
AUC studies macromolecular structures in solution by following their 
sedimentation behaviour under a high centrifugal force (Cole  et al., 2008). The 
observed sedimentation boundaries are fitted to yield a sedimentation coefficient 
distribution c(s) according to the Lamm equation using SEDFIT (Section 8.4.2). This 
takes into account all the species present in the sample, although the algorithm 
assumes that the same frictional ratio f/fo applies for all the sedimenting species   254
  
 
Figure 8. 1.  
Electrostatic views of FH and CRP. Red denotes acidic regions while blue 
denotes basic regions. Both FH and CRP are drawn to the same scale. The solution 
structural model for FH in 137 mM NaCl (PDB code 3gav) is shown as three 
fragments which are each rotated individually in order to display the large basic 
surfaces at SCR-7, SCR-13 and SCR-20. All 20 SCR domains are numbered. The 
front and back views of the crystal structure of pentameric CRP (PDB code 1b09) are 
shown as the A-face and B-face. The locations of calcium on the B-face are shown in 
yellow in a ribbon view of CRP. The basic surfaces of FH may interact with a 
preponderance of acidic surfaces on CRP when this is bound to cell surfaces.    255
(where fo is the frictional coefficient of the sphere with the same volume as the 
hydrated glycoprotein). Macromolecular elongation is monitored through the 
sedimentation coefficient s
0
20,w values. For a non-interacting system, sample 
polydispersity is determined from the number of peaks observed in the c(s) plot. For 
an interacting system, the c(s) peaks may correspond instead to reaction boundaries 
and not discrete species if rapid exchange occurs during sedimentation. Previous 
studies by size exclusion chromatography and AUC sedimentation equilibrium in 146 
mM NaCl buffer reported that FH does not interact with CRP in solution (Table 8.1) 
(Hakobyan et al., 2008). However, FH and CRP are reported to interact in 49 mM 
NaCl buffer by SPR (Jarva et al., 1999). To investigate this discrepancy, sedimentation 
velocity experiments were performed with FH and CRP mixed in molar ratios of 1:0.5, 
1:1 and 1:2. in both 50 mM NaCl and 137 mM NaCl buffers. These correspond to 
concentrations of 0.1 mg/ml to 1.1 mg/ml (FH) and 0.1 mg/ml to 1.4 mg/ml (CRP).  The 
c(s) analyses of interference optics data resulted in good boundary fits (Figure 8.2). 
AUC velocity experiments on unbound FH and CRP show that both proteins 
form multimers (Fernando  et al., 2007; Nan et al., 2008a;  Chapter 5; Chapter 7). 
Unbound FH forms dimers in a concentration-dependent manner in at least two different 
sites within SCR-6/8 and SCR-16/20, and the combination of both sites lead to FH 
dimers and higher FH oligomers in both 50 mM NaCl and 137 mM NaCl. By AUC, 
these correspond respectively to peak 2 and peaks 3-8 at the bottom of Figure 8.2(a,b). 
CRP forms pentamers and decamers in a concentration-dependent manner, and these 
correspond to peaks P and D at the bottom of Figure 8.2(a,b). The absence of Ca
2+ 
resulted in dissociation of the pentamers into smaller protomers that are visible at low s 
values (Chapter 7). 
For 50 mM NaCl, AUC studies of nine FH-CRP mixtures revealed complex 
formation in 2 mM Ca
2+. In 50 mM NaCl, the boundary fits for c(s) plots for FH and 
CRP mixtures were calculated at concentrations of 0.3-1.1 mg/ml of FH (three 
concentrations) and 0.1-1.4 mg/ml CRP (nine concentrations). These maintained three 
FH:CRP ratios of 1:0.5, 1:1 and 1:2. The three representative c(s) plots shown in 
Figure 8.2(a) consistently showed at least two major peaks denoted A and B in all nine 
mixtures, together with a weak peak C. Peak A showed an average s
0
20,w value of 5.7 ± 
0.1 S similar to that of 5.7 ± 0.1 S for unbound FH in 50 mM NaCl buffer (Chapter 7). 
Compared to peak 1 for unbound FH monomer (Figure 8.2(a)), the width of peak A   256
 
Figure 8.2.  
AUC analysis of FH-CRP mixtures in (a) 50 mM and (b) 137 mM NaCl. The c(s) 
size distribution analyses correspond to sedimentation velocity experiments performed at a 
rotor speed of 50,000 r.p.m. in which CRP was titrated against 1.0 mg/ml FH at CRP:FH 
molar ratios of 1:0.5, 1:1 and 1:2 (total concentrations of 1.5 mg/ml, 1.8 mg/ml and 2.5 
mg/ml from bottom to top). Representative boundary fits showing every tenth scan are 
shown in the two upper panels for the 1: 1 mixtures in red (50 mM NaCl) and black (137 
mM NaCl). The plots are displaced vertically on the c(s)-axis and the peak intensities are 
normalised for clarity. For comparison, the c(s) analyses for unbound FH (green) and CRP 
(blue) are shown at the bottom. The insets at the bottom show the peaks at larger s values in 
more detail. For FH, peaks 1, 2 and 3-8 have been assigned to monomeric, dimeric and 
oligomeric FH species in order of increasing s value. For CRP, peak P corresponds to 
pentameric CRP and peak D corresponds to the reaction boundary of decameric CRP 
(Chapter 7). In the FH-CRP mixtures, peaks A, B and C correspond to peaks observed at 
different positions from those seen for unbound FH and CRP that correspond to either FH-
CRP complexes or their reaction boundaries.    257
was broadened and its intensity increased with CRP concentration at a fixed FH 
concentration. No separate peak P for pentameric CRP at a s
0
20,w value of 6.4 ± 0.1 S 
was observed. Both features are consistent with an association between two reacting 
components (Brown & Schuck, 2006). Thus peak A is attributed to an average of 
monomeric FH and pentameric CRP that interact in a rapid equilibrium (Figure 8.2(a)). 
Peak B showed s values in a range between 6.7-7.3 S, where the s value increased with 
increasing CRP concentration, and this indicated a reaction boundary (Dam & Schuck, 
2005). This deduction is consistent with the lack of baseline resolution between peaks 
A and B (Chapter 7). The s value of peak B is greater than that for the CRP pentamer 
at 6.4 S, indicating that this peak corresponds to a 1:1 complex between FH and CRP 
of increased mass. A third peak C corresponding to another sedimentation species 
was observed at the highest CRP concentrations (Figure 8.2(a)). The intensity of 
peak C depends on the CRP concentration. The mean s value of peak C at 9.2 ± 0.4 S 
was higher than the experimentally observed range of s values of 7.7-8.4 S for 
decameric CRP. This increase in s value is consistent with higher complex formation, 
thus this is most likely to correspond to a FH-CRP2 stoichiometry.   
For 50 mM NaCl buffer containing 2 mM Ca
2+, the above assignments of 
peak A, B and C correspond to the simplest interpretation of the c(s) plots. This is in 
terms of unbound FH monomer and CRP pentamer and reaction boundaries for the 
FH-CRP and the FH-CRP2 or FH2-CRP complexes. Other interpretations cannot be 
ruled out. To complete the analysis of peaks A, B and C, the c(s) distributions were 
firstly converted to molecular weight distributions c(M). The c(M) distributions 
provide mass information, provided that the c(s) peaks correspond to non-interacting 
sedimentation species and the individual components have similar frictional ratios 
f/fo. The c(M) plots using a mean f/fo ratio of 1.5 ± 0.2 showed that peaks A, B and C 
corresponded to apparent molecular weights of 122 ± 16 kDa, 169 ± 20 kDa and 239 
± 22 kDa respectively. That for peak A is comparable to a mean value of 136 kDa for 
an equimolar mixture of unbound monomeric FH and pentameric CRP. Those for 
peaks B and C are lower than those predicted for a FH-CRP complex (269 kDa) and 
a FH-CRP2 complex (384 kDa) or even a FH2-CRP complex (423 kDa), supporting 
the deduction that peaks B and C correspond to reaction boundaries. As expected 
from the reaction boundaries and the very different f/fo values of 1.75 for monomeric 
FH and 1.12 for CRP (Nan et al., 2008a; Chapter 5; Chapter 7), the c(M) distribution 
resulted in erroneous molecular weights, although good estimates may be obtained   258
for the most abundant species (Dam & Schuck, 2005; Brown & Schuck, 2006). 
Secondly, the c(s) peak intensities were examined in order to assess the degree of FH 
oligomerisation and CRP decamer formation. The insets at the bottom of Figure 
8.2(a) showed that the intensities of FH oligomer peaks 3-8 were much reduced in 
the mixtures. The interaction between FH and CRP has clearly suppressed the 
formation of higher FH oligomers. It is not clear whether FH dimers or CDP 
decamers still form. Comparison of the ratio of peak sizes of peaks B and C with the 
ratio of peak sizes for peaks P and D for CRP and peaks 1 and 2 for FH suggests that 
peak C is smaller in size relative to peak D and similar to peak 2. This would be 
consistent with the assignment of peak C as a FH-CRP2 complex, although AUC by 
itself is unable to distinguish between the possibilities of a FH2-CRP or FH-CRP2 
stoichiometry for peak C.  
For 137 mM NaCl containing 2 mM Ca
2+, the corresponding analyses of 
peaks A, B and C in further velocity experiments showed that the FH-CRP 
interaction displayed an ionic strength dependence. This is in accord with Figure 8.1. 
Ten experiments were performed using FH:CRP molar ratios of 1:0.5, 1:1 and 1:2 for 
FH concentrations between 0.1-1.1 mg/ml and CRP concentrations between 0.2-1.3 
mg/ml, of which three experiments are shown in Figure 8.2(b). The c(s) plots again 
revealed three peaks A, B and C at all concentrations. Peak A with a s
0
20,w value of 
5.8 ± 0.1 S corresponded closely to peak A in 50 mM NaCl buffer with a s
0
20,w value of 
5.7 ± 0.1 S (Figure 8.2(a) and is again attributed as the average of unbound monomeric 
FH and pentameric CRP interacting with each other. Peak A was less broadened 
compared to that observed in 50 mM NaCl. The c(M) plot yielded a molecular weight of 
127 ± 17 kDa, which is similar to that of 122 ± 16 kDa in 50 mM NaCl buffer. The s 
values for peak B ranged between 6.8-7.5 S in a concentration-dependent manner, which 
is similar to those of 6.7-7.3 S for peak B in 50 mM NaCl buffer. Peak B in 137 mM 
NaCl exhibited two important differences from the 50 mM NaCl analyses. Firstly, the 
baseline resolution between peaks A and B is improved, indicating a reduced association 
between FH and CRP. Secondly, the width of peaks B and A is also reduced compared 
to that in 137 mM NaCl. These two features show that complex formation between FH 
and CRP is reduced in 137 mM NaCl buffer. A third minor peak C was visible at a 
higher s value. In contrast to peak C in 50 mM NaCl, peak C in 137 mM NaCl 
appeared at all concentrations and showed no concentration dependence. Its mean s 
value of 8.8 ± 0.2 S was lower than that of 9.2 ± 0.4 S for peak C in 50 mM NaCl.   259
The most likely assignment of peak C is that at low CRP concentration this 
corresponds to peak 3 of unbound FH (and is labelled “C” for this reason in Figure 
8.2(b)), and at higher CRP concentrations this becomes peak C that is attributed to 
the FH-CRP2 complex. In conclusion, both experiments in 50 mM NaCl and 137 mM 
NaCl buffers show that native FH and CRP interact in solution in an ionic strength-
dependent manner.  
 
(8.2.2) Surface plasmon resonance studies of the Factor H-CRP complex  
SPR monitors the interaction between a binding partner in solution (analyte) 
and an immobilised partner (ligand) attached to the surface of a sensor chip (Tanious 
et al., 2008). Previous SPR studies of the FH-CRP interaction have been questioned 
on the grounds of the possible denaturation of CRP when immobilised (Jarva et al., 
1999;  Hakobyan  et al., 2008). Here, we show that the CRP immobilised on the 
sensor ship remains active from the similar KD value of 22 µM for its pentamer-
decamer self-association when studied either in solution or by SPR, both in the 
presence of 2 mM Ca
2+ ( Chapter 7). Accordingly, the FH-CRP interaction was 
studied by SPR using either immobilised FH or immobilised CRP in duplicate runs 
using 50 mM NaCl and 137 mM NaCl buffers containing 2 mM Ca
2+ (Section 8.4.3).  
Native CRP in solution binds to immobilised FH in both 50 mM NaCl and 
137 mM NaCl in the presence of 2 mM Ca
2+ (Figures 8.3(a-d)), in agreement with 
the AUC data. CRP was flowed over a CM5 sensor chip onto which 150 RU of FH 
had been immobilised (Section 8.4.3). The sensorgrams show that the on- and off-
rates are rapid (Figures 8.3(c,d)). In 50 mM NaCl, the SPR equilibrium studies using 
0.1-15 µM CRP showed that CRP aggregated onto immobilised FH (Figure 8.3(a)). 
This was evidenced by the exponential increase in binding response up to 500 RU, 
which is five times the predicted maximum binding response (Rmax) of 112 RU. This 
large increase is similar to the aggregation of CRP in the same buffer binding to 
immobilised CRP (Chapter 7). Here, CRP first binds to immobilised FH, then the 
FH-bound CRP recruits more CRP. CRP binding was much weakened on 
progressing from 50 mM NaCl to 137 mM NaCl, in which the binding response of 
10 µM CRP decreased 25-fold from 221 RU to 9 RU (Figure 8.3(b)). In 137 mM 
NaCl, an equilibrium KD value could not be determined for 0.1-30 µM CRP because   260
 
Figure 8.3.  
Surface plasmon resonance analysis of the FH-CRP interaction. In plots (a-d), FH 
was immobilised on the chip surface. In plots (e,f), CRP was immobilised.  
(a,b) Equilibrium KD analyses for CRP binding to immobilised FH in 50 mM and 
137 mM NaCl. In 50 mM NaCl, the binding response increased exponentially to well above 
the theoretical maximum response of 112 RU at CRP concentrations between 0-15 µM. In 
137 mM NaCl, saturation was not attained at CRP concentrations between 0-30 µM.   
(c,d) Sensorgrams for the equilibrium studies reported in (a,b). The individual 
responses correspond incrementally to the individual data points shown in (a,b).   
(e,f) Equilibrium KD analyses for FH binding to immobilised CRP in 50 mM and 
137 mM NaCl. In 50 mM NaCl buffer, the binding response approaches the theoretical 
maximum response of 201 RU at FH concentrations between 0-15 µM. The apparent KD 
value was estimated by fitting to a heterogeneous ligand kinetic model (inset). In 137 mM 
NaCl, the KD value was determined at CRP concentrations between 0-15 µM (inset).   261
of the non-saturation of CRP binding. The outcome of this experiment is attributed to 
a combination of the CRP interaction with immobilised FH and the pentamer-
decamer equilibrium of CRP.  
In the reversed SPR equilibrium experiment, native FH in solution binds to 
immobilised CRP (Figures 8.3(e,f)). 150 RU of CRP was immobilised on the sensor 
chip (Chapter 7). In 50 mM NaCl, a much higher response of up to 160 RU was 
observed compared to 23 RU in 137 mM NaCl. In 50 mM NaCl, steady state binding 
equilibria were not achieved for the majority of runs for reason of slower association-
dissociation rates (Figure 8.3(e)). Hence affinity analyses could not be carried out. In 
such cases, a KD value is determined from the kinetic rate constants for association 
and dissociation, provided the fitted model describes the experimental data. A simple 
1:1 kinetic model did not give a good fit to the experimental data. A much improved 
fit was obtained with alternative models, such as for a heterogeneous ligand model 
(Figure 8.3(e), inset; Section 8.4.3). However, this good-fit model did not completely 
describe the experimental data, and the resulting KD values are estimates only. Two 
apparent equilibrium constants KD1-app and KD2-app of 3.4 µM and 0.4 µM were 
obtained. The complexity of this analysis would be consistent with FH binding at 
either one of two different sites to one immobilised CRP molecule, or two different 
sites on FH interact to two immobilised CRP molecules, or the common Tyr402 and 
His402 FH allotypes in native FH exhibit different CRP binding properties. In 137 
mM NaCl, the FH-CRP interaction proceeded to steady state equilibrium (Figure 
8.3(f)), and an equilibrium KD value of 4.2 µM was determined (Figure 8.3(e), inset). 
This analysis was well represented by a 1:1 interaction. Thus CRP binds to FH in a 
NaCl concentration-dependent manner, in agreement with the AUC data.  
SCR-7 has the second-highest basic charge density in FH, surpassed only by 
SCR-20, thus either or both of SCR-7 and SCR-20 may interact with the cationic 
CRP molecule (pI = 5.28) (Figure 8.1) (Chapter 7). Previously by SPR, the binding 
of CRP to FH in 49 mM NaCl was localised to SCR-7 and SCR-8/11 (Table 8.1) 
(Jarva et al., 1999). To investigate further the FH binding sites on CRP, SPR binding 
analyses were carried out using three FH fragments that represent the main 
functional activities of FH, namely SCR-1/5, SCR-6/8 and SCR-16/20. These were 
flowed over immobilised CRP at concentrations between 5 µM to 50 µM in 50 mM 
and 137 mM NaCl buffers containing 2 mM Ca
2+. Binding of SCR-16/20 to CRP   262
 
Figure 8.4.  
Surface plasmon resonance analyses of FH fragments with immobilised CRP.  
(a,b) SCR-16/20 binding in 50 mM and 137 mM NaCl buffer. Here, 10 µM, 
20 µM and 50 µM of SCR-16/20 bind to CRP, while 8 µM of C3u was used as a 
non-binding control. 
(c) The Tyr402 and His402 allotypes of SCR-6/8 binding in 50 mM and 137 
mM NaCl buffer. Here, 5 µM, 10 µM, 15 µM and 20 µM of the SCR-6/8 allotypes 
bind differentially to CRP, while 5 µM of SCR-1/5 was used as a non-binding 
control.   263
was observed at all three concentrations (10 µM, 20 µM and 50 µM), while the use 
of 8 µM C3u as a non-binding control protein showed no binding to CRP (Figure 
8.4(a,b)). The binding of SCR-16/20 at four concentrations of 5 µM, 10 µM, 15 µM 
and 20 µM was consistently weaker in 137 mM NaCl, showing that this interaction is 
electrostatic. It is concluded that a second binding site for CRP exists in FH within 
SCR-16/20. The Tyr402 and His402 allotypes of SCR-6/8 bound differentially to 
immobilised CRP (Figure 8.4(c,d)). Between concentrations of 5 µM to 20 µM, the 
Tyr402 allotype binds more strongly than the His402 allotype in both 50 mM and 
137 mM NaCl. Interestingly, the Try402 allotype binds similarly in 50 mM and 137 
mM NaCl, while the His402 allotype binding is mostly absent in 50 mM NaCl. This 
shows that this interaction is driven by hydrophobic forces, in which the presence of 
the positive charge on His402 in low salt is sufficient to abolish CRP binding. Here, 
the use of SCR-1/5 as a control showed no binding.  
To assess further the FH-CRP interaction, stoichiometric ratios (SR) for the 
FH-CRP interaction were estimated from the intensity of the binding signals at the 
highest protein concentrations.  The SR is the ratio between the observed maximum 
binding response and the calculated maximum binding response Rmax. Rmax is 
given by the molecular weight ratio of FH analyte to CRP ligand multiplied by the 
stoichiometry of 1 and the amount of immobilised CRP ligand (150 RU).  The values 
of Rmax are 201 RU, 55 RU and 28 RU for FH, SCR-16/20 and SCR-6/8 (both 
allotypes) respectively. At an FH concentration of 15 µM in 50 mM NaCl buffer 
containing 2 mM Ca
2+, the binding response was 160 RU. The SR value was 
determined as 0.8, which indicated a 1:1 FH-CRP stoichiometry. The observed FH 
binding saturation at lower signal responses in 137 mM NaCl buffer (approximately 
22 RU in Figure 8.3(f)) is attributable to a weakened FH-CRP interaction as a result 
of increased salt concentration. For SCR-16/20 (Figure 8.4(a,b)), the maximum 
measured binding responses were 91 RU (50 mM NaCl) and 53 RU (137 mM NaCl), 
and the corresponding SR values were 1.7 (2:1) and 1.0 (1:1) in that order. SCR-6/8 
in 137 mM NaCl buffer containing 2 mM Ca
2+  exhibited a marked difference 
between Tyr402 and His402 allotypes, with maximum binding responses of 152 RU 
and 55 RU respectively (Figure 8.4(d)). These corresponded to SR values of 5.5 (5:1) 
and 2.0 (2:1) in that order. In conclusion, although CRP can bind either of SCR-
16/20 or SCR-6/8 with stoichiometries greater than 1:1, a 1:1 ratio is favoured in its   264
physiologically-relevant interaction with FH. 
 
(8.2.3) X-ray scattering studies of the FH-CRP complex 
X-ray scattering is a diffraction technique performed in solution that studies 
the overall structure of biological macromolecules in random orientations (Perkins et 
al., 2008). FH-CRP mixtures were studied in both 50 mM and 137 mM NaCl buffers. 
X-ray data collection in 50 mM NaCl was not successful for reason of the occurrence of 
sufficient minor protein aggregation that precluded linear Guinier RG  analyses. 
Accordingly the FH-CRP interaction was analysed in 137 mM NaCl in the presence 
of 2 mM Ca
2+. A 1:1 mixture of FH and CRP was studied in two dilutions with total 
protein concentrations of 1.78 mg/ml and 0.71 mg/ml in each (Section 8.4.4). Guinier 
analyses of the scattering data I(Q) at low Q values (Q = 4 π sin θ /λ; 2θ = scattering 
angle; λ = wavelength) gave linear RG fits within appropriate Q.RG limits (Section 
8.4.4), showing that the samples displayed good monodispersity (Figure 8.5(a)). The 
mean RG value from three measurements was unchanged at both concentrations, with 
values of 7.6 ± 0.1 nm (1.78 mg/ml total protein) and 7.9 ± 0.3 nm (0.71 mg/ml total 
protein). If no complex formation occurs, the RG value of the mixture is estimated to 
be 7.5 ± 0.3 nm (Section 8.4.4). This RG value is the weighted mean of assumed RG 
values of 8.9 nm for FH, and 3.7 nm and 4.2 nm for the CRP pentamer (80%) and 
decamer (20%) respectively (Perkins  et al., 1985; Nan et al., 2008a;  Chapter 5; 
Chapter 7). The observed and estimated RG values are therefore similar to each other 
in conditions when FH and CRP interact with each other weakly in 137 mM NaCl.  
The distance distribution P(r) curve is calculated from the full I(Q) curve, and 
represents all the distances between pairs of atoms within the macromolecule of 
interest. The P(r) curve provides an independent verification of Guinier RG values, 
and leads to maximum lengths L following an assumption of the maximum 
dimension Dmax. The P(r) curves from Figure 8.5(b) yielded a mean RG value of 8.0 ± 
0.2 nm. Since this agrees well with the Guinier RG value, this shows that the P(r) 
curves refer to the macromolecules being studied. The maximum length L was 
determined from the value of r when P(r) = 0. The L1 value for both P(r) curves was 
27 nm. This is reduced compared to the L3 value of 32 nm for unbound FH in 137 
mM NaCl, while it remains greater than the L2 value of 12 nm for unbound CRP 
pentamer and decamer (Figure 8.5(c)) (Nan et al., 2008a; Chapter 5; Chapter 7). This   265
 
Figure 8.5.  
X-ray scattering analyses for the FH-CRP interaction in 137 mM NaCl. The data 
correspond to two 1:1 mixtures of FH and CRP. 
(a) Guinier RG analyses for a total protein concentration of 1.78 mg/ml (upper) and 
0.71 mg/ml (lower). The filled circles correspond to the data points that were fitted to obtain 
RG values and the straight lines correspond to the best fit through these points using a Q 
range of 0.09-0.14 nm
-1. The Q.RG fit range is arrowed. (b) The corresponding distance 
distribution  P(r) analyses are shown for the two 1:1 mixtures. The total protein 
concentrations were 1.78 mg/ml (upper) and 0.71 mg/ml (lower). The peak maximum M is 
arrowed and the maximum length is denoted as L1. For comparison, the P(r) curve is 
compared with the sum of those for unbound FH and CRP (blue-green dashed line). (c) The 
P(r) curve for unbound FH and CRP are shown for comparison. The P(r) curve for FH at 
0.71 mg/ml is shown in green, and that for CRP at 0.31 mg/ml is shown in blue. The sum of 
the P(r) curves corresponds to a total concentration of 0.71 mg/ml, and is shown as the blue-
green dashed line for the comparisons shown in (b).    266
reduction in the L value of the FH-CRP mixture is consistent with the presence of 
more compact structures in this mixture, even though the RG value is similar or 
slightly increased, i.e. that the length of the FH domain structure is reduced in the 
presence of CRP. The maximum M corresponds to the most frequently occurring 
interatomic distance within the protein structure. A pronounced maximum was 
observed at r = 5.6 nm for the FH-CRP mixture (Figure 8.4(b)). The corresponding 
M values were 4.9 nm for unbound FH, and 3.1 nm and 5.7 nm for unbound 
pentameric and decameric CRP respectively (Figure 8.4(c)). Thus M for the FH-CRP 
mixture is close to the mean M values of unbound FH and CRP. In contrast to this, 
the comparison of the two observed P(r) curves for the FH-CRP mixture with the 
sum of the P(r) curves for unbound FH and CRP mixture showed increased 
intensities between r  values of 10 nm to 25 nm (Figure 8.4(b)). This intensity 
difference indicates the presence of more compact structures in the FH-CRP mixture. 
In conclusion, the P(r) curves show evidence of weak FH-CRP complex formation 
and the FH-CRP complex may have a more compact structure compared to unbound 
FH and CRP. 
 
(8.3) Conclusions  
  Here, it is established rigorously from a combination of AUC, SPR and X-ray 
scattering that wild type FH interacts with native CRP in both the fluid and surface 
phases in conditions when CRP forms stable native pentamers in the presence of 
Ca
2+. FH exists in plasma at concentrations between 0.235 and 0.810 mg/ml (1.6 µM 
to 5.4 µM) (Saunders  et al., 2007). CRP is an acute phase protein, with 
concentrations that increase from less than 50 ng/ml up to 0.5 mg/ml (0.4 nM to 4.4 
µM) during acute phase responses (Pepys & Hirschfield, 2003). These studies were 
carried out at FH concentrations of 0.1-1.1 mg/ml and CRP concentrations of 0.3-1.4 
mg/ml in physiological buffer containing 137 mM NaCl in the presence of 2 mM 
Ca
2+, given that 2.5 mM Ca 
2+ is present in plasma (Hurwitz, 1996). Thus these 
results are of physiological relevance. The overall interaction is ionic strength-
dependent, being stronger with decrease in the NaCl concentration to 50 mM. The 
binding of FH to CRP suppresses the self-association of FH to form dimers and 
higher oligomers, and the formation of CRP decamer. Because FH self-associates in 
at least two sites localised within SCR-6/8 and SCR-16/20 (Figure 8.6(a)), it was 
concluded that CRP interacts with distinct sites in both SCR-6/8 and SCR-16/20.   267
This deduction was verified by additional SPR experiments.  
  Nine previous reports of the FH-CRP interaction employed a range of buffer 
conditions that potentially affect the integrity of CRP used in these studies (Table 
8.1). CRP is denatured by the removal of Ca
2+ which binds with a KD of 60 µM, thus 
Ca
2+ should be present in at least a ten-fold excess of 60 µM to ensure CRP stability, 
and 2 mM has proved to be satisfactory (Chapter 7; Kinoshita et al., 1989). The CRP 
crystal structure shows that Ca
2+ binds to the B-face of CRP (Thompson et al. 1999). 
There is no evidence for denatured CRP in vivo, thus it is essential that CRP is 
correctly folded (Pepys & Hirschfield, 2003). In the studies denoted 1, 2 and 4-8 in 
Table 8.1, the immobilisation of CRP to ELISA plates or sensor chips for SPR either 
did not specify the presence of Ca
2+ during the immobilisation process, or Ca
2+ was 
absent. In four of the studies 1-9 in Table 8.1, no mention was made of the fluid 
phase Ca
2+ concentration used to study FH binding. In study 9, Ca
2+ was present 
during CRP immobilisation for ELISA, but was only 0.3 mM in the fluid phase 
studies (Hakobyan et al., 2008). Another experimental parameter in studies 1-9 has 
been the use of either 49 mM or 150 mM NaCl concentrations in the buffer with no 
comparison of its effect on the FH-CRP interaction (Table 8.1). Furthermore, studies 
1-9 utilised FH or CRP concentrations that were significantly less than their 
physiological levels of 1.6-5.4 µM and 0.4-4.4 µM respectively. Given that the KD of 
the FH-CRP interaction is 4 µM in 137 mM NaCl (Figure 8.3(e,f)), significant FH-
CRP binding will not be observed if the FH or CRP concentrations are much less 
than 4 µM. In this context, only one of the eight studies in Table 8.1 employed 
sufficiently high protein concentrations. In addition, studies 1-9 did not take into 
consideration the previously-reported self-association of FH and its fragments 
(Fernando et al., 2007; Nan et al., 2008a; Chapter 5) or that for CRP (Perkins & 
Pepys, 1986; Blizniukov et al., 2003; Chapter 7), both of which are relevant to the 
FH-CRP interaction.  
   Earlier studies had observed FH-CRP interactions at protein concentrations 
much lower than those used in the present study. Table 8.1 suggests that five earlier 
FH-CRP studies report interactions that correspond to KD values in the region of 0.01 
µM, and not that of 4 µM from this study. This apparent anomaly was resolved by 
the reported strong binding of FH to denatured CRP, but not to native CRP (Bíró et 
al., 2007; Hakobyan et al., 2008). Evidence that FH binds strongly to denatured CRP 
but not native FH is provided from the identification of the CRP peptide 86-  268
SWESASGIVEFWVD-99 as the major linear epitope that binds to FH-like protein-1, 
whose sequence corresponds to SCR-1/7 of FH (Yu et al., 2007). The CRP crystal 
structure shows that this peptide corresponds mostly to β-strand I of the double β-
sheet structure and part of β-strand H (Shrive et al., 1996). β-strand I is almost 
completely buried at the interface between the five protomers in CRP. It is not clear 
how this peptide can interact with FH-like protein-1 unless CRP is first denatured 
into monomers. In this thesis, SPR studies of the FH-CRP interaction confirm that 
this occurs in both 50 mM NaCl and 137 mM NaCl buffers containing Ca
2+ (Figures 
8.3(a-d)). This agrees with the previous SPR study showing a FH-CRP interaction in 
49 mM NaCl (Jarva et al., 1999). It has been suggested that Ca
2+-depletion leads to 
CRP denaturation during its immobilisation on the sensor chip (Bíró et al., 2007; 
Hakobyan et al., 2008). The solution study of CRP showed that its dissociation in the 
absence of Ca
2+  is slow, and only visible after several days’ exposure to such 
conditions (Chapter 7).  Here, CRP immobilisation for SPR was performed in 20 µM 
Ca
2+ using a CRP stock solution stored in 2 mM Ca
2+ (Section 8.4.3), lasted less than 
45 mins, and resulted in immobilised CRP that formed decamers with the same KD of 
22 µM as for CRP in solution (Chapter 7). Therefore it appears unlikely that CRP 
denaturation occurred on the sensor chip, although other modifications of CRP 
activity cannot be ruled out.   
In this study, the stoichiometry of the FH-CRP interaction in solution and on 
surfaces was characterised by a combination of AUC and SPR. The AUC 
sedimentation velocity data used FH concentrations of up to 1.0 mg/ml (6.6 µM) in 
50 mM and 137 mM NaCl and these revealed two distinct FH-CRP complexes in 
solution (Figure 8.2). A previous AUC sedimentation equilibrium study used protein 
concentrations of 0.2 mg/ml (1.3 µM) in 146 mM NaCl, which are below the FH-
CRP KD value of 4.2 µM from SPR, and would not be able to detect the interaction 
(Hakobyan et al., 2008). The AUC data also showed that the formation of higher FH 
oligomers (peaks 3-8) through successive interactions at two different FH sites is 
suppressed by the FH interaction with CRP. FH self-associates to form higher 
oligomers at sites located in SCR-6/8 and SCR-16/20 (Fernando et al., 2007; Nan et 
al., 2008a; 2008b; Chapter 4; Chapter 5).  SCR-7 and SCR-8/11 were previously 
proposed as an interaction site with CRP (Jarva et al., 1999). Steric hindrance effects 
caused by the FH-CRP interaction would block FH dimerisation at SCR-6/8 (Figure    269
 
 
Figure 8.6.  
Cartoon summarising the observed interactions between FH and CRP.  
   (a)  Unbound FH (green) exists as 5-15% monomer in equilibrium with 
dimeric FH with a monomer-dimer KD of 28 µM, and with higher oligomers of FH 
that are formed by contacts between successive pairs of SCR-7 and SCR-20 domains. 
   (b) Pentameric CRP (blue) binds to FH at either SCR-7 or SCR-20 with a 
reduced KD of 4 µM. The interaction blocks the formation of FH dimers and CRP 
decamers. Two molecules of CRP can bind simultaneously to one FH molecule. 
Alternatively one molecule of CRP binds one molecule of FH at SCR-7 and SCR-20 
at two different sites on CRP, in which case FH adopts a compact conformation.   
(c) A schematic illustration of how CRP can recruit FH onto damaged host 
cells at either one of SCR-7 or SCR-20 (upper) or at both SCR-7 and SCR-20, 
thereby regulating the degradation of surface-bound C3b at SCR-1/4, and limiting 
complement activation at the host cell surface.   270
8.6(b)), which would then suppress the formation of higher FH oligomers. This is 
consistent with the FH-CRP KD value of 4.2 µM from SPR, which is smaller and 
takes precedence over the FH-FH KD value of 28 µM and the SCR-6/8 dimer KD 
value of 40 µM. The FH-CRP KD value of 4.2 µM is also smaller than the CRP-CRP 
KD value of 22 µM from AUC, SPR and X-ray scattering and the SCR-16/20 dimer 
KD value of 16 µM from AUC and X-ray scattering. Thus FH-CRP binding can also 
block both FH dimerisation at SCR-16/20 and CRP decamer formation. The AUC 
data in Figure 8.2 do not make it clear whether the formation of CRP decamers or FH 
dimers or both is inhibited by the FH-CRP interaction, however this appears likely 
from the above KD values. This interpretation is consistent with estimated individual 
KD values for the CRP-SCR-6/8 and CRP-SCR-16/20 interactions of around 10 µM 
from Figure 8.4. In summary, the FH-CRP interaction is best represented by the 
formation of both FH-CRP and FH-CRP2 complexes by CRP pentamers binding to 
either or both of the two sites on FH (Figure 8.6(b)).  
Insight into the solution structure of the FH-CRP complex was obtained only 
by X-ray scattering. It was not possible to determine sedimentation coefficients for 
the FH-CRP complexes due to the presence of multiple reaction boundaries. While 
the X-ray Guinier RG analysis was inconclusive, complex formation was detected by 
comparing the P(r) curve of the FH-CRP mixture with those of the two proteins on 
their own (Figure 8.5(b,c)). The P(r) changes showed that complex formation 
resulted in the growth of a more compact structure in 137 mM NaCl. This would be 
consistent with the SPR results showing that each of SCR-6/8 and SCR-16/20 bind to 
CRP, meaning that one FH molecule is able to interact bivalently with CRP, 
illustrated in Figure 8.6(b). In solution, AUC readily identified complex formation in 
50 mM NaCl, but less so in 137 mM NaCl (Figures 8.2(a,b)). At surfaces, a different 
set of structures were obtained. This is best explained in terms of further 
macromolecular interactions noted in the preceding paragraph that are facilitated by 
the high local concentrations of proteins when bound to surfaces. Even though 50 
mM NaCl buffers have clarified the individual roles of SCR-6/8 and SCR-16/20 in 
binding to CRP by SPR, this buffer resulted in aggregation artefacts in the context of 
intact FH binding to CRP by SPR. The binding of fluid-phase CRP to immobilised 
FH was consistently higher in 50 mM NaCl than in 137 mM NaCl (Figures 8.3(a-d)). 
The reversed binding of fluid-phase FH to immobilised CRP in 50 mM NaCl yielded 
similar results (Figures 8.3(e,f)). Therefore low salt buffers promote FH-CRP   271
aggregation at surfaces, and these buffers should only be used with caution for 
biochemical functional studies. In 137 mM NaCl, the FH-CRP interaction by AUC, 
SPR and X-ray scattering all reproducibly showed complex formation.  
Micromolar affinities and ionic strength-dependence binding are common 
features of interactions between FH and its ligands and other complement protein-
ligand interactions including complement receptor type 2 (Chapter 6; Li et al., 2008). 
In general, a combination of low ionic strength buffers and high sample 
concentrations facilitates the observation of weak interactions in solution; however 
artefacts can result from working in low salt conditions. Thus C3d forms oligomers 
in 50 mM NaCl, but not in 137 mM NaCl (Li et al, 2008). The NaCl-concentration 
dependences show that the structural interaction involving SCR-6/8 is principally 
hydrophobic, while that for SCR-16/20 is principally electrostatic (Figure 8.4). The 
overall FH-CRP interaction is NaCl-concentration dependent, indicating the 
dominance of electrostatic forces. Electrostatic maps of CRP show different charge 
distributions between the A-face and the phosphorylcholine- and Ca
2+-binding B-
face (Figure 8.1). The A-face is generally acidic except for basic charges clustered in 
the contact region between two adjacent protomers. The B-face that binds to lipid 
surfaces exhibits more basic charges. FH shows the most basic surfaces at SCR-7, 
SCR-13 and SCR-20 and it is likely that those at SCR-7 and SCR-20 are involved 
with CRP binding at the A-face (Figure 8.1). The C1q-binding site in CRP is also at 
the A-face (Gaboriaud et al., 2004).  
   Recruitment of FH is the principal mechanism by which CRP down-regulates 
complement activation by the alternative pathway (Mold et al., 1999; Jarva et al., 
1999). This regulatory activity will be particularly useful under conditions of 
uncontrolled complement activation leading to host damage. In fact, this current 
study shows that the FH-CRP interaction in solution will only occur during the acute 
phase response when CRP levels become elevated. The effective local concentration 
of surface-bound CRP is however increased compared to CRP in solution, and FH 
will bind to sufficient surface-bound CRP to protect host cells. The suppression of 
higher FH oligomers by CRP will release FH for regulatory function. The 
suppression of FH oligomerisation by CRP shows that this interaction is not involved 
in the molecular mechanism of AMD, given that uncontrolled FH oligomerisation 
may facilitate the slow formation of sub-RPE deposits (including drusen) at the 
retinal surface (Nan et al., 2008b). FH binding to CRP does not eliminate the decay-  272
accelerating and cofactor activities of FH (Jarva et al., 1999). Thus recruitment of 
FH by CRP bound to damaged host cell surfaces may inhibit complement activation 
by interacting with bound C3b to regulate this (Figure 8.6(c)). The location of CRP-
binding sites in both SCR-6/8 and SCR-16/20 (Figure 8.4) suggests that CRP may 
play a role in the mechanism of both AMD and aHUS disease. CRP occurs at 
elevated levels in the retinal layers and drusen deposits of homozygous FH His402 
individuals (Johnson et al., 2006). The His402 allotype of FH predisposes to AMD. 
In this thesis, SPR data showing that the SCR-6/8 His402 variant binds to native 
CRP more weakly than the native SCR-6/8 Tyr402 variant indicates that FH His402 
is less able to protect host cells, which are accordingly more readily damaged (Figure 
8.4). Other CRP-binding studies of the His402/Tyr402 FH allotypes show similar 
trends, but up to now it has not been clear whether native or denatured CRP has been 
studied (Table 8.1). The binding of SCR-16/20 to CRP is of interest as the majority 
of aHUS mutations are localised within SCR-16/20. It is possible that the aHUS 
mutations may affect FH-CRP binding at host renal epithelial cells, thus making 
these more susceptible to inflammatory attack.  
 
(8.4) Materials and Methods 
(8.4.1) Purification of Factor H and CRP 
Native FH was purified and concentrated from a pool of just-outdated 
anonymised human plasma using monoclonal MRC-OX23 Sepharose affinity 
column (Sim et al., 1993; Nan et al., 2008a; 2008b). SCR-1/5 and SCR-16/20 were 
expressed as a hexaHis-tagged product in Pichia pastoris and purified using nickel 
affinity and size exclusion chromatography (Chapter 4). SCR-6/8 was expressed and 
purified following previous procedures (Fernando et al., 2007; A. Miller and S. J. 
Perkins, unpublished data). Human CRP was isolated and purified as described 
previously (De Beer & Pepys, 1982). Samples were extensively dialysed into TBS 
buffers (Tris-buffered saline; 10 mM Tris, 2 mM CaCl2, pH 8.0) containing 50 mM 
NaCl or 137 mM NaCl for AUC. SPR was carried out using HBS buffers (HEPES 
buffered saline; 10 mM HEPES, 2 mM CaCl2, pH 8.0) with 50 mM NaCl or 137 mM 
NaCl. Samples were routinely analysed by SDS-PAGE before and after experiments 
to confirm their integrity. The FH amino acid composition was taken from its 
sequence (SWISSPROT accession code P08603). The glycosylation of FH was taken 
to be eight biantennary oligosaccharides located at SCR-9, SCR-12, SCR-13, SCR-  273
14, SCR-15 (two sites), SCR-17 and SCR-18; note that SCR-4 is not glycosylated 
(Fenaille et al., 2007). This resulted in a calculated FH molecular weight of 154.4 
kDa, an unhydrated volume of 193.1 nm
3, a hydrated volume of 256.2 nm
3 (based on 
a hydration of 0.3g H2O/g of glycoprotein and an electrostricted volume of 0.0245 
nm
3 per bound water molecule), a partial specific volume v of 0.715 ml/g, and an 
absorption coefficient at 280 nm (1%, 1 cm path length) of 16.2 (Perkins, 1986; 
Chapter 7). The CRP amino acid composition was taken from its sequence 
(SWISSPROT accession number P02741). The CRP concentration was determined 
using an absorption coefficient of 17.5 (1%, 280 nm, 1 cm path length) (Nelson et 
al., 1991). CRP is unglycosylated and has a calculated molecular weight of 115.0 
kDa, an unhydrated volume of 150.3 nm
3, a hydrated volume of 197.3 nm
3 and a 
partial specific volume v of 0.7408 ml/g (Perkins, 1986). Compositional data for 
SCR-1/5, SCR-6/8 and SCR-16/20 are reported elsewhere (Chapter 4). For this 
study, SCR-16/20 was taken to be glycosylated at two sites, with a calculated 
molecular weight of 41.9 kDa and absorption coefficient of 14.8 (1%, 280 nm, 1 cm 
path length). Buffer densities for AUC were measured at 20
oC to be 1.000958 g/ml 
(TBS, 50 mM NaCl) and 1.00482 g/ml (TBS, 137 mM NaCl) using an Anton-Paar 
DMA5000 density meter. 
 
(8.4.2) Analytical ultracentrifugation data for Factor H-CRP  
AUC data for FH and CRP complexes were obtained on two Beckman XL-I 
instruments equipped with AnTi50 and AnTi60 rotors. Sedimentation velocity data 
were acquired at 20
oC at a rotor speed of 50,000 r.p.m. in two-sector cells with 
column heights of 12 mm. The sedimentation boundaries were analysed using direct 
boundary Lamm fits of up to 300 scans using SEDFIT (version 11.7) (Schuck, 1998; 
2000). SEDFIT resulted in size-distribution analyses c(s) for which the fit algorithm 
assumes that all species have the same frictional ratio f/fo. The final SEDFIT analyses 
used a fixed resolution of 200 and optimised the c(s) fit by floating f/fo and the 
baseline until the overall root mean square deviations and visual appearance of the 
fits were satisfactory (Figure 8.2).  
 
(8.4.3) Surface plasmon resonance data for FH-CRP  
The binding of FH to CRP was analysed by SPR using a Biacore X100 
instrument and version 1.1 of its evaluation software (GE Healthcare, Uppsala,   274
Sweden). Native FH or CRP was coupled to the flowcell of a carboxylated dextran 
(CM5) research grade sensor chip via a standard amine coupling procedure according 
to the manufacturer’s protocol. FH (20 µg/ml) or CRP (10 µg/ml) in 10 mM acetate 
buffer, pH 5.5 (FH) or pH 4.3 (CRP) was injected over flow cell 2 until 150 response 
units (RU) was attained. The CRP sample was maintained in 20 µM CaCl2 during 
immobilisation. A control surface cell was prepared identically on flow cell 1 but 
without protein immobilisation. Binding and equilibrium analyses were performed at 
25º C using the appropriate Biacore X100 wizards at flow rates of 10-30 µl/min. 
Regeneration after each run was achieved by pulsing 10 mM acetate buffer, 2 M 
NaCl (pH 4.6) across both flow cells once for 30 sec. The running buffer was HBS 
containing 50 mM or 137 mM NaCl. The kinetic fit for a single set of experiments in 
50 mM NaCl (Figure 8.3(e), inset) was performed using the heterogeneous ligand 
model implemented in the Biacore evaluation software. In this model, the ka and kd 
on-rate and off-rate parameters were fitted globally, while two maximum signal 
response values Rmax1 and Rmax2 as well as the bulk refractive index RI were fitted 
locally to give an overall χ
2 value of 1.503 RU
2. 
 
(8.4.4) X-ray scattering data for Factor H-CRP  
X-ray scattering data were obtained in one beam session in four-bunch mode 
at the European Synchrotron Radiation Facility (ESRF), Grenoble, France, operating 
with a ring energy of 6.0 GeV on the Beamline ID02 (Narayanan et al., 2001). 
Storage ring currents ranged from 29 mA to 43 mA. Data were acquired using a 
recently installed fibre optically-coupled high sensitivity and dynamic range CCD 
detector (FReLoN) together with a sample-to-detector distance of 3.0 m (Li et al., 
2008). FH and CRP were mixed in a molar ratio of 1:1 and studied at total protein 
concentrations of 1.78 mg/ml (1.00 mg/ml FH and 0.78 mg/ml CRP) and 0.71 mg/ml 
(0.40 mg/ml FH and 0.31 mg/ml CRP). Samples of volume 100 µl were measured in 
flow cells in which radiation damage was reduced by moving the sample 
continuously during beam exposure. Sets of ten time frames, each of duration 0.1 
sec, 0.15 sec or 0.2 sec, were acquired. Buffers were measured using the same 
exposure times in alternation with the samples to eliminate background subtraction 
errors. On-line checks during data acquisition confirmed the absence of radiation 
damage, after which the ten frames were averaged. Sample temperature 
corresponded to ambient conditions at 20ºC. Other details including the data   275
reduction procedure are described elsewhere (Gilbert et al., 2005). 
 
In a given solute-solvent contrast, the radius of gyration RG is a measure of 
structural elongation if the internal inhomogeneity of scattering densities within the 
protein has no effect. Guinier analyses at low Q gives the RG and the forward 
scattering at zero angle I(0): (Glatter & Kratky, 1982)  
ln I(Q) = ln I(0) - RG
2 Q
2/3. 
This expression is valid in a Q.RG range up to 1.5. The RG analyses were performed 
using an interactive PERL script program SCTPL7 (J. T. Eaton and S. J. Perkins, 
unpublished software) on Silicon Graphics O2 Workstations. The RG value of a 
mixture of two proteins A and B is given by the expression (Perkins et al., 1985): 
            RG
2 = fA Σ bA
2RGA
2 + fB  Σ bB
2RGB
2 
    fA Σ bA
2 + fB  Σ bB
2 
where fA and fB are the fractional proportions of A and B, bA and bB are the total of 
electrons in A and B, and RGA and RGB are the RG values of A and B.  Indirect 
transformation of the scattering data I(Q) in reciprocal space into real space to give 
the distance distribution function P(r) was carried out using the program GNOM: 
(Semenyuk & Svergun, 1991) 
P(r) corresponds to the distribution of distances r between volume elements. For this, 
the X-ray I(Q) curve utilised up to 392 data points in the Q range between 0.09 nm
-1 
and 1.8 nm
-1. 
 
 
 
 
dQ   (Qr)   Qr   I(Q)    
2
1
  =   P(r)
o
2 sin ∫
∞
π
   276
 
Table 8.1. Buffer conditions used in nine studies of the Factor H-CRP interaction. 
 
No.   Technique Immobilised 
phase 
Ca
2+  
(yes/no)
Fluid phase  Concentration 
(mg/ml) 
Concentration 
(µM) 
[Ca
2+] 
(mM) 
Buffer Reference 
1 ELISA  CRP  n.a.  FH  0.00-0.01  0.0-0.06  n.a.  n.a.  Mold  et al., 1999 
2  SPR  CRP  no  FH  0.25  1.6  0.67  1/3 VBS (49 mM 
NaCl) 
Jarva et al., 1999 
 
   “  “ SCR-1/5 0.027  0.8  “  “  “ 
   “  “ SCR-1/6 0.105  1.1  “  “  “ 
   “  “ SCR-1/7  0.05  0.9  “  “  “ 
   “  “  SCR-8/11 0.05  1.6  “  “  “ 
   “  “  SCR-8/20 0.045  0.4  “  “  “ 
   “  “  SCR-15/20  0.045  1.0  “  “  “ 
   FH    CRP  0.037  0.3  “  “  “ 
  ELISA  CRP  no  FH  0.001  0.01  1  VBS (147 mM NaCl)  “ 
3  ELISA  CRP  no  FH  0.0005-0.001  0.003-0.01  5  25 mM Tris (154 mM 
NaCl) 
Bíró et al., 2007 
  PC-KLH-
CRP 
yes FH  0.0005-0.001  0.003-0.01  “  “  “ 
   FH    CRP  0.01  0.1  “  “  “ 
4 SPR  CRP  no  SCR-6/8  Y402 
SCR-6/8 H402 
0.1-0.5 
0.1-0.5  
6-20  
5-21 
n.a.  10 mM HEPES, 150 
mM NaCl 
Herbert et al., 
2007 
5 ELISA  CRP  n.a.  FH  0.00006-
0.0015 
0.00-0.01  n.a.  VBS (147 mM NaCl)  Laine et al., 2007 
   “  “ SCR-5/7  0.0002-0.005  0.01-0.2  “  “  “ 
6  ELISA  CRP  no  FH  0-0.001  0.00-0.01  2  50 mM HEPES, 100 
mM NaCl 
Sjöberg et al., 
2007 
   “  “ SCR-6/8  0-0.001  0.0-0.01  “  “  “   277
7  ELISA  CRP  n.a.  FH  0.001  0.01  n.a.  PBS (137 mM NaCl)  Skerka et al., 
2007 
8  ELISA  CRP  no  FH  0.00-0.01  0-0.05  2  20 mM HEPES, 140 
mM NaCl 
Yu et al., 2007 
9  AUC      CRP, FH  0.4 (0.2, 0.2)
a 1.7,  1.3
 a  0.3  VBS (146 mM NaCl)  Hakobyan et al., 
2008 
  SEC      CRP, FH  2 (1, 1)
a 8.7,  6.5
 a “  “  “ 
 ELISA  CRP  yes  FH  0.005-0.1  0.03-0.6  “  “  “ 
   FH    CRP 0.001-0.1  0.01-0.9  “  “  “ 
10  AUC      CRP, FH  0.3-2.5 (0.2-
1.4, 0.1-1.1)
 a 
1.7-12.2,
  
0.6-7.1
 a 
2  10 mM Tris (137 mM 
NaCl); 10 mM Tris 
(50 mM NaCl) 
 Present study 
(Chapter 8) 
  SPR  FH    CRP  0.01-3.5  0.1-30  “  10 mM Tris (137 mM 
NaCl); 10 mM 
HEPES (50 mM 
NaCl) 
„ 
   CRP yes  FH  0.02-2.3 0.1-15 “  “    “ 
        SCR-16/20  0.2-2.1  5-50  “  10 mM HEPES (137 
mM NaCl); 10 mM 
HEPES (50 mM 
NaCl)  
“ 
      SCR-6/8 0.1-0.4  5-20  “  “  “ 
 X-ray 
scattering 
    CRP, FH  0.7-1.8 (0.3-
0.8, 0.4-1.0)
 a 
2.6-7.0, 
2.6-6.5 
a 
“  10 mM HEPES (137 
mM NaCl) 
“ 
 
n.a. Not available, i.e. either the calcium concentration or the buffer was not stated.  
SPR, surface plasmon resonance; AUC, analytical ultracentrifugation; SEC, size exclusion chromatography; VBS, veronal-buffered saline; PC-
KLH, phosphorylcholine conjugated to keyhole-limpet haemocyanin. 
a The first set of values is for CRP, while the second is for FH    278
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(9.1) Prologue 
FH was first discovered as β1H globulin in 1965 (Nilsson & Müller-
Eberhard, 1965). Since then, several important functions have been ascribed to it. 
The most prominent is the regulation of complement activation by the alternative 
pathway (Section 2.3.1). The implication of FH in the pathophysiology of diseases 
such as aHUS and AMD (Section 2.4) further underlines its importance to the host 
innate immune response. Despite this knowledge, there are currently no high-
resolution structures for the full-length protein. The most recent medium resolution 
structure for FH was published in 2001 (Aslam & Perkins, 2001), at which time only 
three of the current eleven high resolution structures for individual SCR domains 
(Section 2.2.2; Table 2.1) were available. Since then, improved data collection and 
interpretation methods have become available that permit a better understanding of 
the oligomeric properties of FH. For these reasons, there was a need for updated FH 
models created using more high-resolution domain structures, and with data 
interpretation in the light of new information. Structures for shorter fragments could 
help to provide insight on the overall structural and functional properties of the full-
length protein. This thesis presents novel solution structural analyses of the 
functionally important FH fragments SCR-1/5 and SCR-16/20, updated solution 
structures for full-length FH, and studies of its interactions with the ligands C3d and 
CRP.  A multidisciplinary approach involving AUC, X-ray scattering and 
constrained scattering modelling (Sections 3.2; 3.3; 3.4) was used firstly to determine 
three-dimensional solution structures for FH, C3d and CRP to medium resolution, 
and secondly these methods in combination with SPR (Section 3.5) were used to 
elucidate the interactions of FH with its ligands. 
 
(9.2) Solution structures of SCR-1/5, SCR-16/20 and full-length Factor H 
The previously reported FH solution structure was updated in this thesis. The 
three-dimensional structures for SCR-1/5 and SCR-16/20 (Chapter 4) were found to 
be moderately extended, with relatively folded back but not fully compact domain 
arrangements. A number of best-fit molecular models with varying orientations were 
found to meet this criterion (Figure 4.18). These were similar to the structures of the 
corresponding regions within intact FH (Aslam & Perkins, 2001). Considered in the 
context of the overall structure of FH, this suggests that the flexibility of the intact 
molecule is preserved locally between SCR domains within close distances of each   280
other. A major implication of this finding is that FH can reorientate locally in such a 
way as to “wrap” itself around its ligands. The interdomain linkers within these two 
fragments are relatively short, only a maximum of four residues long (except the 
SCR-18/19 linker, six residues long). The longest interdomain linkers within full-
length FH are found in the middle region between SCR-10/15 (Figure 2.2). This 
central region of FH is heavily glycosylated. Flexibility within this region of FH may 
allow the functional regions in SCR-1/5 and SCR-16/20 to maintain multiple 
contacts with the same ligand. SCR-16/20 was found to exist in a monomer-dimer 
equilibrium in solution. This would have physiological relevance if seen to also 
occur in the full-length protein, as it could potentially influence the regulatory 
activity of FH. 
New solution structures for full-length FH at ionic strengths of 50 mM NaCl, 
137 mM NaCl and 250 mM NaCl (Chapter 5) were used to refine the earlier FH 
solution structure (Aslam & Perkins, 2001) and confirm the physiological relevance 
of these results. These new structures showed that the flexible structure of native FH 
is facilitated by flexible linkers that permit short-to-middle distance interactions 
between neighbouring SCR domains (Figure 5.11(c)). There was no evidence of a 
longer-distance interaction between the N- and C-termini within the same FH 
molecule (Oppermann et al., 2006). Two novel features of FH were revealed by this 
study. Firstly, these structures showed that the interactions between domains are at 
least partially electrostatic in nature, and decrease with increased NaCl 
concentration. Thus FH becomes more elongated with increased ionic strength 
(Figure 5.14). Secondly, FH forms dimers and oligomers under a range of solution 
conditions in a NaCl concentration-dependent manner, thus validating the 
observation of dimerisation in the SCR-16/20 fragment (Chapter 4), as well as in the 
SCR-6/8 fragment (Fernando  et al., 2007). This outcome supports and extends 
previous observations of FH oligomerisation by examining this in a range of solution 
conditions (Perkins, 1991; Nan et al., 2008a). The influence of ionic strength on FH 
conformation suggests that its interaction with ligands may also be partially 
electrostatic in nature.  
 
(9.3) Interactions of Factor H with C3d and C-reactive protein 
The major ligand of FH is C3b of complement which is regulated by FH. 
Elucidation of the binding of FH to the C3d fragment of C3b (Chapter 6) provided   281
insights into an aspect of this interaction following the degradation of C3b to C3c 
and C3d. It has been commonly assumed that the interaction between FH and C3d is 
a simple 1:1 association. This study revealed, for the first time, that FH forms 
multimeric complexes with C3d (Figures 6.5-6.7). Dimerisation in SCR-16/20 and 
oligomerisation in full-length FH were not eliminated by this interaction. Rather, FH 
forms a ternary complex with C3d and itself (Figures 6.8; 6.10; 6.11). This 
previously-unknown feature suggests a role for FH oligomers in complement 
activation where, following C3b cleavage and the deposition of C3d on host cell 
surfaces, dimeric or oligomeric FH molecules are cross-linked on the host cell 
surface by C3d (Figure 6.16). This may up-regulate FH in local regions where this is 
required during inflammation. As hypothesised (Chapter 5; see above), the 
interaction of FH with this ligand was at least partially electrostatic in nature, thus 
complex formation was reduced as NaCl concentration increased. This suggests that 
ionic strength-dependence may be a general feature of the interactions of FH with its 
ligands.  
CRP is an acute-phase protein of the pentraxin protein family that binds 
ligand in a Ca
2+-dependent manner. In this thesis, it is shown that CRP exists in a 
pentamer-decamer equilibrium in physiological buffer (Chapter 7). The pentamer-
decamer equilibrium is affected by NaCl concentration and this finding is consistent 
with that observed for the interaction between FH and C3d. In addition, CRP 
partially dissociates into lower oligomers, and decamer formation is reduced in the 
absence of Ca
2+ (Figure 7.4(b)). These two observations show that earlier studies of 
CRP carried out in Ca
2+-depleted buffers can yield artefactual results.  
Previous studies of the interaction between FH and CRP have been 
inconclusive and contradictory. Initial reports indicated that FH interacts with CRP 
(Mold et al., 1999; Jarva et al., 1999; Laine et al. 2007; Sjoberg et al., 2007; Skerka 
et al., 2007; Yu et al., 2007; Herbert et al., 2007). However, several of these studies 
were performed in non-physiological buffers lacking Ca
2+, meaning that the results 
obtained could be artefactual. A more recent study has suggested that the observed 
interaction is non-physiological and only occurs with denatured CRP (Hakobyan et 
al., 2008). However, because the 2008 experiments were conducted at below 
physiological protein concentrations, the biological relevance of this is uncertain. To 
clarify the details of this interaction, binding of FH to native CRP was studied in 
both fluid and solid phases in physiological buffers containing Ca
2+ (Chapter 8), and   282
at physiological concentration ranges for both FH and CRP. This study revealed that 
FH binds to CRP in both fluid and solid phases in an NaCl concentration-dependent 
manner, and the interaction suppresses FH oligomerisation (Figure 8.2). In addition, 
FH binding to CRP leads to a more compact FH domain arrangement (Figure 8.5).  It 
was hypothesised that both known dimerisation sites in FH (SCR-6/8 and SCR-
16/20) are involved in binding to CRP. SPR studies confirmed this, identifying for 
the first time an additional binding site for CRP within SCR-16/20 of FH.  
 
(9.4) Implications for disease 
Determination of the solution structures of the functional FH fragments SCR-
1/5 and SCR-16/20, as well as the intact FH molecule considered in the context of 
their interactions with C3d and CRP, provides new insight on the association of FH 
with aHUS. The potential role of non C3b- or heparin-binding regions of FH in 
orientating the molecule for optimal contacts with these ligands may explain the 
occurrence of Type II mutations (Section 2.4) within SCR-16/19 as well as in SCR-
20 (Saunders et al., 2007).  FH oligomers are potentially relevant for AMD, given 
that the hall mark of AMD is the formation of sub-RPE deposits (including drusen, 
of which FH is a component) at the retinal surface. The suppression of FH 
oligomerisation by CRP binding provides an insight into how such an interaction at 
the retinal surface may influence drusen formation, as CRP would hinder drusen 
growth assuming no other factors are taken into consideration. 
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